<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=us-ascii">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>Liprolog, INN-insulin lispro</title>

<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:Courier;
	panose-1:2 7 4 9 2 2 5 2 4 4;}
@font-face
	{font-family:"Tms Rmn";
	panose-1:2 2 6 3 4 5 5 2 3 4;}
@font-face
	{font-family:Helv;
	panose-1:2 11 6 4 2 2 2 3 2 4;}
@font-face
	{font-family:"New York";
	panose-1:2 4 5 3 6 5 6 2 3 4;}
@font-face
	{font-family:System;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:Batang;
	panose-1:2 3 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:PMingLiU;
	panose-1:2 1 6 1 0 1 1 1 1 1;}
@font-face
	{font-family:"MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;}
@font-face
	{font-family:Dotum;
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:SimHei;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:MingLiU;
	panose-1:2 1 6 9 0 1 1 1 1 1;}
@font-face
	{font-family:Mincho;
	panose-1:2 2 6 9 4 3 5 8 3 5;}
@font-face
	{font-family:Gulim;
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:Century;
	panose-1:2 4 6 4 5 5 5 2 3 4;}
@font-face
	{font-family:"Angsana New";
	panose-1:2 2 6 3 5 4 5 2 3 4;}
@font-face
	{font-family:"Cordia New";
	panose-1:2 11 3 4 2 2 2 2 2 4;}
@font-face
	{font-family:Mangal;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Latha;
	panose-1:2 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Sylfaen;
	panose-1:1 10 5 2 5 3 6 3 3 3;}
@font-face
	{font-family:Vrinda;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Raavi;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Shruti;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Sendnya;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Gautami;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tunga;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Estrangelo Edessa";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Yu Gothic";
	panose-1:2 11 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:DengXian;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Palatino Linotype";
	panose-1:2 4 5 2 5 5 5 3 3 4;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:"Segoe UI Emoji";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Segoe UI Symbol";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:BISansCond;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Arial Black";
	panose-1:2 11 10 4 2 1 2 2 2 4;}
@font-face
	{font-family:"Bahnschrift Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiLight";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Bahnschrift;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiBold";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift Light SemiCondensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiLight SemiConde";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiCondensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiBold SemiConden";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift Light Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiLight Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiBold Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Candara;
	panose-1:2 14 5 2 3 3 3 2 2 4;}
@font-face
	{font-family:"Candara Light";
	panose-1:2 14 5 2 3 3 3 2 2 4;}
@font-face
	{font-family:"Comic Sans MS";
	panose-1:3 15 7 2 3 3 2 2 2 4;}
@font-face
	{font-family:Consolas;
	panose-1:2 11 6 9 2 2 4 3 2 4;}
@font-face
	{font-family:Constantia;
	panose-1:2 3 6 2 5 3 6 3 3 3;}
@font-face
	{font-family:Corbel;
	panose-1:2 11 5 3 2 2 4 2 2 4;}
@font-face
	{font-family:"Corbel Light";
	panose-1:2 11 3 3 2 2 4 2 2 4;}
@font-face
	{font-family:Ebrima;
	panose-1:2 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Franklin Gothic Medium";
	panose-1:2 11 6 3 2 1 2 2 2 4;}
@font-face
	{font-family:Gabriola;
	panose-1:4 4 6 5 5 16 2 2 13 2;}
@font-face
	{font-family:Gadugi;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Georgia;
	panose-1:2 4 5 2 5 4 5 2 3 3;}
@font-face
	{font-family:Impact;
	panose-1:2 11 8 6 3 9 2 5 2 4;}
@font-face
	{font-family:"Ink Free";
	panose-1:3 8 4 2 0 5 0 0 0 0;}
@font-face
	{font-family:"Javanese Text";
	panose-1:2 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Leelawadee UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Leelawadee UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Lucida Console";
	panose-1:2 11 6 9 4 5 4 2 2 4;}
@font-face
	{font-family:"Lucida Sans Unicode";
	panose-1:2 11 6 2 3 5 4 2 2 4;}
@font-face
	{font-family:"Malgun Gothic";
	panose-1:2 11 5 3 2 0 0 2 0 4;}
@font-face
	{font-family:"\@Malgun Gothic";}
@font-face
	{font-family:"Malgun Gothic Semilight";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"\@Malgun Gothic Semilight";}
@font-face
	{font-family:"Microsoft Himalaya";
	panose-1:1 1 1 0 1 1 1 1 1 1;}
@font-face
	{font-family:"Microsoft JhengHei";
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@Microsoft JhengHei";}
@font-face
	{font-family:"Microsoft JhengHei UI";
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@Microsoft JhengHei UI";}
@font-face
	{font-family:"Microsoft JhengHei Light";
	panose-1:2 11 3 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@Microsoft JhengHei Light";}
@font-face
	{font-family:"Microsoft JhengHei UI Light";
	panose-1:2 11 3 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@Microsoft JhengHei UI Light";}
@font-face
	{font-family:"Microsoft New Tai Lue";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Microsoft PhagsPa";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Microsoft Sans Serif";
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:"Microsoft Tai Le";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Microsoft YaHei";
	panose-1:2 11 5 3 2 2 4 2 2 4;}
@font-face
	{font-family:"\@Microsoft YaHei";}
@font-face
	{font-family:"Microsoft YaHei UI";
	panose-1:2 11 5 3 2 2 4 2 2 4;}
@font-face
	{font-family:"\@Microsoft YaHei UI";}
@font-face
	{font-family:"Microsoft YaHei Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"\@Microsoft YaHei Light";}
@font-face
	{font-family:"Microsoft YaHei UI Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"\@Microsoft YaHei UI Light";}
@font-face
	{font-family:"Microsoft Yi Baiti";
	panose-1:3 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:MingLiU-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@MingLiU-ExtB";}
@font-face
	{font-family:PMingLiU-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@PMingLiU-ExtB";}
@font-face
	{font-family:MingLiU_HKSCS-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@MingLiU_HKSCS-ExtB";}
@font-face
	{font-family:"Mongolian Baiti";
	panose-1:3 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;}
@font-face
	{font-family:"MS UI Gothic";
	panose-1:2 11 6 0 7 2 5 8 2 4;}
@font-face
	{font-family:"\@MS UI Gothic";}
@font-face
	{font-family:"MS PGothic";
	panose-1:2 11 6 0 7 2 5 8 2 4;}
@font-face
	{font-family:"\@MS PGothic";}
@font-face
	{font-family:"MV Boli";
	panose-1:2 0 5 0 3 2 0 9 0 0;}
@font-face
	{font-family:"Myanmar Text";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Nirmala UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Nirmala UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe MDL2 Assets";
	panose-1:5 10 1 2 1 1 1 1 1 1;}
@font-face
	{font-family:"Segoe Print";
	panose-1:2 0 6 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Segoe Script";
	panose-1:3 11 5 4 2 0 0 0 0 3;}
@font-face
	{font-family:"Segoe UI Black";
	panose-1:2 11 10 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Historic";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Semibold";
	panose-1:2 11 7 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:NSimSun;
	panose-1:2 1 6 9 3 1 1 1 1 1;}
@font-face
	{font-family:"\@NSimSun";}
@font-face
	{font-family:SimSun-ExtB;
	panose-1:2 1 6 9 6 1 1 1 1 1;}
@font-face
	{font-family:"\@SimSun-ExtB";}
@font-face
	{font-family:"Sitka Small";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Text";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Subheading";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Heading";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Display";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Banner";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Trebuchet MS";
	panose-1:2 11 6 3 2 2 2 2 2 4;}
@font-face
	{font-family:Webdings;
	panose-1:5 3 1 2 1 5 9 6 7 3;}
@font-face
	{font-family:"\@Yu Gothic";
	panose-1:2 11 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Yu Gothic UI";
	panose-1:2 11 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic UI";}
@font-face
	{font-family:"Yu Gothic UI Semibold";
	panose-1:2 11 7 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic UI Semibold";}
@font-face
	{font-family:"Yu Gothic Light";
	panose-1:2 11 3 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic Light";}
@font-face
	{font-family:"Yu Gothic UI Light";
	panose-1:2 11 3 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic UI Light";}
@font-face
	{font-family:"Yu Gothic Medium";
	panose-1:2 11 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic Medium";}
@font-face
	{font-family:"Yu Gothic UI Semilight";
	panose-1:2 11 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic UI Semilight";}
@font-face
	{font-family:"HoloLens MDL2 Assets";
	panose-1:5 10 1 2 1 1 1 1 1 1;}
@font-face
	{font-family:"Agency FB";
	panose-1:2 11 5 3 2 2 2 2 2 4;}
@font-face
	{font-family:Algerian;
	panose-1:4 2 7 5 4 10 2 6 7 2;}
@font-face
	{font-family:"Book Antiqua";
	panose-1:2 4 6 2 5 3 5 3 3 4;}
@font-face
	{font-family:"Arial Narrow";
	panose-1:2 11 6 6 2 2 2 3 2 4;}
@font-face
	{font-family:"Arial Rounded MT Bold";
	panose-1:2 15 7 4 3 5 4 3 2 4;}
@font-face
	{font-family:"Baskerville Old Face";
	panose-1:2 2 6 2 8 5 5 2 3 3;}
@font-face
	{font-family:"Bauhaus 93";
	panose-1:4 3 9 5 2 11 2 2 12 2;}
@font-face
	{font-family:"Bell MT";
	panose-1:2 2 5 3 6 3 5 2 3 3;}
@font-face
	{font-family:"Bernard MT Condensed";
	panose-1:2 5 8 6 6 9 5 2 4 4;}
@font-face
	{font-family:"Bodoni MT";
	panose-1:2 7 6 3 8 6 6 2 2 3;}
@font-face
	{font-family:"Bodoni MT Black";
	panose-1:2 7 10 3 8 6 6 2 2 3;}
@font-face
	{font-family:"Bodoni MT Condensed";
	panose-1:2 7 6 6 8 6 6 2 2 3;}
@font-face
	{font-family:"Bodoni MT Poster Compressed";
	panose-1:2 7 7 6 8 6 1 5 2 4;}
@font-face
	{font-family:"Bookman Old Style";
	panose-1:2 5 6 4 5 5 5 2 2 4;}
@font-face
	{font-family:"Bradley Hand ITC";
	panose-1:3 7 4 2 5 3 2 3 2 3;}
@font-face
	{font-family:"Britannic Bold";
	panose-1:2 11 9 3 6 7 3 2 2 4;}
@font-face
	{font-family:"Berlin Sans FB";
	panose-1:2 14 6 2 2 5 2 2 3 6;}
@font-face
	{font-family:"Berlin Sans FB Demi";
	panose-1:2 14 8 2 2 5 2 2 3 6;}
@font-face
	{font-family:Broadway;
	panose-1:4 4 9 5 8 11 2 2 5 2;}
@font-face
	{font-family:"Brush Script MT";
	panose-1:3 6 8 2 4 4 6 7 3 4;}
@font-face
	{font-family:"Bookshelf Symbol 7";
	panose-1:5 1 1 1 1 1 1 1 1 1;}
@font-face
	{font-family:"Californian FB";
	panose-1:2 7 4 3 6 8 11 3 2 4;}
@font-face
	{font-family:"Calisto MT";
	panose-1:2 4 6 3 5 5 5 3 3 4;}
@font-face
	{font-family:Castellar;
	panose-1:2 10 4 2 6 4 6 1 3 1;}
@font-face
	{font-family:"Century Schoolbook";
	panose-1:2 4 6 4 5 5 5 2 3 4;}
@font-face
	{font-family:Centaur;
	panose-1:2 3 5 4 5 2 5 2 3 4;}
@font-face
	{font-family:Chiller;
	panose-1:4 2 4 4 3 16 7 2 6 2;}
@font-face
	{font-family:"Colonna MT";
	panose-1:4 2 8 5 6 2 2 3 2 3;}
@font-face
	{font-family:"Cooper Black";
	panose-1:2 8 9 4 4 3 11 2 4 4;}
@font-face
	{font-family:"Copperplate Gothic Bold";
	panose-1:2 14 7 5 2 2 6 2 4 4;}
@font-face
	{font-family:"Copperplate Gothic Light";
	panose-1:2 14 5 7 2 2 6 2 4 4;}
@font-face
	{font-family:"Curlz MT";
	panose-1:4 4 4 4 5 7 2 2 2 2;}
@font-face
	{font-family:Dubai;
	panose-1:2 11 5 3 3 4 3 3 2 4;}
@font-face
	{font-family:"Dubai Light";
	panose-1:2 11 3 3 3 4 3 3 2 4;}
@font-face
	{font-family:"Dubai Medium";
	panose-1:2 11 6 3 3 4 3 3 2 4;}
@font-face
	{font-family:Elephant;
	panose-1:2 2 9 4 9 5 5 2 3 3;}
@font-face
	{font-family:"Engravers MT";
	panose-1:2 9 7 7 8 5 5 2 3 4;}
@font-face
	{font-family:"Eras Bold ITC";
	panose-1:2 11 9 7 3 5 4 2 2 4;}
@font-face
	{font-family:"Eras Demi ITC";
	panose-1:2 11 8 5 3 5 4 2 8 4;}
@font-face
	{font-family:"Eras Light ITC";
	panose-1:2 11 4 2 3 5 4 2 8 4;}
@font-face
	{font-family:"Eras Medium ITC";
	panose-1:2 11 6 2 3 5 4 2 8 4;}
@font-face
	{font-family:"Felix Titling";
	panose-1:4 6 5 5 6 2 2 2 10 4;}
@font-face
	{font-family:Forte;
	panose-1:3 6 9 2 4 5 2 7 2 3;}
@font-face
	{font-family:"Franklin Gothic Book";
	panose-1:2 11 5 3 2 1 2 2 2 4;}
@font-face
	{font-family:"Franklin Gothic Demi";
	panose-1:2 11 7 3 2 1 2 2 2 4;}
@font-face
	{font-family:"Franklin Gothic Demi Cond";
	panose-1:2 11 7 6 3 4 2 2 2 4;}
@font-face
	{font-family:"Franklin Gothic Heavy";
	panose-1:2 11 9 3 2 1 2 2 2 4;}
@font-face
	{font-family:"Franklin Gothic Medium Cond";
	panose-1:2 11 6 6 3 4 2 2 2 4;}
@font-face
	{font-family:"Freestyle Script";
	panose-1:3 8 4 2 3 2 5 11 4 4;}
@font-face
	{font-family:"French Script MT";
	panose-1:3 2 4 2 4 6 7 4 6 5;}
@font-face
	{font-family:"Footlight MT Light";
	panose-1:2 4 6 2 6 3 10 2 3 4;}
@font-face
	{font-family:Garamond;
	panose-1:2 2 4 4 3 3 1 1 8 3;}
@font-face
	{font-family:Gigi;
	panose-1:4 4 5 4 6 16 7 2 13 2;}
@font-face
	{font-family:"Gill Sans MT";
	panose-1:2 11 5 2 2 1 4 2 2 3;}
@font-face
	{font-family:"Gill Sans MT Condensed";
	panose-1:2 11 5 6 2 1 4 2 2 3;}
@font-face
	{font-family:"Gill Sans Ultra Bold Condensed";
	panose-1:2 11 10 6 2 1 4 2 2 3;}
@font-face
	{font-family:"Gill Sans Ultra Bold";
	panose-1:2 11 10 2 2 1 4 2 2 3;}
@font-face
	{font-family:"Gloucester MT Extra Condensed";
	panose-1:2 3 8 8 2 6 1 1 1 1;}
@font-face
	{font-family:"Gill Sans MT Ext Condensed Bold";
	panose-1:2 11 9 2 2 1 4 2 2 3;}
@font-face
	{font-family:"Century Gothic";
	panose-1:2 11 5 2 2 2 2 2 2 4;}
@font-face
	{font-family:"Goudy Old Style";
	panose-1:2 2 5 2 5 3 5 2 3 3;}
@font-face
	{font-family:"Goudy Stout";
	panose-1:2 2 9 4 7 3 11 2 4 1;}
@font-face
	{font-family:"Harlow Solid Italic";
	panose-1:4 3 6 4 2 15 2 2 13 2;}
@font-face
	{font-family:Harrington;
	panose-1:4 4 5 5 5 10 2 2 7 2;}
@font-face
	{font-family:Haettenschweiler;
	panose-1:2 11 7 6 4 9 2 6 2 4;}
@font-face
	{font-family:"High Tower Text";
	panose-1:2 4 5 2 5 5 6 3 3 3;}
@font-face
	{font-family:"Imprint MT Shadow";
	panose-1:4 2 6 5 6 3 3 3 2 2;}
@font-face
	{font-family:"Informal Roman";
	panose-1:3 6 4 2 3 4 6 11 2 4;}
@font-face
	{font-family:"Blackadder ITC";
	panose-1:4 2 5 5 5 16 7 2 13 2;}
@font-face
	{font-family:"Edwardian Script ITC";
	panose-1:3 3 3 2 4 7 7 13 8 4;}
@font-face
	{font-family:"Kristen ITC";
	panose-1:3 5 5 2 4 2 2 3 2 2;}
@font-face
	{font-family:Jokerman;
	panose-1:4 9 6 5 6 13 6 2 7 2;}
@font-face
	{font-family:"Juice ITC";
	panose-1:4 4 4 3 4 10 2 2 2 2;}
@font-face
	{font-family:"Kunstler Script";
	panose-1:3 3 4 2 2 6 7 13 13 6;}
@font-face
	{font-family:"Wide Latin";
	panose-1:2 10 10 7 5 5 5 2 4 4;}
@font-face
	{font-family:"Lucida Bright";
	panose-1:2 4 6 2 5 5 5 2 3 4;}
@font-face
	{font-family:"Lucida Calligraphy";
	panose-1:3 1 1 1 1 1 1 1 1 1;}
@font-face
	{font-family:"Lucida Fax";
	panose-1:2 6 6 2 5 5 5 2 2 4;}
@font-face
	{font-family:"Lucida Handwriting";
	panose-1:3 1 1 1 1 1 1 1 1 1;}
@font-face
	{font-family:"Lucida Sans";
	panose-1:2 11 6 2 3 5 4 2 2 4;}
@font-face
	{font-family:"Lucida Sans Typewriter";
	panose-1:2 11 5 9 3 5 4 3 2 4;}
@font-face
	{font-family:Magneto;
	panose-1:4 3 8 5 5 8 2 2 13 2;}
@font-face
	{font-family:"Maiandra GD";
	panose-1:2 14 5 2 3 3 8 2 2 4;}
@font-face
	{font-family:"Matura MT Script Capitals";
	panose-1:3 2 8 2 6 6 2 7 2 2;}
@font-face
	{font-family:Mistral;
	panose-1:3 9 7 2 3 4 7 2 4 3;}
@font-face
	{font-family:"Modern No\. 20";
	panose-1:2 7 7 4 7 5 5 2 3 3;}
@font-face
	{font-family:"Monotype Corsiva";
	panose-1:3 1 1 1 1 2 1 1 1 1;}
@font-face
	{font-family:"Niagara Engraved";
	panose-1:4 2 5 2 7 7 3 3 2 2;}
@font-face
	{font-family:"Niagara Solid";
	panose-1:4 2 5 2 7 7 2 2 2 2;}
@font-face
	{font-family:"OCR A Extended";
	panose-1:2 1 5 9 2 1 2 1 3 3;}
@font-face
	{font-family:"Old English Text MT";
	panose-1:3 4 9 2 4 5 8 3 8 6;}
@font-face
	{font-family:Onyx;
	panose-1:4 5 6 2 8 7 2 2 2 3;}
@font-face
	{font-family:"MS Outlook";
	panose-1:5 1 1 0 1 0 0 0 0 0;}
@font-face
	{font-family:"Palace Script MT";
	panose-1:3 3 3 2 2 6 7 12 11 5;}
@font-face
	{font-family:Papyrus;
	panose-1:3 7 5 2 6 5 2 3 2 5;}
@font-face
	{font-family:Parchment;
	panose-1:3 4 6 2 4 7 8 4 8 4;}
@font-face
	{font-family:Perpetua;
	panose-1:2 2 5 2 6 4 1 2 3 3;}
@font-face
	{font-family:"Perpetua Titling MT";
	panose-1:2 2 5 2 6 5 5 2 8 4;}
@font-face
	{font-family:Playbill;
	panose-1:4 5 6 3 10 6 2 2 2 2;}
@font-face
	{font-family:"Poor Richard";
	panose-1:2 8 5 2 5 5 5 2 7 2;}
@font-face
	{font-family:Pristina;
	panose-1:3 6 4 2 4 4 6 8 2 4;}
@font-face
	{font-family:"Rage Italic";
	panose-1:3 7 5 2 4 5 7 7 3 4;}
@font-face
	{font-family:Ravie;
	panose-1:4 4 8 5 5 8 9 2 6 2;}
@font-face
	{font-family:"MS Reference Sans Serif";
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"MS Reference Specialty";
	panose-1:5 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Rockwell Condensed";
	panose-1:2 6 6 3 5 4 5 2 1 4;}
@font-face
	{font-family:Rockwell;
	panose-1:2 6 6 3 2 2 5 2 4 3;}
@font-face
	{font-family:"Rockwell Extra Bold";
	panose-1:2 6 9 3 4 5 5 2 4 3;}
@font-face
	{font-family:"Script MT Bold";
	panose-1:3 4 6 2 4 6 7 8 9 4;}
@font-face
	{font-family:"Showcard Gothic";
	panose-1:4 2 9 4 2 1 2 2 6 4;}
@font-face
	{font-family:"Snap ITC";
	panose-1:4 4 10 7 6 10 2 2 2 2;}
@font-face
	{font-family:Stencil;
	panose-1:4 4 9 5 13 8 2 2 4 4;}
@font-face
	{font-family:"Tw Cen MT";
	panose-1:2 11 6 2 2 1 4 2 6 3;}
@font-face
	{font-family:"Tw Cen MT Condensed";
	panose-1:2 11 6 6 2 1 4 2 2 3;}
@font-face
	{font-family:"Tw Cen MT Condensed Extra Bold";
	panose-1:2 11 8 3 2 2 2 2 2 4;}
@font-face
	{font-family:"Tempus Sans ITC";
	panose-1:4 2 4 4 3 13 7 2 2 2;}
@font-face
	{font-family:"Viner Hand ITC";
	panose-1:3 7 5 2 3 5 2 2 2 3;}
@font-face
	{font-family:Vivaldi;
	panose-1:3 2 6 2 5 5 6 9 8 4;}
@font-face
	{font-family:"Vladimir Script";
	panose-1:3 5 4 2 4 4 7 7 3 5;}
@font-face
	{font-family:"Wingdings 2";
	panose-1:5 2 1 2 1 5 7 7 7 7;}
@font-face
	{font-family:"Wingdings 3";
	panose-1:5 4 1 2 1 8 7 7 7 7;}
@font-face
	{font-family:AngsanaUPC;}
@font-face
	{font-family:CordiaUPC;}
@font-face
	{font-family:Abadi;}
@font-face
	{font-family:"Abadi Extra Light";}
@font-face
	{font-family:Aharoni;}
@font-face
	{font-family:Aldhabi;}
@font-face
	{font-family:Aparajita;}
@font-face
	{font-family:"Arabic Typesetting";}
@font-face
	{font-family:"Arial Nova";}
@font-face
	{font-family:"Arial Nova Cond";}
@font-face
	{font-family:"Arial Nova Cond Light";}
@font-face
	{font-family:"Arial Nova Light";}
@font-face
	{font-family:"Avenir Next LT Pro";}
@font-face
	{font-family:"Avenir Next LT Pro Light";}
@font-face
	{font-family:BatangChe;}
@font-face
	{font-family:Bembo;}
@font-face
	{font-family:Biome;}
@font-face
	{font-family:"Biome Light";}
@font-face
	{font-family:"Browallia New";}
@font-face
	{font-family:BrowalliaUPC;}
@font-face
	{font-family:Cavolini;}
@font-face
	{font-family:Dante;}
@font-face
	{font-family:DaunPenh;}
@font-face
	{font-family:David;}
@font-face
	{font-family:Daytona;}
@font-face
	{font-family:"Daytona Condensed";}
@font-face
	{font-family:"Daytona Condensed Light";}
@font-face
	{font-family:"Daytona Light";}
@font-face
	{font-family:"DengXian Light";}
@font-face
	{font-family:DilleniaUPC;}
@font-face
	{font-family:DokChampa;}
@font-face
	{font-family:DotumChe;}
@font-face
	{font-family:"Elephant Pro";}
@font-face
	{font-family:EucrosiaUPC;}
@font-face
	{font-family:Euphemia;}
@font-face
	{font-family:FangSong;}
@font-face
	{font-family:FrankRuehl;}
@font-face
	{font-family:FreesiaUPC;}
@font-face
	{font-family:"Georgia Pro";}
@font-face
	{font-family:"Georgia Pro Black";}
@font-face
	{font-family:"Georgia Pro Cond";}
@font-face
	{font-family:"Georgia Pro Cond Black";}
@font-face
	{font-family:"Georgia Pro Cond Light";}
@font-face
	{font-family:"Georgia Pro Cond Semibold";}
@font-face
	{font-family:"Georgia Pro Light";}
@font-face
	{font-family:"Georgia Pro Semibold";}
@font-face
	{font-family:"Gill Sans Nova";}
@font-face
	{font-family:"Gill Sans Nova Cond";}
@font-face
	{font-family:"Gill Sans Nova Cond Lt";}
@font-face
	{font-family:"Gill Sans Nova Cond Ultra Bold";}
@font-face
	{font-family:"Gill Sans Nova Cond XBd";}
@font-face
	{font-family:"Gill Sans Nova Light";}
@font-face
	{font-family:"Gill Sans Nova Ultra Bold";}
@font-face
	{font-family:Gisha;}
@font-face
	{font-family:Grotesque;}
@font-face
	{font-family:"Grotesque Light";}
@font-face
	{font-family:GulimChe;}
@font-face
	{font-family:Gungsuh;}
@font-face
	{font-family:GungsuhChe;}
@font-face
	{font-family:"Hadassah Friedlaender";}
@font-face
	{font-family:HGGothicE;}
@font-face
	{font-family:HGMaruGothicMPRO;}
@font-face
	{font-family:HGMinchoE;}
@font-face
	{font-family:HGPGothicE;}
@font-face
	{font-family:HGPMinchoE;}
@font-face
	{font-family:HGPSoeiKakugothicUB;}
@font-face
	{font-family:HGSGothicE;}
@font-face
	{font-family:HGSMinchoE;}
@font-face
	{font-family:HGSoeiKakugothicUB;}
@font-face
	{font-family:HGSSoeiKakugothicUB;}
@font-face
	{font-family:IrisUPC;}
@font-face
	{font-family:"Iskoola Pota";}
@font-face
	{font-family:JasmineUPC;}
@font-face
	{font-family:KaiTi;}
@font-face
	{font-family:Kalinga;}
@font-face
	{font-family:Kartika;}
@font-face
	{font-family:"Khmer UI";}
@font-face
	{font-family:Kigelia;}
@font-face
	{font-family:"Kigelia Arabic";}
@font-face
	{font-family:"Kigelia Arabic Light";}
@font-face
	{font-family:"Kigelia Light";}
@font-face
	{font-family:KodchiangUPC;}
@font-face
	{font-family:Kokila;}
@font-face
	{font-family:"Lao UI";}
@font-face
	{font-family:Leelawadee;}
@font-face
	{font-family:"Levenim MT";}
@font-face
	{font-family:LilyUPC;}
@font-face
	{font-family:"Mangal Pro";}
@font-face
	{font-family:Meiryo;}
@font-face
	{font-family:"Meiryo UI";}
@font-face
	{font-family:"Microsoft GothicNeo";}
@font-face
	{font-family:"Microsoft GothicNeo Light";}
@font-face
	{font-family:"Microsoft Uighur";}
@font-face
	{font-family:MingLiU_HKSCS;}
@font-face
	{font-family:Miriam;}
@font-face
	{font-family:"Miriam Fixed";}
@font-face
	{font-family:"Modern Love";}
@font-face
	{font-family:"Modern Love Caps";}
@font-face
	{font-family:"Modern Love Grunge";}
@font-face
	{font-family:MoolBoran;}
@font-face
	{font-family:"MS PMincho";}
@font-face
	{font-family:"MT Extra";}
@font-face
	{font-family:Narkisim;}
@font-face
	{font-family:"Neue Haas Grotesk Text Pro";}
@font-face
	{font-family:"News Gothic MT";}
@font-face
	{font-family:Nyala;}
@font-face
	{font-family:OCRB;}
@font-face
	{font-family:"Plantagenet Cherokee";}
@font-face
	{font-family:Posterama;}
@font-face
	{font-family:"Quire Sans";}
@font-face
	{font-family:"Quire Sans Light";}
@font-face
	{font-family:"Quire Sans Pro Light";}
@font-face
	{font-family:"Rockwell Light";}
@font-face
	{font-family:"Rockwell Nova";}
@font-face
	{font-family:"Rockwell Nova Cond";}
@font-face
	{font-family:"Rockwell Nova Cond Light";}
@font-face
	{font-family:"Rockwell Nova Extra Bold";}
@font-face
	{font-family:"Rockwell Nova Light";}
@font-face
	{font-family:Rod;}
@font-face
	{font-family:"Sabon Next LT";}
@font-face
	{font-family:"Sagona Book";}
@font-face
	{font-family:"Sagona ExtraLight";}
@font-face
	{font-family:"Sakkal Majalla";}
@font-face
	{font-family:"Sanskrit Text";}
@font-face
	{font-family:Selawik;}
@font-face
	{font-family:"Selawik Light";}
@font-face
	{font-family:"Selawik Semibold";}
@font-face
	{font-family:"Shonar Bangla";}
@font-face
	{font-family:"Simplified Arabic";}
@font-face
	{font-family:"Simplified Arabic Fixed";}
@font-face
	{font-family:"Sitka Banner Semibold";}
@font-face
	{font-family:"Sitka Display Semibold";}
@font-face
	{font-family:"Sitka Heading Semibold";}
@font-face
	{font-family:"Sitka Small Semibold";}
@font-face
	{font-family:"Sitka Subheading Semibold";}
@font-face
	{font-family:"Sitka Text Semibold";}
@font-face
	{font-family:"Source Sans Pro";}
@font-face
	{font-family:"Source Sans Pro Black";}
@font-face
	{font-family:"Source Sans Pro ExtraLight";}
@font-face
	{font-family:"Source Sans Pro Light";}
@font-face
	{font-family:"Source Sans Pro SemiBold";}
@font-face
	{font-family:"Speak Pro";}
@font-face
	{font-family:"Speak Pro Light";}
@font-face
	{font-family:STCaiyun;}
@font-face
	{font-family:STFangsong;}
@font-face
	{font-family:STHupo;}
@font-face
	{font-family:STKaiti;}
@font-face
	{font-family:STXihei;}
@font-face
	{font-family:STXingkai;}
@font-face
	{font-family:STXinwei;}
@font-face
	{font-family:STZhongsong;}
@font-face
	{font-family:"TH SarabunPSK";}
@font-face
	{font-family:"The Hand";}
@font-face
	{font-family:"The Hand Black";}
@font-face
	{font-family:"The Hand Extrablack";}
@font-face
	{font-family:"The Hand Light";}
@font-face
	{font-family:"The Serif Hand";}
@font-face
	{font-family:"The Serif Hand Black";}
@font-face
	{font-family:"The Serif Hand Extrablack";}
@font-face
	{font-family:"The Serif Hand Light";}
@font-face
	{font-family:"Tisa Offc Serif Pro";}
@font-face
	{font-family:"Tisa Offc Serif Pro Thin";}
@font-face
	{font-family:"Trade Gothic Next";}
@font-face
	{font-family:"Trade Gothic Next Cond";}
@font-face
	{font-family:"Trade Gothic Next Cond Hv";}
@font-face
	{font-family:"Trade Gothic Next Heavy";}
@font-face
	{font-family:"Trade Gothic Next Light";}
@font-face
	{font-family:"Traditional Arabic";}
@font-face
	{font-family:"UD Digi Kyokasho N-B";}
@font-face
	{font-family:"UD Digi Kyokasho N-R";}
@font-face
	{font-family:"UD Digi Kyokasho NK-B";}
@font-face
	{font-family:"UD Digi Kyokasho NK-R";}
@font-face
	{font-family:"UD Digi Kyokasho NP-B";}
@font-face
	{font-family:"UD Digi Kyokasho NP-R";}
@font-face
	{font-family:Univers;}
@font-face
	{font-family:"Univers Condensed";}
@font-face
	{font-family:"Univers Condensed Light";}
@font-face
	{font-family:"Univers Light";}
@font-face
	{font-family:"Urdu Typesetting";}
@font-face
	{font-family:Utsaah;}
@font-face
	{font-family:Vani;}
@font-face
	{font-family:"Verdana Pro";}
@font-face
	{font-family:"Verdana Pro Black";}
@font-face
	{font-family:"Verdana Pro Cond";}
@font-face
	{font-family:"Verdana Pro Cond Black";}
@font-face
	{font-family:"Verdana Pro Cond Light";}
@font-face
	{font-family:"Verdana Pro Cond SemiBold";}
@font-face
	{font-family:"Verdana Pro Light";}
@font-face
	{font-family:"Verdana Pro SemiBold";}
@font-face
	{font-family:Vijaya;}
@font-face
	{font-family:"Walbaum Display";}
@font-face
	{font-family:"Walbaum Display Heavy";}
@font-face
	{font-family:"Walbaum Display Light";}
@font-face
	{font-family:"Walbaum Display SemiBold";}
@font-face
	{font-family:"Walbaum Heading";}
@font-face
	{font-family:"Walbaum Text";}
@font-face
	{font-family:"Yu Mincho";}
@font-face
	{font-family:"Yu Mincho Demibold";}
@font-face
	{font-family:"Yu Mincho Light";}
@font-face
	{font-family:"TimesNewRoman\,Italic";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:TimesNewRoman;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Arial\,Italic";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:TimesNewRomanPSMT;}
@font-face
	{font-family:"Times New Roman Bold";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:PraxisCom-Regular;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Arial Bold";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:EUAlbertina;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 5 4 5 2 3 4;}
@font-face
	{font-family:"\@TimesNewRoman\,Italic";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Arial\,Italic";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:"\@Batang";
	panose-1:2 3 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:"\@BatangChe";}
@font-face
	{font-family:"\@Gungsuh";}
@font-face
	{font-family:"\@GungsuhChe";}
@font-face
	{font-family:"\@DengXian Light";}
@font-face
	{font-family:"\@Gulim";
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:"\@GulimChe";}
@font-face
	{font-family:"\@Dotum";
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:"\@DotumChe";}
@font-face
	{font-family:"\@Meiryo";}
@font-face
	{font-family:"\@Meiryo UI";}
@font-face
	{font-family:"\@MingLiU";
	panose-1:2 1 6 9 0 1 1 1 1 1;}
@font-face
	{font-family:"\@PMingLiU";
	panose-1:2 1 6 1 0 1 1 1 1 1;}
@font-face
	{font-family:"\@MingLiU_HKSCS";}
@font-face
	{font-family:"\@MS PMincho";}
@font-face
	{font-family:"\@STXingkai";}
@font-face
	{font-family:"\@STZhongsong";}
@font-face
	{font-family:"\@Yu Mincho";}
@font-face
	{font-family:"\@Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:Times-Roman;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:CourierNewPSMT;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"SAS Monospace";}
@font-face
	{font-family:"Bookshelf Symbol 3";}
@font-face
	{font-family:Goudy;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Garamond-Italic;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Arial\,Bold";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:DIN-Bold;}
@font-face
	{font-family:"CG Times \(W1\)";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"HelveticaNeue Condensed";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:17.85pt;
	text-indent:-17.85pt;
	line-height:13.0pt;
	font-size:13.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;}
h2
	{margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Helvetica",sans-serif;
	font-style:italic;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:4.0pt;
	margin-left:0in;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
h4
	{margin:0in;
	text-align:justify;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
h5
	{mso-style-link:"Heading 5 Char";
	margin-top:0in;
	margin-right:28.35pt;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
h6
	{margin-top:0in;
	margin-right:5.65pt;
	margin-bottom:0in;
	margin-left:0in;
	text-align:center;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{margin:0in;
	text-align:justify;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	font-size:10.0pt;
	font-family:"CG Times (W1)",serif;
	font-style:italic;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	font-size:10.0pt;
	font-family:"CG Times (W1)",serif;
	font-style:italic;}
p.MsoNormalIndent, li.MsoNormalIndent, div.MsoNormalIndent
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-link:"Footnote Text Char";
	margin:0in;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-link:"Comment Text Char";
	margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-link:"Header Char";
	margin:0in;
	font-size:10.0pt;
	font-family:"Helvetica",sans-serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	font-size:8.0pt;
	font-family:"Helvetica",sans-serif;}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{margin:0in;
	font-size:14.0pt;
	font-family:"Arial",sans-serif;
	color:fuchsia;}
span.MsoFootnoteReference
	{position:relative;
	top:-3.0pt;}
span.MsoEndnoteReference
	{vertical-align:super;}
p.MsoEndnoteText, li.MsoEndnoteText, div.MsoEndnoteText
	{mso-style-link:"Endnote Text Char";
	margin:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList, li.MsoList, div.MsoList
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoClosing, li.MsoClosing, div.MsoClosing
	{mso-style-link:"Closing Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:255.15pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.MsoSignature, li.MsoSignature, div.MsoSignature
	{mso-style-link:"Signature Char";
	margin-top:60.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:255.15pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin-top:0in;
	margin-right:-2.25pt;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{margin-top:0in;
	margin-right:-2.25pt;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoMessageHeader, li.MsoMessageHeader, div.MsoMessageHeader
	{mso-style-link:"Message Header Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:.75in;
	text-indent:-.75in;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;}
p.MsoDate, li.MsoDate, div.MsoDate
	{mso-style-link:"Date Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:255.15pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin:0in;
	text-align:center;
	line-height:13.0pt;
	font-size:9.0pt;
	font-family:"Helvetica",sans-serif;}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin-top:0in;
	margin-right:.55pt;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-align:justify;
	text-indent:-28.35pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{mso-style-link:"Body Text Indent 3 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:12.6pt;
	text-indent:-12.6pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBlockText, li.MsoBlockText, div.MsoBlockText
	{margin-top:0in;
	margin-right:.55pt;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-align:justify;
	text-indent:-28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-link:"Document Map Char";
	margin:0in;
	line-height:13.0pt;
	background:navy;
	font-size:11.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-link:"Comment Subject Char";
	margin:0in;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoRMPane, li.MsoRMPane, div.MsoRMPane
	{margin:0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:35.4pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.headings, li.headings, div.headings
	{mso-style-name:headings;
	margin-top:0in;
	margin-right:8.5pt;
	margin-bottom:0in;
	margin-left:8.5pt;
	text-align:center;
	line-height:9.0pt;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;
	color:red;
	letter-spacing:-.25pt;
	font-weight:bold;}
p.Pages, li.Pages, div.Pages
	{mso-style-name:Pages;
	margin:0in;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
p.MessageHeaderFirst, li.MessageHeaderFirst, div.MessageHeaderFirst
	{mso-style-name:"Message Header First";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:.75in;
	text-indent:-.75in;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;}
p.MessageHeaderLast, li.MessageHeaderLast, div.MessageHeaderLast
	{mso-style-name:"Message Header Last";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:.25in;
	margin-left:.75in;
	text-indent:-.75in;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;}
p.Address, li.Address, div.Address
	{mso-style-name:Address;
	margin:0in;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.AddressTL, li.AddressTL, div.AddressTL
	{mso-style-name:AddressTL;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:.5in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.AddressTR, li.AddressTR, div.AddressTR
	{mso-style-name:AddressTR;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:.5in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.References, li.References, div.References
	{mso-style-name:References;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:255.15pt;
	font-size:10.0pt;
	font-family:"CG Times (W1)",serif;}
p.Subject, li.Subject, div.Subject
	{mso-style-name:Subject;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:24.0pt;
	margin-left:53.85pt;
	text-indent:-53.85pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;
	font-weight:bold;}
p.NoteHead, li.NoteHead, div.NoteHead
	{mso-style-name:NoteHead;
	margin-top:.5in;
	margin-right:0in;
	margin-bottom:.5in;
	margin-left:0in;
	text-align:center;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;
	font-variant:small-caps;
	font-weight:bold;}
p.NoteList, li.NoteList, div.NoteList
	{mso-style-name:NoteList;
	margin-top:.5in;
	margin-right:0in;
	margin-bottom:.5in;
	margin-left:255.15pt;
	text-indent:-155.95pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;
	font-variant:small-caps;
	font-weight:bold;}
p.YReferences, li.YReferences, div.YReferences
	{mso-style-name:YReferences;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:24.0pt;
	margin-left:53.85pt;
	text-indent:-53.85pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.Text1, li.Text1, div.Text1
	{mso-style-name:"Text 1";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:22.7pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.Text2, li.Text2, div.Text2
	{mso-style-name:"Text 2";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:53.85pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.Text3, li.Text3, div.Text3
	{mso-style-name:"Text 3";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:96.4pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.NumPar1, li.NumPar1, div.NumPar1
	{mso-style-name:"NumPar 1";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:22.7pt;
	text-indent:-22.7pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.NumPar2, li.NumPar2, div.NumPar2
	{mso-style-name:"NumPar 2";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:53.85pt;
	text-indent:-31.2pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.NumPar3, li.NumPar3, div.NumPar3
	{mso-style-name:"NumPar 3";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:96.4pt;
	text-indent:-42.55pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.Dash1, li.Dash1, div.Dash1
	{mso-style-name:"Dash 1";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:36.85pt;
	text-align:justify;
	text-indent:-14.2pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.Dash2, li.Dash2, div.Dash2
	{mso-style-name:"Dash 2";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:68.05pt;
	text-align:justify;
	text-indent:-14.2pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.Dash3, li.Dash3, div.Dash3
	{mso-style-name:"Dash 3";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:110.55pt;
	text-align:justify;
	text-indent:-14.2pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.Alpha1, li.Alpha1, div.Alpha1
	{mso-style-name:"Alpha 1";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:45.35pt;
	text-align:justify;
	text-indent:-22.7pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.Alpha2, li.Alpha2, div.Alpha2
	{mso-style-name:"Alpha 2";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:76.55pt;
	text-align:justify;
	text-indent:-22.7pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.Alpha3, li.Alpha3, div.Alpha3
	{mso-style-name:"Alpha 3";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:119.05pt;
	text-align:justify;
	text-indent:-22.7pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.FirstDash, li.FirstDash, div.FirstDash
	{mso-style-name:FirstDash;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:14.2pt;
	text-align:justify;
	text-indent:-14.2pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.Copies, li.Copies, div.Copies
	{mso-style-name:Copies;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:53.85pt;
	text-indent:-53.85pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.Participants, li.Participants, div.Participants
	{mso-style-name:Participants;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:53.85pt;
	text-indent:-53.85pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.Enclosures, li.Enclosures, div.Enclosures
	{mso-style-name:Enclosures;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:53.85pt;
	text-indent:-53.85pt;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.DoubSign, li.DoubSign, div.DoubSign
	{mso-style-name:DoubSign;
	margin-top:60.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"CG Times (W1)",serif;}
p.Logo, li.Logo, div.Logo
	{mso-style-name:Logo;
	margin-top:2.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;}
p.Logo-CCE, li.Logo-CCE, div.Logo-CCE
	{mso-style-name:Logo-CCE;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;
	text-transform:uppercase;}
p.Logo-Unit, li.Logo-Unit, div.Logo-Unit
	{mso-style-name:Logo-Unit;
	margin:0in;
	font-size:8.0pt;
	font-family:"Arial",sans-serif;}
p.Logo-Address, li.Logo-Address, div.Logo-Address
	{mso-style-name:Logo-Address;
	margin:0in;
	font-size:8.0pt;
	font-family:"Arial",sans-serif;
	letter-spacing:.5pt;}
span.Initial
	{mso-style-name:Initial;
	font-family:"Times New Roman",serif;}
p.Janis-Addition, li.Janis-Addition, div.Janis-Addition
	{mso-style-name:"Janis - Addition";
	margin-top:0in;
	margin-right:.55pt;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	color:red;
	text-decoration:underline;}
p.Janis-Deletion, li.Janis-Deletion, div.Janis-Deletion
	{mso-style-name:"Janis - Deletion";
	margin-top:0in;
	margin-right:.55pt;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	text-decoration:line-through;}
p.AHeader1, li.AHeader1, div.AHeader1
	{mso-style-name:"AHeader 1";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.2pt;
	text-indent:-14.2pt;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
p.AHeader2, li.AHeader2, div.AHeader2
	{mso-style-name:"AHeader 2";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:27.0pt;
	text-indent:-27.0pt;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
p.AHeader3, li.AHeader3, div.AHeader3
	{mso-style-name:"AHeader 3";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:27.0pt;
	text-indent:-27.0pt;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
p.AHeader2abc, li.AHeader2abc, div.AHeader2abc
	{mso-style-name:"AHeader 2 abc";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:27.0pt;
	text-align:justify;
	text-indent:-27.0pt;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;}
p.AHeader3abc, li.AHeader3abc, div.AHeader3abc
	{mso-style-name:"AHeader 3 abc";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:27.0pt;
	text-align:justify;
	text-indent:-27.0pt;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;}
p.TableText, li.TableText, div.TableText
	{mso-style-name:"Table Text";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;
	color:black;}
p.Sprechblasentext1, li.Sprechblasentext1, div.Sprechblasentext1
	{mso-style-name:Sprechblasentext1;
	margin:0in;
	line-height:13.0pt;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;}
p.TitleA, li.TitleA, div.TitleA
	{mso-style-name:"Title A";
	margin-top:0in;
	margin-right:.55pt;
	margin-bottom:0in;
	margin-left:0in;
	text-align:center;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.TitleB, li.TitleB, div.TitleB
	{mso-style-name:"Title B";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-indent:-28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Heading5Char
	{mso-style-name:"Heading 5 Char";
	mso-style-link:"Heading 5";
	font-weight:bold;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-link:Header;
	font-family:"Helvetica",sans-serif;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-link:"Comment Text";}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Tahoma",sans-serif;}
p.BodytextAgency, li.BodytextAgency, div.BodytextAgency
	{mso-style-name:"Body text \(Agency\)";
	mso-style-link:"Body text \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
span.BodytextAgencyChar
	{mso-style-name:"Body text \(Agency\) Char";
	mso-style-link:"Body text \(Agency\)";
	font-family:"Verdana",sans-serif;}
p.BalloonText1, li.BalloonText1, div.BalloonText1
	{mso-style-name:"Balloon Text1";
	margin:0in;
	line-height:13.0pt;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;}
p.space7, li.space7, div.space7
	{mso-style-name:space7;
	margin:0in;
	page-break-after:avoid;
	font-size:7.0pt;
	font-family:"Arial",sans-serif;
	color:black;
	layout-grid-mode:line;}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-link:"Comment Subject";
	font-weight:bold;}
p.Default, li.Default, div.Default
	{mso-style-name:Default;
	margin:0in;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"HelveticaNeue Condensed",sans-serif;
	color:black;}
span.A8
	{mso-style-name:A8;
	font-family:"HelveticaNeue Condensed",sans-serif;
	color:#211D1E;
	font-weight:bold;
	text-decoration:underline;}
span.A1
	{mso-style-name:A1;
	font-family:"HelveticaNeue Condensed",sans-serif;
	color:#EE3022;
	font-weight:bold;}
span.EndnoteTextChar
	{mso-style-name:"Endnote Text Char";
	mso-style-link:"Endnote Text";}
span.MessageHeaderChar
	{mso-style-name:"Message Header Char";
	mso-style-link:"Message Header";
	font-family:"Arial",sans-serif;}
span.FootnoteTextChar
	{mso-style-name:"Footnote Text Char";
	mso-style-link:"Footnote Text";}
span.DateChar
	{mso-style-name:"Date Char";
	mso-style-link:Date;
	font-family:"CG Times (W1)",serif;}
span.SignatureChar
	{mso-style-name:"Signature Char";
	mso-style-link:Signature;
	font-family:"CG Times (W1)",serif;}
span.ClosingChar
	{mso-style-name:"Closing Char";
	mso-style-link:Closing;
	font-family:"CG Times (W1)",serif;}
span.BodyTextIndent3Char
	{mso-style-name:"Body Text Indent 3 Char";
	mso-style-link:"Body Text Indent 3";}
span.DocumentMapChar
	{mso-style-name:"Document Map Char";
	mso-style-link:"Document Map";
	font-family:"Tahoma",sans-serif;
	background:navy;}
p.PPIBulletedList, li.PPIBulletedList, div.PPIBulletedList
	{mso-style-name:"PPI_Bulleted List";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.5in;
	text-indent:-.2in;
	line-height:12.0pt;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;}
span.breve
	{mso-style-name:breve;}
p.PLRTextUnindented, li.PLRTextUnindented, div.PLRTextUnindented
	{mso-style-name:PLR_Text_Unindented;
	mso-style-link:"PLR_Text_Unindented Char";
	margin:0in;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;}
span.PLRTextUnindentedChar
	{mso-style-name:"PLR_Text_Unindented Char";
	mso-style-link:PLR_Text_Unindented;
	font-family:"Arial",sans-serif;}
p.berarbeitung1, li.berarbeitung1, div.berarbeitung1
	{mso-style-name:\00DCberarbeitung1;
	margin:0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Listenabsatz2, li.Listenabsatz2, div.Listenabsatz2
	{mso-style-name:Listenabsatz2;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:35.4pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.Listenabsatz1, li.Listenabsatz1, div.Listenabsatz1
	{mso-style-name:Listenabsatz1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:35.4pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	text-transform:uppercase;
	font-weight:bold;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-weight:bold;}
p.TableParagraph, li.TableParagraph, div.TableParagraph
	{mso-style-name:"Table Paragraph";
	margin:0in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.IFUInstructionalText1, li.IFUInstructionalText1, div.IFUInstructionalText1
	{mso-style-name:"IFU Instructional Text 1";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:1.0pt;
	margin-left:0in;
	text-align:center;
	font-size:8.5pt;
	font-family:"Arial",sans-serif;}
p.IFUBulletedBodyText, li.IFUBulletedBodyText, div.IFUBulletedBodyText
	{mso-style-name:"IFU Bulleted Body Text";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	text-indent:-.25in;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	color:black;}
p.PPIBulletedList2, li.PPIBulletedList2, div.PPIBulletedList2
	{mso-style-name:"PPI_Bulleted List 2";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	text-indent:-.25in;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;}
p.PPIBlockBody, li.PPIBlockBody, div.PPIBlockBody
	{mso-style-name:"PPI_Block Body";
	margin:0in;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;}
p.PPIBulletedList1, li.PPIBulletedList1, div.PPIBulletedList1
	{mso-style-name:"PPI_Bulleted List 1";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	text-indent:-.25in;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;}
p.PPIBulletedList3, li.PPIBulletedList3, div.PPIBulletedList3
	{mso-style-name:"PPI_Bulleted List 3";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.5in;
	text-indent:-.25in;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;}
p.PPIGenericName, li.PPIGenericName, div.PPIGenericName
	{mso-style-name:"PPI_Generic Name";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	text-align:center;
	line-height:17.0pt;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;
	color:black;
	font-weight:bold;}
p.PPIHeading1, li.PPIHeading1, div.PPIHeading1
	{mso-style-name:"PPI_Heading 1";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	background:#FF9933;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.PPIHeading2, li.PPIHeading2, div.PPIHeading2
	{mso-style-name:"PPI_Heading 2";
	margin:0in;
	line-height:12.0pt;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.PPILabelingBodyText, li.PPILabelingBodyText, div.PPILabelingBodyText
	{mso-style-name:"PPI_Labeling Body Text";
	margin-top:2.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;}
span.msoIns
	{mso-style-name:"";
	text-decoration:underline;
	color:teal;}
span.msoDel
	{mso-style-name:"";
	text-decoration:line-through;
	color:red;}
 /* Page Definitions */
 @page WordSection1
	{size:595.35pt 842.0pt;
	margin:56.7pt 70.9pt 56.7pt 70.9pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>

</head>

<body lang=EN-US link=blue vlink=purple style='word-wrap:break-word'>

<div class=WordSection1>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=DE>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>ANNEX I</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=TitleA><span lang=EN-GB>SUMMARY OF PRODUCT CHARACTERISTICS</span></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><span
lang=EN-GB>&nbsp;</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Liprolog
100&nbsp;units/ml, solution for injection in vial</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; QUALITATIVE
AND QUANTITATIVE COMPOSITION</span></b></p>

<p class=Janis-Deletion align=left style='text-align:left'><span lang=EN-GB
style='text-decoration:none'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>2.1&nbsp;&nbsp;&nbsp;&nbsp; General
description</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=Janis-Addition align=left style='text-align:left'><span lang=EN-GB
style='color:windowtext;text-decoration:none'>Liprolog is a sterile, clear,
colourless, aqueous solution. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>2.2&nbsp;&nbsp;&nbsp;&nbsp; Qualitative
and quantitative composition</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>One
ml contains 100&nbsp;units (equivalent to 3.5mg) insulin lispro (recombinant
DNA origin produced in E.coli). Each container includes 10ml equivalent to 1000&nbsp;units
insulin lispro.</span></p>

<p class=Janis-Deletion align=left style='text-align:left'><span lang=EN-GB
style='text-decoration:none'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>For a full list
of excipients, see section 6.1.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=Janis-Addition align=left style='text-align:left'><span lang=EN-GB
style='color:windowtext;text-decoration:none'>Solution for injection.</span></p>

<p class=Janis-Addition align=left style='text-align:left'><span lang=EN-GB
style='color:windowtext;text-decoration:none'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CLINICAL
PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.1&nbsp;&nbsp;&nbsp;&nbsp; Therapeutic
indications</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>For the
treatment of adults and children with diabetes mellitus who require insulin for
the maintenance of normal glucose homeostasis. Liprolog is also indicated for
the initial stabilisation of diabetes mellitus. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.2&nbsp;&nbsp;&nbsp;&nbsp; Posology
and method of administration</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The dosage
should be determined by the physician, according to the requirement of the
patient. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Liprolog
may be given shortly before meals. When necessary Liprolog can be given soon
after meals. Liprolog preparations should be given by subcutaneous injection or
by continuous subcutaneous infusion pump (see section 4.2) and may, although
not recommended, also be given by intramuscular injection. If necessary,
Liprolog may also be administered intravenously, for example; for the control
of blood glucose levels during ketoacidosis, acute illnesses or during intra
and post operative periods.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Subcutaneous
administration should be in the upper arms, thighs, buttocks, or abdomen. Use
of injection sites should be rotated so that the same site is not used more
than approximately once a month.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>When
administered subcutaneously care should be taken when injecting Liprolog to
ensure that a blood vessel has not been entered. After injection, the site of
injection should not be massaged. Patients must be educated to use the proper
injection techniques.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Liprolog
takes effect rapidly and has a shorter duration of activity (2 to 5&nbsp;hours)
given subcutaneously as compared with regular insulin. This rapid onset of
activity allows a Liprolog injection (or, in the case of administration by
continuous subcutaneous infusion, a Liprolog bolus) to be given very close to
mealtime. The time course of action of any insulin may vary considerably in
different individuals or at different times in the same individual. The faster
onset of action compared to soluble human insulin is maintained regardless of
injection site. As with all insulin preparations, the duration of action of
Liprolog is dependent on dose, site of injection, blood supply, temperature,
and physical activity.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Liprolog can be
used in conjunction with a longer-acting insulin or oral sulphonylurea agents,
on the advice of a physician. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><u><span lang=EN-GB>Use of
Liprolog in an insulin infusion pump</span></u><span lang=EN-GB>:</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Only certain
CE-marked insulin infusion pumps may be used to infuse insulin lispro. Before
infusing insulin lispro, the manufacturers instructions should be studied to
ascertain the suitability or otherwise for the particular pump. Read and follow
the instructions that accompany the infusion pump. Use the correct reservoir
and catheter for the pump. </span>The infusion set (tubing and cannula) should
be changed in accordance with the instructions in the product information
supplied with the infusion set. <span lang=EN-GB>&nbsp;In the event of a
hypoglycaemic episode, the infusion should be stopped until the episode is
resolved. If repeated or severe low blood glucose levels occur, notify your
health care professional and consider the need to reduce or stop your insulin
infusion. A pump malfunction or obstruction of the infusion set can result in a
rapid rise in glucose levels. If an interruption to insulin flow is suspected,
follow the instructions in the product literature and if appropriate, notify
your health care professional. When used with an insulin infusion pump,
Liprolog should not be mixed with any other insulin.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><u><span lang=EN-GB>Intravenous
administration of insulin</span></u><span lang=EN-GB>:</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Intravenous
injection of insulin lispro should be carried out following normal clinical
practise for intravenous injections, for example by an intravenous bolus or by
an infusion system. Frequent monitoring of the blood glucose levels is
required.</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Infusion
systems at concentrations from 0.1&nbsp;units/ml to 1.0&nbsp;units/ml insulin
lispro in 0.9% sodium chloride or 5% dextrose are stable at room temperature
for 48&nbsp;hours. It is recommended that the system is primed before starting
the infusion to the patient.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><span
lang=EN-GB>Paediatric population</span></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Liprolog can be used in adolescents and children (see section 5.1).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.3&nbsp;&nbsp;&nbsp;&nbsp; Contraindications</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Hypersensitivity
to insulin lispro or to any of the excipients.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.4&nbsp;&nbsp;&nbsp;&nbsp; Special
warnings and precautions for use</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Transferring a
patient to another type or brand of insulin should be done under strict medical
supervision. Changes in strength, brand (manufacturer), type (regular, NPH,
lente, etc.), species (animal, human, human insulin analogue), and/or method of
manufacture (recombinant DNA versus animal-source insulin) may result in the
need for a change in dosage. </span><span lang=EN-GB style='color:black'>For
fast-acting insulins, any patient also on basal insulin must optimise dosage of
both insulins to obtain glucose control across the whole day, particularly
nocturnal/fasting glucose control.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The
shorter-acting Liprolog should be drawn into the syringe first, to prevent
contamination of the vial by the longer-acting insulin. Mixing of the insulins
ahead of time or just before the injection should be on advice of the
physician. However, a consistent routine must be followed.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Conditions
which may make the early warning symptoms of hypoglycaemia different or less
pronounced include long duration of diabetes, intensified insulin therapy,
diabetic nerve disease or medications such as beta-blockers.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>A few patients
who have experienced hypoglycaemic reactions after transfer from animal-source
insulin to human insulin have reported that the early warning symptoms of
hypoglycaemia were less pronounced or different from those experienced with
their previous insulin. Uncorrected hypoglycaemic or hyperglycaemic reactions
can cause loss of consciousness, coma, or death.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The use of
dosages which are inadequate or discontinuation of treatment, especially in
insulin-dependent diabetics, may lead to hyperglycaemia and diabetic
ketoacidosis; conditions which are potentially lethal.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin requirements may be reduced in the
presence of renal impairment. Insulin requirements may be reduced in patients
with hepatic impairment due to reduced capacity for gluconeogenesis and reduced
insulin breakdown; however, in patients with chronic hepatic impairment, an
increase in insulin resistance may lead to increased insulin requirements.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin
requirements may be increased during illness or emotional disturbances.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Adjustment of
dosage may also be necessary if patients undertake increased physical activity
or change their usual diet. Exercise taken immediately after a meal may
increase the risk of hypoglycaemia. A consequence of the pharmacodynamics of
rapid-acting insulin analogues is that if hypoglycaemia occurs, it may occur
earlier after an injection when compared with soluble human insulin.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB>Combination of Liprolog with
pioglitazone:</span></u></p>

<p class=MsoNormal><span lang=EN-GB>Cases of cardiac failure have been reported
when pioglitazone was used in combination with insulin, especially in patients
with risk factors for development of cardiac heart failure. This should be kept
in mind if treatment with the combination of pioglitazone and Liprolog is
considered. If the combination is used, patients should be observed for signs
and symptoms of heart failure, weight gain and oedema. Pioglitazone should be
discontinued if any deterioration in cardiac symptoms occurs.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.5&nbsp;&nbsp;&nbsp;&nbsp; Interaction
with other medicinal products and other forms of interaction</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin
requirements may be increased by medicinal products with hyperglycaemic
activity, such as oral contraceptives, corticosteroids, or thyroid replacement
therapy, danazol, beta<sub>2</sub> stimulants (such as ritodrine, salbutamol,
terbutaline). </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Insulin
requirements may be reduced in the presence of medicinal products with hypoglycaemic
activity, such as oral hypoglycaemics, salicylates (for example,
acetylsalicylic acid), sulpha antibiotics, certain antidepressants (monoamine
oxidase inhibitors, selective serotonin reuptake inhibitors), certain
angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II
receptor blockers, beta-blockers, octreotide or alcohol. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The physician
should be consulted when using other medications in addition to Liprolog </span>(see
section <span lang=EN-GB>4.4</span>)<span lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.6&nbsp;&nbsp;&nbsp;&nbsp; Fertility,
pregnancy and lactation</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Data
on a large number of exposed pregnancies do not indicate any adverse effect of
insulin lispro on pregnancy or on the health of the foetus/newborn.&nbsp;&nbsp;
</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>It is
essential to maintain good control of the insulin-treated (insulin-dependent or
gestational diabetes) patient throughout pregnancy. Insulin requirements
usually fall during the first trimester and increase during the second and
third trimesters. Patients with diabetes should be advised to inform their
doctor if they are pregnant or are contemplating pregnancy. Careful monitoring
of glucose control, as well as general health, is essential in pregnant
patients with diabetes. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Patients with
diabetes who are breast-feeding may require adjustments in insulin dose, diet
or both. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;page-break-after:
avoid'><b><span lang=EN-GB>4.7&nbsp;&nbsp;&nbsp;&nbsp; Effects on ability to
drive and use machines</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;page-break-after:avoid'><span
lang=EN-GB>The patient&#8217;s ability to concentrate and react may be impaired
as a result of hypoglycaemia. This may constitute a risk in situations where
these abilities are of special importance (e.g. driving a car or operating
machinery).</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Patients
should be advised to take precautions to avoid hypoglycaemia whilst driving,
this is particularly important in those who have reduced or absent awareness of
the warning signs of hypoglycaemia or have frequent episodes of hypoglycaemia.
The advisability of driving should be considered in these circumstances.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.8&nbsp;&nbsp;&nbsp;&nbsp; Undesirable
effects</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>Hypoglycaemia
is the most frequent undesirable effect of insulin therapy that a patient with
diabetes may suffer. Severe hypoglycaemia may lead to loss of consciousness, and
in extreme cases, death. No specific frequency for hypoglycaemia is presented,
since hypoglycaemia is a result of both the insulin dose and other factors e.g.
a patient`s level of diet and exercise.</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>Local allergy
in patients is common (1/100 to &lt;1/10). Redness, swelling, and itching can
occur at the site of insulin injection. This condition usually resolves in a
few days to a few weeks. In some instances, this condition may be related to
factors other than insulin, such as irritants in the skin cleansing agent or
poor injection technique. Systemic allergy,&nbsp; which is rare (1/10,000 to
&lt;1/1,000) but potentially more serious, is a generalised allergy to insulin.
It may cause a rash over the whole body, shortness of breath, wheezing,
reduction in blood pressure, fast pulse, or sweating. Severe cases of
generalised allergy may be life-threatening.</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'>Lipodystrophy
at the injection site is uncommon (1/1,000 to &lt;1/100).</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Cases of oedema have been
reported with insulin therapy, particularly if previous poor metabolic control
is improved by intensified insulin therapy.</p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB>Reporting of
suspected adverse reactions</span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Reporting
suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals are asked to report any suspected
adverse reactions via <span style='background:silver'>the national reporting
system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span>.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.9&nbsp;&nbsp;&nbsp;&nbsp; Overdose</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulins have no
specific overdose definitions because serum glucose concentrations are a result
of complex interactions between insulin levels, glucose availability and other
metabolic processes. Hypoglycaemia may occur as a result of an excess of
insulin activity relative to food intake and energy expenditure.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Hypoglycaemia
may be associated with listlessness, confusion, palpitations, headache,
sweating and vomiting.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Mild
hypoglycaemic episodes will respond to oral administration of glucose or other
sugar or saccharated products.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Correction of
moderately severe hypoglycaemia can be accomplished by intramuscular or
subcutaneous administration of glucagon, followed by oral carbohydrate when the
patient recovers sufficiently. Patients who fail to respond to glucagon must be
given glucose solution intravenously.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>If the patient
is comatose, glucagon should be administered intramuscularly or subcutaneously.
However, glucose solution must be given intravenously if glucagon is not available
or if the patient fails to respond to glucagon. The patient should be given a
meal as soon as consciousness is recovered.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Sustained
carbohydrate intake and observation may be necessary because hypoglycaemia may
recur after apparent clinical recovery.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACOLOGICAL
PROPERTIES</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>5.1&nbsp;&nbsp;&nbsp;&nbsp; Pharmacodynamic
properties</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Pharmacotherapeutic
group : Fast-acting human insulin analogue. ATC code: A10A B04</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The primary
activity of insulin lispro is the regulation of glucose metabolism.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>In addition,
insulins have several anabolic and anti-catabolic actions on a variety of
different tissues. Within muscle tissue this includes increasing glycogen,
fatty acid, glycerol and protein synthesis and amino acid uptake, while
decreasing glycogenolysis, gluconeogenesis, ketogenesis, lipolysis, protein
catabolism and amino acid output.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin lispro
has a rapid onset of action (approximately 15&nbsp;minutes), thus allowing it
to be given closer to a meal (within zero to 15 minutes of the meal) when
compared to regular insulin (30 to 45&nbsp;minutes before). Insulin lispro
takes effect rapidly and has a shorter duration of activity (2 to 5&nbsp;hours)
when compared to regular insulin. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Clinical trials
in patients with type 1 and type 2 diabetes have demonstrated reduced
postprandial<u> </u>hyperglycaemia with insulin lispro compared to soluble
human insulin. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><img width=403 height=257
src="Humalo_files/image001.gif"><br clear=ALL>
<span lang=EN-GB>As with all insulin preparations, the time course of insulin
lispro action may vary in different individuals or at different times in the
same individual and is dependent on dose, site of injection, blood supply,
temperature and physical activity. The typical activity profile following
subcutaneous injection is illustrated below.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The above
representation reflects the relative amount of glucose over time required to
maintain the subject's whole blood glucose concentrations near fasting levels
and is an indicator of the effect of these insulins on glucose metabolism over
time.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Clinical trials
have been performed in children (61 patients aged 2 to 11) and children and
adolescents (481 patients aged 9 to 19 years), comparing insulin lispro to
human soluble insulin. The pharmacodynamic profile of insulin lispro in
children is similar to that seen in adults. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB
style='layout-grid-mode:line'>When used in subcutaneous infusion pumps,
treatment with insulin lispro has been shown to result in lower glycosylated
haemoglobin levels compared to soluble insulin.&nbsp; In a double-blind,
crossover study, the reduction in glycosylated haemoglobin levels after 12
weeks dosing was 0.37 percentage points with insulin lispro, compared to 0.03
percentage points for soluble insulin (p&nbsp;=&nbsp;0.004).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB
style='layout-grid-mode:line'>In patients with type 2 diabetes on maximum doses
of sulphonyl urea agents, studies have shown that the addition of insulin
lispro significantly reduces HbA<sub>1c</sub> compared to sulphonyl urea alone.
The reduction of HbA<sub>1c</sub> would also be expected with other insulin
products e.g. soluble or isophane insulins.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB
style='layout-grid-mode:line'>Clinical trials in patients with type 1 and type
2 diabetes have demonstrated a reduced number of episodes of nocturnal
hypoglycaemia with insulin lispro compared to soluble human insulin. In some
studies, reduction of nocturnal hypoglycaemia was associated with increased
episodes of daytime hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The glucodynamic
response to insulin lispro is not affected by renal or hepatic function
impairment. Glucodynamic differences between insulin lispro and soluble human
insulin, as measured during a glucose clamp procedure, were maintained over a
wide range of renal function. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Insulin
lispro has been shown to be equipotent to human insulin on a molar basis but its
effect is more rapid and of a shorter duration.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>5.2&nbsp;&nbsp;&nbsp;&nbsp; Pharmacokinetic
properties</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The
pharmacokinetics of insulin lispro reflect a compound that is rapidly absorbed,
and achieves peak blood levels 30 to 70&nbsp;minutes following subcutaneous
injection. When considering the clinical relevance of these kinetics, it is
more appropriate to examine the glucose utilisation curves (as discussed in
5.1).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin lispro
maintains more rapid absorption when compared to soluble human insulin in
patients with renal impairment. In patients with type 2 diabetes over a wide
range of renal function&nbsp; the pharmacokinetic differences between insulin
lispro and soluble human insulin were generally maintained and shown to be
independent of renal function.&nbsp; Insulin lispro maintains more rapid
absorption and elimination when compared to soluble human insulin in patients
with hepatic impairment.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>5.3&nbsp;&nbsp;&nbsp;&nbsp; Preclinical
safety data</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>In <i>in vitro</i>
tests, including binding to insulin receptor sites and effects on growing
cells, insulin lispro behaved in a manner that closely resembled human insulin.
Studies also demonstrate that the dissociation of binding to the insulin
receptor of insulin lispro is equivalent to human insulin. Acute, one month and
twelve month toxicology studies produced no significant toxicity findings.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin lispro
did not induce fertility impairment, embryotoxicity or teratogenicity in animal
studies. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>6.1&nbsp;&nbsp;&nbsp;&nbsp; List
of excipients</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>m-</span></i><span
lang=EN-GB>Cresol </span><span lang=EN-GB>[3.15&nbsp;mg/ml]</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Glycerol</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Dibasic sodium
phosphate.&nbsp;7H<span style='position:relative;top:3.0pt'>2</span>O</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Zinc oxide</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Water for
injections</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Hydrochloric
acid and sodium hydroxide maybe used to adjust pH to 7.0 &#8211; 7.8.</span></p>

<p class=Janis-Deletion align=left style='text-align:left'><span lang=EN-GB
style='text-decoration:none'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>6.2&nbsp;&nbsp;&nbsp;&nbsp; Incompatibilities</span></b></p>

<p class=Janis-Deletion align=left style='text-align:left'><span lang=EN-GB
style='text-decoration:none'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Liprolog
preparations should not be mixed with insulins produced by other manufacturers
or with animal insulin preparations. This medicinal product must not be mixed
with other medicinal products except those mentioned in section 6.6.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>6.3&nbsp;&nbsp;&nbsp;&nbsp; Shelf
life</span></b></p>

<p class=Janis-Deletion align=left style='text-align:left'><span lang=EN-GB
style='text-decoration:none'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><u><span lang=EN-GB>Unopened
vials</span></u></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>3 years. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><u><span lang=EN-GB>After
first use</span></u></i><span lang=EN-GB> </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>28 days.</span></p>

<p class=Janis-Deletion align=left style='text-align:left'><span lang=EN-GB
style='text-decoration:none'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>6.4&nbsp;&nbsp;&nbsp;&nbsp; Special
precautions for storage</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not freeze.
Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><u><span lang=EN-GB>Unopened
vials</span></u></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C).&nbsp; </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><u><span lang=EN-GB>After
first use</span></u></i><span lang=EN-GB> </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C) or below 30&deg;C.</span></p>

<p class=Janis-Deletion align=left style='text-align:left'><span lang=EN-GB
style='text-decoration:none'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>6.5&nbsp;&nbsp;&nbsp;&nbsp; Nature and contents of container</span></b><b><span
lang=EN-GB> and special equipment for use, administration or implantation</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The solution is
contained in type I flint glass vials, sealed with butyl or halobutyl stoppers
and secured with aluminium seals. Dimeticone or silicone emulsion may be used
to treat the vial stoppers.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Not all packs
may be marketed.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=ES>1 x 10&nbsp;ml
Liprolog vial.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=ES>2 x 10&nbsp;ml
Liprolog vials.</span></p>

<p class=MsoNormal style='margin-right:.55pt'>5 x (1 x 10&nbsp;ml) Liprolog
vials.</p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.6&nbsp;&nbsp;&nbsp;&nbsp; Special precautions for
disposal and other handling</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Any unused
product or waste material should be disposed of in accordance with local
requirements.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><u><span lang=EN-GB>Instructions
for use and handling</span></u></p>

<p class=Janis-Addition align=left style='text-align:left'><span lang=EN-GB
style='color:windowtext;text-decoration:none'>The vial is to be used in
conjunction with an appropriate syringe (100 unit markings).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Preparing
a dose</u></span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Inspect the
Liprolog solution<i>.</i> It should be clear and colourless. Do not use
Liprolog if it appears cloudy, thickened, or slightly coloured or if solid particles
are visible.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Liprolog</u></span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wash
your hands. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If
using a new vial, flip off the plastic protective cap, but <b>do not</b> remove
the stopper.&nbsp; </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If the therapeutic regimen
requires the injection of basal insulin and Liprolog at the same time, the two
can be mixed in the syringe. If mixing insulins, refer to the instructions for
mixing that follow in Section (ii) and 6.2. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBlockText align=left style='text-align:left;line-height:13.0pt'><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Draw air into the syringe
equal to the prescribed Liprolog dose. Wipe the top of the vial with an alcohol
swab. Put the needle through the rubber top of the Liprolog vial and inject the
air into the vial. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turn
the vial and syringe upside down. Hold the vial and syringe firmly in one hand.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Making sure the tip of the
needle is in the Liprolog, withdraw the correct dose into the syringe. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Before removing the needle
from the vial, check the syringe for air bubbles that reduce the amount of
Liprolog in it. If bubbles are present, hold the syringe straight up and tap
its side until the bubbles float to the top. Push them out with the plunger and
withdraw the correct dose. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBlockText align=left style='text-align:left'><span lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove
the needle from the vial and lay the syringe down so that the needle does not
touch anything.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Mixing
Liprolog with longer-acting Human Insulins (see section 6.2)</u></span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liprolog
should be mixed with longer-acting human insulins only on the advice of a
doctor.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Draw air into the syringe
equal to the amount of longer-acting insulin being taken. Insert the needle
into the longer-acting insulin vial and inject the air. Withdraw the needle. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Now
inject air into the Liprolog vial in the same manner, but <b>do not</b>
withdraw the needle. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turn
the vial and syringe upside down. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Making sure the tip of the
needle is in the Liprolog, withdraw the correct dose of Liprolog into the
syringe. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Before removing the needle
from the vial, check the syringe for air bubbles that reduce the amount of
Liprolog in it. If bubbles are present, hold the syringe straight up and tap
its side until the bubbles float to the top. Push them out with the plunger and
withdraw the correct dose. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove the needle from the
vial of Liprolog and insert it into the vial of the longer-acting insulin. Turn
the vial and syringe upside down. Hold the vial and syringe firmly in one hand
and shake gently. Making sure the tip of the needle is in the insulin, withdraw
the dose of longer-acting insulin.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdraw
the needle and lay the syringe down so that the needle does not touch anything.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Injecting
a dose</u></span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Choose
a site for injection.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clean
the skin as instructed.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stabilise the skin by
spreading it or pinching up a large area. Insert the needle and inject as
instructed.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pull the needle out and apply
gentle pressure over the injection site for several seconds. Do not rub the
area.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dispose of the syringe and
needle safely.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Use of the injection sites
should be rotated so that the same is not used more than approximately once a
month.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Mixing
insulins</u></span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not mix
insulin in vials with insulin in cartridges. See section 6.2.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION HOLDER</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Eli Lilly
Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=FR>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBERS</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=FR>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=FR>EU/1/01/195/001&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1
x 10&nbsp;ml Liprolog vial</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=FR>EU/1/01/195/008&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2
x 10&nbsp;ml Liprolog vials</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=FR>EU/1/01/195/009&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5
x (1 x 10&nbsp;ml) Liprolog vials</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=FR>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=FR>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DATE
OF FIRST AUTHORISATION/RENEWAL OF AUTHORISATION</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Date of first
authorisation: 1<sup>st</sup> August 2001</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Date of last
renewal: 1<sup>st</sup> August 2006</span></p>

<p class=MsoNormal style='margin-right:.55pt'>&nbsp;</p>

<p class=MsoNormal style='margin-right:.55pt'>&nbsp;</p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:25.65pt;margin-bottom:.0001pt;text-indent:-25.65pt'><b><span
lang=EN-GB>10. <span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB>DATE OF REVISION OF THE TEXT</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Liprolog
100&nbsp;units/ml, solution for injection in cartridge</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=Janis-Deletion align=left style='text-align:left'><span lang=EN-GB
style='text-decoration:none'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; QUALITATIVE
AND QUANTITATIVE COMPOSITION</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>2.1&nbsp;&nbsp;&nbsp;&nbsp; General
description</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=Janis-Addition align=left style='text-align:left'><span lang=EN-GB
style='color:windowtext;text-decoration:none'>Liprolog is a sterile, clear,
colourless, aqueous solution.</span><span lang=EN-GB style='color:windowtext'> </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>2.2&nbsp;&nbsp;&nbsp;&nbsp; Qualitative
and quantitative composition</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>One
ml contains 100&nbsp;units (equivalent to 3.5mg) insulin lispro (recombinant
DNA origin produced in E.coli). Each container includes 3ml equivalent to 300&nbsp;units
insulin lispro.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>For a full list
of excipients, see section 6.1.</span></p>

<p class=Janis-Deletion align=left style='text-align:left'><span lang=EN-GB
style='text-decoration:none'>&nbsp;</span></p>

<p class=Janis-Deletion align=left style='text-align:left'><span lang=EN-GB
style='text-decoration:none'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM</span></b></p>

<p class=Janis-Deletion align=left style='text-align:left'><span lang=EN-GB
style='text-decoration:none'>&nbsp;</span></p>

<p class=Janis-Addition align=left style='text-align:left'><span lang=EN-GB
style='color:windowtext;text-decoration:none'>Solution for injection.</span></p>

<p class=Janis-Addition align=left style='text-align:left'><span lang=EN-GB
style='color:windowtext;text-decoration:none'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CLINICAL
PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.<span
style='background:white'>1&nbsp;&nbsp;&nbsp;&nbsp; Therapeutic indications</span></span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>For the
treatment of adults and children with diabetes mellitus who require insulin for
the maintenance of normal glucose homeostasis. Liprolog is also indicated for
the initial stabilisation of diabetes mellitus. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.2&nbsp;&nbsp;&nbsp;&nbsp; Posology
and method of administration</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The dosage
should be determined by the physician, according to the requirement of the
patient. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Liprolog
may be given shortly before meals. When necessary Liprolog can be given soon
after meals. Liprolog preparations should be given by subcutaneous injection or
by continuous subcutaneous infusion pump (see section 4.2) and may, although
not recommended, also be given by intramuscular injection. If necessary,
Liprolog may also be administered intravenously, for example; for the control of
blood glucose levels during ketoacidosis, acute illnesses or during intra and
post operative periods.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Subcutaneous
administration should be in the upper arms, thighs, buttocks, or abdomen. Use
of injection sites should be rotated so that the same site is not used more
than approximately once a month.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>When
administered subcutaneously care should be taken when injecting Liprolog to
ensure that a blood vessel has not been entered. After injection, the site of
injection should not be massaged. Patients must be educated to use the proper
injection techniques.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Liprolog
takes effect rapidly and has a shorter duration of activity (2 to 5&nbsp;hours)
given subcutaneously as compared with regular insulin. This rapid onset of
activity allows a Liprolog injection (or, in the case of administration by
continuous subcutaneous infusion, a Liprolog bolus) to be given very close to
mealtime. The time course of action of any insulin may vary considerably in
different individuals or at different times in the same individual. The faster
onset of action compared to soluble human insulin is maintained regardless of
injection site As with all insulin preparations, the duration of action of
Liprolog is dependent on dose, site of injection, blood supply, temperature,
and physical activity.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Liprolog can be
used in conjunction with a longer-acting insulin or oral sulphonylurea agents,
on the advice of a physician. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><u><span lang=EN-GB>Use of
Liprolog in an insulin infusion pump</span></u><span lang=EN-GB>:</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Only
certain CE-marked insulin infusion pumps may be used to infuse insulin lispro.
Before infusing insulin lispro, the manufacturers instructions should be
studied to ascertain the suitability or otherwise for the particular pump. Read
and follow the instructions that accompany the infusion pump. Use the correct
reservoir and catheter for the pump. </span>The infusion set (tubing and
cannula) should be changed in accordance with the instructions in the product
information supplied with the infusion set. <span lang=EN-GB>&nbsp;In the event
of a hypoglycaemic episode, the infusion should be stopped until the episode is
resolved. If repeated or severe low blood glucose levels occur, notify your
health care professional and consider the need to reduce or stop your insulin
infusion. A pump malfunction or obstruction of the infusion set can result in a
rapid rise in glucose levels. If an interruption to insulin flow is suspected,
follow the instructions in the product literature and if appropriate, notify
your health care professional. When used with an insulin infusion pump,
Liprolog should not be mixed with any other insulin.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><u><span lang=EN-GB>Intravenous
administration of insulin</span></u><span lang=EN-GB>:</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Intravenous
injection of insulin lispro should be carried out following normal clinical
practise for intravenous injections, for example by an intravenous bolus or by
an infusion system. Frequent monitoring of the blood glucose levels is
required.</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Infusion
systems at concentrations from 0.1&nbsp;units/ml to 1.0&nbsp;units/ml insulin
lispro in 0.9% sodium chloride or 5% dextrose are stable at room temperature
for 48&nbsp;hours. It is recommended that the system is primed before starting
the infusion to the patient.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><span
lang=EN-GB>Paediatric population</span></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Liprolog can be used in adolescents and children (see section 5.1).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.3&nbsp;&nbsp;&nbsp;&nbsp; Contraindications</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Hypersensitivity
to insulin lispro or to any of the excipients.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.4&nbsp;&nbsp;&nbsp;&nbsp; Special
warnings and precautions for use</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Transferring a
patient to another type or brand of insulin should be done under strict medical
supervision. Changes in strength, brand (manufacturer), type (regular, NPH,
lente, etc.), species (animal, human, human insulin analogue), and/or method of
manufacture (recombinant DNA versus animal-source insulin) may result in the
need for a change in dosage. </span><span lang=EN-GB style='color:black'>For
fast-acting insulins, any patient also on basal insulin must optimise dosage of
both insulins to obtain glucose control across the whole day, particularly
nocturnal/fasting glucose control.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Conditions
which may make the early warning symptoms of hypoglycaemia different or less
pronounced include long duration of diabetes, intensified insulin therapy,
diabetic nerve disease or medications such as beta-blockers.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>A few patients
who have experienced hypoglycaemic reactions after transfer from animal-source
insulin to human insulin have reported that the early warning symptoms of
hypoglycaemia were less pronounced or different from those experienced with
their previous insulin. Uncorrected hypoglycaemic or hyperglycaemic reactions
can cause loss of consciousness, coma, or death.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The use of
dosages which are inadequate or discontinuation of treatment, especially in
insulin-dependent diabetics, may lead to hyperglycaemia and diabetic
ketoacidosis; conditions which are potentially lethal.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin requirements may be reduced in the
presence of renal impairment.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin
requirements may be reduced in patients with hepatic impairment due to reduced
capacity for gluconeogenesis and reduced insulin breakdown; however, in
patients with chronic hepatic impairment, an increase in insulin resistance may
lead to increased insulin requirements.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin
requirements may be increased during illness or emotional disturbances.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Adjustment of
dosage may also be necessary if patients undertake increased physical activity
or change their usual diet. Exercise taken immediately after a meal may
increase the risk of hypoglycaemia. A consequence of the pharmacodynamics of
rapid-acting insulin analogues is that if hypoglycaemia occurs, it may occur
earlier after an injection when compared with soluble human insulin.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>If the 40&nbsp;units/ml
vial is the product normally prescribed, do not take insulin from a 100&nbsp;units/ml
cartridge using a 40&nbsp;units/ml syringe.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB>Combination of Liprolog with
pioglitazone:</span></u></p>

<p class=MsoNormal><span lang=EN-GB>Cases of cardiac failure have been reported
when pioglitazone was used in combination with insulin, especially in patients
with risk factors for development of cardiac heart failure. This should be kept
in mind if treatment with the combination of pioglitazone and Liprolog is
considered. If the combination is used, patients should be observed for signs
and symptoms of heart failure, weight gain and oedema. Pioglitazone should be
discontinued if any deterioration in cardiac symptoms occurs.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u>Instructions
for use and handling </u></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'>To prevent the
possible transmission of disease, each cartridge must be used by one patient
only, even if the needle on the delivery device is changed.</p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.5&nbsp;&nbsp;&nbsp;&nbsp; Interaction
with other medicinal products and other forms of interaction</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin
requirements may be increased by medicinal products with hyperglycaemic
activity, such as oral contraceptives, corticosteroids, or thyroid replacement
therapy, danazol, beta<sub>2</sub> stimulants (such as ritodrine, salbutamol,
terbutaline). </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Insulin
requirements may be reduced in the presence of medicinal products with
hypoglycaemic activity, such as oral hypoglycaemics, salicylates (for example,
acetylsalicylic acid), sulpha antibiotics, certain antidepressants (monoamine
oxidase inhibitors, selective serotonin reuptake inhibitors), certain
angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II
receptor blockers, beta-blockers, octreotide or alcohol. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The physician
should be consulted when using other medications in addition to Liprolog </span>(see
section <span lang=EN-GB>4.4</span>)<span lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.6&nbsp;&nbsp;&nbsp;&nbsp; Fertility,
pregnancy and lactation</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Data
on a large number of exposed pregnancies do not indicate any adverse effect of
insulin lispro on pregnancy or on the health of the foetus/newborn.&nbsp;&nbsp;
</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>It is essential
to maintain good control of the insulin-treated (insulin-dependent or
gestational diabetes) patient throughout pregnancy. Insulin requirements
usually fall during the first trimester and increase during the second and
third trimesters. Patients with diabetes should be advised to inform their
doctor if they are pregnant or are contemplating pregnancy. Careful monitoring
of glucose control, as well as general health, is essential in pregnant patients
with diabetes. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Patients with
diabetes who are breast-feeding may require adjustments in insulin dose, diet
or both. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>4.7&nbsp;&nbsp;&nbsp;&nbsp; Effects on ability to drive and use
machines</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>The
patient&#8217;s ability to concentrate and react may be impaired as a result of
hypoglycaemia. This may constitute a risk in situations where these abilities
are of special importance (e.g. driving a car or operating machinery).</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Patients
should be advised to take precautions to avoid hypoglycaemia whilst driving,
this is particularly important in those who have reduced or absent awareness of
the warning signs of hypoglycaemia or have frequent episodes of hypoglycaemia.
The advisability of driving should be considered in these circumstances.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.8&nbsp;&nbsp;&nbsp;&nbsp; Undesirable
effects</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>Hypoglycaemia
is the most frequent undesirable effect of insulin therapy that a patient with
diabetes may suffer. Severe hypoglycaemia may lead to loss of consciousness,
and in extreme cases, death. No specific frequency for hypoglycaemia is
presented, since hypoglycaemia is a result of both the insulin dose and other
factors e.g. a patient`s level of diet and exercise.</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>Local allergy
in patients is common (1/100 to &lt;1/10). Redness, swelling, and itching can
occur at the site of insulin injection. This condition usually resolves in a
few days to a few weeks. In some instances, this condition may be related to
factors other than insulin, such as irritants in the skin cleansing agent or
poor injection technique. Systemic allergy,&nbsp; which is rare (1/10,000 to
&lt;1/1,000) but potentially more serious, is a generalised allergy to insulin.
It may cause a rash over the whole body, shortness of breath, wheezing,
reduction in blood pressure, fast pulse, or sweating. Severe cases of
generalised allergy may be life-threatening.</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'>Lipodystrophy
at the injection site is uncommon (1/1,000 to &lt;1/100).</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Cases of oedema have been
reported with insulin therapy, particularly if previous poor metabolic control
is improved by intensified insulin therapy.</p>

<p class=MsoNormal style='margin-right:.55pt'>&nbsp;</p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB>Reporting of
suspected adverse reactions</span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Reporting
suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals are asked to report any suspected
adverse reactions via <span style='background:silver'>the national reporting
system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span>.</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>4.9&nbsp;&nbsp;&nbsp;&nbsp; Overdose</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulins have no
specific overdose definitions because serum glucose concentrations are a result
of complex interactions between insulin levels, glucose availability and other
metabolic processes. Hypoglycaemia may occur as a result of an excess of
insulin activity relative to food intake and energy expenditure.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Hypoglycaemia
may be associated with listlessness, confusion, palpitations, headache,
sweating and vomiting.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Mild
hypoglycaemic episodes will respond to oral administration of glucose or other
sugar or saccharated products.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Correction of
moderately severe hypoglycaemia can be accomplished by intramuscular or
subcutaneous administration of glucagon, followed by oral carbohydrate when the
patient recovers sufficiently. Patients who fail to respond to glucagon must be
given glucose solution intravenously.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>If the patient
is comatose, glucagon should be administered intramuscularly or subcutaneously.
However, glucose solution must be given intravenously if glucagon is not
available or if the patient fails to respond to glucagon. The patient should be
given a meal as soon as consciousness is recovered.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Sustained
carbohydrate intake and observation may be necessary because hypoglycaemia may
recur after apparent clinical recovery.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACOLOGICAL
PROPERTIES</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>5.1&nbsp;&nbsp;&nbsp;&nbsp; Pharmacodynamic
properties</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Pharmacotherapeutic
group :Fast-acting human insulin analogue. ATC code: A10A B04</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The primary
activity of insulin lispro is the regulation of glucose metabolism.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>In addition,
insulins have several anabolic and anti-catabolic actions on a variety of
different tissues. Within muscle tissue this includes increasing glycogen,
fatty acid, glycerol and protein synthesis and amino acid uptake, while
decreasing glycogenolysis, gluconeogenesis, ketogenesis, lipolysis, protein
catabolism and amino acid output.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Insulin
lispro has a rapid onset of action (approximately 15&nbsp;minutes), thus
allowing it to be given closer to a meal (within zero to 15 minutes of the
meal) when compared to regular insulin (30 to 45&nbsp;minutes before). Insulin
lispro takes effect rapidly and has a shorter duration of activity (2 to
5&nbsp;hours) when compared to regular insulin. </span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Clinical trials
in patients with type 1 and type 2 diabetes have demonstrated reduced
postprandial hyperglycaemia with insulin lispro compared to soluble human
insulin. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>As
with all insulin preparations, the time course of insulin lispro action may
vary in different individuals or at different times in the same individual and
is dependent on dose, site of injection, blood supply, temperature and physical
activity. The typical activity profile following subcutaneous injection is
illustrated below.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<div>

<table cellspacing=0 cellpadding=0 hspace=0 vspace=0>
 <tr>
  <td valign=top align=left style='padding-top:0in;padding-right:9.05pt;
  padding-bottom:0in;padding-left:9.05pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB><img border=0
  width=403 height=259 src="Humalo_files/image002.gif"></span></p>
  </td>
 </tr>
</table>

</div>

<br clear=ALL>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The above
representation reflects the relative amount of glucose over time required to
maintain the subject's whole blood glucose concentrations near fasting levels
and is an indicator of the effect of these insulins on glucose metabolism over
time.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Clinical trials
have been performed in children (61 patients aged 2 to 11) and children and
adolescents (481 patients aged 9 to 19 years), comparing insulin lispro to
human soluble insulin. The pharmacodynamic profile of insulin lispro in
children is similar to that seen in adults. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB
style='layout-grid-mode:line'>When used in subcutaneous infusion pumps,
treatment with insulin lispro has been shown to result in lower glycosylated
haemoglobin levels compared to soluble insulin.&nbsp; In a double-blind, crossover
study, the reduction in glycosylated haemoglobin levels after 12 weeks dosing
was 0.37 percentage points with insulin lispro, compared to 0.03 percentage
points for soluble insulin (p&nbsp;=&nbsp;0.004).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB
style='layout-grid-mode:line'>In patients with type 2 diabetes on maximum doses
of sulphonyl urea agents, studies have shown that the addition of insulin
lispro significantly reduces HbA<sub>1c</sub> compared to sulphonyl urea alone.
The reduction of HbA<sub>1c</sub> would also be expected with other insulin
products e.g. soluble or isophane insulins.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB
style='layout-grid-mode:line'>Clinical trials in patients with type 1 and type
2 diabetes have demonstrated a reduced number of episodes of nocturnal
hypoglycaemia with insulin lispro compared to soluble human insulin. In some
studies, reduction of nocturnal hypoglycaemia was associated with increased
episodes of daytime hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The glucodynamic
response to insulin lispro is not affected by renal or hepatic function
impairment. Glucodynamic differences between insulin lispro and soluble human
insulin, as measured during a glucose clamp procedure, were maintained over a
wide range of renal function. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Insulin
lispro has been shown to be equipotent to human insulin on a molar basis but
its effect is more rapid and of a shorter duration.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>5.2&nbsp;&nbsp;&nbsp;&nbsp; Pharmacokinetic
properties</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The pharmacokinetics
of insulin lispro reflect a compound that is rapidly absorbed, and achieves
peak blood levels 30 to 70 minutes following subcutaneous injection. When
considering the clinical relevance of these kinetics, it is more appropriate to
examine the glucose utilisation curves (as discussed in 5.1).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin lispro
maintains more rapid absorption when compared to soluble human insulin in
patients with renal impairment. In patients with type 2 diabetes over a wide
range of renal function&nbsp; the pharmacokinetic differences between insulin
lispro and soluble human insulin were generally maintained and shown to be
independent of renal function.&nbsp; Insulin lispro maintains more rapid
absorption and elimination when compared to soluble human insulin in patients
with hepatic impairment.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>5.3&nbsp;&nbsp;&nbsp;&nbsp; Preclinical
safety data</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>In <i>in vitro</i>
tests, including binding to insulin receptor sites and effects on growing
cells, insulin lispro behaved in a manner that closely resembled human insulin.
Studies also demonstrate that the dissociation of binding to the insulin
receptor of insulin lispro is equivalent to human insulin. Acute, one month and
twelve month toxicology studies produced no significant toxicity findings.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin lispro
did not induce fertility impairment, embryotoxicity or teratogenicity in animal
studies. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>6.1&nbsp;&nbsp;&nbsp;&nbsp; List
of excipients</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>m-</span></i><span
lang=EN-GB>Cresol </span><span lang=EN-GB>[3.15&nbsp;mg/ml]</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Glycerol</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Dibasic sodium
phosphate.&nbsp;7H<span style='position:relative;top:3.0pt'>2</span>O</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Zinc oxide</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Water for
injections</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Hydrochloric
acid and sodium hydroxide maybe used to adjust pH to 7.0 &#8211; 7.8.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>6.2&nbsp;&nbsp;&nbsp;&nbsp; Incompatibilities</span></b></p>

<p class=Janis-Deletion align=left style='text-align:left'><span lang=EN-GB
style='text-decoration:none'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog
preparations should not be mixed with insulins produced by other manufacturers
or with animal insulin preparations. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>6.3&nbsp;&nbsp;&nbsp;&nbsp; Shelf
life</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><i><u><span
lang=EN-GB>Unused cartridge</span></u></i></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>3 years.
</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><i><u><span
lang=EN-GB>After cartridge insertion</span></u></i><span lang=EN-GB> </span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>28
days.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>6.4&nbsp;&nbsp;&nbsp;&nbsp; Special
precautions for storage</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><i><u><span
lang=EN-GB>Unused cartridge</span></u></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C). Do not freeze. Do not expose to excessive
heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><u><span
lang=EN-GB>After cartridge insertion</span></u></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Store below 30&deg;C. Do not refrigerate. The pen with the inserted
cartridge should not be stored with the needle attached.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>6.5&nbsp;&nbsp;&nbsp;&nbsp; Nature and contents of container</span></b><b><span
lang=EN-GB> and special equipment for use, administration or implantation</span></b></p>

<p class=Janis-Deletion align=left style='text-align:left'><span lang=EN-GB
style='text-decoration:none'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The solution is
contained in type I flint glass cartridges, sealed with butyl or halobutyl disc
seals and plunger heads, and are secured with aluminium seals. Dimeticone or
silicone emulsion may be used to treat the cartridge plungers, and/or the glass
cartridges.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Not all packs
may be marketed.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>5 x 3&nbsp;ml
Liprolog cartridges for a 3&nbsp;ml pen</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>10 x 3&nbsp;ml
Liprolog cartridges for a 3&nbsp;ml pen</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.6&nbsp;&nbsp;&nbsp;&nbsp; Special precautions for
disposal and other handling</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Any unused
product or waste material should be disposed of in accordance with local
requirements.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><u><span lang=EN-GB>Instructions
for use and handling </span></u></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'>To prevent the
possible transmission of disease, each cartridge must be used by one patient
only, even if the needle on the delivery device is changed.</p>

<p class=MsoNormal style='margin-right:.55pt'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=Janis-Addition align=left style='text-align:left'><span lang=EN-GB
style='color:windowtext;text-decoration:none'>Liprolog cartridges are to be
used with a CE marked pen as recommended in the information provided by the
device manufacturer.</span></p>

<p class=Janis-Addition align=left style='text-align:left'><span lang=EN-GB
style='color:windowtext;text-decoration:none'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Preparing
a dose</u></span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Inspect the
Liprolog solution. It should be clear and colourless. Do not use Liprolog if it
appears cloudy, thickened, or slightly coloured or if solid particles are
visible.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>The following is a general description. The
manufacturer&#8217;s instructions with each individual pen must be followed for
loading the cartridge, attaching the needle and administering the insulin
injection.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Injecting
a dose</u></span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wash
your hands.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Choose
a site for injection.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clean
the skin as instructed.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove
outer needle cap.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stabili<span
style='background:white'>s</span>e the skin by spreading it or pinching up a
large area. Insert the needle as instructed.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Press
the knob.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pull the needle out and apply
gentle pressure over the injection site for several seconds. Do not rub the
area.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Using
the outer needle cap, unscrew the needle and dispose of it safely.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Use of injection sites should
be rotated so that the same site is not used more than approximately once a
month.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Mixing
insulins</u></span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not mix
insulin in vials with insulin in cartridges. See section 6.2.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION HOLDER</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Eli Lilly Nederland B V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBERS</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>EU/1/01/195/002&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5
x 3&nbsp;ml Liprolog cartridges for a 3&nbsp;ml pen</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>EU/1/01/195/010&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10
x 3&nbsp;ml Liprolog cartridges for a 3&nbsp;ml pen</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DATE
OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Date of first
authorisation: 1<sup>st</sup> August 2001</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Date of last
renewal: 1<sup>st</sup> August 2006</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b>&nbsp;</b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>10.&nbsp;&nbsp;&nbsp;&nbsp; DATE
OF REVISION OF THE TEXT</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF THE MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Liprolog Mix25
100&nbsp;units/ml, suspension for injection in cartridge</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; QUALITATIVE AND QUANTITATIVE
COMPOSITION</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>2.1&nbsp;&nbsp;&nbsp;&nbsp; General
description</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Liprolog Mix25
is a white, sterile suspension. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>2.2&nbsp;&nbsp;&nbsp;&nbsp; Qualitative
and quantitative composition</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>One
ml contains 100&nbsp;units (equivalent to 3.5mg) insulin lispro (recombinant
DNA origin produced in E.coli). Each container includes 3ml equivalent to 300&nbsp;units
insulin lispro.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>Liprolog Mix25 consists of 25% insulin lispro solution and 75%
insulin lispro protamine suspension.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>For a full list of excipients, see section 6.1.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL FORM</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Suspension for
injection.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CLINICAL PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>4.1&nbsp;&nbsp;&nbsp;&nbsp; Therapeutic indications</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Liprolog Mix25
is indicated for the treatment of patients with diabetes mellitus who require
insulin for the maintenance of normal glucose homeostasis. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>4.2&nbsp;&nbsp;&nbsp;&nbsp; Posology and method of administration</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>The dosage
should be determined by the physician, according to the requirement of the
patient.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Liprolog Mix25
may be given shortly before meals. When necessary, Liprolog Mix25 can be given
soon after meals. Liprolog Mix25 should only be given by subcutaneous
injection. Under no circumstances should Liprolog Mix25 be given intravenously.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Subcutaneous
administration should be in the upper arms, thighs, buttocks, or abdomen.&nbsp;
Use of injection sites should be rotated so that the same site is not used more
than approximately once a month.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>When
administered subcutaneously care should be taken when injecting Liprolog Mix25
to ensure that a blood vessel has not been entered. After injection, the site
of injection should not be massaged. Patients must be educated to use the
proper injection techniques.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>The rapid
onset and early peak of activity of Liprolog itself is observed following the
subcutaneous administration of Liprolog Mix25. This allows Liprolog Mix25 to be
given very close to mealtime. The duration of action of the insulin lispro
protamine suspension (Basal) component of Liprolog Mix25 is similar to that of
a basal insulin NPH.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>The time
course of action of any insulin may vary considerably in different individuals
or at different times in the same individual. As with all insulin preparations,
the duration of action of Liprolog Mix25 is dependent on dose, site of
injection, blood supply, temperature, and physical activity.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><span
lang=EN-GB>Paediatric population</span></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Administration of Liprolog Mix25 to children below 12 years of age
should be considered only in case of an expected benefit when compared to
regular insulin.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>4.3&nbsp;&nbsp;&nbsp;&nbsp; Contraindications</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>Hypersensitivity to insulin lispro or to any of the excipients.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>Hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:25.65pt;margin-bottom:.0001pt;text-indent:-25.65pt'><b><span
lang=EN-GB>4.4 <span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB>Special warnings and precautions for use</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in'><span lang=EN-GB>Under
no circumstances should Liprolog Mix25 be given intravenously.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Transferring a
patient to another type or brand of insulin should be done under strict medical
supervision.&nbsp; Changes in strength, brand (manufacturer), type (regular,
NPH, lente, etc.), species (animal, human, human insulin analogue), and/or
method of manufacture (recombinant DNA versus animal-source insulin) may result
in the need for a change in dosage.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Conditions
which may make the early warning symptoms of hypoglycaemia different or less
pronounced include long duration of diabetes, intensified insulin therapy,
diabetic nerve disease or medications such as beta-blockers.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>A few patients
who have experienced hypoglycaemic reactions after transfer from animal-source
insulin to human insulin have reported that the early warning symptoms of
hypoglycaemia were less pronounced or different from those experienced with
their previous insulin. Uncorrected hypoglycaemic or hyperglycaemic reactions
can cause loss of consciousness, coma, or death.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>The use of
dosages which are inadequate or discontinuation of treatment, especially in
insulin-dependent diabetics, may lead to hyperglycaemia and diabetic
ketoacidosis; conditions which are potentially lethal.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin requirements may be reduced in the
presence of renal impairment.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin
requirements may be reduced in patients with hepatic impairment due to reduced
capacity for gluconeogenesis and reduced insulin breakdown; however, in
patients with chronic hepatic impairment, an increase in insulin resistance may
lead to increased insulin requirements.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin
requirements may be increased during illness or emotional disturbances.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Adjustment of
dosage may also be necessary if patients undertake increased physical activity
or change their usual diet. Exercise taken immediately after a meal may
increase the risk of hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB>Combination of Liprolog Mix25 with
pioglitazone:</span></u></p>

<p class=MsoNormal><span lang=EN-GB>Cases of cardiac failure have been reported
when pioglitazone was used in combination with insulin, especially in patients
with risk factors for development of cardiac heart failure. This should be kept
in mind if treatment with the combination of pioglitazone and Liprolog Mix25 is
considered. If the combination is used, patients should be observed for signs
and symptoms of heart failure, weight gain and oedema. Pioglitazone should be
discontinued if any deterioration in cardiac symptoms occurs.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u>Instructions
for use and handling </u></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'>To prevent the
possible transmission of disease, each cartridge must be used by one patient
only, even if the needle on the delivery device is changed.</p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;page-break-after:
avoid'><b><span lang=EN-GB>4.5&nbsp;&nbsp;&nbsp;&nbsp; Interaction with other
medicinal products and other forms of interaction</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;page-break-after:avoid'><span
lang=EN-GB>Insulin requirements may be increased by substances with
hyperglycaemic activity, such as oral contraceptives, corticosteroids, or
thyroid replacement therapy, danazol, beta<sub>2</sub> stimulants (such as
ritodrine, salbutamol, terbutaline). </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin
requirements may be reduced in the presence of substances with hypoglycaemic
activity, such as oral hypoglycaemics, salicylates (for example,
acetylsalicylic acid), sulpha antibiotics, certain antidepressants (monoamine
oxidase inhibitors, selective serotonin reuptake inhibitors), certain
angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II
receptor blockers, beta-blockers, octreotide or alcohol. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>Mixing Liprolog Mix25 with other insulins has not been studied.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>The physician
should be consulted when using other medications in addition to Liprolog Mix25 </span>(see
section <span lang=EN-GB>4.4</span>)<span lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>4.6&nbsp;&nbsp;&nbsp;&nbsp; Fertility, pregnancy and lactation</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Data
on a large number of exposed pregnancies do not indicate any adverse effect of
insulin lispro on pregnancy or on the health of the foetus/newborn.&nbsp;&nbsp;
</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>It is
essential to maintain good control of the insulin-treated (insulin-dependent or
gestational diabetes) patient throughout pregnancy. Insulin requirements
usually fall during the first trimester and increase during the second and
third trimesters. Patients with diabetes should be advised to inform their
doctor if they are pregnant or are contemplating pregnancy. Careful monitoring
of glucose control, as well as general health, is essential in pregnant
patients with diabetes. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Patients with
diabetes who are breast-feeding may require adjustments in insulin dose, diet
or both. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>4.7&nbsp;&nbsp;&nbsp;&nbsp; Effects on ability to drive and use
machines</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>The
patient&#8217;s ability to concentrate and react may be impaired as a result of
hypoglycaemia. This may constitute a risk in situations where these abilities are
of special importance (e.g. driving a car or operating machinery).</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Patients
should be advised to take precautions to avoid hypoglycaemia whilst driving,
this is particularly important in those who have reduced or absent awareness of
the warning signs of hypoglycaemia or have frequent episodes of hypoglycaemia.
The advisability of driving should be considered in these circumstances.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>4.8&nbsp;&nbsp;&nbsp;&nbsp; Undesirable effects</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>Hypoglycaemia
is the most frequent undesirable effect of insulin therapy that a patient with
diabetes may suffer. Severe hypoglycaemia may lead to loss of consciousness,
and in extreme cases, death. No specific frequency for hypoglycaemia is
presented, since hypoglycaemia is a result of both the insulin dose and other
factors e.g. a patient`s level of diet and exercise.</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>Local allergy
in patients is common (1/100 to &lt;1/10). Redness, swelling, and itching can
occur at the site of insulin injection. This condition usually resolves in a
few days to a few weeks. In some instances, this condition may be related to
factors other than insulin, such as irritants in the skin cleansing agent or
poor injection technique. Systemic allergy, which is rare (1/10,000 to
&lt;1/1,000) but potentially more serious, is a generalised allergy to insulin.
It may cause a rash over the whole body, shortness of breath, wheezing,
reduction in blood pressure, fast pulse, or sweating. Severe cases of
generalised allergy may be life-threatening.</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'>Lipodystrophy
at the injection site is uncommon (1/1,000 to &lt;1/100).</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Cases of oedema have been
reported with insulin therapy, particularly if previous poor metabolic control
is improved by intensified insulin therapy.</p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt'>&nbsp;</p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB>Reporting of
suspected adverse reactions</span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Reporting
suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals are asked to report any suspected
adverse reactions via <span style='background:silver'>the national reporting
system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span>.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>4.9&nbsp;&nbsp;&nbsp;&nbsp; Overdose</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Insulins have
no specific overdose definitions because serum glucose concentrations are a
result of complex interactions between insulin levels, glucose availability and
other metabolic processes.&nbsp; Hypoglycaemia may occur as a result of an
excess of insulin activity relative to food intake and energy expenditure.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Hypoglycaemia
may be associated with listlessness, confusion, palpitations, headache,
sweating and vomiting.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Mild
hypoglycaemic episodes will respond to oral administration of glucose or other
sugar or saccharated products.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Correction of
moderately severe hypoglycaemia can be accomplished by intramuscular or
subcutaneous administration of glucagon, followed by oral carbohydrate when the
patient recovers sufficiently.&nbsp; Patients who fail to respond to glucagon
must be given glucose solution intravenously.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>If the patient
is comatose, glucagon should be administered intramuscularly or
subcutaneously.&nbsp; However, glucose solution must be given intravenously if
glucagon is not available or if the patient fails to respond to glucagon. The
patient should be given a meal as soon as consciousness is recovered.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Sustained
carbohydrate intake and observation may be necessary because hypoglycaemia may
recur after apparent clinical recovery.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACOLOGICAL PROPERTIES</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>5.1&nbsp;&nbsp;&nbsp;&nbsp; Pharmacodynamic properties</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Pharmaco-therapeutic
group: ATC Code: A10A D04.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Liprolog Mix25
is a premixed suspension consisting of insulin lispro (fast-acting human
insulin analogue) and insulin lispro protamine suspension (intermediate acting
human insulin analogue). </span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>The primary
activity of insulin lispro is the regulation of glucose metabolism.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>In addition,
insulins have several anabolic and anti-catabolic actions on a variety of
different tissues.&nbsp; Within muscle tissue this includes increasing
glycogen, fatty acid, glycerol and protein synthesis and amino acid uptake,
while decreasing glycogenolysis, gluconeogenesis, ketogenesis, lipolysis,
protein catabolism and amino acid output.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:13.0pt'><span
lang=EN-GB>Insulin lispro has a rapid onset of action (approximately 15
minutes), thus allowing it to be given closer to a meal (within zero to 15
minutes of the meal) when compared to regular insulin (30 to 45 minutes before).
The rapid onset and early peak of activity of insulin lispro is observed
following the subcutaneous administration of Liprolog Mix25. Liprolog Basal has
an activity profile that is very similar to that of a basal insulin (NPH) over
a period of approximately 15 hours. </span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:13.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Clinical trials in patients with type 1 and
type 2 diabetes have demonstrated reduced postprandial hyperglycaemia with
Liprolog Mix25 compared to human insulin mixture 30/70. In one clinical study
there was a small (0.38 mmol/l) increase in blood glucose levels at night
(3a.m.).</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:13.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:13.0pt'><span
lang=EN-GB>In the figure below the pharmacodynamics of Liprolog Mix25 and
Liprolog Basal are illustrated.</span></p>

<p class=MsoNormal style='text-indent:113.4pt;line-height:normal'><span
style='position:absolute;z-index:251622400;left:0px;margin-left:1px;margin-top:
49px;width:350px;height:273px'><img width=350 height=273
src="Humalo_files/image003.gif"></span><a name="_MON_1046863113"></a><a
name="_MON_1046865540"></a><a name="_MON_1208865060"></a><a
name="_MON_1259496555"></a><a name="_MON_1259496877"></a><a
name="_MON_1046862617"></a><a name="_MON_1046862712"></a><span lang=EN-GB><img
border=0 width=387 height=279 src="Humalo_files/image004.gif"></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:2.0in;margin-bottom:.0001pt;text-indent:23.5pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:2.0in;margin-bottom:.0001pt;text-indent:23.5pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>The above
representation reflects the relative amount of glucose over time required to
maintain the subject's whole blood glucose concentrations near fasting levels
and is an indicator of the effect of these insulins on glucose metabolism over
time.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The glucodynamic
response to insulin lispro is not affected by renal or hepatic function impairment.
Glucodynamic differences between insulin lispro and soluble human insulin, as
measured during a glucose clamp procedure, were maintained over a wide range of
renal function. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Insulin
lispro has been shown to be equipotent to human insulin on a molar basis but
its effect is more rapid and of a shorter duration.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormalIndent style='margin-left:0in'><span lang=EN-GB
style='font-size:11.0pt'>In two 8-month open label crossover studies, type 2
diabetes patients who were either new to insulin therapy or already using one
or two injections of insulin, received 4 months of treatment with Liprolog
Mix25 (used twice daily with metformin) and insulin glargine (used once daily
with metformin) in a randomised sequence. Detailed information can be found in
the following table.</span></p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=609
 style='margin-left:2.0pt;border-collapse:collapse;border:none'>
 <tr>
  <td width=255 valign=top style='width:191.4pt;border:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='margin-top:0in;margin-right:2.0pt;margin-bottom:
  0in;margin-left:2.0pt;margin-bottom:.0001pt;line-height:12.0pt;page-break-after:
  avoid;text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=177 valign=top style='width:132.65pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:2.0pt;
  margin-bottom:0in;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><b><span
  lang=FR style='color:black'>Insulin-Naive Patients</span></b></p>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:2.0pt;
  margin-bottom:0in;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span lang=FR
  style='color:black'>n = 78</span></p>
  </td>
  <td width=177 valign=top style='width:132.7pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:2.0pt;
  margin-bottom:0in;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><b><span
  lang=EN-GB style='color:black'>Not Insulin-Naive Patients</span></b></p>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:2.0pt;
  margin-bottom:0in;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>n = 97</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top style='width:191.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='margin-top:0in;margin-right:2.0pt;margin-bottom:
  0in;margin-left:2.0pt;margin-bottom:.0001pt;line-height:12.0pt;page-break-after:
  avoid;text-autospace:none'><span lang=EN-GB>Mean total daily insulin dose at
  endpoint</span></p>
  </td>
  <td width=177 valign=top style='width:132.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:2.0pt;
  margin-bottom:0in;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>0.63&nbsp;units/kg</span></p>
  </td>
  <td width=177 valign=top style='width:132.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:2.0pt;
  margin-bottom:0in;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>0.42&nbsp;units/kg</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top style='width:191.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='margin-left:.75pt;line-height:12.0pt;page-break-after:
  avoid;text-autospace:none'><span lang=EN-GB style='color:black'>Haemoglobin
  A1c &#8211;Reduction<sup><span style='position:relative;top:-3.0pt'>1</span></sup>&nbsp;</span></p>
  </td>
  <td width=177 valign=top style='width:132.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>1.30%</span></p>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=DE-AT style='color:black'>(mean at baseline = 8.7%)</span></p>
  </td>
  <td width=177 valign=top style='width:132.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=DE-AT style='color:black'>1.00 %</span></p>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>(mean at baseline = 8.5%)</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top style='width:191.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='margin-left:.75pt;line-height:12.0pt;page-break-after:
  avoid;text-autospace:none'><span lang=EN-GB style='color:black'>Reduction of
  the mean of combined morning / evening two-hour postprandial blood glucose<sup><span
  style='position:relative;top:-3.0pt'>1</span></sup>&nbsp;</span></p>
  </td>
  <td width=177 valign=top style='width:132.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>3.46 mM</span></p>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  </td>
  <td width=177 valign=top style='width:132.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>2.48 mM</span></p>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top style='width:191.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='margin-left:.75pt;line-height:12.0pt;page-break-after:
  avoid;text-autospace:none'><span lang=EN-GB style='color:black'>Reduction of
  the mean fasting blood glucose<sup><span style='position:relative;top:-3.0pt'>1</span></sup>&nbsp;</span></p>
  </td>
  <td width=177 valign=top style='width:132.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>0.55 mM</span></p>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  </td>
  <td width=177 valign=top style='width:132.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>0.65 mM</span></p>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top style='width:191.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='margin-left:.75pt;line-height:12.0pt;page-break-after:
  avoid;text-autospace:none'><span lang=EN-GB style='color:black'>Incidence of
  hypoglycaemia at endpoint</span></p>
  </td>
  <td width=177 valign=top style='width:132.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>25%</span></p>
  </td>
  <td width=177 valign=top style='width:132.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>25%</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top style='width:191.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='margin-left:.75pt;line-height:12.0pt;page-break-after:
  avoid;text-autospace:none'><span lang=EN-GB style='color:black'>Bodyweight
  gain<sup>2</sup></span></p>
  </td>
  <td width=177 valign=top style='width:132.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>2.33 kg</span></p>
  </td>
  <td width=177 valign=top style='width:132.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>0.96 kg</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='line-height:12.0pt;page-break-after:avoid;text-autospace:
none'><span lang=EN-GB style='font-size:9.0pt;color:black;position:relative;
top:-3.0pt'>1</span><span lang=EN-GB style='font-size:10.0pt;color:black'>&nbsp;from
baseline to end of Liprolog Mix25 treatment</span></p>

<p class=MsoNormal style='line-height:12.0pt;page-break-after:avoid;text-autospace:
none'><sup><span lang=EN-GB style='color:black'>2</span></sup><span lang=EN-GB
style='font-size:10.0pt;color:black'> in patients randomised to Liprolog Mix25
during the first crossover period</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b><span
lang=EN-GB>5.2&nbsp;&nbsp;&nbsp; Pharmacokinetic properties</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>The
pharmacokinetics of insulin lispro reflect a compound that is rapidly absorbed,
and achieves peak blood levels 30 to 70 minutes following subcutaneous
injection. The pharmacokinetics of insulin lispro protamine suspension are
consistent with those of an intermediate acting insulin such as NPH. The
pharmacokinetics of Liprolog Mix25 are representative of the individual
pharmacokinetic properties of the two components. When considering the clinical
relevance of these kinetics, it is more appropriate to examine the glucose
utilisation curves (as discussed in 5.1).</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin lispro
maintains more rapid absorption when compared to soluble human insulin in
patients with renal impairment. In patients with type 2 diabetes over a wide
range of renal function the pharmacokinetic differences between insulin lispro
and soluble human insulin were generally maintained and shown to be independent
of renal function.&nbsp; Insulin lispro maintains more rapid absorption and
elimination when compared to soluble human insulin in patients with hepatic
impairment.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><b><span lang=EN-GB>5.3&nbsp;&nbsp;&nbsp;&nbsp; Preclinical
safety data</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>In <i>in vitro</i>
tests, including binding to insulin receptor sites and effects on growing
cells, insulin lispro behaved in a manner that closely resembled human
insulin.&nbsp; Studies also demonstrate that the dissociation of binding to the
insulin receptor of insulin lispro is equivalent to human insulin. Acute, one
month and twelve month toxicology studies produced no significant toxicity
findings.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Insulin lispro
did not induce fertility impairment, embryotoxicity or teratogenicity in animal
studies. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>6.1&nbsp;&nbsp;&nbsp;&nbsp; List of excipients</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Protamine sulphate</span></p>

<p class=MsoNormal><i><span lang=EN-GB>m-</span></i><span lang=EN-GB>cresol</span><span
lang=EN-GB> [1.76 mg/ml]</span></p>

<p class=MsoNormal><span lang=EN-GB>Phenol [0.80 mg/ml]</span></p>

<p class=MsoNormal><span lang=EN-GB>Glycerol</span></p>

<p class=MsoNormal><span lang=EN-GB>Dibasic sodium phosphate.7H<span
style='position:relative;top:2.0pt'>2</span>O</span></p>

<p class=MsoNormal><span lang=EN-GB>Zinc oxide</span></p>

<p class=MsoNormal><span lang=EN-GB>Water for injections</span></p>

<p class=MsoNormal><span lang=EN-GB>Hydrochloric acid and sodium hydroxide may
be used to adjust pH to 7.0 &#8211; 7.8.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;page-break-after:
avoid'><b><span lang=EN-GB>6.2&nbsp;&nbsp;&nbsp;&nbsp; Incompatibilities</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Mixing
Liprolog Mix25 with other insulins has not been studied. In the absence of
compatibility studies, this medicinal product must not be mixed with other
medicinal products.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>6.3&nbsp;&nbsp;&nbsp;&nbsp; Shelf life</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><i><u><span
lang=EN-GB>Unused cartridge</span></u></i></p>

<p class=MsoNormal><span lang=EN-GB>3 years. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><i><u><span lang=EN-GB>After cartridge insertion</span></u></i></p>

<p class=MsoNormal><span lang=EN-GB>28 days.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>6.4&nbsp;&nbsp;&nbsp;&nbsp; Special precautions for storage</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><i><u><span
lang=EN-GB>Unused cartridge</span></u></i></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C). Do not freeze. Do not expose to excessive
heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><u><span
lang=EN-GB>After cartridge insertion</span></u></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Store below 30&deg;C. Do not refrigerate. The pen with the inserted
cartridge should not be stored with the needle attached.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>6.5&nbsp;&nbsp;&nbsp;&nbsp; Nature and contents of container</span></b><b><span
lang=EN-GB> and special equipment for use, administration or implantation</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>The suspension
is contained in type I flint glass cartridges, sealed with butyl or halobutyl
disc seals and plunger heads and secured with aluminium seals. Dimeticone or
silicone emulsion may have been used to treat the cartridge plunger, and/or the
glass cartridge.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Not all packs
may be marketed.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>5 x 3 ml Liprolog Mix25 cartridges for a 3 ml pen.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>10 x 3 ml Liprolog Mix25 cartridges for a 3 ml pen.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.6&nbsp;&nbsp;&nbsp;&nbsp; Special precautions for
disposal and other handling</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Any unused
product or waste material should be disposed of in accordance with local
requirements.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><u><span
lang=EN-GB>Instructions for use and handling</span></u></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'>To prevent the
possible transmission of disease, each cartridge must be used by one patient
only, even if the needle on the delivery device is changed.</p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:13.0pt'><span
lang=EN-GB>Liprolog Mix25 cartridges are to be used with a CE marked pen as
recommended in the information provided by the device manufacturer.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:13.0pt'><span
lang=EN-GB>a) Preparing a dose</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Cartridges
containing Liprolog Mix25 should be rotated in the palms of the hands ten times
and inverted 180&deg; ten times immediately before use to resuspend the insulin
until it appears uniformly cloudy or milky.&nbsp; If not, repeat the above
procedure until contents are mixed.&nbsp; Cartridges contain a small glass bead
to assist mixing.&nbsp; Do not shake vigorously as this may cause frothing
which may interfere with the correct measurement of the dose.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>The cartridges
should be examined frequently and should not be used if clumps of material are
present or if solid white particles stick to the bottom or wall of the
cartridge, giving a frosted appearance.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Liprolog Mix25
cartridges are not designed to allow any other insulin to be mixed in the
cartridge.&nbsp; Cartridges are not designed to be refilled.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>The following
is a general description. The manufacturer's instructions with each individual
pen must be followed for loading the cartridge, attaching the needle and
administering the insulin injection.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>b) <u>Injecting a dose</u></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wash
your hands.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Choose
a site for injection.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clean
the skin as instructed.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove
outer needle cap.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:13.0pt'><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stabilise the skin by
spreading it or pinching up a large area. Insert the needle as instructed.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Press
the knob.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pull the needle out and apply
gentle pressure over the injection site for several seconds. Do not rub the
area.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Using
the outer needle cap, unscrew the needle and dispose of it safely.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Use of injection sites should
be rotated so that the same site is not used more than approximately once a
month.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING AUTHORISATION
HOLDER</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING AUTHORISATION
NUMBERS</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>EU/1/01/195/003&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5
x 3 ml Liprolog Mix25 cartridges for a 3 ml pen</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>EU/1/01/195/011&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10
x 3 ml Liprolog Mix25 cartridges for a 3 ml pen</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DATE OF FIRST
AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Date of first
authorisation: 1<sup>st</sup> August 2001</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Date of last
renewal: 1<sup>st</sup> August 2006</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b>&nbsp;</b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>10.&nbsp;&nbsp;&nbsp;&nbsp; DATE OF REVISION OF THE TEXT</span></b></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF THE MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Liprolog Mix50 100&nbsp;units/ml, suspension for injection in
cartridge</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; QUALITATIVE
AND QUANTITATIVE COMPOSITION</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>2.1&nbsp;&nbsp;&nbsp;&nbsp; General
description</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Liprolog Mix50 is a white, sterile suspension. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>2.2&nbsp;&nbsp;&nbsp;&nbsp; Qualitative
and quantitative composition</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>One
ml contains 100&nbsp;units (equivalent to 3.5mg) insulin lispro (recombinant
DNA origin produced in E.coli). Each container includes 3ml equivalent to 300&nbsp;units
insulin lispro.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Liprolog Mix50 consists of 50% insulin lispro solution
and 50% insulin lispro protamine suspension.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>For a full list of excipients, see section 6.1.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Suspension for injection.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CLINICAL
PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.1&nbsp;&nbsp;&nbsp;&nbsp; Therapeutic indications</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Liprolog Mix50 is indicated for the treatment of patients with
diabetes mellitus who require insulin for the maintenance of normal glucose
homeostasis. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.2&nbsp;&nbsp;&nbsp;&nbsp; Posology and method of
administration</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The dosage should be determined by the physician, according to the
requirement of the patient.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Liprolog Mix50 may be given shortly before meals. When necessary,
Liprolog Mix50 can be given soon after meals. Liprolog Mix50 should only be
given by subcutaneous injection. Under no circumstances should Liprolog Mix50
be given intravenously.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left'><span lang=EN-GB>Subcutaneous
administration should be in the upper arms, thighs, buttocks, or abdomen.&nbsp;
Use of injection sites should be rotated so that the same site is not used more
than approximately once a month.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>When
administered subcutaneously care should be taken when injecting Liprolog Mix50
to ensure that a blood vessel has not been entered. After injection, the site of
injection should not be massaged. Patients must be educated to use the proper
injection techniques.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The rapid onset and early peak of activity of Liprolog itself is
observed following the subcutaneous administration of Liprolog Mix50. This
allows Liprolog Mix50 to be given very close to mealtime. The duration of
action of the insulin lispro protamine suspension (Basal) component of Liprolog
Mix50 is similar to that of a basal insulin (NPH).</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The time course of action of any insulin may vary considerably in
different individuals or at different times in the same individual. As with all
insulin preparations, the duration of action of Liprolog Mix50 is dependent on
dose, site of injection, blood supply, temperature, and physical activity.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><span
lang=EN-GB>Paediatric population</span></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Administration of Liprolog Mix50 to children below 12 years of age
should be considered only in case of an expected benefit when compared to
regular insulin.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.3&nbsp;&nbsp;&nbsp;&nbsp; Contraindications</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Hypersensitivity to insulin lispro or to any of the
excipients.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.4&nbsp;&nbsp;&nbsp;&nbsp; Special warnings and
precautions for use</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in;line-height:normal'><span
lang=EN-GB>Under no circumstances should Liprolog Mix50 be given intravenously.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Transferring a patient to another type or brand of insulin should be
done under strict medical supervision.&nbsp; Changes in strength, brand
(manufacturer), type (regular, NPH, lente, etc.), species (animal, human, human
insulin analogue), and/or method of manufacture (recombinant DNA versus
animal-source insulin) may result in the need for a change in dosage.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Conditions which may make the early warning symptoms of
hypoglycaemia different or less pronounced include long duration of diabetes,
intensified insulin therapy, diabetic nerve disease or medications such as
beta-blockers.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>A few patients
who have experienced hypoglycaemic reactions after transfer from animal-source
insulin to human insulin have reported that the early warning symptoms of
hypoglycaemia were less pronounced or different from those experienced with
their previous insulin. Uncorrected hypoglycaemic or hyperglycaemic reactions
can cause loss of consciousness, coma, or death.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The use of dosages which are inadequate or discontinuation of
treatment, especially in insulin-dependent diabetics, may lead to
hyperglycaemia and diabetic ketoacidosis; conditions which are potentially
lethal.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin requirements may be reduced in the
presence of renal impairment. Insulin requirements may be reduced in patients
with hepatic impairment due to reduced capacity for gluconeogenesis and reduced
insulin breakdown; however, in patients with chronic hepatic impairment, an
increase in insulin resistance may lead to increased insulin requirements.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin
requirements may be increased during illness or emotional disturbances.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Adjustment of dosage may also be necessary if patients undertake
increased physical activity or change their usual diet. Exercise taken
immediately after a meal may increase the risk of hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB>Combination of Liprolog Mix50 with
pioglitazone:</span></u></p>

<p class=MsoNormal><span lang=EN-GB>Cases of cardiac failure have been reported
when pioglitazone was used in combination with insulin, especially in patients
with risk factors for development of cardiac heart failure. This should be kept
in mind if treatment with the combination of pioglitazone and Liprolog Mix50 is
considered. If the combination is used, patients should be observed for signs
and symptoms of heart failure, weight gain and oedema. Pioglitazone should be
discontinued if any deterioration in cardiac symptoms occurs.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u>Instructions
for use and handling </u></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'>To prevent the
possible transmission of disease, each cartridge must be used by one patient
only, even if the needle on the delivery device is changed.</p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.5&nbsp;&nbsp;&nbsp;&nbsp; Interaction
with other medicinal products and other forms of interaction</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>Insulin requirements may be increased by substances
with hyperglycaemic activity, such as oral contraceptives, corticosteroids, or
thyroid replacement therapy, danazol, beta<sub>2</sub> stimulants (such as
ritodrine, salbutamol, terbutaline). </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin
requirements may be reduced in the presence of substances with hypoglycaemic
activity, such as oral hypoglycaemics, salicylates (for example,
acetylsalicylic acid), sulpha antibiotics, certain antidepressants, (monoamine
oxidase inhibitors, selective serotonin reuptake inhibitors), certain
angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II
receptor blockers, beta-blockers, octreotide or alcohol. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Mixing Liprolog Mix50 with other insulins has not been
studied.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The physician should be consulted when using other medications in
addition to Liprolog Mix50 </span>(see section <span lang=EN-GB>4.4</span>)<span
lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.6&nbsp;&nbsp;&nbsp;&nbsp; Fertility, pregnancy
and lactation</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Data
on a large number of exposed pregnancies do not indicate any adverse effect of
insulin lispro on pregnancy or on the health of the foetus/newborn.&nbsp;&nbsp;
</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>It is essential
to maintain good control of the insulin-treated (insulin-dependent or
gestational diabetes) patient throughout pregnancy. Insulin requirements
usually fall during the first trimester and increase during the second and
third trimesters. Patients with diabetes should be advised to inform their
doctor if they are pregnant or are contemplating pregnancy. Careful monitoring
of glucose control, as well as general health, is essential in pregnant
patients with diabetes. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Patients with
diabetes who are breast-feeding may require adjustments in insulin dose, diet
or both. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.7&nbsp;&nbsp;&nbsp;&nbsp; Effects on ability to
drive and use machines</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The patient&#8217;s ability to concentrate and react may be impaired
as a result of hypoglycaemia. This may constitute a risk in situations where
these abilities are of special importance (e.g. driving a car or operating
machinery).</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Patients should be advised to take precautions to avoid
hypoglycaemia whilst driving, this is particularly important in those who have
reduced or absent awareness of the warning signs of hypoglycaemia or have
frequent episodes of hypoglycaemia. The advisability of driving should be
considered in these circumstances.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.8&nbsp;&nbsp;&nbsp;&nbsp; Undesirable effects</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>Hypoglycaemia
is the most frequent undesirable effect of insulin therapy that a patient with
diabetes may suffer. Severe hypoglycaemia may lead to loss of consciousness,
and in extreme cases, death. No specific frequency for hypoglycaemia is
presented, since hypoglycaemia is a result of both the insulin dose and other
factors e.g. a patient`s level of diet and exercise.</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>Local allergy
in patients is common (1/100 to &lt;1/10). Redness, swelling, and itching can
occur at the site of insulin injection. This condition usually resolves in a
few days to a few weeks. In some instances, this condition may be related to
factors other than insulin, such as irritants in the skin cleansing agent or
poor injection technique. Systemic allergy, which is rare (1/10,000 to
&lt;1/1,000) but potentially more serious, is a generalised allergy to insulin.
It may cause a rash over the whole body, shortness of breath, wheezing,
reduction in blood pressure, fast pulse, or sweating. Severe cases of
generalised allergy may be life-threatening.</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'>Lipodystrophy
at the injection site is uncommon (1/1,000 to &lt;1/100).</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Cases of oedema have been
reported with insulin therapy, particularly if previous poor metabolic control
is improved by intensified insulin therapy.</p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB>Reporting of
suspected adverse reactions</span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Reporting
suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals are asked to report any suspected
adverse reactions via <span style='background:silver'>the national reporting
system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span>.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.9&nbsp;&nbsp;&nbsp;&nbsp; Overdose</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Insulins have no specific overdose definitions because serum glucose
concentrations are a result of complex interactions between insulin levels,
glucose availability and other metabolic processes.&nbsp; Hypoglycaemia may
occur as a result of an excess of insulin activity relative to food intake and
energy expenditure.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Hypoglycaemia may be associated with listlessness, confusion,
palpitations, headache, sweating and vomiting.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Mild hypoglycaemic episodes will respond to oral administration of
glucose or other sugar or saccharated products.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Correction of moderately severe hypoglycaemia can be accomplished by
intramuscular or subcutaneous administration of glucagon, followed by oral carbohydrate
when the patient recovers sufficiently.&nbsp; Patients who fail to respond to
glucagon must be given glucose solution intravenously.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>If the patient is comatose, glucagon should be administered
intramuscularly or subcutaneously.&nbsp; However, glucose solution must be
given intravenously if glucagon is not available or if the patient fails to
respond to glucagon.&nbsp; The patient should be given a meal as soon as
consciousness is recovered.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Sustained
carbohydrate intake and observation may be necessary because hypoglycaemia may
recur after apparent clinical recovery.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><b><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACOLOGICAL PROPERTIES</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>5.1&nbsp;&nbsp;&nbsp;&nbsp; Pharmacodynamic
properties</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Pharmaco-therapeutic group: ATC Code: A10A D04.</span></p>

<p class=MsoBodyText align=left style='text-align:left'><span lang=EN-GB>Liprolog
Mix50 is a premixed suspension consisting of insulin lispro (fast-acting human
insulin analogue) and insulin lispro protamine suspension (intermediate acting
human insulin analogue).</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The primary activity of insulin lispro is the regulation of glucose
metabolism.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>In addition, insulins have several anabolic and anti-catabolic actions
on a variety of different tissues.&nbsp; Within muscle tissue this includes
increasing glycogen, fatty acid, glycerol and protein synthesis and amino acid
uptake, while decreasing glycogenolysis, gluconeogenesis, ketogenesis,
lipolysis, protein catabolism and amino acid output.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Insulin lispro has a rapid onset of action (approximately 15
minutes), thus allowing it to be given closer to a meal (within zero to 15
minutes of the meal) when compared to regular insulin (30 to 45 minutes
before). The rapid onset and early peak of activity of insulin lispro is
observed following the subcutaneous administration of Liprolog Mix50. Liprolog
Basal has an activity profile that is very similar to that of a basal insulin
(NPH) over a period of approximately 15 hours.&nbsp; In the figure below the
pharmacodynamics of Liprolog Mix50 and Liprolog Basal are illustrated.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse'>
 <tr>
  <td width=158 valign=top style='width:1.65in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
  0in;margin-left:99.25pt;margin-bottom:.0001pt;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
  0in;margin-left:99.25pt;margin-bottom:.0001pt;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
  0in;margin-left:99.25pt;margin-bottom:.0001pt;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
  0in;margin-left:99.25pt;margin-bottom:.0001pt;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
  0in;margin-left:99.25pt;margin-bottom:.0001pt;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
  0in;margin-left:99.25pt;margin-bottom:.0001pt;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
  0in;margin-left:99.25pt;margin-bottom:.0001pt;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
  0in;margin-left:99.25pt;margin-bottom:.0001pt;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
  0in;margin-left:35.45pt;margin-bottom:.0001pt;line-height:normal'><span
  lang=EN-GB>Hypoglycaemic <br>
  activity</span></p>
  </td>
  <td width=458 valign=top style='width:343.3pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
  lang=EN-GB><img width=304 height=338 src="Humalo_files/image005.gif"></span></p>
  <p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
  lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  Time, hours</span></p>
  <p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:2.0in;margin-bottom:.0001pt;text-indent:23.5pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left'><span lang=EN-GB>The
above representation reflects the relative amount of glucose over time required
to maintain the subject's whole blood glucose concentrations near fasting
levels and is an indicator of the effect of these insulins on glucose
metabolism over time.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The glucodynamic
response to insulin lispro is not affected by renal or hepatic function
impairment. Glucodynamic differences between insulin lispro and soluble human
insulin, as measured during a glucose clamp procedure, were maintained over a
wide range of renal function. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Insulin
lispro has been shown to be equipotent to human insulin on a molar basis but
its effect is more rapid and of a shorter duration.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>5.2&nbsp;&nbsp;&nbsp;&nbsp; Pharmacokinetic
properties</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The pharmacokinetics of insulin lispro reflect a compound that is
rapidly absorbed, and achieves peak blood levels 30 to 70 minutes following
subcutaneous injection. The pharmacokinetics of insulin lispro protamine
suspension are consistent with those of an intermediate acting insulin such as
NPH. The pharmacokinetics of Liprolog Mix50 are representative of the
individual pharmacokinetic properties of the two components. When considering
the clinical relevance of these kinetics, it is more appropriate to examine the
glucose utilisation curves (as discussed in 5.1).</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin lispro
maintains more rapid absorption when compared to soluble human insulin in
patients with renal impairment. In patients with type 2 diabetes over a wide
range of renal function&nbsp; the pharmacokinetic differences between insulin
lispro and soluble human insulin were generally maintained and shown to be
independent of renal function.&nbsp; Insulin lispro maintains more rapid
absorption and elimination when compared to soluble human insulin in patients
with hepatic impairment.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.3&nbsp;&nbsp;&nbsp;&nbsp; Preclinical
safety data</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>In <i>in vitro</i> tests, including binding to insulin
receptor sites and effects on growing cells, insulin lispro behaved in a manner
that closely resembled human insulin. Studies also demonstrate that the
dissociation of binding to the insulin receptor of insulin lispro&nbsp; is
equivalent to human insulin. Acute, one month and twelve month toxicology
studies produced no significant toxicity findings.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Insulin lispro did not induce fertility impairment, embryotoxicity
or teratogenicity in animal studies. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.1&nbsp;&nbsp;&nbsp;&nbsp; List of excipients</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Protamine
sulphate</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>m-cresol [2.20
mg/ml]</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Phenol [1.00
mg/ml]</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Glycerol</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Dibasic sodium
phosphate.7H<span style='position:relative;top:3.0pt'>2</span>O</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Zinc oxide</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Water for
injections</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Hydrochloric
acid and sodium hydroxide may be used to adjust pH to 7.0-7.8.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.2&nbsp;&nbsp;&nbsp;&nbsp; Incompatibilities</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Mixing Liprolog Mix50 with other insulins has not been studied. In
the absence of compatibility studies, this medicinal product must not be mixed
with other medicinal products.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.3&nbsp;&nbsp;&nbsp;&nbsp; Shelf life</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><i><u><span
lang=EN-GB>Unused cartridge</span></u></i></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>3 years.&nbsp; </span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left'><i><u><span lang=EN-GB>After
cartridge insertion</span></u></i><span lang=EN-GB> </span></p>

<p class=MsoBodyText align=left style='text-align:left'><span lang=EN-GB>28
days.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.4&nbsp;&nbsp;&nbsp;&nbsp; Special precautions for
storage</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><i><u><span
lang=EN-GB>Unused cartridge</span></u></i></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Store in a refrigerator (2&deg;C - 8&deg;C). Do not freeze. Do not
expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><u><span
lang=EN-GB>After cartridge insertion</span></u></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Store below 30&deg;C. Do not refrigerate. The pen with the inserted
cartridge should not be stored with the needle attached.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.5&nbsp;&nbsp;&nbsp;&nbsp; Nature and contents of
container</span></b><b><span lang=EN-GB> and special equipment for use,
administration or implantation</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The suspension is contained in type I flint glass cartridges, sealed
with butyl or halobutyl disc seals and plunger heads and secured with aluminium
seals.&nbsp; Dimeticone or silicone emulsion may have been used to treat the
cartridge plunger, and/or the glass cartridge.&nbsp; </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Not all packs
may be marketed.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>5 x 3 ml Liprolog Mix50 cartridges for a 3 ml pen.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>10 x 3 ml Liprolog Mix50 cartridges for a 3 ml pen.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.6&nbsp;&nbsp;&nbsp;&nbsp; Special precautions for
disposal and other handling</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Any unused
product or waste material should be disposed of in accordance with local
requirements.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><u><span lang=EN-GB>Instructions for use and handling </span></u></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'>To prevent the
possible transmission of disease, each cartridge must be used by one patient
only, even if the needle on the delivery device is changed.</p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><u><span lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Liprolog Mix50 cartridges are to be used with a CE marked pen as
recommended in the information provided by the device manufacturer.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>a) <u>Preparing a dose</u></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Cartridges containing Liprolog Mix50 should be rotated in the palms
of the hands ten times and inverted 180&deg; ten times immediately before use
to resuspend the insulin until it appears uniformly cloudy or milky.&nbsp; If
not, repeat the above procedure until contents are mixed.&nbsp; Cartridges
contain a small glass bead to assist mixing.&nbsp; Do not shake vigorously as
this may cause frothing which may interfere with the correct measurement of the
dose.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The cartridges should be examined frequently and should not be used
if clumps of material are present or if solid white particles stick to the
bottom or wall of the cartridge, giving a frosted appearance.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Liprolog Mix50 cartridges are not designed to allow any other
insulin to be mixed in the cartridge .&nbsp; Cartridges are not designed to be
refilled.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The following is a general description. The manufacturer's
instructions with each individual pen must be followed for loading the
cartridge, attaching the needle and administering the insulin injection.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>b) <u>Injecting a dose</u></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wash your hands.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left'><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Choose
a site for injection.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clean the skin as instructed.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove outer needle cap.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stabilise the skin by
spreading it or pinching up a large area.&nbsp; Insert the needle as
instructed.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Press the knob.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pull the needle
out and apply gentle pressure over the injection site for several
seconds.&nbsp; Do not rub the area.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Using the outer needle cap,
unscrew the needle and dispose of it safely.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Use of
injection sites should be rotated so that the same site is not used more than
approximately once a month.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION HOLDER</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ
Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBERS</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>EU/1/01/195/004&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5
x 3 ml Liprolog Mix50 cartridges for a 3 ml pen</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>EU/1/01/195/012&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10
x 3 ml Liprolog Mix50 cartridges for a 3 ml pen</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DATE OF
FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Date of first
authorisation: 1<sup>st</sup> August 2001</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Date of last
renewal: 1<sup>st</sup> August 2006</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>10.&nbsp;&nbsp;&nbsp;&nbsp; DATE OF REVISION OF THE
TEXT</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-38.3pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF THE
MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Liprolog Basal 100&nbsp;units/ml, suspension for
injection in cartridge </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; QUALITATIVE
AND QUANTITATIVE COMPOSITION</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>2.1&nbsp;&nbsp;&nbsp;&nbsp; General
description</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Liprolog Basal is a white, sterile suspension. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>2.2&nbsp;&nbsp;&nbsp;&nbsp; Qualitative
and quantitative composition</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>One ml contains 100&nbsp;units (equivalent to 3.5mg) insulin lispro
(recombinant DNA origin produced in E.coli). Each container includes 3ml
equivalent to 300&nbsp;units insulin lispro.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Liprolog Basal consists of insulin lispro protamine
suspension.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>For a full list of excipients, see section 6.1.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Suspension for injection.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CLINICAL
PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.1&nbsp;&nbsp;&nbsp;&nbsp; Therapeutic indications</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Liprolog Basal is indicated for the treatment of patients with
diabetes mellitus who require insulin for the maintenance of normal glucose
homeostasis. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.2&nbsp;&nbsp;&nbsp;&nbsp; Posology and method of
administration</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The dosage should be determined by the physician, according to the
requirement of the patient.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left'><span lang=EN-GB>Liprolog
Basal can be mixed with or given in conjunction with Liprolog. Liprolog Basal
should only be given by subcutaneous injection. Under no circumstance should
Liprolog Basal be given intravenously. </span></p>

<p class=MsoBodyText align=left style='text-align:left'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left'><span lang=EN-GB>Subcutaneous
administration should be in the upper arms, thighs, buttocks, or abdomen.&nbsp;
Use of injection sites should be rotated so that the same site is not used more
than approximately once a month.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>When administered subcutaneously care should be taken when injecting
Liprolog Basal to ensure that a blood vessel has not been entered. After
injection, the site of injection should not be massaged. Patients must be
educated to use the proper injection techniques.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Liprolog Basal has an activity profile that is very similar to that
of a basal insulin (NPH) over a period of approximately 15 hours. The time
course of action of any insulin may vary considerably in different individuals
or at different times in the same individual. As with all insulin preparations,
the duration of action of Liprolog Basal is dependent on dose, site of
injection, blood supply, temperature, and physical activity.&nbsp; </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><span
lang=EN-GB>Paediatric population</span></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Administration of Liprolog Basal to children below 12 years of age
should be considered only in case of an expected benefit when compared to
regular insulin.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.3&nbsp;&nbsp;&nbsp;&nbsp; Contraindications</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB>Hypersensitivity to insulin
lispro or to any of the excipients.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB>Hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.4&nbsp;&nbsp;&nbsp;&nbsp; Special warnings and
precautions for use</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in;line-height:normal'><span
lang=EN-GB>Under no circumstances should Liprolog Basal be given intravenously.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Transferring a patient to another type or brand of insulin should be
done under strict medical supervision. Changes in strength, brand
(manufacturer), type (regular, NPH, lente, etc.), species (animal, human, human
insulin analogue), and/or method of manufacture (recombinant DNA versus
animal-source insulin) may result in the need for a change in dosage.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Conditions which may make the early warning symptoms of
hypoglycaemia different or less pronounced include long duration of diabetes,
intensified insulin therapy, diabetic nerve disease or medications such as
beta-blockers.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>A few patients who have experienced hypoglycaemic reactions after
transfer from animal-source insulin to human insulin have reported that the
early warning symptoms of hypoglycaemia were less pronounced or different from
those experienced with their previous insulin. Uncorrected hypoglycaemic or
hyperglycaemic reactions can cause loss of consciousness, coma, or death.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The use of dosages which are inadequate or discontinuation of
treatment, especially in insulin-dependent diabetics, may lead to
hyperglycaemia and diabetic ketoacidosis; conditions which are potentially
lethal.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Insulin
requirements may be reduced in the presence of renal impairment.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Insulin requirements may be reduced in patients with hepatic
impairment due to reduced capacity for gluconeogenesis and reduced insulin breakdown;
however, in patients with chronic hepatic impairment, an increase in insulin
resistance may lead to increased insulin requirements.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Insulin requirements may be increased during illness or emotional
disturbances.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Adjustment of dosage may also be necessary if patients undertake
increased physical activity or change their usual diet. Exercise taken
immediately after a meal may increase the risk of hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB>Combination of Liprolog Basal with
pioglitazone:</span></u></p>

<p class=MsoNormal><span lang=EN-GB>Cases of cardiac failure have been reported
when pioglitazone was used in combination with insulin, especially in patients
with risk factors for development of cardiac heart failure. This should be kept
in mind if treatment with the combination of pioglitazone and Liprolog Basal is
considered. If the combination is used, patients should be observed for signs
and symptoms of heart failure, weight gain and oedema. Pioglitazone should be
discontinued if any deterioration in cardiac symptoms occurs.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u>Instructions
for use and handling </u></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'>To prevent the
possible transmission of disease, each cartridge must be used by one patient
only, even if the needle on the delivery device is changed.</p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.5&nbsp;&nbsp;&nbsp;&nbsp; Interaction
with other medicinal products and other forms of interaction</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>Insulin requirements may be increased by substances
with hyperglycaemic activity, such as oral contraceptives, corticosteroids, or
thyroid replacement therapy, danazol, beta<sub>2</sub> stimulants (such as
ritodrine, salbutamol, terbutaline). </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Insulin requirements may be reduced in the presence of substances
with hypoglycaemic activity, such as oral hypoglycaemics, salicylates (for
example, acetylsalicylic acid), sulpha antibiotics, certain antidepressants
(monoamine oxidase inhibitors, selective serotonin reuptake inhibitors),
certain angiotensin converting enzyme inhibitors (captopril, enalapril),
angiotensin II receptor blockers, beta-blockers, octreotide or alcohol. </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Mixing Liprolog Basal with insulins other than
Liprolog has not been studied.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The physician should be consulted when using other medications in
addition to Liprolog Basal </span>(see section <span lang=EN-GB>4.4</span>)<span
lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.6&nbsp;&nbsp;&nbsp;&nbsp; Fertility, pregnancy
and lactation</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Data on a large number of exposed pregnancies do not indicate any
adverse effect of insulin lispro on pregnancy or on the health of the
foetus/newborn.&nbsp;&nbsp; </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>It is essential to maintain good control of the insulin-treated
(insulin-dependent or gestational diabetes) patient throughout pregnancy.
Insulin requirements usually fall during the first trimester and increase
during the second and third trimesters. Patients with diabetes should be
advised to inform their doctor if they are pregnant or are contemplating
pregnancy. Careful monitoring of glucose control, as well as general health, is
essential in pregnant patients with diabetes. </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Patients with diabetes who are breast-feeding may require
adjustments in insulin dose, diet or both. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.7&nbsp;&nbsp;&nbsp;&nbsp; Effects on ability to
drive and use machines</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The patient&#8217;s ability to concentrate and react may be impaired
as a result of hypoglycaemia. This may constitute a risk in situations where
these abilities are of special importance (e.g. driving a car or operating
machinery).</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Patients should be advised to take precautions to avoid
hypoglycaemia whilst driving, this is particularly important in those who have
reduced or absent awareness of the warning signs of hypoglycaemia or have
frequent episodes of hypoglycaemia. The advisability of driving should be
considered in these circumstances.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.8&nbsp;&nbsp;&nbsp;&nbsp; Undesirable effects</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'>Hypoglycaemia
is the most frequent undesirable effect of insulin therapy that a patient with
diabetes may suffer. Severe hypoglycaemia may lead to loss of consciousness,
and in extreme cases, death. No specific frequency for hypoglycaemia is
presented, since hypoglycaemia is a result of both the insulin dose and other
factors e.g. a patient`s level of diet and exercise.</p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'>Local allergy
in patients is common (1/100 to &lt;1/10). Redness, swelling, and itching can
occur at the site of insulin injection. This condition usually resolves in a
few days to a few weeks. In some instances, this condition may be related to
factors other than insulin, such as irritants in the skin cleansing agent or
poor injection technique. Systemic allergy,&nbsp; which is rare (1/10,000 to
&lt;1/1,000) but potentially more serious, is a generalised allergy to insulin.
It may cause a rash over the whole body, shortness of breath, wheezing,
reduction in blood pressure, fast pulse, or sweating. Severe cases of
generalised allergy may be life-threatening.</p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>Lipodystrophy at the injection site is uncommon (1/1,000 to &lt;1/100).</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Cases of oedema have been
reported with insulin therapy, particularly if previous poor metabolic control
is improved by intensified insulin therapy.</p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB>Reporting of
suspected adverse reactions</span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Reporting
suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals are asked to report any suspected
adverse reactions via <span style='background:silver'>the national reporting
system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span>.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.9&nbsp;&nbsp;&nbsp;&nbsp; Overdose</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Insulins have no specific overdose definitions because serum glucose
concentrations are a result of complex interactions between insulin levels,
glucose availability and other metabolic processes.&nbsp; Hypoglycaemia may
occur as a result of an excess of insulin activity relative to food intake and
energy expenditure.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Hypoglycaemia may be associated with listlessness, confusion,
palpitations, headache, sweating and vomiting.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Mild hypoglycaemic episodes will respond to oral administration of
glucose or other sugar or saccharated products.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Correction of moderately severe hypoglycaemia can be accomplished by
intramuscular or subcutaneous administration of glucagon, followed by oral
carbohydrate when the patient recovers sufficiently.&nbsp; Patients who fail to
respond to glucagon must be given glucose solution intravenously.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>If the patient is comatose, glucagon should be administered
intramuscularly or subcutaneously.&nbsp; However, glucose solution must be
given intravenously if glucagon is not available or if the patient fails to
respond to glucagon.&nbsp; The patient should be given a meal as soon as
consciousness is recovered.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Sustained carbohydrate intake and observation may be necessary
because hypoglycaemia may recur after apparent clinical recovery.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACOLOGICAL
PROPERTIES</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>5.1&nbsp;&nbsp;&nbsp;&nbsp; Pharmacodynamic
properties</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Pharmaco-therapeutic group: Intermediate acting human
insulin analogue. ATC Code: A10A C04.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>The primary activity of insulin lispro is the
regulation of glucose metabolism.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>In addition, insulins have several anabolic and anti-catabolic
actions on a variety of different tissues.&nbsp; Within muscle tissue this
includes increasing glycogen, fatty acid, glycerol and protein synthesis and
amino acid uptake, while decreasing glycogenolysis, gluconeogenesis,
ketogenesis, lipolysis, protein catabolism and amino acid output.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Liprolog Basal has an activity profile that is very similar to that
of a basal insulin (NPH) over a period of approximately 15 hours.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>The glucodynamic response to insulin lispro is not affected by renal
or hepatic function impairment. Glucodynamic differences between insulin lispro
and soluble human insulin, as measured during a glucose clamp procedure, were
maintained over a wide range of renal function. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Insulin lispro has been shown to be equipotent to human insulin on a
molar basis but its effect is more rapid and of a shorter duration.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>5.2&nbsp;&nbsp;&nbsp;&nbsp; Pharmacokinetic
properties</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Liprolog Basal has a prolonged absorption profile, achieving a
maximum insulin concentration approximately 6 hours after dosing. When
considering the clinical relevance of these kinetics, it is more appropriate to
examine the glucose utilisation curves.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Insulin lispro maintains more rapid absorption when compared to
soluble human insulin in patients with renal impairment. In patients with type
2 diabetes over a wide range of renal function the pharmacokinetic differences
between insulin lispro and soluble human insulin were generally maintained and
shown to be independent of renal function.&nbsp; Insulin lispro maintains more
rapid absorption and elimination when compared to soluble human insulin in
patients with hepatic impairment.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>5.3&nbsp;&nbsp;&nbsp;&nbsp; Preclinical safety data</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>In <i>in vitro</i> tests, including binding to insulin receptor
sites and effects on growing cells, insulin lispro behaved in a manner that
closely resembled human insulin.&nbsp; Studies also demonstrate that the
dissociation of binding to the insulin receptor of insulin lispro&nbsp; is
equivalent to human insulin. Acute, one month and twelve month toxicology
studies produced no significant toxicity findings.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Insulin lispro did not induce fertility impairment, embryotoxicity
or teratogenicity in animal studies. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.1&nbsp;&nbsp;&nbsp;&nbsp; List of excipients</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Protamine sulphate</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><i><span
lang=EN-GB>m-</span></i><span lang=EN-GB>cresol</span><span lang=EN-GB> [1.76
mg/ml]</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Phenol [0.80 mg/ml]</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Glycerol</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Dibasic sodium phosphate.7H<span style='position:relative;
top:2.0pt'>2</span>O</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Zinc oxide</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Water for injections</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Hydrochloric acid and sodium hydroxide may be used to adjust pH to
7.0 &#8211; 7.8.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.2&nbsp;&nbsp;&nbsp;&nbsp; Incompatibilities</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Mixing Liprolog Basal with insulins other than Liprolog has not been
studied. This medicinal product must not be mixed with other medicinal products
than Liprolog.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.3&nbsp;&nbsp;&nbsp;&nbsp; Shelf life</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><i><u><span
lang=EN-GB>Unused cartridge</span></u></i></p>

<p class=MsoBodyText align=left style='text-align:left'><span lang=EN-GB>2 years.&nbsp;
</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left'><i><u><span lang=EN-GB>After
cartridge insertion</span></u></i><span lang=EN-GB> </span></p>

<p class=MsoBodyText align=left style='text-align:left'><span lang=EN-GB>21 days.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.4&nbsp;&nbsp;&nbsp;&nbsp; Special precautions for
storage</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><i><u><span
lang=EN-GB>Unused cartridge</span></u></i></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Store in a refrigerator (2&deg;C - 8&deg;C). Do not freeze. Do not
expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><u><span
lang=EN-GB>After cartridge insertion</span></u></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Store below 30&deg;C. Do not refrigerate. The pen with the inserted cartridge
should not be stored with the needle attached.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.5&nbsp;&nbsp;&nbsp;&nbsp; Nature and contents of
container</span></b><b><span lang=EN-GB> and special equipment for use,
administration or implantation</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The suspension is contained in type I flint glass cartridges, sealed
with butyl or halobutyl disc seals and plunger heads and secured with aluminium
seals. Dimeticone or silicone emulsion may have been used to treat the
cartridge plunger, and/or the glass cartridge.&nbsp; </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Not all packs may be marketed.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>5 x 3&nbsp;ml Liprolog Basal cartridges for a 3&nbsp;ml pen</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>10 x 3&nbsp;ml Liprolog Basal cartridges for a 3&nbsp;ml pen</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.6&nbsp;&nbsp;&nbsp;&nbsp; Special precautions for
disposal and other handling</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Any unused
product or waste material should be disposed of in accordance with local
requirements.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><u><span
lang=EN-GB>Instructions for use and handling</span></u></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'>To prevent the
possible transmission of disease, each cartridge must be used by one patient
only, even if the needle on the delivery device is changed.</p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoBodyText align=left style='text-align:left'><span lang=EN-GB>Liprolog
Basal cartridges are to be used with a CE marked pen as recommended in the
information provided by the device manufacturer.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>a) <u>Preparing a dose</u></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Cartridges containing Liprolog Basal should be rotated in the palms
of the hands ten times and inverted 180&deg; ten times immediately before use
to resuspend the insulin until it appears uniformly cloudy or milky.&nbsp; If
not, repeat the above procedure until contents are mixed.&nbsp; Cartridges
contain a small glass bead to assist mixing.&nbsp; Do not shake vigorously as
this may cause frothing which may interfere with the correct measurement of the
dose.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The cartridges should be examined frequently and should not be used
if clumps of material are present or if solid white particles stick to the
bottom or wall of the cartridge, giving a frosted appearance.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Liprolog Basal cartridges are not designed to allow any other
insulin to be mixed in the cartridge .&nbsp; Cartridges are not designed to be
refilled.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>The following is a general description. The manufacturer's
instructions with each individual pen must be followed for loading the
cartridge, attaching the needle and administering the insulin injection.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>b) <u>Injecting a dose</u></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wash your hands.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText align=left style='text-align:left'><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Choose
a site for injection.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clean the skin as instructed.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove outer needle cap.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stabilise the skin by
spreading it or pinching up a large area.&nbsp; Insert the needle as
instructed.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Press the knob.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pull the needle
out and apply gentle pressure over the injection site for several
seconds.&nbsp; Do not rub the area.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Using the outer needle cap,
unscrew the needle and dispose of it safely.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Use of
injection sites should be rotated so that the same site is not used more than
approximately once a month.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>c) <u>Mixing insulins</u></span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Do not mix insulin in vials with insulin in cartridges. See section
6.2.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORIZATION HOLDER</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht,
The Netherlands.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBERS</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>EU/1/01/195/022&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5
x 3&nbsp;ml Liprolog Basal cartridges for a 3&nbsp;ml pen</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>EU/1/01/195/023&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10
x 3&nbsp;ml Liprolog Basal cartridges for a 3&nbsp;ml pen</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DATE OF
FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Date of first
authorisation: 1<sup>st</sup> August 2001</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Date of last
renewal: 1<sup>st</sup> August 2006</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b>&nbsp;</b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>10.&nbsp;&nbsp;&nbsp;&nbsp; DATE OF REVISION OF THE
TEXT</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><b><s><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></s></b></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF THE MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Liprolog 100&nbsp;units/ml KwikPen, solution for injection in a </span><span
lang=EN-GB>pre-filled pen</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Qualitative
and Quantitative Composition</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>One
ml contains 100&nbsp;units (equivalent to 3.5mg) insulin lispro (recombinant
DNA origin produced in E.coli). Each container includes 3ml equivalent to 300&nbsp;units
insulin lispro.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Each KwikPen delivers 1-60 units in steps
of 1 unit.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>For a full list of excipients, see section
6.1.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmaceutical
Form</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Solution for injection.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Clear, colourless, aqueous solution.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clinical
Particulars</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>4.1&nbsp;&nbsp;&nbsp; Therapeutic indications</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>For the treatment of adults and children
with diabetes mellitus who require insulin for the maintenance of normal
glucose homeostasis. Liprolog KwikPen is also indicated for the initial
stabilisation of diabetes mellitus. </span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>4.2&nbsp;&nbsp;&nbsp; Posology and method of administration</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>The dosage should be determined by the
physician, according to the requirement of the patient. </span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Liprolog
may be given shortly before meals. When necessary Liprolog can be given soon
after meals. Liprolog preparations should be given by subcutaneous injection
and may, although not recommended, also be given by intramuscular injection. </span></p>

<p class=BodytextAgency><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>The KwikPen is only suitable for subcutaneous
injections.&nbsp; Liprolog 100&nbsp;units/ml is available in vials if
administration of intravenous injection or infusion pump is necessary.&nbsp; </span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Subcutaneous administration should be in
the upper arms, thighs, buttocks, or abdomen. Use of injection sites should be
rotated so that the same site is not used more than approximately once a month.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>When
administered subcutaneously care should be taken when injecting Liprolog
KwikPen to ensure that a blood vessel has not been entered. After injection,
the site of injection should not be massaged. Patients must be educated to use
the proper injection techniques.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog KwikPen takes effect rapidly and
has a shorter duration of activity (2 to 5&nbsp;hours) given subcutaneously as
compared with regular insulin. This rapid onset of activity allows a Liprolog
injection (or, in the case of administration by continuous subcutaneous
infusion, a Liprolog bolus) to be given very close to mealtime. The time course
of action of any insulin may vary considerably in different individuals or at
different times in the same individual. The faster onset of action compared to
soluble human insulin is maintained regardless of injection site. As with all
insulin preparations, the duration of action of Liprolog KwikPen is dependent
on dose, site of injection, blood supply, temperature, and physical activity.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog can be used in conjunction with a
longer-acting insulin or oral sulphonylurea agents, on the advice of a physician.
</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=Default><i><u><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>Liprolog
100&nbsp;units/ml KwikPen and Liprolog 200&nbsp;units/ml KwikPen and Liprolog 100
units/ml Junior KwikPen</span></u></i></p>

<p class=Default><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>Liprolog
KwikPen is available in two strengths. The Liprolog 100&nbsp;units/ml KwikPen and
the Liprolog 200&nbsp;units/ml KwikPen deliver
1&nbsp;&#8211;&nbsp;60&nbsp;units in steps of 1 unit in a single injection. The
Liprolog 100 units/ml Junior KwikPen delivers 0.5 &#8211; 30 units in steps of
0.5 units in a single injection. <b>The number of insulin units is shown in the
dose window of the pen regardless of strength</b> and <b>no </b>dose conversion
should be done when transferring a patient to a new strength or to a pen with a
different dose step. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><span
lang=EN-GB>Paediatric population</span></i></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog can be used in adolescents and
children (see section 5.1).</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>4.3&nbsp;&nbsp;&nbsp; Contraindications</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Hypersensitivity to insulin lispro or to any of the excipients.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>4.4&nbsp;&nbsp;&nbsp; Special warnings and precautions for use</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Transferring a patient to another type or
brand of insulin should be done under strict medical supervision. Changes in
strength, brand (manufacturer), type (regular, NPH, lente, etc.), species
(animal, human, human insulin analogue), and/or method of manufacture
(recombinant DNA versus animal-source insulin) may result in the need for a
change in dosage. </span><span lang=EN-GB style='color:black'>For fast-acting
insulins, any patient also on basal insulin must optimise dosage of both
insulins to obtain glucose control across the whole day, particularly
nocturnal/fasting glucose control.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Conditions
which may make the early warning symptoms of hypoglycaemia different or less
pronounced include long duration of diabetes, intensified insulin therapy,
diabetic nerve disease or medications such as beta-blockers.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>A few patients
who have experienced hypoglycaemic reactions after transfer from animal-source
insulin to human insulin have reported that the early warning symptoms of
hypoglycaemia were less pronounced or different from those experienced with
their previous insulin. Uncorrected hypoglycaemic or hyperglycaemic reactions
can cause loss of consciousness, coma, or death.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>The use of dosages which are inadequate or
discontinuation of treatment, especially in insulin-dependent diabetics, may
lead to hyperglycaemia and diabetic ketoacidosis; conditions which are
potentially lethal.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin requirements may be reduced in the
presence of renal impairment. Insulin requirements may be reduced in patients
with hepatic impairment due to reduced capacity for gluconeogenesis and reduced
insulin breakdown; however, in patients with chronic hepatic impairment, an
increase in insulin resistance may lead to increased insulin requirements</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Insulin requirements may be increased during illness or emotional
disturbances.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Adjustment of dosage may also be necessary
if patients undertake increased physical activity or change their usual diet.
Exercise taken immediately after a meal may increase the risk of hypoglycaemia.
A consequence of the pharmacodynamics of rapid-acting insulin analogues is that
if hypoglycaemia occurs, it may occur earlier after an injection when compared
with soluble human insulin.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB>Combination of Liprolog with
pioglitazone:</span></u></p>

<p class=MsoNormal><span lang=EN-GB>Cases of cardiac failure have been reported
when pioglitazone was used in combination with insulin, especially in patients
with risk factors for development of cardiac heart failure. This should be kept
in mind if treatment with the combination of pioglitazone and Liprolog is
considered. If the combination is used, patients should be observed for signs
and symptoms of heart failure, weight gain and oedema. Pioglitazone should be
discontinued if any deterioration in cardiac symptoms occurs.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u>Instructions
for use and handling </u></p>

<p class=MsoNormal style='line-height:normal'>To prevent the possible
transmission of disease, each pen must be used by one patient only, even if the
needle is changed.</p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=BodytextAgency style='margin-bottom:0in'><u><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>Avoidance of
medication </span></u><u><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>errors</span></u></p>

<p class=BodytextAgency><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>Patients must be instructed to always check the
insulin label before each injection to avoid accidental mix-ups between the two
different strengths of Liprolog KwikPen as well as other insulin products.</span></p>

<p class=BodytextAgency><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>Patients must visually verify the dialled units on the
dose counter of the pen. Therefore, the requirement for patients to self-inject
is that they can read the dose counter on the pen. Patients who are blind or
have poor vision must be instructed to always get help/assistance from another
person who has good vision and is trained in using the insulin device.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>4.5&nbsp;&nbsp;&nbsp; Interaction with other medicinal products and
other forms of interaction</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin requirements may be increased by
medicinal products with hyperglycaemic activity, such as oral contraceptives,
corticosteroids, or thyroid replacement therapy, danazol, beta2 stimulants
(such as ritodrine, salbutamol, terbutaline). </span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin requirements may be reduced in the
presence of medicinal products with hypoglycaemic activity, such as oral
hypoglycemics, salicylates (for example, acetylsalicylic acid), sulpha
antibiotics, certain antidepressants (monoamine oxidase inhibitors, selective
serotonin reuptake inhibitors), certain angiotensin converting enzyme
inhibitors (captopril, enalapril), angiotensin II receptor blockers,
beta-blockers, octreotide or alcohol. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>The physician should be consulted when
using other medications in addition to Liprolog KwikPen </span>(see section <span
lang=EN-GB>4.4</span>)<span lang=EN-GB>.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>4.6&nbsp;&nbsp;&nbsp;&nbsp; Fertility,
pregnancy and lactation</span></b></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Data
on a large number of exposed pregnancies do not indicate any adverse effect of
insulin lispro on pregnancy or on the health of the foetus/newborn.&nbsp;&nbsp;
</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>It is essential
to maintain good control of the insulin-treated (insulin-dependent or
gestational diabetes) patient throughout pregnancy. Insulin requirements
usually fall during the first trimester and increase during the second and
third trimesters. Patients with diabetes should be advised to inform their
doctor if they are pregnant or are contemplating pregnancy. Careful monitoring
of glucose control, as well as general health, is essential in pregnant patients
with diabetes. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Patients
with diabetes who are breast-feeding may require adjustments in insulin dose,
diet or both. </span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;page-break-after:
avoid'><b><span lang=EN-GB>4.7&nbsp;&nbsp;&nbsp;&nbsp; Effects on ability to
drive and use machines</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;page-break-after:avoid'><span
lang=EN-GB>The patient&#8217;s ability to concentrate and react may be impaired
as a result of hypoglycaemia. This may constitute a risk in situations where
these abilities are of special importance (e.g. driving a car or operating
machinery).</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Patients
should be advised to take precautions to avoid hypoglycaemia whilst driving,
this is particularly important in those who have reduced or absent awareness of
the warning signs of hypoglycaemia or have frequent episodes of hypoglycaemia.
The advisability of driving should be considered in these circumstances.</span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>4.8&nbsp;&nbsp;&nbsp;&nbsp; Undesirable
effects</span></b></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>Hypoglycaemia
is the most frequent undesirable effect of insulin therapy that a patient with
diabetes may suffer. Severe hypoglycaemia may lead to loss of consciousness,
and in extreme cases, death. No specific frequency for hypoglycaemia is
presented, since hypoglycaemia is a result of both the insulin dose and other
factors e.g. a patient`s level of diet and exercise.</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>Local allergy
in patients is common (1/100 to &lt;1/10). Redness, swelling, and itching can
occur at the site of insulin injection. This condition usually resolves in a
few days to a few weeks. In some instances, this condition may be related to
factors other than insulin, such as irritants in the skin cleansing agent or
poor injection technique. Systemic allergy,&nbsp; which is rare (1/10,000 to
&lt;1/1,000) but potentially more serious, is a generalised allergy to insulin.
It may cause a rash over the whole body, shortness of breath, wheezing,
reduction in blood pressure, fast pulse, or sweating. Severe cases of
generalised allergy may be life-threatening.</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'>Lipodystrophy
at the injection site is uncommon (1/1,000 to &lt;1/100).</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Cases of oedema have been
reported with insulin therapy, particularly if previous poor metabolic control
is improved by intensified insulin therapy.</p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'>&nbsp;</p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB>Reporting of
suspected adverse reactions</span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Reporting suspected
adverse reactions after authorisation of the medicinal product is important. It
allows continued monitoring of the benefit/risk balance of the medicinal
product. Healthcare professionals are asked to report any suspected adverse
reactions via <span style='background:silver'>the national reporting system
listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span>.</span></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>4.9&nbsp;&nbsp;&nbsp;&nbsp; Overdose</span></b></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulins have no specific overdose
definitions because serum glucose concentrations are a result of complex
interactions between insulin levels, glucose availability and other metabolic
processes. Hypoglycaemia may occur as a result of an excess of insulin
activity&nbsp; relative to food intake and energy expenditure.</span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Hypoglycaemia may be associated with
listlessness, confusion, palpitations, headache, sweating and vomiting.</span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Mild hypoglycaemic episodes will respond to
oral administration of glucose or other sugar or saccharated products.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Correction of moderately severe
hypoglycaemia can be accomplished by intramuscular or subcutaneous
administration of glucagon, followed by oral carbohydrate when the patient
recovers sufficiently. Patients who fail to respond to glucagon must be given
glucose solution intravenously.</span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>If the patient is comatose, glucagon should
be administered intramuscularly or subcutaneously. However, glucose solution
must be given intravenously if glucagon is not available or if the patient
fails to respond to glucagon. The patient should be given a meal as soon as
consciousness is recovered.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Sustained
carbohydrate intake and observation may be necessary because hypoglycaemia may
recur after apparent clinical recovery.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmacological
Properties</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>5.1&nbsp;&nbsp;&nbsp; Pharmacodynamic properties</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Pharmacotherapeutic group : Fast-acting human insulin analogue, ATC
code: A10A B04</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>The primary activity of insulin lispro is the regulation of glucose
metabolism.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>In addition, insulins have several anabolic
and anti-catabolic actions on a variety of different tissues. Within muscle
tissue this includes increasing glycogen, fatty acid, glycerol and protein
synthesis and amino acid uptake, while decreasing glycogenolysis,
gluconeogenesis, ketogenesis, lipolysis, protein catabolism and amino acid
output.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin lispro
has a rapid onset of action (approximately 15&nbsp;minutes), thus allowing it
to be given closer to a meal (within zero to 15&nbsp;minutes of the meal) when
compared to regular insulin <br>
(30 to 45 minutes before). Insulin lispro takes effect rapidly and has a
shorter duration of activity (2 to 5&nbsp;hours) when compared to regular
insulin. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Clinical trials
in patients with type 1 and type 2 diabetes have demonstrated reduced
postprandial hyperglycaemia with insulin lispro compared to soluble human
insulin. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>As with all
insulin preparations, the time course of insulin lispro action may vary in
different individuals or at different times in the same individual and is
dependent on dose, site of injection, blood supply, temperature and physical
activity. The typical activity profile following subcutaneous injection is
illustrated below.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal>

<table cellpadding=0 cellspacing=0>
 <tr>
  <td width=59 height=0></td>
 </tr>
 <tr>
  <td></td>
  <td><img width=416 height=1 src="Humalo_files/image006.gif"></td>
 </tr>
</table>

<br clear=ALL>
<span lang=EN-GB>The above representation reflects the relative amount of
glucose over time required to maintain the subject's whole blood glucose
concentrations near fasting levels and is an indicator of the effect of these
insulins on glucose metabolism over time.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Clinical trials
have been performed in children (61 patients aged 2 to 11) and children and
adolescents (481 patients aged 9 to 19 years), comparing insulin lispro to
human soluble insulin. The pharmacodynamic profile of insulin lispro in
children is similar to that seen in adults. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB
style='layout-grid-mode:line'>When used in subcutaneous infusion pumps,
treatment with insulin lispro has been shown to result in lower glycosylated
haemoglobin levels compared to soluble insulin.&nbsp; In a double-blind,
crossover study, the reduction in glycosylated haemoglobin levels after 12
weeks dosing was 0.37 percentage points with insulin lispro, compared to 0.03
percentage points for soluble insulin (p&nbsp;=</span><span lang=EN-GB>&nbsp;<span
style='layout-grid-mode:line'>0.004).</span></span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB
style='layout-grid-mode:line'>In patients with type 2 diabetes on maximum doses
of sulphonyl urea agents, studies have shown that the addition of insulin
lispro significantly reduces HbA1c compared to sulphonyl urea alone. The
reduction of HbA1c would also be expected with other insulin products e.g.
soluble or isophane insulins.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB
style='layout-grid-mode:line'>Clinical trials in patients with type 1 and type
2 diabetes have demonstrated a reduced number of episodes of nocturnal
hypoglycaemia with insulin lispro compared to soluble human insulin. In some
studies, reduction of nocturnal hypoglycaemia was associated with increased
episodes of daytime hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>The glucodynamic response to insulin lispro
is not affected by renal or hepatic function impairment. Glucodynamic
differences between insulin lispro and soluble human insulin, as measured
during a glucose clamp procedure, were maintained over a wide range of renal
function.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Insulin
lispro has been shown to be equipotent to human insulin on a molar basis but
its effect is more rapid and of a shorter duration.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>5.2&nbsp;&nbsp;&nbsp;&nbsp; Pharmacokinetic
properties</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>The pharmacokinetics of insulin lispro
reflect a compound that is rapidly absorbed, and achieves peak blood levels 30
to 70&nbsp;minutes following subcutaneous injection. When considering the
clinical relevance of these kinetics, it is more appropriate to examine the
glucose utilisation curves (as discussed in 5.1).</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Insulin
lispro maintains more rapid absorption when compared to soluble human insulin
in patients with renal impairment. In patients with type 2 diabetes over a wide
range of renal function&nbsp; the pharmacokinetic differences between insulin
lispro and soluble human insulin were generally maintained and shown to be
independent of renal function.&nbsp; Insulin lispro maintains more rapid
absorption and elimination when compared to soluble human insulin in patients
with hepatic impairment.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>5.3&nbsp;&nbsp;&nbsp; Preclinical safety data</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>In in vitro tests, including binding to
insulin receptor sites and effects on growing cells, insulin lispro behaved in
a manner that closely resembled human insulin. Studies also demonstrate that
the dissociation of binding to the insulin receptor of insulin lispro is
equivalent to human insulin. Acute, one month and twelve month toxicology
studies produced no significant toxicity findings.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin lispro did not induce fertility
impairment, embryotoxicity or teratogenicity in animal studies. </span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmaceutical
Particulars</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>6.1&nbsp;&nbsp;&nbsp; List of excipients</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>m-</span></i><span
lang=EN-GB>Cresol </span><span lang=EN-GB>[3.15&nbsp;mg/ml]</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Glycerol</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Dibasic sodium
phosphate.&nbsp;7H<span style='position:relative;top:3.0pt'>2</span>O</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Zinc oxide</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Water for
injections</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Hydrochloric
acid and sodium hydroxide maybe used to adjust pH to 7.0 &#8211; 7.8.</span></p>

<p class=MsoNormal><s><span lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></s></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>6.2&nbsp;&nbsp;&nbsp;&nbsp; Incompatibilities</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog preparations should not be mixed
with insulins produced by other manufacturers or with animal insulin
preparations.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>6.3&nbsp;&nbsp;&nbsp; Shelf life</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>Unused
pre-filled pens</span></u></i></p>

<p class=MsoNormal><span lang=EN-GB>3&nbsp;years. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><i><u><span lang=EN-GB>After first use</span></u></i></p>

<p class=MsoNormal><span lang=EN-GB>28 days.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>6.4&nbsp;&nbsp;&nbsp; Special precautions for storage</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>Unused
pre-filled pens</span></u></i></p>

<p class=MsoNormal><span lang=EN-GB>Store in a refrigerator (2&deg;C -
8&deg;C). Do not freeze. Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>After
first use</span></u></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Store below 30&deg;C. Do not refrigerate. The pre-filled pen should
not be stored with the needle attached.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>6.5&nbsp;&nbsp;&nbsp; Nature and contents of container</span></b><b><span
lang=EN-GB> and special equipment for use, administration or implantation</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>The solution is contained in type I flint
glass cartridges, sealed with butyl or halobutyl disc seals and plunger heads
and are secured with aluminium seals. Dimeticone or silicone emulsion may be
used to treat the cartridge plunger, and/or the glass cartridge. The 3 ml
cartridges are sealed in a disposable pen injector. Needles are not included.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Not all packs
may be marketed.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=ES>5 x 3&nbsp;ml Liprolog 100&nbsp;units/ml KwikPen</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=ES>2 x (5 x 3&nbsp;ml) Liprolog 100&nbsp;units/ml KwikPen</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=ES>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.6&nbsp;&nbsp;&nbsp;&nbsp; Special precautions for
disposal and other handling</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Any unused
product or waste material should be disposed of in accordance with local
requirements.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><u><span lang=EN-GB>Instructions for use and handling</span></u></p>

<p class=MsoNormal style='line-height:normal'>To prevent the possible
transmission of disease, each pen must be used by one patient only, even if the
needle is changed.</p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Inspect the Liprolog KwikPen solution. It
should be clear and colourless. Do not use Liprolog KwikPen if it appears
cloudy, thickened, or slightly coloured or if solid particles are visible.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><u><span
lang=EN-GB>a) Handling of the pre-filled pen</span></u></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Before using the KwikPen the user manual included in the package
leaflet must be read carefully.&nbsp; The KwikPen has to be used as recommended
in the user manual.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Mixing insulins</u></span></p>

<p class=MsoNormal><span lang=EN-GB>Do not mix insulin in vials with insulin in
cartridges. See section 6.2.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Marketing
Authorisation Holder</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBERS</b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'>&nbsp;</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=ES>EU/1/01/195/016&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5
x 3&nbsp;ml Liprolog 100&nbsp;units/ml KwikPen</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=ES>EU/1/01/195/017&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2
x (5 x 3&nbsp;ml) Liprolog 100&nbsp;units/ml KwikPen</span></p>

<p class=MsoNormal><span lang=ES>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=ES>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Date
of First Authorisation / Renewal of the Authorisation</span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Date of first
authorisation: 1<sup>st</sup> August 2001</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Date of last
renewal: 1<sup>st</sup> August 2006</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'>&nbsp;</p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='text-transform:uppercase'>10.&nbsp;&nbsp;&nbsp;&nbsp; Date
of Revision of THE Text</span></b></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Mix25
100&nbsp;units/ml KwikPen, suspension for injection in a pre-filled pen</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Qualitative
and Quantitative Composition</span></b></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>One
ml contains 100&nbsp;units (equivalent to 3.5mg) insulin lispro (recombinant
DNA origin produced in E.coli). Each container includes 3ml equivalent to 300&nbsp;units
insulin lispro.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Liprolog Mix25 consists of 25% insulin lispro solution
and 75% insulin lispro protamine suspension.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Each KwikPen delivers 1-60 units in steps of 1 unit.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>For a full list of excipients, see section 6.1.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmaceutical
Form</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Suspension for injection.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>White, sterile suspension.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clinical
Particulars</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.1&nbsp;&nbsp;&nbsp;&nbsp; Therapeutic
indications</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Mix25
is indicated for the treatment of patients with diabetes mellitus who require
insulin for the maintenance of normal glucose homeostasis. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.2&nbsp;&nbsp;&nbsp;&nbsp; Posology
and method of administration</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The dosage
should be determined by the physician, according to the requirement of the
patient.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Mix25
may be given shortly before meals. When necessary, Liprolog Mix25 can be given
soon after meals. Liprolog Mix25 should only be given by subcutaneous
injection. Under no circumstances should Liprolog Mix25 be given intravenously.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Subcutaneous
administration should be in the upper arms, thighs, buttocks, or abdomen.&nbsp;
Use of injection sites should be rotated so that the same site is not used more
than approximately once a month.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>When
administered subcutaneously care should be taken when injecting Liprolog Mix25
to ensure that a blood vessel has not been entered. After injection, the site
of injection should not be massaged. Patients must be educated to use the
proper injection techniques.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The rapid onset
and early peak of activity of Liprolog itself is observed following the subcutaneous
administration of Liprolog Mix25. This allows Liprolog Mix25 to be given very
close to mealtime. The duration of action of the insulin lispro protamine
suspension (Basal) component of Liprolog Mix25 is similar to that of a basal
insulin (NPH).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The time course
of action of any insulin may vary considerably in different individuals or at
different times in the same individual. As with all insulin preparations, the
duration of action of Liprolog Mix25 is dependent on dose, site of injection,
blood supply, temperature, and physical activity.</span></p>

<p class=Default><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>The
KwikPen delivers 1&nbsp;&#8211;&nbsp;60&nbsp;units in steps of 1 unit in a
single injection. The needed dose is dialled in units. <b>The number of units
is shown in the dose window of the pen</b>. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><span
lang=EN-GB>Paediatric population</span></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Administration of Liprolog Mix25 to children below 12 years of age
should be considered only in case of an expected benefit when compared to
regular insulin. </span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.3&nbsp;&nbsp;&nbsp;&nbsp; Contraindications</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Hypersensitivity
to insulin lispro or to any of the excipients.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Hypoglycaemia.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.4&nbsp;&nbsp;&nbsp;&nbsp; Special
warnings and precautions for use</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Under no
circumstances should Liprolog Mix25 be given intravenously.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Transferring a
patient to another type or brand of insulin should be done under strict medical
supervision.&nbsp; Changes in strength, brand (manufacturer), type (regular,
NPH, lente, etc.), species (animal, human, human insulin analogue), and/or
method of manufacture (recombinant DNA versus animal-source insulin) may result
in the need for a change in dosage. </span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Conditions which
may make the early warning symptoms of hypoglycaemia different or less
pronounced include long duration of diabetes, intensified insulin therapy,
diabetic nerve disease or medications such as beta-blockers.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>A few patients
who have experienced hypoglycaemic reactions after transfer from animal-source
insulin to human insulin have reported that the early warning symptoms of
hypoglycaemia were less pronounced or different from those experienced with
their previous insulin. Uncorrected hypoglycaemic or hyperglycaemic reactions
can cause loss of consciousness, coma, or death.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The use of
dosages which are inadequate or discontinuation of treatment, especially in
insulin-dependent diabetics, may lead to hyperglycaemia and diabetic
ketoacidosis; conditions which are potentially lethal.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin requirements may be reduced in the
presence of renal impairment. Insulin requirements may be reduced in patients
with hepatic impairment due to reduced capacity for gluconeogenesis and reduced
insulin breakdown; however, in patients with chronic hepatic impairment, an
increase in insulin resistance may lead to increased insulin requirements</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Insulin requirements may be increased during illness or emotional
disturbances.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Adjustment of
dosage may also be necessary if patients undertake increased physical activity
or change their usual diet.&nbsp; Exercise taken immediately after a meal may
increase the risk of hypoglycaemia.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB>Combination of Liprolog Mix25 with
pioglitazone:</span></u></p>

<p class=MsoNormal><span lang=EN-GB>Cases of cardiac failure have been reported
when pioglitazone was used in combination with insulin, especially in patients
with risk factors for development of cardiac heart failure. This should be kept
in mind if treatment with the combination of pioglitazone and Liprolog Mix25 is
considered. If the combination is used, patients should be observed for signs
and symptoms of heart failure, weight gain and oedema. Pioglitazone should be
discontinued if any deterioration in cardiac symptoms occurs.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u>Instructions
for use and handling </u></p>

<p class=MsoNormal style='line-height:normal'>To prevent the possible
transmission of disease, each pen must be used by one patient only, even if the
needle is changed.</p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=BodytextAgency style='margin-bottom:0in'><u><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>Avoidance of
medication </span></u><u><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>errors</span></u></p>

<p class=BodytextAgency><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>Patients must be instructed to always check the
insulin label before each injection to avoid accidental mix-ups between the two
different strengths of Liprolog KwikPen as well as other insulin products.</span></p>

<p class=BodytextAgency><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>Patients must visually verify the dialled units on the
dose counter of the pen. Therefore, the requirement for patients to self-inject
is that they can read the dose counter on the pen. Patients who are blind or have
poor vision must be instructed to always get help/assistance from another
person who has good vision and is trained in using the insulin device.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.5&nbsp;&nbsp;&nbsp;&nbsp; Interaction
with other medicinal products and other forms of interaction</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Insulin
requirements may be increased by substances with hyperglycaemic activity, such
as oral contraceptives, corticosteroids, or thyroid replacement therapy,
danazol, beta<sub>2</sub> stimulants (such as ritodrine, salbutamol,
terbutaline). </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin
requirements may be reduced in the presence of substances with hypoglycaemic
activity, such as oral hypoglycaemics, salicylates (for example,
acetylsalicylic acid), sulpha antibiotics, certain antidepressants (monoamine
oxidase inhibitors, selective serotonin reuptake inhibitors), certain angiotensin
converting enzyme inhibitors (captopril, enalapril), angiotensin II receptor
blockers, beta-blockers, octreotide or alcohol. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Mixing Liprolog
Mix25 with other insulins has not been studied.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The physician
should be consulted when using other medications in addition to Liprolog Mix25 </span>(see
section <span lang=EN-GB>4.4</span>)<span lang=EN-GB>.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.6&nbsp;&nbsp;&nbsp;&nbsp; Fertility,
pregnancy and lactation</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Data
on a large number of exposed pregnancies do not indicate any adverse effect of
insulin lispro on pregnancy or on the health of the foetus/newborn.&nbsp;&nbsp;
</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>It is
essential to maintain good control of the insulin-treated (insulin-dependent or
gestational diabetes) patient throughout pregnancy. Insulin requirements
usually fall during the first trimester and increase during the second and
third trimesters. Patients with diabetes should be advised to inform their
doctor if they are pregnant or are contemplating pregnancy. Careful monitoring
of glucose control, as well as general health, is essential in pregnant
patients with diabetes. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Patients with
diabetes who are breast-feeding may require adjustments in insulin dose, diet
or both. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.7&nbsp;&nbsp;&nbsp;&nbsp; Effects
on ability to drive and use machines</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The
patient&#8217;s ability to concentrate and react may be impaired as a result of
hypoglycaemia. This may constitute a risk in situations where these abilities
are of special importance (e.g. driving a car or operating machinery).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Patients should
be advised to take precautions to avoid hypoglycaemia whilst driving, this is
particularly important in those who have reduced or absent awareness of the
warning signs of hypoglycaemia or have frequent episodes of hypoglycaemia. The
advisability of driving should be considered in these circumstances.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.8&nbsp;&nbsp;&nbsp;&nbsp; Undesirable
effects</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>Hypoglycaemia
is the most frequent undesirable effect of insulin therapy that a patient with
diabetes may suffer. Severe hypoglycaemia may lead to loss of consciousness,
and in extreme cases, death. No specific frequency for hypoglycaemia is
presented, since hypoglycaemia is a result of both the insulin dose and other
factors e.g. a patient`s level of diet and exercise.</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>Local allergy
in patients is common (1/100 to &lt;1/10). Redness, swelling, and itching can
occur at the site of insulin injection. This condition usually resolves in a
few days to a few weeks. In some instances, this condition may be related to
factors other than insulin, such as irritants in the skin cleansing agent or
poor injection technique. Systemic allergy, which is rare (1/10,000 to
&lt;1/1,000) but potentially more serious, is a generalised allergy to insulin.
It may cause a rash over the whole body, shortness of breath, wheezing,
reduction in blood pressure, fast pulse, or sweating. Severe cases of
generalised allergy may be life-threatening.</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'>Lipodystrophy
at the injection site is uncommon (1/1,000 to &lt;1/100).</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Cases of oedema have been
reported with insulin therapy, particularly if previous poor metabolic control
is improved by intensified insulin therapy.</p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB>Reporting of
suspected adverse reactions</span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Reporting
suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals are asked to report any suspected
adverse reactions via <span style='background:silver'>the national reporting
system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span>.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.9&nbsp;&nbsp;&nbsp;&nbsp; Overdose</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Insulins have no
specific overdose definitions because serum glucose concentrations are a result
of complex interactions between insulin levels, glucose availability and other
metabolic processes.&nbsp; Hypoglycaemia may occur as a result of an excess of
insulin activity relative to food intake and energy expenditure.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Hypoglycaemia
may be associated with listlessness, confusion, palpitations, headache,
sweating and vomiting.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Mild
hypoglycaemic episodes will respond to oral administration of glucose or other
sugar or saccharated products.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Correction of
moderately severe hypoglycaemia can be accomplished by intramuscular or
subcutaneous administration of glucagon, followed by oral carbohydrate when the
patient recovers sufficiently.&nbsp; Patients who fail to respond to glucagon
must be given glucose solution intravenously.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If the patient
is comatose, glucagon should be administered intramuscularly or
subcutaneously.&nbsp; However, glucose solution must be given intravenously if
glucagon is not available or if the patient fails to respond to glucagon.&nbsp;
The patient should be given a meal as soon as consciousness is recovered.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Sustained
carbohydrate intake and observation may be necessary because hypoglycaemia may
recur after apparent clinical recovery.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACOLOGICAL
PROPERTIES</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>5.1&nbsp;&nbsp;&nbsp;&nbsp; Pharmacodynamic
properties</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Pharmaco-therapeutic
group:</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Mix25
is a premixed suspension consisting of insulin lispro (fast-acting human
insulin analogue) and insulin lispro protamine suspension (intermediate acting
human insulin analogue). ATC Code: A10A D04.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The primary
activity of insulin lispro is the regulation of glucose metabolism.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In addition,
insulins have several anabolic and anti-catabolic actions on a variety of
different tissues.&nbsp; Within muscle tissue this includes increasing
glycogen, fatty acid, glycerol and protein synthesis and amino acid uptake,
while decreasing glycogenolysis, gluconeogenesis, ketogenesis, lipolysis,
protein catabolism and amino acid output.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Insulin lispro
has a rapid onset of action (approximately 15 minutes), thus allowing it to be
given closer to a meal (within zero to 15 minutes of the meal) when compared to
regular insulin (30 to 45 minutes before). The rapid onset and early peak of
activity of insulin lispro is observed following the subcutaneous
administration of Liprolog Mix25. Liprolog Basal has an activity profile that
is very similar to that of a basal insulin (NPH) over a period of approximately
15 hours. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Clinical trials in patients with type 1 and
type 2 diabetes have demonstrated reduced postprandial hyperglycaemia with
Liprolog Mix25 compared to human insulin mixture 30/70. In one clinical study
there was a small (0.38 mmol/l) increase in blood glucose levels at night
(3a.m.).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In the figure
below the pharmacodynamics of Liprolog Mix25 and Liprolog Basal are
illustrated.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-indent:113.4pt;line-height:normal'><span
style='position:relative;z-index:251625472'><span style='left:0px;position:
absolute;left:1px;top:-13208px;width:350px;height:4px'><img width=350 height=4
src="Humalo_files/image007.gif"></span></span><span lang=EN-GB><img border=0
width=387 height=279 src="Humalo_files/image008.gif"></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:2.0in;margin-bottom:.0001pt;text-indent:23.5pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:2.0in;margin-bottom:.0001pt;text-indent:23.5pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The above
representation reflects the relative amount of glucose over time required to
maintain the subject's whole blood glucose concentrations near fasting levels
and is an indicator of the effect of these insulins on glucose metabolism over
time.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><span lang=EN-GB>The glucodynamic response to insulin lispro
is not affected by renal or hepatic function impairment. Glucodynamic
differences between insulin lispro and soluble human insulin, as measured
during a glucose clamp procedure, were maintained over a wide range of renal
function.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Insulin
lispro has been shown to be equipotent to human insulin on a molar basis but
its effect is more rapid and of a shorter duration.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormalIndent style='margin-left:0in'><span lang=EN-GB
style='font-size:11.0pt'>In two 8-month open label crossover studies, type 2
diabetes patients who were either new to insulin therapy or already using one
or two injections of insulin, received 4 months of treatment with Liprolog
Mix25 (used twice daily with metformin) and insulin glargine (used once daily
with metformin) in a randomised sequence. Detailed information can be found in
the following table.</span></p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'><i><span
lang=EN-GB>&nbsp;</span></i></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=609
 style='margin-left:2.0pt;border-collapse:collapse;border:none'>
 <tr>
  <td width=255 valign=top style='width:191.4pt;border:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='margin-top:0in;margin-right:2.0pt;margin-bottom:
  0in;margin-left:2.0pt;margin-bottom:.0001pt;line-height:12.0pt;page-break-after:
  avoid;text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=177 valign=top style='width:132.65pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:2.0pt;
  margin-bottom:0in;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><b><span
  lang=FR style='color:black'>Insulin-Naive Patients</span></b></p>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:2.0pt;
  margin-bottom:0in;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span lang=FR
  style='color:black'>n = 78</span></p>
  </td>
  <td width=177 valign=top style='width:132.7pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:2.0pt;
  margin-bottom:0in;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><b><span
  lang=EN-GB style='color:black'>Not Insulin-Naive Patients</span></b></p>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:2.0pt;
  margin-bottom:0in;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>n = 97</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top style='width:191.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='margin-top:0in;margin-right:2.0pt;margin-bottom:
  0in;margin-left:2.0pt;margin-bottom:.0001pt;line-height:12.0pt;page-break-after:
  avoid;text-autospace:none'><span lang=EN-GB>Mean total daily insulin dose at
  endpoint</span></p>
  </td>
  <td width=177 valign=top style='width:132.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:2.0pt;
  margin-bottom:0in;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>0.63&nbsp;units/kg</span></p>
  </td>
  <td width=177 valign=top style='width:132.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:2.0pt;
  margin-bottom:0in;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>0.42&nbsp;units/kg</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top style='width:191.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='margin-left:.75pt;line-height:12.0pt;page-break-after:
  avoid;text-autospace:none'><span lang=EN-GB style='color:black'>Haemoglobin
  A1c &#8211;Reduction<sup><span style='position:relative;top:-3.0pt'>1</span></sup>&nbsp;</span></p>
  </td>
  <td width=177 valign=top style='width:132.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>1.30%</span></p>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=DE-AT style='color:black'>(mean at baseline = 8.7%)</span></p>
  </td>
  <td width=177 valign=top style='width:132.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=DE-AT style='color:black'>1.00 %</span></p>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>(mean at baseline = 8.5%)</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top style='width:191.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='margin-left:.75pt;line-height:12.0pt;page-break-after:
  avoid;text-autospace:none'><span lang=EN-GB style='color:black'>Reduction of
  the mean of combined morning / evening two-hour postprandial blood glucose<sup><span
  style='position:relative;top:-3.0pt'>1</span></sup>&nbsp;</span></p>
  </td>
  <td width=177 valign=top style='width:132.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>3.46 mM</span></p>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  </td>
  <td width=177 valign=top style='width:132.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>2.48 mM</span></p>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top style='width:191.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='margin-left:.75pt;line-height:12.0pt;page-break-after:
  avoid;text-autospace:none'><span lang=EN-GB style='color:black'>Reduction of
  the mean fasting blood glucose<sup><span style='position:relative;top:-3.0pt'>1</span></sup>&nbsp;</span></p>
  </td>
  <td width=177 valign=top style='width:132.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>0.55 mM</span></p>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  </td>
  <td width=177 valign=top style='width:132.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>0.65 mM</span></p>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top style='width:191.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='margin-left:.75pt;line-height:12.0pt;page-break-after:
  avoid;text-autospace:none'><span lang=EN-GB style='color:black'>Incidence of
  hypoglycaemia at endpoint</span></p>
  </td>
  <td width=177 valign=top style='width:132.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>25%</span></p>
  </td>
  <td width=177 valign=top style='width:132.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>25%</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top style='width:191.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='margin-left:.75pt;line-height:12.0pt;page-break-after:
  avoid;text-autospace:none'><span lang=EN-GB style='color:black'>Bodyweight
  gain<sup>2</sup></span></p>
  </td>
  <td width=177 valign=top style='width:132.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>2.33 kg</span></p>
  </td>
  <td width=177 valign=top style='width:132.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal align=center style='margin-left:.75pt;text-align:center;
  line-height:12.0pt;page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>0.96 kg</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='line-height:12.0pt;page-break-after:avoid;text-autospace:
none'><span lang=EN-GB style='font-size:9.0pt;color:black;position:relative;
top:-3.0pt'>1</span><span lang=EN-GB style='font-size:10.0pt;color:black'>&nbsp;from
baseline to end of Liprolog Mix25 treatment</span></p>

<p class=MsoNormal style='line-height:12.0pt;page-break-after:avoid;text-autospace:
none'><sup><span lang=EN-GB style='color:black'>2</span></sup><span lang=EN-GB
style='font-size:10.0pt;color:black'> in patients randomised to Liprolog Mix25
during the first crossover period</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>5.2&nbsp;&nbsp;&nbsp;&nbsp; Pharmacokinetic
properties</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The
pharmacokinetics of insulin lispro reflect a compound that is rapidly absorbed,
and achieves peak blood levels 30 to 70 minutes following subcutaneous injection.
The pharmacokinetics of insulin lispro protamine suspension are consistent with
those of an intermediate acting insulin such as NPH. The pharmacokinetics of
Liprolog Mix25 are representative of the individual pharmacokinetic properties
of the two components. When considering the clinical relevance of these
kinetics, it is more appropriate to examine the glucose utilisation curves (as
discussed in 5.1).</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><span lang=EN-GB>Insulin lispro maintains more rapid
absorption when compared to soluble human insulin in patients with renal
impairment. In patients with type 2 diabetes over a wide range of renal
function the pharmacokinetic differences between insulin lispro and soluble
human insulin were generally maintained and shown to be independent of renal
function.&nbsp; Insulin lispro maintains more rapid absorption and elimination
when compared to soluble human insulin in patients with hepatic impairment.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>5.3&nbsp;&nbsp;&nbsp;&nbsp; Preclinical
safety data</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In <i>in vitro</i>
tests, including binding to insulin receptor sites and effects on growing
cells, insulin lispro behaved in a manner that closely resembled human
insulin.&nbsp; Studies also demonstrate that the dissociation of binding to the
insulin receptor of insulin lispro is equivalent to human insulin.&nbsp; Acute,
one month and twelve month toxicology studies produced no significant toxicity
findings.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Insulin lispro
did not induce fertility impairment, embryotoxicity or teratogenicity in animal
studies. </span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmaceutical
Particulars</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>6.1&nbsp;&nbsp;&nbsp;&nbsp; List
of excipients</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><span lang=EN-GB>Protamine sulphate</span></p>

<p class=MsoNormal><i><span lang=EN-GB>m-</span></i><span lang=EN-GB>cresol</span><span
lang=EN-GB> [1.76 mg/ml]</span></p>

<p class=MsoNormal><span lang=EN-GB>Phenol [0.80 mg/ml]</span></p>

<p class=MsoNormal><span lang=EN-GB>Glycerol</span></p>

<p class=MsoNormal><span lang=EN-GB>Dibasic sodium phosphate.7H<span
style='position:relative;top:2.0pt'>2</span>O</span></p>

<p class=MsoNormal><span lang=EN-GB>Zinc oxide</span></p>

<p class=MsoNormal><span lang=EN-GB>Water for injections</span></p>

<p class=MsoNormal><span lang=EN-GB>Hydrochloric acid and sodium hydroxide may
be used to adjust pH to 7.0 &#8211; 7.8.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>6.2&nbsp;&nbsp;&nbsp;&nbsp; Incompatibilities</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Mixing Liprolog
Mix25 with other insulins has not been studied. In the absence of compatibility
studies, this medicinal product must not be mixed with other medicinal
products.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>6.3&nbsp;&nbsp;&nbsp;&nbsp; Shelf
life</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>Unused
pre-filled pens</span></u></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>3 years.&nbsp; </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>After
first use</span></u></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>28 days.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>6.4&nbsp;&nbsp;&nbsp;&nbsp; Special
precautions for storage</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>Unused
pre-filled pens</span></u></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Store in a refrigerator
(2&deg;C - 8&deg;C). Do not freeze. Do not expose to excessive heat or direct
sunlight. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>After
first use</span></u></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Store below 30&deg;C. Do not refrigerate. The pre-filled pen should
not be stored with the needle attached.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.5&nbsp;&nbsp;&nbsp;&nbsp; Nature and contents of
container</span></b><b><span lang=EN-GB> and special equipment for use,
administration or implantation</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The suspension
is contained in type I flint glass cartridges, sealed with halobutyl disc seals
and plunger heads and secured with aluminium seals.&nbsp; Dimeticone or
silicone emulsion may have been used to treat the cartridge plunger, and/or the
glass cartridge. The 3 ml cartridges are sealed in a disposable pen injector,
called the &#8220;Pen&#8221;.&nbsp; Needles are not included.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Not all packs
may be marketed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=ES>5 x 3 ml Liprolog
Mix25 100&nbsp;units/ml KwikPens.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=ES>2 x (5 x 3 ml)
Liprolog Mix25 100&nbsp;units/ml KwikPens.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=ES>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.6&nbsp;&nbsp;&nbsp;&nbsp; Special precautions for
disposal and other handling</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Any unused
product or waste material should be disposed of in accordance with local
requirements.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Instructions
for use and handling</span></u></p>

<p class=MsoNormal style='line-height:normal'>To prevent the possible
transmission of disease, each pen must be used by one patient only, even if the
needle is changed.</p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The KwikPen
should be rotated in the palms of the hands ten times and inverted 180&deg; ten
times immediately before use to resuspend the insulin until it appears
uniformly cloudy or milky.&nbsp; If not, repeat the above procedure until
contents are mixed.&nbsp; Cartridges contain a small glass bead to assist
mixing.&nbsp; Do not shake vigorously as this may cause frothing which may
interfere with the correct measurement of the dose.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The cartridges
should be examined frequently and should not be used if clumps of material are
present or if solid white particles stick to the bottom or wall of the
cartridge, giving a frosted appearance.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><u><span
lang=EN-GB>Handling of the pre-filled pen</span></u></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Before using the KwikPen the user manual included in the package
leaflet must be read carefully.&nbsp; The KwikPen has to be used as recommended
in the user manual.</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Marketing
Authorisation Holder</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span style='text-transform:
uppercase'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING AUTHORISATION
NUMBERS</span></b></p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'><span lang=NL>EU/1/01/195/018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5
x 3 ml Liprolog Mix25 100&nbsp;units/ml KwikPens</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=NL>EU/1/01/195/019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2
x (5 x 3 ml) Liprolog Mix25 100&nbsp;units/ml KwikPens</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=NL>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=NL>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Date of
First Authorisation / Renewal of the Authorisation</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Date of first
authorisation: 1<sup>st</sup> August 2001</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Date of last
renewal: 1<sup>st</sup> August 2006</span></p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>10.&nbsp;&nbsp;&nbsp;&nbsp; Date of Revision
of THE Text</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Mix50
100&nbsp;units/ml KwikPen, suspension for injection in a pre-filled pen</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Qualitative
and Quantitative Composition</span></b></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>One
ml contains 100&nbsp;units (equivalent to 3.5mg) insulin lispro (recombinant
DNA origin produced in E.coli). Each container includes 3ml equivalent to 300&nbsp;units
insulin lispro.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Liprolog Mix50 consists of 50% insulin lispro solution
and 50% insulin lispro protamine suspension.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Each KwikPen delivers 1-60 units in steps of 1 unit.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt'><span
lang=EN-GB>For a full list of excipients, see section 6.1.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmaceutical
Form</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Suspension for
injection.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>White, sterile
suspension.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clinical
Particulars</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.1&nbsp;&nbsp;&nbsp;&nbsp; Therapeutic
indications</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Mix50
is indicated for the treatment of patients with diabetes mellitus who require
insulin for the maintenance of normal glucose homeostasis. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.2&nbsp;&nbsp;&nbsp;&nbsp; Posology
and method of administration</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The dosage
should be determined by the physician, according to the requirement of the
patient.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Mix50
may be given shortly before meals. When necessary, Liprolog Mix50 can be given
soon after meals. Liprolog Mix50 should only be given by subcutaneous
injection. Under no circumstances should Liprolog Mix50 be given intravenously.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Subcutaneous
administration should be in the upper arms, thighs, buttocks, or abdomen.&nbsp;
Use of injection sites should be rotated so that the same site is not used more
than approximately once a month.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>When administered
subcutaneously care should be taken when injecting Liprolog Mix50 to ensure
that a blood vessel has not been entered. After injection, the site of
injection should not be massaged. Patients must be educated to use the proper
injection techniques.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The rapid onset
and early peak of activity of Liprolog itself is observed following the
subcutaneous administration of Liprolog Mix50. This allows Liprolog Mix50 to be
given very close to mealtime. The duration of action of the insulin lispro
protamine suspension (Basal) component of Liprolog Mix50 is similar to that of
a basal insulin NPH.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The time course
of action of any insulin may vary considerably in different individuals or at
different times in the same individual. As with all insulin preparations, the
duration of action of Liprolog Mix50 is dependent on dose, site of injection,
blood supply, temperature, and physical activity.</span></p>

<p class=Default><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>The
KwikPen delivers 1&nbsp;&#8211;&nbsp;60&nbsp;units in steps of 1 unit in a
single injection. The needed dose is dialled in units. <b>The number of units
is shown in the dose window of the pen</b>. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><span
lang=EN-GB>Paediatric population</span></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Administration of Liprolog Mix50 to children below 12 years of age
should be considered only in case of an expected benefit when compared to
regular insulin. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.3&nbsp;&nbsp;&nbsp;&nbsp; Contraindications</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Hypersensitivity
to insulin lispro or to any of the excipients.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Hypoglycaemia.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.4&nbsp;&nbsp;&nbsp;&nbsp; Special
warnings and precautions for use</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Under no
circumstances should Liprolog Mix50 be given intravenously.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Transferring a
patient to another type or brand of insulin should be done under strict medical
supervision.&nbsp; Changes in strength, brand (manufacturer), type (regular,
NPH, lente, etc.), species (animal, human, human insulin analogue), and/or
method of manufacture (recombinant DNA versus animal-source insulin) may result
in the need for a change in dosage. </span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Conditions
which may make the early warning symptoms of hypoglycaemia different or less
pronounced include long duration of diabetes, intensified insulin therapy,
diabetic nerve disease or medications such as beta-blockers.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>A few patients
who have experienced hypoglycaemic reactions after transfer from animal-source
insulin to human insulin have reported that the early warning symptoms of
hypoglycaemia were less pronounced or different from those experienced with
their previous insulin. Uncorrected hypoglycaemic or hyperglycaemic reactions
can cause loss of consciousness, coma, or death.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The use of
dosages which are inadequate or discontinuation of treatment, especially in
insulin-dependent diabetics, may lead to hyperglycaemia and diabetic
ketoacidosis; conditions which are potentially lethal.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin requirements may be reduced in the
presence of renal impairment. Insulin requirements may be reduced in patients
with hepatic impairment due to reduced capacity for gluconeogenesis and reduced
insulin breakdown; however, in patients with chronic hepatic impairment, an
increase in insulin resistance may lead to increased insulin requirements</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Insulin requirements may be increased during illness or emotional
disturbances.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Adjustment of
dosage may also be necessary if patients undertake increased physical activity
or change their usual diet. Exercise taken immediately after a meal may
increase the risk of hypoglycaemia.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB>Combination of Liprolog Mix50 with
pioglitazone:</span></u></p>

<p class=MsoNormal><span lang=EN-GB>Cases of cardiac failure have been reported
when pioglitazone was used in combination with insulin, especially in patients
with risk factors for development of cardiac heart failure. This should be kept
in mind if treatment with the combination of pioglitazone and Liprolog Mix50 is
considered. If the combination is used, patients should be observed for signs
and symptoms of heart failure, weight gain and oedema. Pioglitazone should be
discontinued if any deterioration in cardiac symptoms occurs.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u>Instructions
for use and handling </u></p>

<p class=MsoNormal style='line-height:normal'>To prevent the possible
transmission of disease, each pen must be used by one patient only, even if the
needle is changed.</p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=BodytextAgency style='margin-bottom:0in'><u><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>Avoidance of
medication </span></u><u><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>errors</span></u></p>

<p class=BodytextAgency><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>Patients must be instructed to always check the
insulin label before each injection to avoid accidental mix-ups between the two
different strengths of Liprolog KwikPen as well as other insulin products.</span></p>

<p class=BodytextAgency><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>Patients must visually verify the dialled units on the
dose counter of the pen. Therefore, the requirement for patients to self-inject
is that they can read the dose counter on the pen. Patients who are blind or
have poor vision must be instructed to always get help/assistance from another
person who has good vision and is trained in using the insulin device.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>4.5&nbsp;&nbsp;&nbsp;&nbsp; Interaction with other medicinal
products and other forms of interaction</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Insulin requirements may be increased by substances with
hyperglycaemic activity, such as oral contraceptives, corticosteroids, or
thyroid replacement therapy, danazol, beta<sub>2</sub> stimulants (such as
ritodrine, salbutamol, terbutaline). </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Insulin
requirements may be reduced in the presence of substances with hypoglycaemic
activity, such as oral hypoglycaemics, salicylates (for example,
acetylsalicylic acid), sulpha antibiotics, certain antidepressants (monoamine
oxidase inhibitors, selective serotonin reuptake inhibitors), certain
angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II
receptor blockers, beta-blockers, octreotide or alcohol. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Mixing Liprolog
Mix50 with other insulins has not been studied.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The physician
should be consulted when using other medications in addition to Liprolog Mix50 </span>(see
section <span lang=EN-GB>4.4</span>)<span lang=EN-GB>.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.6&nbsp;&nbsp;&nbsp;&nbsp; Fertility,
pregnancy and lactation</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Data
on a large number of exposed pregnancies do not indicate any adverse effect of
insulin lispro on pregnancy or on the health of the foetus/newborn.&nbsp;&nbsp;
</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>It is
essential to maintain good control of the insulin-treated (insulin-dependent or
gestational diabetes) patient throughout pregnancy. Insulin requirements
usually fall during the first trimester and increase during the second and
third trimesters. Patients with diabetes should be advised to inform their
doctor if they are pregnant or are contemplating pregnancy. Careful monitoring
of glucose control, as well as general health, is essential in pregnant
patients with diabetes. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Patients with
diabetes who are breast-feeding may require adjustments in insulin dose, diet
or both. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.7&nbsp;&nbsp;&nbsp;&nbsp; Effects
on ability to drive and use machines</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The
patient&#8217;s ability to concentrate and react may be impaired as a result of
hypoglycaemia. This may constitute a risk in situations where these abilities
are of special importance (e.g. driving a car or operating machinery).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Patients should
be advised to take precautions to avoid hypoglycaemia whilst driving, this is
particularly important in those who have reduced or absent awareness of the
warning signs of hypoglycaemia or have frequent episodes of hypoglycaemia. The
advisability of driving should be considered in these circumstances.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.8&nbsp;&nbsp;&nbsp;&nbsp; Undesirable
effects</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>Hypoglycaemia
is the most frequent undesirable effect of insulin therapy that a patient with
diabetes may suffer. Severe hypoglycaemia may lead to loss of consciousness,
and in extreme cases, death. No specific frequency for hypoglycaemia is
presented, since hypoglycaemia is a result of both the insulin dose and other
factors e.g. a patient`s level of diet and exercise.</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>Local allergy
in patients is common (1/100 to &lt;1/10). Redness, swelling, and itching can
occur at the site of insulin injection. This condition usually resolves in a
few days to a few weeks. In some instances, this condition may be related to
factors other than insulin, such as irritants in the skin cleansing agent or
poor injection technique. Systemic allergy, which is rare (1/10,000 to
&lt;1/1,000) but potentially more serious, is a generalised allergy to insulin.
It may cause a rash over the whole body, shortness of breath, wheezing,
reduction in blood pressure, fast pulse, or sweating. Severe cases of
generalised allergy may be life-threatening.</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'>Lipodystrophy
at the injection site is uncommon (1/1,000 to &lt;1/100).</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Cases of oedema have been
reported with insulin therapy, particularly if previous poor metabolic control
is improved by intensified insulin therapy.</p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB>Reporting of
suspected adverse reactions</span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Reporting
suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals are asked to report any suspected
adverse reactions via <span style='background:silver'>the national reporting
system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span>.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.9&nbsp;&nbsp;&nbsp;&nbsp; Overdose</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Insulins have no
specific overdose definitions because serum glucose concentrations are a result
of complex interactions between insulin levels, glucose availability and other
metabolic processes.&nbsp; Hypoglycaemia may occur as a result of an excess of
insulin activity relative to food intake and energy expenditure.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Hypoglycaemia
may be associated with listlessness, confusion, palpitations, headache,
sweating and vomiting.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Mild
hypoglycaemic episodes will respond to oral administration of glucose or other
sugar or saccharated products.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Correction of moderately
severe hypoglycaemia can be accomplished by intramuscular or subcutaneous
administration of glucagon, followed by oral carbohydrate when the patient
recovers sufficiently.&nbsp; Patients who fail to respond to glucagon must be
given glucose solution intravenously.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If the patient
is comatose, glucagon should be administered intramuscularly or
subcutaneously.&nbsp; However, glucose solution must be given intravenously if
glucagon is not available or if the patient fails to respond to glucagon.&nbsp;
The patient should be given a meal as soon as consciousness is recovered.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Sustained
carbohydrate intake and observation may be necessary because hypoglycaemia may
recur after apparent clinical recovery.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACOLOGICAL
PROPERTIES</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>5.1&nbsp;&nbsp;&nbsp;&nbsp; Pharmacodynamic
properties</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Pharmaco-therapeutic
group: </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Mix50
is a premixed suspension consisting of insulin lispro (fast-acting human
insulin analogue) and insulin lispro protamine suspension (intermediate acting
human insulin analogue). ATC Code: A10A D04.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The primary activity
of insulin lispro is the regulation of glucose metabolism.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In addition,
insulins have several anabolic and anti-catabolic actions on a variety of
different tissues.&nbsp; Within muscle tissue this includes increasing
glycogen, fatty acid, glycerol and protein synthesis and amino acid uptake,
while decreasing glycogenolysis, gluconeogenesis, ketogenesis, lipolysis,
protein catabolism and amino acid output.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Insulin lispro
has a rapid onset of action (approximately 15 minutes), thus allowing it to be
given closer to a meal (within zero to 15 minutes of the meal) when compared to
regular insulin (30 to 45 minutes before). The rapid onset and early peak of
activity of insulin lispro is observed following the subcutaneous
administration of Liprolog Mix50. Liprolog Basal has an activity profile that
is very similar to that of a basal insulin (NPH) over a period of approximately
15 hours.&nbsp; In the figure below the pharmacodynamics of Liprolog Mix50 and
Liprolog Basal are illustrated.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse'>
 <tr>
  <td width=158 valign=top style='width:1.65in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Hypoglycaemic <br>
  activity</span></p>
  </td>
  <td width=458 valign=top style='width:343.3pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB><img
  width=304 height=4 src="Humalo_files/image009.gif"></span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  Time, hours</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The above
representation reflects the relative amount of glucose over time required to
maintain the subject's whole blood glucose concentrations near fasting levels
and is an indicator of the effect of these insulins on glucose metabolism over
time.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><span lang=EN-GB>The glucodynamic response to insulin lispro
is not affected by renal or hepatic function impairment. Glucodynamic
differences between insulin lispro and soluble human insulin, as measured during
a glucose clamp procedure, were maintained over a wide range of renal function.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Insulin
lispro has been shown to be equipotent to human insulin on a molar basis but
its effect is more rapid and of a shorter duration.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>5.2&nbsp;&nbsp;&nbsp;&nbsp; Pharmacokinetic
properties</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The
pharmacokinetics of insulin lispro reflect a compound that is rapidly absorbed,
and achieves peak blood levels 30 to 70 minutes following subcutaneous
injection. The pharmacokinetics of insulin lispro protamine suspension are
consistent with those of an intermediate acting insulin such as NPH. The
pharmacokinetics of Liprolog Mix50 are representative of the individual
pharmacokinetic properties of the two components. When considering the clinical
relevance of these kinetics, it is more appropriate to examine the glucose
utilisation curves (as discussed in 5.1).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin lispro
maintains more rapid absorption when compared to soluble human insulin in
patients with renal impairment. In patients with type 2 diabetes over a wide
range of renal function&nbsp; the pharmacokinetic differences between insulin
lispro and soluble human insulin were generally maintained and shown to be
independent of renal function.&nbsp; Insulin lispro maintains more rapid
absorption and elimination when compared to soluble human insulin in patients
with hepatic impairment.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>5.3&nbsp;&nbsp;&nbsp;&nbsp; Preclinical safety data</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>In <i>in vitro</i> tests, including binding to insulin receptor
sites and effects on growing cells, insulin lispro behaved in a manner that
closely resembled human insulin.&nbsp; Studies also demonstrate that the
dissociation of binding to the insulin receptor of insulin lispro is equivalent
to human insulin.&nbsp; Acute, one month and twelve month toxicology studies
produced no significant toxicity findings.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Insulin lispro
did not induce fertility impairment, embryotoxicity or teratogenicity in animal
studies. </span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmaceutical
Particulars</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>6.1&nbsp;&nbsp;&nbsp;&nbsp; List
of excipients</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Protamine
sulphate</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>m-cresol [2.20
mg/ml]</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Phenol [1.00
mg/ml]</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Glycerol</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Dibasic sodium
phosphate.7H<span style='position:relative;top:3.0pt'>2</span>O</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Zinc oxide</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Water for
injections</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Hydrochloric
acid and sodium hydroxide may be used to adjust pH to 7.0-7.8.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>6.2&nbsp;&nbsp;&nbsp;&nbsp; Incompatibilities</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Mixing Liprolog
Mix50 with other insulins has not been studied. In the absence of compatibility
studies, this medicinal product must not be mixed with other medicinal products.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>6.3&nbsp;&nbsp;&nbsp;&nbsp; Shelf
life</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>Unused
pre-filled pens</span></u></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>3 years.&nbsp; </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>After
first use</span></u></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>28 days.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>6.4&nbsp;&nbsp;&nbsp;&nbsp; Special
precautions for storage</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>Unused
pre-filled pens</span></u></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C). Do not freeze. Do not expose to excessive
heat or direct sunlight. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>After
first use</span></u></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Store below 30&deg;C. Do not refrigerate. The pre-filled pen should
not be stored with the needle attached.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.5&nbsp;&nbsp;&nbsp;&nbsp; Nature and contents of
container</span></b><b><span lang=EN-GB> and special equipment for use,
administration or implantation</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The suspension
is contained in type I flint glass cartridges, sealed with halobutyl disc seals
and plunger heads and secured with aluminium seals.&nbsp; Dimeticone or
silicone emulsion may have been used to treat the cartridge plunger, and/or the
glass cartridge. The 3 ml cartridges are sealed in a disposable pen injector,
called the &#8220;Pen&#8221;.&nbsp; Needles are not included.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Not all packs
may be marketed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=ES>5 x 3 ml Liprolog Mix50 100&nbsp;units/ml
KwikPens</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=ES>2 x (5 x 3 ml)
Liprolog Mix50 100&nbsp;units/ml KwikPens.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=ES>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.6&nbsp;&nbsp;&nbsp;&nbsp; Special precautions for
disposal and other handling</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Any unused
product or waste material should be disposed of in accordance with local
requirements.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Instructions
for use and handling</span></u></p>

<p class=MsoNormal style='line-height:normal'>To prevent the possible
transmission of disease, each pen must be used by one patient only, even if the
needle is changed.</p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The KwikPen
should be rotated in the palms of the hands ten times and inverted 180&deg; ten
times immediately before use to resuspend the insulin until it appears
uniformly cloudy or milky.&nbsp; If not, repeat the above procedure until
contents are mixed.&nbsp; Cartridges contain a small glass bead to assist
mixing.&nbsp; Do not shake vigorously as this may cause frothing which may
interfere with the correct measurement of the dose.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The cartridges
should be examined frequently and should not be used if clumps of material are
present or if solid white particles stick to the bottom or wall of the
cartridge, giving a frosted appearance.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><u><span
lang=EN-GB>Handling of the pre-filled pen</span></u></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Before using the KwikPen the user manual included in the package
leaflet must be read carefully.&nbsp; The KwikPen has to be used as recommended
in the user manual.</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Marketing
Authorisation Holder</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span style='text-transform:
uppercase'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING AUTHORISATION
NUMBERS</span></b></p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=MsoEndnoteText><span lang=NL>EU/1/01/195/020&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5
x 3 ml Liprolog Mix50 100&nbsp;units/ml KwikPens</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=NL>EU/1/01/195/021&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2
x (5 x 3 ml) Liprolog Mix50 100&nbsp;units/ml KwikPens</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=NL>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=NL>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span style='text-transform:
uppercase'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Date of </span><span
lang=EN-GB style='text-transform:uppercase'>First Authorisation / Renewal of
the Authorisation</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Date of first
authorisation: 1<sup>st</sup> August 2001</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Date of last
renewal: 1<sup>st</sup> August 2006</span></p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'><b>&nbsp;</b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>10.&nbsp;&nbsp;&nbsp;&nbsp; Date of Revision of
THE Text</span></b></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Basal
100&nbsp;units/ml KwikPen, suspension for injection in a pre-filled pen</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Qualitative
and Quantitative Composition</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>One ml contains 100&nbsp;units (equivalent to 3.5mg) insulin lispro
(recombinant DNA origin produced in E.coli). Each container includes 3ml
equivalent to 300&nbsp;units insulin lispro.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Liprolog Basal consists of insulin lispro protamine
suspension.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Each KwikPen delivers 1-60 units in steps of 1 unit.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>For a full list of excipients, see section 6.1.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmaceutical
Form</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Suspension for
injection.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>White, sterile
suspension.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clinical
Particulars</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.1&nbsp;&nbsp;&nbsp;&nbsp; Therapeutic
indications</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Basal
is indicated for the treatment of patients with diabetes mellitus who require
insulin for the maintenance of normal glucose homeostasis. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.2&nbsp;&nbsp;&nbsp;&nbsp; Posology
and method of administration</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The dosage
should be determined by the physician, according to the requirement of the
patient.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Basal
can be mixed with or given in conjunction with Liprolog. Liprolog Basal should
only be given by subcutaneous injection. Under no circumstances should Liprolog
Basal be given intravenously. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Subcutaneous
administration should be in the upper arms, thighs, buttocks, or abdomen.&nbsp;
Use of injection sites should be rotated so that the same site is not used more
than approximately once a month.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>When administered subcutaneously care should be taken when injecting
Liprolog Basal to ensure that a blood vessel has not been entered. After
injection, the site of injection should not be massaged. Patients must be
educated to use the proper injection techniques.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Basal
has an activity profile that is very similar to that of a basal insulin (NPH)
over a period of approximately 15 hours. The time course of action of any insulin
may vary considerably in different individuals or at different times in the
same individual. As with all insulin preparations, the duration of action of
Liprolog Basal is dependent on dose, site of injection, blood supply,
temperature, and physical activity.</span></p>

<p class=Default><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>The KwikPen delivers 1&nbsp;&#8211;&nbsp;60&nbsp;units in steps of 1
unit in a single injection. The needed dose is dialled in units. <b>The number
of units is shown in the dose window of the pen.</b> </span><i><span
lang=EN-GB>Paediatric population</span></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Administration of Liprolog Basal to children below 12 years of age
should be considered only in case of an expected benefit when compared to
regular insulin.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.3&nbsp;&nbsp;&nbsp;&nbsp; Contraindications</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Hypersensitivity
to insulin lispro or to any of the excipients.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Hypoglycaemia.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.4&nbsp;&nbsp;&nbsp;&nbsp; Special
warnings and precautions for use</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Under no
circumstances should Liprolog Basal be given intravenously.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Transferring a
patient to another type or brand of insulin should be done under strict medical
supervision.&nbsp; Changes in strength, brand (manufacturer), type (regular,
NPH, lente, etc.), species (animal, human, human insulin analogue), and/or
method of manufacture (recombinant DNA versus animal-source insulin) may result
in the need for a change in dosage. </span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Conditions which may make the early warning symptoms of
hypoglycaemia different or less pronounced include long duration of diabetes,
intensified insulin therapy, diabetic nerve disease or medications such as
beta-blockers.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>A few patients who have experienced hypoglycaemic reactions after
transfer from animal-source insulin to human insulin have reported that the
early warning symptoms of hypoglycaemia were less pronounced or different from
those experienced with their previous insulin. Uncorrected hypoglycaemic or
hyperglycaemic reactions can cause loss of consciousness, coma, or death.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The use of
dosages which are inadequate or discontinuation of treatment, especially in
insulin-dependent diabetics, may lead to hyperglycaemia and diabetic
ketoacidosis; conditions which are potentially lethal.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Insulin
requirements may be reduced in the presence of renal impairment. Insulin
requirements may be reduced in patients with hepatic impairment due to reduced
capacity for gluconeogenesis and reduced insulin breakdown; however, in
patients with chronic hepatic impairment, an increase in insulin resistance may
lead to increased insulin requirements</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Insulin requirements may be increased
during illness or emotional disturbances.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Adjustment of
dosage may also be necessary if patients undertake increased physical activity
or change their usual diet. Exercise taken immediately after a meal may
increase the risk of hypoglycaemia.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB>Combination of Liprolog Basal with
pioglitazone:</span></u></p>

<p class=MsoNormal><span lang=EN-GB>Cases of cardiac failure have been reported
when pioglitazone was used in combination with insulin, especially in patients
with risk factors for development of cardiac heart failure. This should be kept
in mind if treatment with the combination of pioglitazone and Liprolog Basal is
considered. If the combination is used, patients should be observed for signs
and symptoms of heart failure, weight gain and oedema. Pioglitazone should be
discontinued if any deterioration in cardiac symptoms occurs.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u>Instructions
for use and handling </u></p>

<p class=MsoNormal style='line-height:normal'>To prevent the possible
transmission of disease, each pen must be used by one patient only, even if the
needle is changed.</p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=BodytextAgency style='margin-bottom:0in'><u><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>Avoidance of
medication </span></u><u><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>errors</span></u></p>

<p class=BodytextAgency><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>Patients must be instructed to always check the
insulin label before each injection to avoid accidental mix-ups between the two
different strengths of Liprolog KwikPen as well as other insulin products.</span></p>

<p class=BodytextAgency><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>Patients must visually verify the dialled units on the
dose counter of the pen. Therefore, the requirement for patients to self-inject
is that they can read the dose counter on the pen. Patients who are blind or
have poor vision must be instructed to always get help/assistance from another
person who has good vision and is trained in using the insulin device.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>4.5&nbsp;&nbsp;&nbsp;&nbsp; Interaction with other medicinal
products and other forms of interaction</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Insulin requirements may be increased by substances with hyperglycaemic
activity, such as oral contraceptives, corticosteroids, or thyroid replacement
therapy, danazol, beta<sub>2</sub> stimulants (such as ritodrine, salbutamol,
terbutaline). </span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Insulin requirements may be reduced in the presence of substances
with hypoglycaemic activity, such as oral hypoglycaemics, salicylates (for
example, acetylsalicylic acid), sulpha antibiotics, certain antidepressants
(monoamine oxidase inhibitors, selective serotonin reuptake inhibitors),
certain angiotensin converting enzyme inhibitors (captopril, enalapril),
angiotensin II receptor blockers, beta-blockers, octreotide or alcohol. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Mixing Liprolog
Basal with insulins other than Liprolog has not been studied.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The physician
should be consulted when using other medications in addition to Liprolog Basal
100&nbsp;units/ml KwikPen </span>(see section <span lang=EN-GB>4.4</span>)<span
lang=EN-GB>.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.6&nbsp;&nbsp;&nbsp;&nbsp; Fertility,
pregnancy and lactation</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Data on a large number of exposed pregnancies do not indicate any
adverse effect of insulin lispro on pregnancy or on the health of the
foetus/newborn.&nbsp;&nbsp; </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>It is essential to maintain good control of the insulin-treated
(insulin-dependent or gestational diabetes) patient throughout pregnancy.
Insulin requirements usually fall during the first trimester and increase
during the second and third trimesters. Patients with diabetes should be
advised to inform their doctor if they are pregnant or are contemplating
pregnancy. Careful monitoring of glucose control, as well as general health, is
essential in pregnant patients with diabetes. </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Patients with diabetes who are breast-feeding may require
adjustments in insulin dose, diet or both. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.7&nbsp;&nbsp;&nbsp;&nbsp; Effects
on ability to drive and use machines</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The
patient&#8217;s ability to concentrate and react may be impaired as a result of
hypoglycaemia. This may constitute a risk in situations where these abilities
are of special importance (e.g. driving a car or operating machinery).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Patients should
be advised to take precautions to avoid hypoglycaemia whilst driving, this is
particularly important in those who have reduced or absent awareness of the
warning signs of hypoglycaemia or have frequent episodes of hypoglycaemia. The
advisability of driving should be considered in these circumstances.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.8&nbsp;&nbsp;&nbsp;&nbsp; Undesirable
effects</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'>Hypoglycaemia
is the most frequent undesirable effect of insulin therapy that a patient with
diabetes may suffer. Severe hypoglycaemia may lead to loss of consciousness,
and in extreme cases, death. No specific frequency for hypoglycaemia is
presented, since hypoglycaemia is a result of both the insulin dose and other
factors e.g. a patient`s level of diet and exercise.</p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
style='color:black'>&nbsp;</span></p>

<p class=MsoEndnoteText style='text-autospace:none'>Local allergy in patients
is common (1/100 to &lt;1/10). Redness, swelling, and itching can occur at the
site of insulin injection. This condition usually resolves in a few days to a
few weeks. In some instances, this condition may be related to factors other
than insulin, such as irritants in the skin cleansing agent or poor injection
technique. Systemic allergy, which is rare (1/10,000 to &lt;1/1,000) but
potentially more serious, is a generalised allergy to insulin. It may cause a
rash over the whole body, shortness of breath, wheezing, reduction in blood
pressure, fast pulse, or sweating. Severe cases of generalised allergy may be
life-threatening.</p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>Lipodystrophy at the injection site is uncommon (1/1,000 to &lt;1/100).</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Cases of oedema have been
reported with insulin therapy, particularly if previous poor metabolic control
is improved by intensified insulin therapy.</p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB>Reporting of
suspected adverse reactions</span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Reporting
suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals are asked to report any suspected
adverse reactions via <span style='background:silver'>the national reporting
system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span>.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.9&nbsp;&nbsp;&nbsp;&nbsp; Overdose</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Insulins have no
specific overdose definitions because serum glucose concentrations are a result
of complex interactions between insulin levels, glucose availability and other
metabolic processes.&nbsp; Hypoglycaemia may occur as a result of an excess of
insulin activity relative to food intake and energy expenditure.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Hypoglycaemia
may be associated with listlessness, confusion, palpitations, headache,
sweating and vomiting.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Mild
hypoglycaemic episodes will respond to oral administration of glucose or other
sugar or saccharated products.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Correction of
moderately severe hypoglycaemia can be accomplished by intramuscular or
subcutaneous administration of glucagon, followed by oral carbohydrate when the
patient recovers sufficiently.&nbsp; Patients who fail to respond to glucagon
must be given glucose solution intravenously.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If the patient
is comatose, glucagon should be administered intramuscularly or subcutaneously.&nbsp;
However, glucose solution must be given intravenously if glucagon is not
available or if the patient fails to respond to glucagon. The patient should be
given a meal as soon as consciousness is recovered.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Sustained carbohydrate intake and observation may be necessary
because hypoglycaemia may recur after apparent clinical recovery.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACOLOGICAL
PROPERTIES</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>5.1&nbsp;&nbsp;&nbsp;&nbsp; Pharmacodynamic
properties</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Pharmaco-therapeutic
group: Intermediate acting human insulin analogue. ATC Code: A10A C04.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The primary
activity of insulin lispro is the regulation of glucose metabolism.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In addition,
insulins have several anabolic and anti-catabolic actions on a variety of
different tissues.&nbsp; Within muscle tissue this includes increasing
glycogen, fatty acid, glycerol and protein synthesis and amino acid uptake,
while decreasing glycogenolysis, gluconeogenesis, ketogenesis, lipolysis,
protein catabolism and amino acid output.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Basal
has an activity profile that is very similar to that of a basal insulin (NPH)
over a period of approximately 15 hours.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The glucodynamic
response to insulin lispro is not affected by renal or hepatic function
impairment. Glucodynamic differences between insulin lispro and soluble human
insulin, as measured during a glucose clamp procedure, were maintained over a
wide range of renal function.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Insulin lispro
has been shown to be equipotent to human insulin on a molar basis but its
effect is more rapid and of a shorter duration.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>5.2&nbsp;&nbsp;&nbsp;&nbsp; Pharmacokinetic
properties</span></b></p>

<p class=MsoNormal style='line-height:normal'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Basal
has a prolonged absorption profile, achieving a maximum insulin concentration
approximately 6 hours after dosing. When considering the clinical relevance of
these kinetics, it is more appropriate to examine the glucose utilisation
curves properties.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Insulin lispro maintains more rapid absorption when compared to
soluble human insulin in patients with renal impairment. In patients with type
2 diabetes over a wide range of renal function the pharmacokinetic differences
between insulin lispro and soluble human insulin were generally maintained and
shown to be independent of renal function.&nbsp; Insulin lispro maintains more
rapid absorption and elimination when compared to soluble human insulin in
patients with hepatic impairment.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>5.3&nbsp;&nbsp;&nbsp;&nbsp; Preclinical
safety data</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In <i>in vitro</i>
tests, including binding to insulin receptor sites and effects on growing
cells, insulin lispro behaved in a manner that closely resembled human
insulin.&nbsp; Studies also demonstrate that the dissociation of binding to the
insulin receptor of insulin lispro is equivalent to human insulin.&nbsp; Acute,
one month and twelve month toxicology studies produced no significant toxicity
findings.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Insulin lispro
did not induce fertility impairment, embryotoxicity or teratogenicity in animal
studies. </span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmaceutical
Particulars</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>6.1&nbsp;&nbsp;&nbsp;&nbsp; List
of excipients</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Protamine sulphate</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><i><span
lang=EN-GB>m-</span></i><span lang=EN-GB>cresol</span><span lang=EN-GB> [1.76
mg/ml]</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Phenol [0.80 mg/ml]</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Glycerol</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Dibasic sodium phosphate.7H<span style='position:relative;
top:2.0pt'>2</span>O</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Zinc oxide</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Water for injections</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Hydrochloric acid and sodium hydroxide may be used to adjust pH to
7.0 &#8211; 7.8.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>6.2&nbsp;&nbsp;&nbsp;&nbsp; Incompatibilities</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Mixing Liprolog
Basal with insulins other than Liprolog has not been studied. This medicinal
product must not be mixed with other medicinal products than Liprolog.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>6.3&nbsp;&nbsp;&nbsp;&nbsp; Shelf
life</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>Unused
pre-filled pens</span></u></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>2 years.&nbsp; </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>After
first use</span></u></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>21 days.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>6.4&nbsp;&nbsp;&nbsp;&nbsp; Special
precautions for storage</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>Unused
pre-filled pens</span></u></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C). Do not freeze. Do not expose to excessive
heat or direct sunlight. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>After
first use</span></u></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Store below 30&deg;C. Do not refrigerate. The pre-filled pen should
not be stored with the needle attached.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.5&nbsp;&nbsp;&nbsp;&nbsp; Nature and contents of
container</span></b><b><span lang=EN-GB> and special equipment for use,
administration or implantation</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The suspension
is contained in type I flint glass cartridges, sealed with halobutyl disc seals
and plunger heads and secured with aluminium seals.&nbsp; Dimeticone or
silicone emulsion may have been used to treat the cartridge plunger, and/or the
glass cartridge. The 3 ml cartridges are sealed in a disposable pen injector,
called the &#8220;KwikPen&#8221;.&nbsp; Needles are not included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Not all packs may be marketed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=ES>5 x 3 ml Liprolog Basal 100&nbsp;units/ml
KwikPens</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=ES>2 x (5 x 3 ml)
Liprolog Basal 100&nbsp;units/ml KwikPens</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=ES>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.6&nbsp;&nbsp;&nbsp;&nbsp; Special precautions for
disposal and other handling</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Any unused
product or waste material should be disposed of in accordance with local
requirements.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><u><span
lang=EN-GB>Instructions for use and handling</span></u></p>

<p class=MsoNormal style='line-height:normal'>To prevent the possible
transmission of disease, each pen must be used by one patient only, even if the
needle is changed.</p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The KwikPen
should be rotated in the palms of the hands ten times and inverted 180&deg; ten
times immediately before use to resuspend the insulin until it appears
uniformly cloudy or milky.&nbsp; If not, repeat the above procedure until
contents are mixed.&nbsp; Cartridges contain a small glass bead to assist
mixing.&nbsp; Do not shake vigorously as this may cause frothing which may
interfere with the correct measurement of the dose.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The cartridges
should be examined frequently and should not be used if clumps of material are
present or if solid white particles stick to the bottom or wall of the cartridge,
giving a frosted appearance.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><u><span
lang=EN-GB>Handling of the pre-filled pen</span></u></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Before using the KwikPen the user manual included in the package
leaflet must be read carefully.&nbsp; The KwikPen has to be used as recommended
in the user manual.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Marketing
Authorisation Holder</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBERS</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=ES>EU/1/01/195/026&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5
x 3&nbsp;ml Liprolog Basal 100&nbsp;units/ml KwikPen</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:
normal'><span lang=ES>EU/1/01/195/027&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2
x (5 x 3&nbsp;ml) Liprolog Basal 100&nbsp;units/ml KwikPen</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=ES>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=ES>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
style='text-transform:uppercase'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Date of
First Authorisation / Renewal of the Authorisation</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Date of first
authorisation: 1<sup>st</sup> August 2001</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Date of last
renewal: 1<sup>st</sup> August 2006</span></p>

<p class=MsoNormal style='line-height:normal'><b>&nbsp;</b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.5pt;text-indent:-28.5pt;line-height:
normal'><b><span lang=EN-GB style='text-transform:uppercase'>10.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB style='text-transform:uppercase'>Date of
Revision of THE Text</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><s><span lang=EN-GB
style='text-transform:uppercase'><span style='text-decoration:none'>&nbsp;</span></span></s></b></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Liprolog 200&nbsp;units/ml KwikPen, solution for injection in a pre-filled
pen</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Qualitative
and Quantitative Composition</span></b></p>

<p class=MsoBodyText3><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3><span lang=EN-GB>One ml solution contains 200&nbsp;units
(equivalent to 6.9&nbsp;mg) insulin lispro*. Each pen contains 600&nbsp;units
of insulin lispro in 3&nbsp;ml solution.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Each KwikPen delivers 1-60 units in steps
of 1 unit.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>* produced in <i>E.coli</i> by recombinant
DNA technology.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>For the full list of excipients, see
section 6.1.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmaceutical
Form</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Solution for injection. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Clear, colourless, aqueous solution.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clinical
Particulars</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>4.1&nbsp;&nbsp;&nbsp; Therapeutic indications</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>For the treatment of adults with diabetes
mellitus who require insulin for the maintenance of normal glucose homeostasis.
Liprolog 200&nbsp;units/ml KwikPen is also indicated for the initial
stabilisation of diabetes mellitus. </span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>4.2&nbsp;&nbsp;&nbsp; Posology and method of administration</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><u><span
lang=EN-GB>Posology</span></u></p>

<p class=MsoNormal><span lang=EN-GB>The dosage should be determined by the
physician, according to the requirement of the patient. </span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3><span lang=EN-GB>Liprolog may be given shortly before
meals. When necessary Liprolog can be given soon after meals. </span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog takes effect rapidly and has a
shorter duration of activity (2 to 5&nbsp;hours) given subcutaneously as
compared with regular insulin. This rapid onset of activity allows a Liprolog
injection to be given very close to mealtime. The time course of action of any
insulin may vary considerably in different individuals or at different times in
the same individual. The faster onset of action compared to soluble human
insulin is maintained regardless of injection site. The duration of action of
Liprolog is dependent on dose, site of injection, blood supply, temperature,
and physical activity.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog can be used in conjunction with a
longer-acting insulin or oral sulphonylurea medicinal products, on the advice
of a physician. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=Default><i><u><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>Liprolog
100&nbsp;units/ml KwikPen and Liprolog 200&nbsp;units/ml KwikPen and Liprolog
100 units/ml Junior KwikPen</span></u></i></p>

<p class=Default><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>Liprolog
KwikPen is available in two strengths. The Liprolog 100&nbsp;units/ml KwikPen
and the Liprolog 200&nbsp;units/ml KwikPen deliver
1&nbsp;&#8211;&nbsp;60&nbsp;units in steps of 1 unit in a single injection. The
Liprolog 100 units/ml Junior KwikPen delivers 0.5 &#8211; 30 units in steps of
0.5 units in a single injection. <b>The number of insulin units is shown in the
dose window of the pen regardless of strength</b> and <b>no </b>dose conversion
should be done when transferring a patient to a new strength or to a pen with a
different dose step. </span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Liprolog
200&nbsp;units/ml KwikPen should be reserved for the treatment of patients with
diabetes requiring daily doses of more than 20 units of rapid-acting insulin.
The insulin lispro solution containing 200&nbsp;units/ml should not be
withdrawn from the pre-filled pen (the KwikPen) or mixed with any other insulin
(see section 4.4 and section 6.2).</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><i><span lang=EN-GB>Special
populations</span></i></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Renal
impairment</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Insulin
requirements may be reduced in the presence of renal impairment.</span></p>

<p class=MsoNormal style='text-autospace:none'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Hepatic impairment</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin requirements may be reduced in
patients with hepatic impairment due to reduced capacity for gluconeogenesis
and reduced insulin breakdown; however, in patients with chronic hepatic
impairment, an increase in insulin resistance may lead to increased insulin
requirements.</span></p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB>Method of
administration</span></u></p>

<p class=MsoBodyText3><span lang=EN-GB>Liprolog solution for injection should
be given subcutaneously. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Subcutaneous administration should be in
the upper arms, thighs, buttocks, or abdomen. Use of injection sites should be
rotated so that the same site is not used more than approximately once a month.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>When
administered subcutaneously care should be taken when injecting Liprolog to
ensure that a blood vessel has not been entered. After injection, the site of
injection should not be massaged. Patients must be educated to use the proper
injection techniques.</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Liprolog
200&nbsp;units/ml KwikPen solution for injection should not be used in an
insulin infusion pump.</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Liprolog
200&nbsp;units/ml KwikPen solution for injection should not be used intravenously.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>4.3&nbsp;&nbsp;&nbsp; Contraindications</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;page-break-after:
avoid'><b><span lang=EN-GB>4.4&nbsp;&nbsp;&nbsp; Special warnings and
precautions for use</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><u><span lang=EN-GB>Transferring
a patient to another type or brand of insulin </span></u></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Transferring
a patient to another type or brand of insulin should be done under strict
medical supervision. Changes in strength, brand (manufacturer), type (regular,
NPH, lente, etc.), species (animal, human, human insulin analogue), and/or
method of manufacture (recombinant DNA <i>versus</i> animal-source insulin) may
result in the need for a change in dosage. <span style='color:black'>For
fast-acting insulins, any patient also on basal insulin must optimise dosage of
both insulins to obtain glucose control across the whole day, particularly
nocturnal/fasting glucose control.</span></span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3><u><span lang=EN-GB>Hypoglycaemia and hyperglycaemia</span></u></p>

<p class=MsoBodyText3><span lang=EN-GB>Conditions which may make the early
warning symptoms of hypoglycaemia different or less pronounced include long
duration of diabetes, intensified insulin therapy, diabetic nerve disease or
medicinal products such as beta-blockers.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>A few patients
who have experienced hypoglycaemic reactions after transfer from animal-source
insulin to human insulin have reported that the early warning symptoms of
hypoglycaemia were less pronounced or different from those experienced with
their previous insulin. Uncorrected hypoglycaemic or hyperglycaemic reactions
can cause loss of consciousness, coma, or death.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>The use of dosages which are inadequate or
discontinuation of treatment, especially in insulin-dependent diabetics, may
lead to hyperglycaemia and diabetic ketoacidosis; conditions which are
potentially lethal.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:26.95pt;text-indent:-26.95pt;page-break-after:
avoid'><u><span lang=EN-GB>Insulin requirements and dosage adjustment</span></u></p>

<p class=MsoNormal style='margin-left:26.95pt;text-indent:-26.95pt;page-break-after:
avoid'><span lang=EN-GB>Insulin requirements may be increased during illness or
emotional disturbances.</span></p>

<p class=MsoNormal><span lang=EN-GB>Adjustment of dosage may also be necessary
if patients undertake increased physical activity or change their usual diet.
Exercise taken immediately after a meal may increase the risk of hypoglycaemia.
A consequence of the pharmacodynamics of rapid-acting insulin analogues is that
if hypoglycaemia occurs, it may occur earlier after an injection when compared
with soluble human insulin.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB>Combination of Liprolog with
pioglitazone:</span></u></p>

<p class=MsoNormal><span lang=EN-GB>Cases of cardiac failure have been reported
when pioglitazone was used in combination with insulin, especially in patients
with risk factors for development of cardiac heart failure. This should be kept
in mind, if treatment with the combination of pioglitazone and Liprolog is
considered. If the combination is used, patients should be observed for signs and
symptoms of heart failure, weight gain and oedema. Pioglitazone should be
discontinued, if any deterioration in cardiac symptoms occurs.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u>Instructions
for use and handling </u></p>

<p class=MsoNormal style='line-height:normal'>To prevent the possible
transmission of disease, each pen must be used by one patient only, even if the
needle is changed.</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB>Avoidance of
medication errors when using insulin lispro (200&nbsp;units/ml) in pre-filled
pen:</span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>The insulin
lispro solution for injection containing </span><span lang=EN-GB>200&nbsp;units/ml
must not be transferred from the pre-filled pen, the KwikPen, to a syringe. The
markings on the insulin syringe will not measure the dose correctly. Overdose
can result causing severe hypoglycemia.&nbsp; </span><span lang=EN-GB>The
insulin lispro solution for injection containing </span><span lang=EN-GB>200&nbsp;units/ml
must not be transferred from the KwikPen to any other insulin delivery device,
including insulin infusion pumps.</span></p>

<p class=MsoNormal><span lang=EN-GB>Patients must be instructed to always check
the insulin label before each injection to avoid accidental mix-ups between the
two different strengths of Liprolog as well as other insulin products.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=BodytextAgency><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>Patients must visually verify the dialled units on the
dose counter of the pen. Therefore, the requirement for patients to self-inject
is that they can read the dose counter on the pen. Patients who are blind or
have poor vision must be instructed to always get help/assistance from another
person who has good vision and is trained in using the insulin device.</span></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><u><span lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal><u><span lang=EN-GB>Excipients</span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>This medicinal
product contains less than 1&nbsp;mmol sodium (23&nbsp;mg) per dose, i.e.,
essentially &#8220;sodium&#8209;free&#8221;.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;page-break-after:
avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;page-break-after:
avoid'><b><span lang=EN-GB>4.5&nbsp;&nbsp;&nbsp; Interaction with other
medicinal products and other forms of interaction</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Insulin
requirements may be increased by medicinal products with hyperglycaemic
activity, such as oral contraceptives, corticosteroids, or thyroid replacement
therapy, danazol, beta2 stimulants (such as ritodrine, salbutamol,
terbutaline). </span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin requirements may be reduced in the
presence of medicinal products with hypoglycaemic activity, such as oral
hypoglycemics, salicylates (for example, acetylsalicylic acid), sulpha
antibiotics, certain antidepressants (monoamine oxidase inhibitors, selective
serotonin reuptake inhibitors), certain angiotensin converting enzyme
inhibitors (captopril, enalapril), angiotensin II receptor blockers,
beta-blockers, octreotide or alcohol. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>The physician should be consulted when
using other medicinal products in addition to Liprolog 200&nbsp;units/ml
KwikPen </span><span lang=EN-GB>(see section </span><span lang=EN-GB>4.4</span><span
lang=EN-GB>)</span><span lang=EN-GB>.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><b><span lang=EN-GB>4.6&nbsp;&nbsp;&nbsp;&nbsp; Fertility,
pregnancy and lactation</span></b></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 style='page-break-after:avoid'><u><span lang=EN-GB>Pregnancy</span></u></p>

<p class=MsoBodyText3 style='page-break-after:avoid'><span lang=EN-GB>Data on a
large number of exposed pregnancies do not indicate any adverse effect of
insulin lispro on pregnancy or on the health of the foetus/newborn.&nbsp; </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>It is essential
to maintain good control of the insulin-treated (insulin-dependent or
gestational diabetes) patient throughout pregnancy. Insulin requirements
usually fall during the first trimester and increase during the second and
third trimesters. Patients with diabetes should be advised to inform their
doctor if they are pregnant or are contemplating pregnancy. Careful monitoring
of glucose control, as well as general health, is essential in pregnant
patients with diabetes. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3><u><span lang=EN-GB>Breast-feeding</span></u></p>

<p class=MsoBodyText3><span lang=EN-GB>Patients with diabetes who are
breast-feeding may require adjustments in insulin dose, diet or both. </span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><u><span
lang=EN-GB>Fertility</span></u></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>Insulin lispro did not induce fertility impairment in animal studies
(see section 5.3).</span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>4.7&nbsp;&nbsp;&nbsp;&nbsp; Effects on ability to drive and use
machines</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>The
patient&#8217;s ability to concentrate and react may be impaired as a result of
hypoglycaemia. This may constitute a risk in situations where these abilities
are of special importance (e.g. driving a car or using machines).</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Patients
should be advised to take precautions to avoid hypoglycaemia whilst driving.
This is particularly important in those who have reduced or absent awareness of
the warning signs of hypoglycaemia or have frequent episodes of hypoglycaemia.
The advisability of driving should be considered in these circumstances.</span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>4.8&nbsp;&nbsp;&nbsp;&nbsp; Undesirable
effects</span></b></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB>Summary of
safety profile</span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Hypoglycaemia
is the most frequent adverse reaction of insulin lispro therapy that a patient
with diabetes may suffer. Severe hypoglycaemia may lead to loss of
consciousness, and in extreme cases, death. No specific frequency for
hypoglycaemia is presented, since hypoglycaemia is a result of both the insulin
dose and other factors e.g. a patient`s level of diet and exercise.</span></p>

<p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB>Tabulated list
of adverse reactions</span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>The following
related adverse reactions from clinical trials are listed below as MedDRA
preferred term by system organ class and in order of decreasing incidence (very
common: &#8805;1/10; common: &#8805;1/100 to &lt;1/10; uncommon: &#8805;1/1,000
to &lt;1/100; rare: &#8805;1/10,000 to &lt;1/1,000; very rare: &lt;1/10,000).</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Within each
frequency grouping, adverse reactions are presented in order of decreasing
seriousness.</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="90%"
 style='margin-left:12.5pt;border-collapse:collapse;border:none'>
 <tr style='height:16.75pt'>
  <td width="25%" valign=top style='width:25.56%;border:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt;page-break-after:avoid'><b><span
  lang=EN-GB>MedDRA system organ classes</span></b></p>
  </td>
  <td width="17%" valign=top style='width:17.48%;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt;page-break-after:avoid'><b><span
  lang=EN-GB>Very common</span></b></p>
  </td>
  <td width="14%" valign=top style='width:14.1%;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt'><b><span lang=EN-GB>Common</span></b></p>
  </td>
  <td width="17%" valign=top style='width:17.46%;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt'><b><span lang=EN-GB>Uncommon</span></b></p>
  </td>
  <td width="12%" valign=top style='width:12.68%;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt'><b><span lang=EN-GB>Rare</span></b></p>
  </td>
  <td width="12%" valign=top style='width:12.72%;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt'><b><span lang=EN-GB>Very rare</span></b></p>
  </td>
 </tr>
 <tr style='height:16.3pt'>
  <td width="100%" colspan=6 valign=top style='width:100.0%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:16.3pt'>
  <p class=MsoNormal style='page-break-after:avoid'><b><span lang=EN-GB>Immune
  system disorders </span></b></p>
  </td>
 </tr>
 <tr style='height:16.75pt'>
  <td width="25%" valign=top style='width:25.56%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt;page-break-after:avoid'><span
  lang=EN-GB>Local allergy</span></p>
  </td>
  <td width="17%" valign=top style='width:17.48%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="14%" valign=top style='width:14.1%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>X</span></p>
  </td>
  <td width="17%" valign=top style='width:17.46%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="12%" valign=top style='width:12.68%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="12%" valign=top style='width:12.72%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:16.75pt'>
  <td width="25%" valign=top style='width:25.56%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt;page-break-after:avoid'><span
  lang=EN-GB>Systemic allergy</span></p>
  </td>
  <td width="17%" valign=top style='width:17.48%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="14%" valign=top style='width:14.1%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="17%" valign=top style='width:17.46%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="12%" valign=top style='width:12.68%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>X</span></p>
  </td>
  <td width="12%" valign=top style='width:12.72%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:5.75pt'>
  <td width="100%" colspan=6 valign=top style='width:100.0%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:5.75pt'>
  <p class=MsoNormal style='page-break-after:avoid'><b><span lang=EN-GB>Skin
  and subcutaneous tissue disorders</span></b></p>
  </td>
 </tr>
 <tr style='height:5.75pt'>
  <td width="25%" valign=top style='width:25.56%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:5.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt;page-break-after:avoid'><span
  lang=EN-GB>Lipodystrophy</span></p>
  </td>
  <td width="17%" valign=top style='width:17.48%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:5.75pt'>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="14%" valign=top style='width:14.1%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:5.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="17%" valign=top style='width:17.46%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:5.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>X</span></p>
  </td>
  <td width="12%" valign=top style='width:12.68%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:5.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="12%" valign=top style='width:12.72%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:5.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB>Description
of selected adverse reactions</span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><i><span lang=EN-GB>Local
allergy </span></i></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Local allergy
in patients is common). Redness, swelling, and itching can occur at the site of
insulin injection. This condition usually resolves in a few days to a few
weeks. In some instances, this condition may be related to factors other than
insulin, such as irritants in the skin cleansing agent or poor injection
technique. </span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><i><span lang=EN-GB>Systemic allergy
</span></i></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Systemic
allergy, which is rare but potentially more serious, is a generalised allergy
to insulin. It may cause a rash over the whole body, shortness of breath,
wheezing, reduction in blood pressure, fast pulse, or sweating. Severe cases of
generalised allergy may be life-threatening.</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><i><span
lang=EN-GB>Lipodystrophy </span></i></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Lipodystrophy at the injection site is uncommon.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><i><span lang=EN-GB>Oedema </span></i></p>

<p class=MsoNormal><span lang=EN-GB>Cases of oedema have been reported with
insulin therapy, particularly if previous poor metabolic control is improved by
intensified insulin therapy.</span></p>

<p class=MsoNormal style='text-align:justify;text-autospace:none'><b><i><span
lang=EN-GB>&nbsp;</span></i></b></p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB>Reporting of
suspected adverse reactions</span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Reporting
suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals are asked to report any suspected
adverse reactions via <span style='background:silver'>the national reporting
system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span>.</span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>4.9&nbsp;&nbsp;&nbsp;&nbsp; Overdose</span></b></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulins have no specific overdose
definitions because serum glucose concentrations are a result of complex
interactions between insulin levels, glucose availability and other metabolic
processes. Hypoglycaemia may occur as a result of an excess of insulin activity
relative to food intake and energy expenditure.</span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Hypoglycaemia may be associated with
listlessness, confusion, palpitations, headache, sweating and vomiting.</span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Mild hypoglycaemic episodes will respond to
oral administration of glucose or other sugar or saccharated products.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Correction of moderately severe
hypoglycaemia can be accomplished by intramuscular or subcutaneous
administration of glucagon, followed by oral carbohydrate when the patient
recovers sufficiently. Patients who fail to respond to glucagon must be given glucose
solution intravenously.</span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>If the patient is comatose, glucagon should
be administered intramuscularly or subcutaneously. However, glucose solution
must be given intravenously if glucagon is not available or if the patient
fails to respond to glucagon. The patient should be given a meal as soon as
consciousness is recovered.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Sustained
carbohydrate intake and observation may be necessary because hypoglycaemia may
recur after apparent clinical recovery.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmacological
Properties</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>5.1&nbsp;&nbsp;&nbsp; Pharmacodynamic properties</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Pharmacotherapeutic group : Drugs used in
diabetes, insulins and analogues for injection, fast-acting, ATC code: A10AB04</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>The primary activity of insulin lispro is the regulation of glucose
metabolism.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>In addition, insulins have several anabolic
and anti-catabolic actions on a variety of different tissues. Within muscle
tissue this includes increasing glycogen, fatty acid, glycerol and protein
synthesis and amino acid uptake, while decreasing glycogenolysis,
gluconeogenesis, ketogenesis, lipolysis, protein catabolism and amino acid
output.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin lispro
has a rapid onset of action (approximately 15&nbsp;minutes), thus allowing it
to be given closer to a meal (within zero to 15&nbsp;minutes of the meal) when
compared to regular insulin <br>
(30 to 45 minutes before). Insulin lispro takes effect rapidly and has a
shorter duration of activity (2 to 5&nbsp;hours) when compared to regular
insulin. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Clinical trials
in patients with type 1 and type 2 diabetes have demonstrated reduced
postprandial hyperglycaemia with insulin lispro compared to soluble human
insulin. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The time course
of insulin lispro action may vary in different individuals or at different
times in the same individual and is dependent on dose, site of injection, blood
supply, temperature and physical activity. The typical activity profile
following subcutaneous injection is illustrated below.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Figure 1:</span></b></p>

<p class=MsoNormal>

<table cellpadding=0 cellspacing=0>
 <tr>
  <td width=59 height=0></td>
 </tr>
 <tr>
  <td></td>
  <td><img width=416 height=1 src="Humalo_files/image006.gif"></td>
 </tr>
</table>

<br clear=ALL>
<span lang=EN-GB>The above representation (figure 1) reflects the relative
amount of glucose over time required to maintain the subject's whole blood
glucose concentrations near fasting levels and is an indicator of the effect of
these insulins (100&nbsp;units/ml) on glucose metabolism over time.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>The
pharmacodynamic responses of insulin lispro 200&nbsp;units/ml solution for
injection were similar to those for insulin lispro 100&nbsp;units/ml solution
for injection after subcutaneous administration of a single 20 unit dose in
healthy subjects as shown in the graph below (figure 2).</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=PLRTextUnindented><a name="_Ref283718639"></a><a name="_Toc286308786"></a><span
lang=X-NONE><img width=645 height=4 src="Humalo_files/image010.gif"></span></p>

<p class=PLRTextUnindented><b><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>Figure
2:</span></b><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>
</span><span lang=X-NONE style='font-size:11.0pt;font-family:"Times New Roman",serif'>Arithmetic
mean glucose infusion rate versus time profiles following subcutaneous
administration of 20</span><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>&nbsp;</span><span
lang=X-NONE style='font-size:11.0pt;font-family:"Times New Roman",serif'>units
of </span><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>insulin
lispro</span><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>
</span><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>200&nbsp;units/ml</span><span
lang=X-NONE style='font-size:11.0pt;font-family:"Times New Roman",serif'> or </span><span
style='font-size:11.0pt;font-family:"Times New Roman",serif'>insulin lispro</span><span
style='font-size:11.0pt;font-family:"Times New Roman",serif'> </span><span
style='font-size:11.0pt;font-family:"Times New Roman",serif'>1</span><span
lang=X-NONE style='font-size:11.0pt;font-family:"Times New Roman",serif'>00</span><span
style='font-size:11.0pt;font-family:"Times New Roman",serif'>&nbsp;units/ml</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3><span lang=EN-GB style='layout-grid-mode:line'>In
patients with type 2 diabetes on maximum doses of sulphonyl urea agents,
studies have shown that the addition of insulin lispro significantly reduces
HbA1c compared to sulphonyl urea alone. The reduction of HbA1c would also be
expected with other insulin products e.g. soluble or isophane insulins.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB
style='layout-grid-mode:line'>Clinical trials in patients with type 1 and type
2 diabetes have demonstrated a reduced number of episodes of nocturnal
hypoglycaemia with insulin lispro compared to soluble human insulin. In some
studies, reduction of nocturnal hypoglycaemia was associated with increased
episodes of daytime hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>The glucodynamic response to insulin lispro
is not affected by renal or hepatic function impairment. Glucodynamic
differences between insulin lispro and soluble human insulin, as measured
during a glucose clamp procedure, were maintained over a wide range of renal
function.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3><span lang=EN-GB>Insulin lispro has been shown to be
equipotent to human insulin on a molar basis but its effect is more rapid and
of a shorter duration.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>5.2&nbsp;&nbsp;&nbsp;&nbsp; Pharmacokinetic
properties</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>The pharmacokinetics of insulin lispro
reflect a compound that is rapidly absorbed, and achieves peak blood levels 30
to 70&nbsp;minutes following subcutaneous injection. When considering the
clinical relevance of these kinetics, it is more appropriate to examine the
glucose utilisation curves (as discussed in 5.1).</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3><span lang=EN-GB>Insulin lispro maintains more rapid
absorption when compared to soluble human insulin in patients with renal
impairment. In patients with type 2 diabetes over a wide range of renal
function the pharmacokinetic differences between insulin lispro and soluble
human insulin were generally maintained and shown to be independent of renal
function.&nbsp; Insulin lispro maintains more rapid absorption and elimination
when compared to soluble human insulin in patients with hepatic impairment.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Insulin lispro
200&nbsp;units/ml solution for injection was bioequivalent to insulin lispro
100&nbsp;units/ml solution for injection after subcutaneous administration of a
single 20 unit dose in healthy subjects. Time to maximum concentration was also
similar between formulations.<b> </b></span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>5.3&nbsp;&nbsp;&nbsp; Preclinical safety data</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>In <i>in vitro </i>tests, including binding
to insulin receptor sites and effects on growing cells, insulin lispro behaved
in a manner that closely resembled human insulin. Studies also demonstrate that
the dissociation of binding to the insulin receptor of insulin lispro is
equivalent to human insulin. Acute, one month and twelve month toxicology
studies produced no significant toxicity findings.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin lispro did not induce </span><span
lang=EN-GB>fertility impairment, </span><span lang=EN-GB>embryotoxicity or
teratogenicity in animal studies. </span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmaceutical
Particulars</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>6.1&nbsp;&nbsp;&nbsp; List of excipients</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Metacresol </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Glycerol</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span class=breve><span
lang=EN-GB>Trometamol</span></span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Zinc oxide</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Water for
injections</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Hydrochloric
acid and sodium hydroxide (for pH adjustment).</span></p>

<p class=MsoNormal><s><span lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></s></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><b><span
lang=EN-GB>6.2&nbsp;&nbsp;&nbsp;&nbsp; Incompatibilities</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>This
medicinal product should not be mixed with any other insulin or any other
medicinal product. The solution for injection should not be diluted. </span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;page-break-after:
avoid'><b><span lang=EN-GB>6.3&nbsp;&nbsp;&nbsp; Shelf life</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><i><u><span lang=EN-GB>Unused
pre-filled pens</span></u></i></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>3&nbsp;years.
</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><i><u><span lang=EN-GB>After
first use</span></u></i></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>28 days.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>6.4&nbsp;&nbsp;&nbsp; Special precautions for storage</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><i><u><span lang=EN-GB>Unused pre-filled pens</span></u></i></p>

<p class=MsoNormal><span lang=EN-GB>Store in a refrigerator (2&deg;C -
8&deg;C). Do not freeze. Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><i><u><span lang=EN-GB>After first use</span></u></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Store below
30&deg;C. Do not refrigerate. The pre-filled pen should not be stored with the
needle attached.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>6.5&nbsp;&nbsp;&nbsp; Nature and contents of container</span></b><b><span
lang=EN-GB> </span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>Type I glass
cartridges, sealed with chlorobutyldisc seals and plunger heads and secured
with aluminium seals. Dimeticone or silicone emulsion may be used to treat the
cartridge plunger, and/or the glass cartridge. The 3 ml cartridges which
contain 600&nbsp;units insulin lispro (200&nbsp;units/ml), are sealed in a
disposable pen injector, called the &#8220;KwikPen&#8221;. Needles are not
included.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>5 </span><span lang=ES>pre-filled pens</span><span lang=EN-GB> of
3&nbsp;ml</span><span lang=ES> </span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Multipacks containing 10 (2 packs of 5) pre-filled pen of 3&nbsp;ml </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Not all packs
may be marketed.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=ES>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><b><span
lang=EN-GB>6.6&nbsp;&nbsp;&nbsp;&nbsp; Special precautions for disposal and
other handling</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><u><span lang=EN-GB>Instructions
for use and handling</span></u></p>

<p class=MsoNormal style='line-height:normal'>To prevent the possible
transmission of disease, each pen must be used by one patient only, even if the
needle is changed.</p>

<p class=MsoNormal style='margin-right:.55pt'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The Liprolog
solution should be clear and colourless. Liprolog should not be used if it
appears cloudy, thickened, or slightly coloured or if solid particles are
visible.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><u><span lang=EN-GB>Handling of
the pre-filled pen</span></u></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Before using the
KwikPen the user manual included in the package leaflet must be read
carefully.&nbsp; The KwikPen has to be used as recommended in the user manual.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Any unused product or waste material should
be disposed of in accordance with local requirements.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:26.95pt;text-indent:-26.95pt;page-break-after:
avoid'><b><span lang=EN-GB style='text-transform:uppercase'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Marketing
Authorisation Holder</span></b></p>

<p class=MsoNormal style='margin-left:26.95pt;text-indent:-26.95pt;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:26.95pt;text-indent:-26.95pt;page-break-after:
avoid'><span lang=EN-GB>Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ
Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBERS</b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'>&nbsp;</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=ES>EU/1/01/195/028</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=ES>EU/1/01/195/029</span></p>

<p class=MsoNormal><span lang=ES>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=ES>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Date
of First Authorisation / Renewal of the Authorisation</span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
style='color:black'>Date of first authorisation: 1<sup>st</sup> August 2001 </span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB style='color:black'>Date of last renewal: 1<sup>st</sup> August 2006</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='text-transform:uppercase'>10.&nbsp;&nbsp;&nbsp;&nbsp; Date
of Revision of THE Text</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='text-transform:uppercase'>&nbsp;</span></b></p>

<p class=MsoNormal><span lang=EN-GB>Detailed information on this medicinal product
is available on the website of the European Medicines Agency
http://www.ema.europa.eu</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF THE MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Liprolog 100&nbsp;units/ml Junior KwikPen, solution for injection in
a pre-filled pen</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Qualitative
and Quantitative Composition</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>One ml solution contains 100&nbsp;units (equivalent to 3.5mg)
insulin lispro*. Each pen contains 300 units of insulin lispro in 3ml solution.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Each </span><span
lang=EN-GB>Junior KwikPen </span><span lang=EN-GB>delivers 0.5 &#8211; 30 units
in steps of 0.5 units.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>*produced in
E.coli by recombinant DNA technology.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>For the full
list of excipients, see section 6.1.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmaceutical
Form</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Solution for
injection. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Clear,
colourless, aqueous solution. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clinical
Particulars</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>4.1&nbsp;&nbsp;&nbsp; Therapeutic indications</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>For the treatment of adults and children
with diabetes mellitus who require insulin for the maintenance of normal
glucose homeostasis. Liprolog 100&nbsp;units/ml Junior KwikPen is also
indicated for the initial stabilisation of diabetes mellitus. </span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>4.2&nbsp;&nbsp;&nbsp; Posology and method of administration</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><u><span
lang=EN-GB>Posology</span></u></p>

<p class=MsoNormal><span lang=EN-GB>The dosage should be determined by the
physician, according to the requirement of the patient. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog 100
units/ml Junior KwikPen is suitable for patients who may benefit from finer
insulin dose adjustments.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Liprolog
may be given shortly before meals. When necessary Liprolog can be given soon
after meals. </span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog takes effect rapidly and has a
shorter duration of activity (2 to 5&nbsp;hours) given subcutaneously as
compared with regular insulin. This rapid onset of activity allows a Liprolog
injection (or, in the case of administration by continuous subcutaneous
infusion, a Liprolog bolus) to be given very close to mealtime. The time course
of action of any insulin may vary considerably in different individuals or at
different times in the same individual. The faster onset of action compared to
soluble human insulin is maintained regardless of injection site. As with all
insulin preparations, the duration of action of Liprolog is dependent on dose,
site of injection, blood supply, temperature, and physical activity.</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog can be used in conjunction with a
longer-acting insulin or oral sulphonylurea agents, on the advice of a
physician. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=Default><i><u><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>Liprolog
100&nbsp;units/ml KwikPen and Liprolog 200&nbsp;units/ml KwikPen and Liprolog 100&nbsp;units/ml
Junior KwikPen</span></u></i></p>

<p class=Default><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>Liprolog
KwikPen is available in two strengths. The Liprolog 100&nbsp;units/ml KwikPen and
the Liprolog 200&nbsp;units/ml KwikPen deliver
1&nbsp;&#8211;&nbsp;60&nbsp;units in steps of 1 unit in a single injection. The
Liprolog 100 units/ml Junior KwikPen delivers 0.5 &#8211; 30 units in steps of
0.5 units in a single injection. <b>The number of insulin units is shown in the
dose window of the pen regardless of strength</b> and <b>no </b>dose conversion
should be done when transferring a patient to a new strength or to a pen with a
different dose step. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'><i><span lang=EN-GB>Special populations</span></i></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Renal impairment</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Insulin requirements may be reduced in the presence of
renal impairment.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'><span lang=EN-GB>Hepatic impairment</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Insulin
requirements may be reduced in patients with hepatic impairment due to reduced
capacity for gluconeogenesis and reduced insulin breakdown; however, in patients
with chronic hepatic impairment, an increase in insulin resistance may lkead to
increased insulin requirements.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><i><span
lang=EN-GB>Paediatric population</span></i></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog can be used in adolescents and
children (see section 5.1).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Method of
administration</span></u></p>

<p class=BodytextAgency><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>Liprolog preparations should be given by subcutaneous
injection and may, although not recommended, also be given by intramuscular
injection. </span></p>

<p class=BodytextAgency><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>The Junior KwikPen is only suitable for subcutaneous
injections.&nbsp; Liprolog 100&nbsp;units/ml is available in vials if
administration of intravenous injection or infusion pump is necessary.&nbsp; </span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Subcutaneous administration should be in
the upper arms, thighs, buttocks, or abdomen. Use of injection sites should be
rotated so that the same site is not used more than approximately once a month.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>When
administered subcutaneously care should be taken when injecting Liprolog to
ensure that a blood vessel has not been entered. After injection, the site of
injection should not be massaged. Patients must be educated to use the proper
injection techniques.</span></p>

<p class=MsoNormal><u><span lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>4.3&nbsp;&nbsp;&nbsp; Contraindications</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>4.4&nbsp;&nbsp;&nbsp; Special warnings and precautions for use</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><u><span
lang=EN-GB>Transferring a patient to another type or brand of insulin</span></u></p>

<p class=MsoNormal><span lang=EN-GB>Transferring a patient to another type or
brand of insulin should be done under strict medical supervision. Changes in
strength, brand (manufacturer), type (regular, NPH, lente, etc.), species
(animal, human, human insulin analogue), and/or method of manufacture (recombinant
DNA versus animal-source insulin) may result in the need for a change in
dosage. </span><span lang=EN-GB style='color:black'>For fast-acting insulins,
any patient also on basal insulin must optimise dosage of both insulins to
obtain glucose control across the whole day, particularly nocturnal/fasting
glucose control.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><u><span lang=EN-GB>Hypoglycaemia
and hyperglycaemia</span></u></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Conditions
which may make the early warning symptoms of hypoglycaemia different or less
pronounced include long duration of diabetes, intensified insulin therapy,
diabetic nerve disease or medications such as beta-blockers.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>A few patients
who have experienced hypoglycaemic reactions after transfer from animal-source
insulin to human insulin have reported that the early warning symptoms of
hypoglycaemia were less pronounced or different from those experienced with
their previous insulin. Uncorrected hypoglycaemic or hyperglycaemic reactions
can cause loss of consciousness, coma, or death.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>The use of dosages which are inadequate or
discontinuation of treatment, especially in insulin-dependent diabetics, may
lead to hyperglycaemia and diabetic ketoacidosis; conditions which are
potentially lethal.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><u><span
lang=EN-GB>Insulin requirements and dosage adjustment</span></u></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Insulin requirements may be increased during illness or emotional
disturbances.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Adjustment of dosage may also be necessary
if patients undertake increased physical activity or change their usual diet.
Exercise taken immediately after a meal may increase the risk of hypoglycaemia.
A consequence of the pharmacodynamics of rapid-acting insulin analogues is that
if hypoglycaemia occurs, it may occur earlier after an injection when compared
with soluble human insulin.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB>Combination of Liprolog with
pioglitazone:</span></u></p>

<p class=MsoNormal><span lang=EN-GB>Cases of cardiac failure have been reported
when pioglitazone was used in combination with insulin, especially in patients
with risk factors for development of cardiac heart failure. This should be kept
in mind if treatment with the combination of pioglitazone and Liprolog is
considered. If the combination is used, patients should be observed for signs
and symptoms of heart failure, weight gain and oedema. Pioglitazone should be
discontinued if any deterioration in cardiac symptoms occurs.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u>Instructions
for use and handling </u></p>

<p class=MsoNormal style='line-height:normal'>To prevent the possible
transmission of disease, each pen must be used by one patient only, even if the
needle is changed.</p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=BodytextAgency style='margin-bottom:0in'><u><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>Avoidance of
medication </span></u><u><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>errors</span></u></p>

<p class=BodytextAgency><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>Patients must be instructed to always check the
insulin label before each injection to avoid accidental mix-ups between the two
different strengths of Liprolog KwikPen as well as other insulin products.</span></p>

<p class=BodytextAgency><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>Patients must visually verify the dialled units on the
dose counter of the pen. Therefore, the requirement for patients to self-inject
is that they can read the dose counter on the pen. Patients who are blind or
have poor vision must be instructed to always get help/assistance from another
person who has good vision and is trained in using the insulin device.</span></p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=MsoNormal><u><span lang=EN-GB>Excipients</span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>This medicinal
product contains less than 1&nbsp;mmol sodium (23&nbsp;mg) per dose, i.e.,
essentially &#8220;sodium&#8209;free&#8221;.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>4.5&nbsp;&nbsp;&nbsp; Interaction with other medicinal products and
other forms of interaction</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin requirements may be increased by
medicinal products with hyperglycaemic activity, such as oral contraceptives,
corticosteroids, or thyroid replacement therapy, danazol, beta2 stimulants
(such as ritodrine, salbutamol, terbutaline). </span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin requirements may be reduced in the
presence of medicinal products with hypoglycaemic activity, such as oral
hypoglycemics, salicylates (for example, acetylsalicylic acid), sulpha
antibiotics, certain antidepressants (monoamine oxidase inhibitors, selective
serotonin reuptake inhibitors), certain angiotensin converting enzyme
inhibitors (captopril, enalapril), angiotensin II receptor blockers,
beta-blockers, octreotide or alcohol. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>The physician should be consulted when
using other medications in addition to Liprolog 100&nbsp;units/ml Junior
KwikPen </span>(see section <span lang=EN-GB>4.4</span>)<span lang=EN-GB>.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>4.6&nbsp;&nbsp;&nbsp;&nbsp; Fertility,
pregnancy and lactation</span></b></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><u><span lang=EN-GB>Pregnancy</span></u></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Data
on a large number of exposed pregnancies do not indicate any adverse effect of
insulin lispro on pregnancy or on the health of the foetus/newborn.&nbsp;&nbsp;
</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>It is essential
to maintain good control of the insulin-treated (insulin-dependent or
gestational diabetes) patient throughout pregnancy. Insulin requirements
usually fall during the first trimester and increase during the second and
third trimesters. Patients with diabetes should be advised to inform their
doctor if they are pregnant or are contemplating pregnancy. Careful monitoring
of glucose control, as well as general health, is essential in pregnant
patients with diabetes. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><u><span
lang=EN-GB>Breast-feeding</span></u></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Patients
with diabetes who are breast-feeding may require adjustments in insulin dose,
diet or both. </span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><u><span
lang=EN-GB>Fertility</span></u></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>Insulin lispro did not induce fertility impairment in animal studies
(see section 5.3).</span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;page-break-after:
avoid'><b><span lang=EN-GB>4.7&nbsp;&nbsp;&nbsp;&nbsp; Effects on ability to
drive and use machines</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;page-break-after:avoid'><span
lang=EN-GB>The patient&#8217;s ability to concentrate and react may be impaired
as a result of hypoglycaemia. This may constitute a risk in situations where
these abilities are of special importance (e.g. driving a car or operating
machinery).</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Patients
should be advised to take precautions to avoid hypoglycaemia whilst driving,
this is particularly important in those who have reduced or absent awareness of
the warning signs of hypoglycaemia or have frequent episodes of hypoglycaemia.
The advisability of driving should be considered in these circumstances.</span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>4.8&nbsp;&nbsp;&nbsp;&nbsp; Undesirable
effects</span></b></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u>Summary of
safety profile</u></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u><span
 style='text-decoration:none'>&nbsp;</span></u></p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>Hypoglycaemia
is the most frequent undesirable effect of insulin therapy that a patient with
diabetes may suffer. Severe hypoglycaemia may lead to loss of consciousness,
and in extreme cases, death. No specific frequency for hypoglycaemia is
presented, since hypoglycaemia is a result of both the insulin dose and other
factors e.g. a patient`s level of diet and exercise.</p>

<p class=MsoNormal style='line-height:12.0pt;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u>Tabulated
list of adverse reactions</u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>The following
related adverse reactions from clinical trials are listed below as MedDRA
preferred term by system organ class and in order of decreasing incidence (very
common: &#8805;1/10; common: &#8805;1/100 to &lt;1/10; uncommon: &#8805;1/1,000
to &lt;1/100; rare: &#8805;1/10,000 to &lt;1/1,000; very rare: &lt;1/10,000).</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Within each
frequency grouping, adverse reactions are presented in order of decreasing
seriousness.</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="90%"
 style='margin-left:12.5pt;border-collapse:collapse;border:none'>
 <tr style='height:16.75pt'>
  <td width="25%" valign=top style='width:25.56%;border:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt;page-break-after:avoid'><b><span
  lang=EN-GB>MedDRA system organ classes</span></b></p>
  </td>
  <td width="17%" valign=top style='width:17.48%;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt;page-break-after:avoid'><b><span
  lang=EN-GB>Very common</span></b></p>
  </td>
  <td width="14%" valign=top style='width:14.1%;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt'><b><span lang=EN-GB>Common</span></b></p>
  </td>
  <td width="17%" valign=top style='width:17.46%;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt'><b><span lang=EN-GB>Uncommon</span></b></p>
  </td>
  <td width="12%" valign=top style='width:12.68%;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt'><b><span lang=EN-GB>Rare</span></b></p>
  </td>
  <td width="12%" valign=top style='width:12.72%;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt'><b><span lang=EN-GB>Very rare</span></b></p>
  </td>
 </tr>
 <tr style='height:16.3pt'>
  <td width="100%" colspan=6 valign=top style='width:100.0%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:16.3pt'>
  <p class=MsoNormal style='page-break-after:avoid'><b><span lang=EN-GB>Immune
  system disorders </span></b></p>
  </td>
 </tr>
 <tr style='height:16.75pt'>
  <td width="25%" valign=top style='width:25.56%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt;page-break-after:avoid'><span
  lang=EN-GB>Local allergy</span></p>
  </td>
  <td width="17%" valign=top style='width:17.48%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="14%" valign=top style='width:14.1%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>X</span></p>
  </td>
  <td width="17%" valign=top style='width:17.46%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="12%" valign=top style='width:12.68%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="12%" valign=top style='width:12.72%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:16.75pt'>
  <td width="25%" valign=top style='width:25.56%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt;page-break-after:avoid'><span
  lang=EN-GB>Systemic allergy</span></p>
  </td>
  <td width="17%" valign=top style='width:17.48%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="14%" valign=top style='width:14.1%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="17%" valign=top style='width:17.46%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="12%" valign=top style='width:12.68%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>X</span></p>
  </td>
  <td width="12%" valign=top style='width:12.72%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:5.75pt'>
  <td width="100%" colspan=6 valign=top style='width:100.0%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:5.75pt'>
  <p class=MsoNormal style='page-break-after:avoid'><b><span lang=EN-GB>Skin
  and subcutaneous tissue disorders</span></b></p>
  </td>
 </tr>
 <tr style='height:5.75pt'>
  <td width="25%" valign=top style='width:25.56%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:5.75pt'>
  <p class=MsoNormal style='margin-bottom:2.55pt;page-break-after:avoid'><span
  lang=EN-GB>Lipodystrophy</span></p>
  </td>
  <td width="17%" valign=top style='width:17.48%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:5.75pt'>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="14%" valign=top style='width:14.1%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:5.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="17%" valign=top style='width:17.46%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:5.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>X</span></p>
  </td>
  <td width="12%" valign=top style='width:12.68%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:5.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="12%" valign=top style='width:12.72%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:5.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB>Description
of selected adverse reactions</span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><i><span lang=EN-GB>Local
allergy </span></i></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'>Local allergy
in patients is common. Redness, swelling, and itching can occur at the site of
insulin injection. This condition usually resolves in a few days to a few
weeks. In some instances, this condition may be related to factors other than
insulin, such as irritants in the skin cleansing agent or poor injection
technique. </p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><i>&nbsp;</i></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><i>Systemic
allergy</i></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'>Systemic
allergy, which is rare but potentially more serious, is a generalised allergy
to insulin. It may cause a rash over the whole body, shortness of breath,
wheezing, reduction in blood pressure, fast pulse, or sweating. Severe cases of
generalised allergy may be life-threatening.</p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><i>Lipodystrophy</i></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>Lipodystrophy at the injection site is uncommon.</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'><i>Oedema </i></p>

<p class=MsoNormal style='line-height:normal'>Cases of oedema have been
reported with insulin therapy, particularly if previous poor metabolic control
is improved by intensified insulin therapy.</p>

<p class=MsoNormal style='text-autospace:none'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Reporting
suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals are asked to report any suspected
adverse reactions via <span style='background:silver'>the national reporting
system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span>.</span></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>4.9&nbsp;&nbsp;&nbsp;&nbsp; Overdose</span></b></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulins have no specific overdose
definitions because serum glucose concentrations are a result of complex
interactions between insulin levels, glucose availability and other metabolic
processes. Hypoglycaemia may occur as a result of an excess of insulin
activity&nbsp; relative to food intake and energy expenditure.</span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Hypoglycaemia may be associated with
listlessness, confusion, palpitations, headache, sweating and vomiting.</span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Mild hypoglycaemic episodes will respond to
oral administration of glucose or other sugar or saccharated products.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Correction of moderately severe hypoglycaemia
can be accomplished by intramuscular or subcutaneous administration of
glucagon, followed by oral carbohydrate when the patient recovers sufficiently.
Patients who fail to respond to glucagon must be given glucose solution
intravenously.</span></p>

<p class=MsoNormal style='margin-left:21.3pt;text-indent:-21.3pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>If the patient is comatose, glucagon should
be administered intramuscularly or subcutaneously. However, glucose solution
must be given intravenously if glucagon is not available or if the patient
fails to respond to glucagon. The patient should be given a meal as soon as
consciousness is recovered.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Sustained
carbohydrate intake and observation may be necessary because hypoglycaemia may
recur after apparent clinical recovery.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmacological
Properties</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>5.1&nbsp;&nbsp;&nbsp; Pharmacodynamic properties</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Pharmacotherapeutic group : Drugs used in
diabetes, insulins and analogues for injection, fast-acting, ATC code: A10AB04</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>The primary activity of insulin lispro is the regulation of glucose
metabolism.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>In addition, insulins have several anabolic
and anti-catabolic actions on a variety of different tissues. Within muscle
tissue this includes increasing glycogen, fatty acid, glycerol and protein
synthesis and amino acid uptake, while decreasing glycogenolysis,
gluconeogenesis, ketogenesis, lipolysis, protein catabolism and amino acid
output.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Insulin lispro
has a rapid onset of action (approximately 15&nbsp;minutes), thus allowing it
to be given closer to a meal (within zero to 15&nbsp;minutes of the meal) when
compared to regular insulin <br>
(30 to 45 minutes before). Insulin lispro takes effect rapidly and has a
shorter duration of activity (2 to 5&nbsp;hours) when compared to regular
insulin. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Clinical trials
in patients with type 1 and type 2 diabetes have demonstrated reduced
postprandial hyperglycaemia with insulin lispro compared to soluble human
insulin. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>As with all
insulin preparations, the time course of insulin lispro action may vary in
different individuals or at different times in the same individual and is
dependent on dose, site of injection, blood supply, temperature and physical
activity. The typical activity profile following subcutaneous injection is
illustrated below.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal>

<table cellpadding=0 cellspacing=0>
 <tr>
  <td width=59 height=0></td>
 </tr>
 <tr>
  <td></td>
  <td><img width=416 height=1 src="Humalo_files/image006.gif"></td>
 </tr>
</table>

<br clear=ALL>
<span lang=EN-GB>The above representation reflects the relative amount of
glucose over time required to maintain the subject's whole blood glucose
concentrations near fasting levels and is an indicator of the effect of these
insulins on glucose metabolism over time.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Clinical trials
have been performed in children (61 patients aged 2 to 11) and children and
adolescents (481 patients aged 9 to 19 years), comparing insulin lispro to human
soluble insulin. The pharmacodynamic profile of insulin lispro in children is
similar to that seen in adults. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB
style='layout-grid-mode:line'>When used in subcutaneous infusion pumps,
treatment with insulin lispro has been shown to result in lower glycosylated
haemoglobin levels compared to soluble insulin.&nbsp; In a double-blind,
crossover study, the reduction in glycosylated haemoglobin levels after 12
weeks dosing was 0.37 percentage points with insulin lispro, compared to 0.03
percentage points for soluble insulin (p&nbsp;=</span><span lang=EN-GB>&nbsp;<span
style='layout-grid-mode:line'>0.004).</span></span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB
style='layout-grid-mode:line'>In patients with type 2 diabetes on maximum doses
of sulphonyl urea agents, studies have shown that the addition of insulin
lispro significantly reduces HbA1c compared to sulphonyl urea alone. The
reduction of HbA1c would also be expected with other insulin products e.g.
soluble or isophane insulins.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB
style='layout-grid-mode:line'>Clinical trials in patients with type 1 and type
2 diabetes have demonstrated a reduced number of episodes of nocturnal
hypoglycaemia with insulin lispro compared to soluble human insulin. In some
studies, reduction of nocturnal hypoglycaemia was associated with increased
episodes of daytime hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>The glucodynamic response to insulin lispro
is not affected by renal or hepatic function impairment. Glucodynamic
differences between insulin lispro and soluble human insulin, as measured
during a glucose clamp procedure, were maintained over a wide range of renal
function.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Insulin
lispro has been shown to be equipotent to human insulin on a molar basis but
its effect is more rapid and of a shorter duration.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>5.2&nbsp;&nbsp;&nbsp;&nbsp; Pharmacokinetic
properties</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>The pharmacokinetics of insulin lispro
reflect a compound that is rapidly absorbed, and achieves peak blood levels 30
to 70&nbsp;minutes following subcutaneous injection. When considering the
clinical relevance of these kinetics, it is more appropriate to examine the
glucose utilisation curves (as discussed in 5.1).</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>Insulin
lispro maintains more rapid absorption when compared to soluble human insulin
in patients with renal impairment. In patients with type 2 diabetes over a wide
range of renal function&nbsp; the pharmacokinetic differences between insulin
lispro and soluble human insulin were generally maintained and shown to be
independent of renal function.&nbsp; Insulin lispro maintains more rapid
absorption and elimination when compared to soluble human insulin in patients
with hepatic impairment.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>5.3&nbsp;&nbsp;&nbsp; Preclinical safety data</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>In in vitro tests, including binding to
insulin receptor sites and effects on growing cells, insulin lispro behaved in
a manner that closely resembled human insulin. Studies also demonstrate that
the dissociation of binding to the insulin receptor of insulin lispro is
equivalent to human insulin. Acute, one month and twelve month toxicology
studies produced no significant toxicity findings.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin lispro did not induce fertility
impairment, embryotoxicity or teratogenicity in animal studies. </span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmaceutical
Particulars</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>6.1&nbsp;&nbsp;&nbsp; List of excipients</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>m-</span></i><span
lang=EN-GB>Cresol </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Glycerol</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Dibasic sodium
phosphate.&nbsp;7H<span style='position:relative;top:3.0pt'>2</span>O</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Zinc oxide</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Water for
injections</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Hydrochloric
acid and sodium hydroxide maybe used to adjust pH.</span></p>

<p class=MsoNormal><s><span lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></s></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>6.2&nbsp;&nbsp;&nbsp;&nbsp; Incompatibilities</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>This medicinal
product should not be mixed with any other insulin or any other medicinal
product. </span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>6.3&nbsp;&nbsp;&nbsp; Shelf life</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>Unused
pre-filled pens</span></u></i></p>

<p class=MsoNormal><span lang=EN-GB>3&nbsp;years. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><i><u><span lang=EN-GB>After first use</span></u></i></p>

<p class=MsoNormal><span lang=EN-GB>28 days.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>6.4&nbsp;&nbsp;&nbsp; Special precautions for storage</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>Unused
pre-filled pens</span></u></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C). Do not freeze. Do not expose to excessive
heat or direct sunlight. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><u><span lang=EN-GB>After
first use</span></u></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Store below 30&deg;C. Do not refrigerate. The pre-filled pen should
not be stored with the needle attached.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB>6.5&nbsp;&nbsp;&nbsp; Nature and contents of container</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Type I glass cartridges, sealed with
halobutyl disc seals secured with aluminium seals and bromobutyl plunger heads.
Dimeticone or silicone emulsion may be used to treat the cartridge plunger. The
3 ml cartridges are sealed in a disposable pen injector, called the
&#8220;Junior KwikPen&#8221;. Needles are not included.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=ES>5 pre-filled pens of 3ml</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=ES>Multipacks containing 10 (2 packs of 5) pre-filled pen of 3ml</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=ES>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Not all packs
may be marketed.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=ES>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.6&nbsp;&nbsp;&nbsp;&nbsp; Special precautions for
disposal and other handling</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB>Instructions for use and handling</span></u></p>

<p class=MsoNormal style='line-height:normal'>To prevent the possible
transmission of disease, each pen must be used by one patient only, even if the
needle is changed.</p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>The Liprolog solution should be clear and
colourless. Liprolog should not be used if it appears cloudy, thickened, or
slightly coloured or if solid particles are visible.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><u><span
lang=EN-GB>Handling of the pre-filled pen</span></u></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Before using the Junior KwikPen the user manual included in the
package leaflet must be read carefully.&nbsp; The Junior KwikPen has to be used
as recommended in the user manual.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=PPIBulletedList2><span style='font-family:"Times New Roman",serif'>The
</span><span style='font-family:"Times New Roman",serif'>Junior KwikPen</span><span
style='font-family:"Times New Roman",serif'> should not be used if any part
looks broken or damaged.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Any unused
product or waste material should be disposed of in accordance with local
requirements.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Marketing
Authorisation Holder</span></b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBERS</b></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'>&nbsp;</p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=ES>EU/1/01/195/030&nbsp; </span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=ES>EU/1/01/195/031&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></p>

<p class=MsoNormal><span lang=ES>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=ES>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><b><span
lang=EN-GB style='text-transform:uppercase'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Date
of First Authorisation / Renewal of the Authorisation</span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Date of first
authorisation: 1<sup>st</sup> August 2001</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Date of last
renewal: 1<sup>st</sup> August 2006</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'>&nbsp;</p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='text-transform:uppercase'>10.&nbsp;&nbsp;&nbsp;&nbsp; Date
of Revision of THE Text</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b>&nbsp;</b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EL>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>ANNEX II</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:70.8pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:70.8pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>A.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB>MANUFACTURERS OF THE BIOLOGICAL ACTIVE
SUBSTANCE AND MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:70.8pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:70.8pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>B.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB>CONDITIONS OR RESTRICTIONS REGARDING
SUPPLY AND USE</span></b></p>

<p class=MsoListParagraph><b><span lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:70.8pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>C.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB>OTHER CONDITIONS AND REQUIREMENTS OF THE
MARKETING AUTHORISATION</span></b></p>

<p class=MsoListParagraph><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:70.8pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>D.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB style='text-transform:uppercase'>conditions
or restrictions with regard to the safe and effective use of the medicinal
product</span></b></p>

<p class=MsoNormal style='margin-right:70.8pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=TitleB><span lang=EN-GB>A&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MANUFACTURERS
OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURERS RESPONSIBLE FOR BATCH
RELEASE</span></p>

<p class=MsoNormal style='margin-right:70.8pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Names and
addresses of the manufacturers of the biological active substance</span></u></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Fermentation:</span></u><span
lang=EN-GB> Eli Lilly and Company, Lilly Technology Center Building
333 and 324, Indianapolis, Indiana, USA</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=ES>Lilly del Caribe,
Inc., Puerto Rico Industrial Park, 12.3 KM (PR05), 65th Infantry Road,
Carolina, Puerto Rico 00985</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Granule
Recovery:</span></u><span lang=EN-GB> Eli Lilly and Company, Lilly Technology
 Center Building 130, Indianapolis, Indiana, USA</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=ES>Lilly del Caribe,
Inc., Puerto Rico Industrial Park, 12.3 KM (PR05), 65th Infantry Road, Carolina,
Puerto Rico 00985</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=ES><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Names and
addresses of the manufacturers responsible for batch release</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:14.2pt;text-indent:-14.2pt;line-height:
normal'><u><span lang=EN-GB>Vials</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=ES-TRAD>Lilly S.A.,
Avda. de la Industria 30, 28108 Alcobendas, Madrid, Spain.</span></p>

<p class=MsoNormal style='line-height:normal'><i>&nbsp;</i></p>

<p class=MsoNormal style='line-height:normal'><u>Cartridges </u></p>

<p class=MsoNormal style='line-height:normal'>Lilly France S.A.S., Rue du
Colonel Lilly, 67640 Fegersheim, France.</p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><u><span
 style='text-decoration:none'>&nbsp;</span></u></p>

<p class=MsoNormal style='line-height:normal'><u>Cartridges besides Liprolog
Basal </u></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span lang=IT>Eli
Lilly Italia S.p.A., Via&nbsp; Gramsci 731-733, 50019 Sesto Fiorentino, (FI)
Italy.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=IT>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><u>Disposable pens called the
&#8222;KwikPen&#8220;(100&nbsp;units/ml)</u></p>

<p class=MsoNormal style='margin-left:14.2pt;text-indent:-14.2pt;line-height:
normal'>Lilly France S.A.S., Rue du Colonel Lilly, 67640 Fegersheim, France.</p>

<p class=MsoNormal style='line-height:normal'><u><span lang=DE><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><u>Disposable pens called the
&#8222;Junior KwikPen&#8220;(100&nbsp;units/ml) </u></p>

<p class=MsoNormal style='margin-left:14.2pt;text-indent:-14.2pt;line-height:
normal'>Lilly France S.A.S., Rue du Colonel Lilly, 67640 Fegersheim, France.</p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span lang=IT>Eli
Lilly Italia S.p.A., Via&nbsp; Gramsci 731-733, 50019 Sesto Fiorentino, (FI)
Italy.</span></p>

<p class=MsoNormal style='margin-left:14.2pt;text-indent:-14.2pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'><u><span lang=DE><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><u>Disposable pens called the
&#8222;KwikPen&#8220;(100&nbsp;units/ml) besides Liprolog BASAL KwikPen
presentations </u></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span lang=IT>Eli
Lilly Italia S.p.A., Via&nbsp; Gramsci 731-733, 50019 Sesto Fiorentino, (FI)
Italy.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=IT>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><u>Disposable pens called the
&#8222;KwikPen&#8220; (200&nbsp;units/ml)</u></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'>Lilly France
S.A.S., Rue du Colonel Lilly, 67640 Fegersheim, France. </p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span lang=IT>Eli
Lilly Italia S.p.A., Via Gramsci 731-733, 50019 Sesto Fiorentino, (FI) Italy.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The printed
package leaflet of the medicinal product must state the name and address of the
manufacturer responsible for the release of the concerned batch</span></p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=TitleB><span lang=EN-GB>B&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CONDITIONS
OR RESTRICTIONS REGARDING SUPPLY AND USE</span><span lang=EN-GB
style='font-weight:normal'> </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Medicinal
product subject to medical prescription </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>C. &nbsp;&nbsp;&nbsp;&nbsp; OTHER CONDITIONS AND
REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:28.35pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB>Periodic Safety Update Reports</span></b></p>

<p class=MsoNormal style='margin-right:28.35pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:28.35pt;line-height:normal'><span
lang=EN-GB>The marketing authorisation holder shall submit </span><span
lang=EN-GB>periodic safety update reports</span><span lang=EN-GB> for this
product in accordance with the requirements set out in the list of Union
reference dates (EURD list) </span><span lang=EN-GB>provided for under Article
107c(7) of Directive 2001/83</span><span lang=EN-GB>/EC</span><span lang=EN-GB>
and </span><span lang=EN-GB>published on the European medicines web-portal</span>.</p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CONDITIONS OR
RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid;text-autospace:
none'><b>Risk Management Plan (RMP)</b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid;text-autospace:
none'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid;text-autospace:
none'>The MAH shall perform the required pharmacovigilance activities and
interventions detailed in the agreed RMP presented in Module 1.8.2 of the
Marketing Authorisation and any agreed subsequent updates of the RMP.</p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'>An updated
RMP should be submitted:</p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='line-height:normal;text-autospace:none'>At the
     request of the European Medicines Agency;</li>
 <li class=MsoNormal style='line-height:normal;text-autospace:none'>Whenever
     the risk management system is modified, especially as the result of new
     information being received that may lead to a significant change to the
     benefit/risk profile or as the result of an important (pharmacovigilance
     or risk minimisation) milestone being reached.</li>
</ul>

<p class=MsoNormal style='line-height:normal;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'>If the dates
for submission of a PSUR and the update of a RMP coincide, they can be submitted
at the same time.</p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'>&nbsp;</p>

<p class=MsoNormal style='margin-left:.45in;text-indent:-33.25pt;line-height:
normal;text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;
font-family:Symbol;color:black'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='color:black'>Additional risk
minimisation measures (Liprolog 200&nbsp;units/ml)</span></b></p>

<p class=MsoNormal style='line-height:normal'><b>&nbsp;</b></p>

<p class=MsoNormal style='text-align:justify;line-height:normal;text-autospace:
none'><span lang=EN-GB style='color:black'>The MAH shall provide a Dear
Healthcare Professional Letter (DHPC) and patient communication prior to launch
targeting all physicians and nurses who are expected to be involved in the
treatment and management of diabetic patients and, where required, all
pharmacists who are expected to dispense Liprolog. </span></p>

<p class=MsoNormal style='text-align:justify;line-height:normal;text-autospace:
none'><span lang=EN-GB style='color:black'>&nbsp;</span></p>

<p class=BodytextAgency style='margin-bottom:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
layout-grid-mode:line'>The target audience and the modalities for distribution
all of these materials are to be agreed at Member State level. </span><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>The MAH
shall agree the final text of the Dear Healthcare Professional Communication
letter and the content of the patient communication together with a
communication plan, with the National Competent Authority in each Member State
prior to launch of the product.</span></p>

<p class=MsoNormal style='text-align:justify;line-height:normal;text-autospace:
none'><span lang=EN-GB style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify;line-height:normal;text-autospace:
none'><span lang=EN-GB style='color:black'>The DHPC and patient communication
are aimed at increasing awareness about the fact that Liprolog is now available
in two strengths and describing key differences in the design of the packages
and the pre-filled pen devices to minimise the risk of medication errors and
mix up between the two different strengths of Liprolog.</span></p>

<p class=MsoNormal style='text-align:justify;line-height:normal;text-autospace:
none'><span lang=EN-GB style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify;line-height:normal;text-autospace:
none'><span lang=EN-GB style='color:black'>The MAH shall ensure that healthcare
professionals are informed that all patients who have been prescribed Liprolog should
be trained on the correct use of the pre-filled pen before prescribing or
dispensing Liprolog.&nbsp; </span></p>

<p class=MsoNormal style='text-align:justify;line-height:normal;text-autospace:
none'><span lang=EN-GB style='color:black'>&nbsp;</span></p>

<p class=BodytextAgency style='margin-bottom:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>The
DHPC should address the following key elements:</span></p>

<p class=BodytextAgency style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;text-indent:-.25in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'>Liprolog</span><span lang=EN-GB style='font-size:11.0pt;
font-family:"Times New Roman",serif'> is now available in 2 strengths</span></p>

<p class=BodytextAgency style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;text-indent:-.25in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>Key
features of the design of the package and pre-filled pen device</span></p>

<p class=BodytextAgency style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;text-indent:-.25in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>When
prescribing, to ensure that the correct strength is mentioned on the
prescription</span></p>

<p class=BodytextAgency style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;text-indent:-.25in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'>Liprolog</span><span lang=EN-GB style='font-size:11.0pt;
font-family:"Times New Roman",serif'> should not be used outside of the pre-filled
pen device </span></p>

<p class=BodytextAgency style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;text-indent:-.25in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>Dose
conversion on switching from </span><span lang=EN-GB style='font-size:11.0pt;
font-family:"Times New Roman",serif;color:black'>Liprolog</span><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'> 100&nbsp;units/ml
to 200&nbsp;units/ml should not be performed</span></p>

<p class=BodytextAgency style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;text-indent:-.25in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>Medication
errors or any side effects should be reported</span></p>

<p class=BodytextAgency style='margin-bottom:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=BodytextAgency style='margin-bottom:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>The
patient communication should address the following key elements:</span></p>

<p class=BodytextAgency style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;text-indent:-.25in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'>Liprolog</span><span lang=EN-GB style='font-size:11.0pt;
font-family:"Times New Roman",serif'> is now available in 2 strengths</span></p>

<p class=BodytextAgency style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;text-indent:-.25in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>Key
features of the design of the package and pre-filled pen device</span></p>

<p class=BodytextAgency style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;text-indent:-.25in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'>Liprolog</span><span lang=EN-GB style='font-size:11.0pt;
font-family:"Times New Roman",serif'> should not be used outside of the pre-filled
pen device </span></p>

<p class=BodytextAgency style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;text-indent:-.25in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>Dose
conversion on switching from </span><span lang=EN-GB style='font-size:11.0pt;
font-family:"Times New Roman",serif;color:black'>Liprolog</span><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'> 100&nbsp;units/ml
to 200&nbsp;units/ml should not be performed</span></p>

<p class=BodytextAgency style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;text-indent:-.25in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>Check
the number of units dialled before injecting</span></p>

<p class=BodytextAgency style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;text-indent:-.25in;line-height:normal'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>Check
the name, type and strength of insulin dispensed</span></p>

<p class=BodytextAgency style='margin-top:0in;margin-right:0in;margin-bottom:
0in;margin-left:.5in;text-indent:-.25in;line-height:normal'><span lang=EN-GB
style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>Reporting
of medication errors or any side effects</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>ANNEX III</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>LABELLING AND PACKAGE LEAFLET</span></b></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=TitleA><span lang=EN-GB>A. LABELLING</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>OUTER CARTON &#8211; Vial. Pack of 1 and 2</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog 100&nbsp;units/ml solution for
injection in vial</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Insulin lispro </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml solution contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText><span lang=ES>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=ES>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Contains
glycerol, zinc oxide, dibasic sodium phosphate 7H</span><sub><span lang=EN-GB
style='font-family:Symbol'>2</span></sub><span lang=EN-GB>0 with m-cresol as a
preservative in water for injection.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Sodium hydroxide
and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Solution for injection</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>1 vial of 10 ml</span></p>

<p class=MsoNormal><span lang=EN-GB style='background:silver'>2 vials of 10ml</span><span
lang=EN-GB> </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous and intravenous use</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b><b><span
lang=EN-GB style='color:black'>SIGHT AND REACH </span><span lang=EN-GB
style='color:black'>OF CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the </span><span lang=EN-GB>sight
and </span><span lang=EN-GB>reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not freeze.
Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal><span lang=EN-GB>Once in use, vials may be used for up to 28
days. Vials in use should be stored below 30</span><span lang=EN-GB
style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL PRECAUTIONS
FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH
MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoBodyTextIndent2 align=left style='margin-left:0in;text-align:left;
text-indent:0in;line-height:normal'><span lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent2 align=left style='margin-left:0in;text-align:left;
text-indent:0in;line-height:normal'><span lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME AND ADDRESS OF
THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Papendorpseweg
83, 3528 BJ Utrecht</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER<span style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/001</span></p>

<p class=MsoNormal><span lang=EN-GB style='background:silver'>EU/1/01/195/008</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Medicinal product subject to medical
prescription</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN
BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: SN: </span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB
style='font-size:8.0pt'>&nbsp;</span></span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>INTERMEDIATE CARTON (without blue box) component
of a multipack - Vial</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog 100&nbsp;units/ml solution for
injection in vial</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Insulin lispro </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml solution contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText><span lang=ES>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=ES>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Contains glycerol,
zinc oxide, dibasic sodium phosphate 7H</span><sub><span lang=EN-GB
style='font-family:Symbol'>2</span></sub><span lang=EN-GB>0 with m-cresol as a
preservative in water for injection.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Sodium hydroxide
and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Solution for injection</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Multipack: 5
vials of 10ml. Component of a multipack, can&#8217;t be sold separately.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use. </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous and intravenous use</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b><b><span
lang=EN-GB style='color:black'>SIGHT AND REACH </span><span lang=EN-GB
style='color:black'>OF CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the </span><span lang=EN-GB>sight
and </span><span lang=EN-GB>reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not freeze.
Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal><span lang=EN-GB>Once in use, vials may be used for up to 28
days. Vials in use should be stored below 30</span><span lang=EN-GB
style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL PRECAUTIONS
FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH
MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoBodyTextIndent2 align=left style='margin-left:0in;text-align:left;
text-indent:0in;line-height:normal'><span lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent2 align=left style='margin-left:0in;text-align:left;
text-indent:0in;line-height:normal'><span lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME AND ADDRESS OF
THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Papendorpseweg
83, 3528 BJ Utrecht</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER<span style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/009&nbsp; </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Medicinal product subject to medical
prescription</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=MsoNormal><span class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN
BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='background:white'><span lang=EN-GB style='background:
yellow'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>PARTICULARS
TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>OUTER
CARTON (with blue box) multipack &#8211; Vial</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='text-align:justify;text-autospace:none'><span
lang=EN-GB style='color:#7030A0'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog 100&nbsp;units/ml solution for
injection in vial</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Insulin lispro </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml solution contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Contains
glycerol, zinc oxide, dibasic sodium phosphate 7H</span><sub><span lang=EN-GB
style='font-family:Symbol'>2</span></sub><span lang=EN-GB>0 with m-cresol as a
preservative in water for injection.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Sodium hydroxide
and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Solution for injection. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='color:black'>Multipack: 5 (5 packs
of 1) vials of 10&nbsp;ml. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous and intravenous use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the sight and reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY DATE</span></b></p>

</div>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL STORAGE
CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not freeze.
Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal><span lang=EN-GB>Once in use, vials may be used for up to 28
days. Vials in use should be stored below 30</span><span lang=EN-GB
style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='background:yellow'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER </span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/009&nbsp; </span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Medicinal product subject to medical
prescription</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN
BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: </span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=X-NONE>NN: </span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<b><u><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></u></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE
PACKAGING UNITS</span></b></p>

</div>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>LABEL TEXT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog 100&nbsp;units/ml solution for
injection in vial</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin lispro</span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=EN-GB>Subcutaneous
and intravenous use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD OF
ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CONTENTS
BY WEIGHT, BY VOLUME OR BY UNIT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal>10 ml (3.5 mg/ml)</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<span style='font-size:11.0pt;font-family:"Times New Roman",serif;color:black'><br
clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=FR style='color:black'>OUTER CARTON - Cartridges. Pack of 5 and 10</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

</div>

<p class=MsoNormal><span lang=FR>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog 100&nbsp;units/ml solution for
injection in cartridge</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Insulin lispro </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml solution contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText><span lang=ES>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=ES>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Contains
glycerol, zinc oxide, dibasic sodium phosphate7H</span><sub><span lang=EN-GB
style='font-family:Symbol'>2</span></sub><span lang=EN-GB>0 with m-cresol as a
preservative in water for injection.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Sodium hydroxide
and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Solution for injection</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>5 cartridges of 3ml</span></p>

<p class=MsoNormal><span lang=EN-GB style='background:silver'>10 cartridges of
3ml</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use. </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous and intravenous use</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b><b><span
lang=EN-GB style='color:black'>SIGHT AND REACH </span><span lang=EN-GB
style='color:black'>OF CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the </span><span lang=EN-GB>sight
and </span><span lang=EN-GB>reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNINGS, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>These cartridges
are for use with a 3 ml pen only.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>If the 40&nbsp;units/ml
vial is the product normally prescribed, do not take insulin from a 100&nbsp;units/ml
cartridge using a 40&nbsp;units/ml syringe.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not freeze.
Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Once in use
cartridges may be used for up to 28 days. Following insertion in a pen, the
cartridge and pen should be stored below 30</span><span lang=EN-GB
style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C and should not be
refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoBodyTextIndent2 align=left style='margin-left:0in;text-align:left;
text-indent:0in;line-height:normal'><span lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent2 align=left style='margin-left:0in;text-align:left;
text-indent:0in;line-height:normal'><span lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Papendorpseweg
83, 3528 BJ Utrecht</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER<span style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/002</span></p>

<p class=MsoNormal><span lang=EN-GB style='background:silver'>EU/1/01/195/010</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Medicinal product subject to medical
prescription</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoFooter style='line-height:13.0pt'><span class=MsoCommentReference><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>&nbsp;</span></span></p>

<p class=MsoNormal><span class=MsoCommentReference><span lang=EN-GB>(To open,
lift here and pull)</span></span></p>

<p class=MsoNormal><span class=MsoCommentReference><span lang=EN-GB>CARTON HAS
BEEN OPENED</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN
BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=EN-GB>Liprolog</span></span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: </span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>MINIMUM
PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS</span></b></p>

</div>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>LABEL
TEXT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog 100&nbsp;units/ml solution for
injection in cartridge</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin lispro</span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=EN-GB>Subcutaneous
and intravenous use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CONTENTS
BY WEIGHT, BY VOLUME OR BY UNIT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal>3 ml (3.5 mg/ml)</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<span style='font-size:11.0pt;font-family:"Times New Roman",serif;color:black'><br
clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=FR style='color:black'>OUTER CARTON &#8211; Cartridges. Pack of 5 and 10</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

</div>

<p class=MsoNormal><span lang=FR>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog Mix25 100&nbsp;units/ml suspension
for injection in cartridge</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>25% insulin
lispro and 75% insulin lispro protamine suspension </span></p>

<p class=MsoNormal style='margin-right:.55pt'>&nbsp;</p>

<p class=MsoNormal style='margin-right:.55pt'>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml suspension contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Contains
protamine sulphate, glycerol, zinc oxide, dibasic sodium phosphate 7 H<sub>2</sub>0
with m-cresol and phenol as preservatives in water for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Sodium
hydroxide and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Suspension for injection</span></p>

<p class=MsoNormal><span lang=EN-GB>5 cartridges of 3ml</span></p>

<p class=MsoNormal><span lang=EN-GB style='background:silver'>10 cartridges of
3ml</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTE OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use. </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b><b><span
lang=EN-GB style='color:black'>SIGHT AND REACH </span><span lang=EN-GB
style='color:black'>OF CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the </span><span lang=EN-GB>sight
and </span><span lang=EN-GB>reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Resuspend
carefully. See enclosed package leaflet.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>These
cartridges are for use with a 3 ml pen only.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Store in a refrigerator
(2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not freeze.
Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Once in use
cartridges may be used for up to 28 days. Following insertion in a pen, the
cartridge and pen should be stored below 30</span><span lang=EN-GB
style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C and should not be
refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=Janis-Deletion align=left style='text-align:left'><span lang=EN-GB
style='text-decoration:none'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Papendorpseweg
83, 3528 BJ Utrecht</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER<span style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/003</span></p>

<p class=MsoNormal><span lang=EN-GB style='background:silver'>EU/1/01/195/011</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Medicinal product subject to medical
prescription</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoFooter style='line-height:13.0pt'><span class=MsoCommentReference><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>&nbsp;</span></span></p>

<p class=MsoNormal><span class=MsoCommentReference><span lang=EN-GB>(To open,
lift here and pull)</span></span></p>

<p class=MsoNormal><span class=MsoCommentReference><span lang=EN-GB>CARTON HAS
BEEN OPENED</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN
BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=EN-GB>Liprolog Mix25</span></span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: </span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>MINIMUM
PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB>&nbsp;</span></b></p>

</div>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>LABEL
TEXT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog Mix25 100&nbsp;units/ml suspension
for injection in cartridge</span></p>

<p class=MsoNormal><span lang=EN-GB>25% insulin lispro and 75% insulin lispro
protamine suspension </span></p>

<p class=MsoNormal><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CONTENTS
BY WEIGHT, BY VOLUME OR BY UNIT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal>3 ml (3.5 mg/ml)</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<span style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-right:-2.25pt'><b><u><span style='text-decoration:
 none'>&nbsp;</span></u></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=FR style='color:black'>OUTER CARTON &#8211; Cartridges. Pack of 5 and 10</span></b></p>

</div>

<p class=MsoNormal><span lang=FR>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog Mix50 100&nbsp;units/ml suspension
for injection in cartridge</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>50% insulin lispro and 50% insulin
lispro protamine suspension </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml suspension contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Contains
protamine sulphate, glycerol, zinc oxide, dibasic sodium phosphate 7 H<sub>2</sub>0
with m-cresol and phenol as preservatives in water for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Sodium
hydroxide and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Suspension for injection</span></p>

<p class=MsoNormal><span lang=EN-GB>5 cartridges of 3ml</span></p>

<p class=MsoNormal><span lang=EN-GB style='background:silver'>10 cartridges of
3ml</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTE OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use. </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b><b><span
lang=EN-GB style='color:black'>SIGHT AND REACH </span><span lang=EN-GB
style='color:black'>OF CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the </span><span lang=EN-GB>sight
and </span><span lang=EN-GB>reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Resuspend
carefully. See enclosed package leaflet.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>These
cartridges are for use with a 3 ml pen only.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not freeze.
Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Once in use
cartridges may be used for up to 28 days. Following insertion in a pen, the
cartridge and pen should be stored below 30</span><span lang=EN-GB
style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C and should not be
refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Papendorpseweg
83, 3528 BJ Utrecht</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER<span style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/004</span></p>

<p class=MsoNormal><span lang=EN-GB style='background:silver'>EU/1/01/195/012</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Medicinal product subject to medical
prescription</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoNormal><span class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=EN-GB>(To open, lift here and pull)</span></span></p>

<p class=MsoNormal><span class=MsoCommentReference><span lang=EN-GB>CARTON HAS
BEEN OPENED</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN
BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=EN-GB>Liprolog Mix50</span></span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: </span></p>

<p class=MsoNormal><span lang=EN-GB>SN:</span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<b><u><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></u></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE
PACKAGING UNITS</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><span
lang=EN-GB style='background:silver'>&nbsp;</span></p>

</div>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>LABEL
TEXT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog Mix50 100&nbsp;units/ml suspension
for injection in cartridge</span></p>

<p class=MsoNormal><span lang=EN-GB>50% insulin lispro and 50% insulin lispro
protamine suspension </span></p>

<p class=MsoNormal><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CONTENTS
BY WEIGHT, BY VOLUME OR BY UNIT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal>3 ml (3.5 mg/ml)</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<span style='font-size:11.0pt;font-family:"Times New Roman",serif;color:black'><br
clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>PARTICULARS TO APPEAR ON
THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>OUTER CARTON &#8211;
Cartridges. Pack of 5 and 10</span></b></p>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB>&nbsp;</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Basal
100&nbsp;units/ml suspension for injection in cartridge</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Insulin lispro protamine suspension </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml suspension contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Contains protamine sulphate, glycerol, zinc oxide, dibasic sodium
phosphate 7 H<sub>2</sub>0 with m-cresol and phenol as preservatives in water
for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Sodium hydroxide and/or hydrochloric acid may have been used to
adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Suspension for injection</span></p>

<p class=MsoNormal><span lang=EN-GB>5 cartridges of 3ml</span></p>

<p class=MsoNormal><span lang=EN-GB style='background:silver'>10 cartridges of
3ml</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTE OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use. </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL WARNING THAT
THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b><b><span lang=EN-GB
style='color:black'>SIGHT AND REACH </span><span lang=EN-GB style='color:black'>OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Keep out of the </span><span
lang=EN-GB>sight and </span><span lang=EN-GB>reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER SPECIAL
WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Resuspend carefully. See enclosed package leaflet.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>These cartridges are for use with a 3 ml pen only.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY DATE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL STORAGE
CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Store in a refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Do not freeze. Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Once in use cartridges may be used for up to 21 days. Following
insertion in a pen, the cartridge and pen should be stored below 30</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C and should
not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL PRECAUTIONS FOR
DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH
MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME AND ADDRESS OF THE
MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span lang=DA>Eli
Lilly Nederland B.V.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING AUTHORISATION NUMBER<span
style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>EU/1/01/195/022</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB style='background:silver'>EU/1/01/195/023</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL CLASSIFICATION FOR
SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Medicinal product subject to medical
prescription</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span class=MsoCommentReference><span
lang=EN-GB>&nbsp;</span></span></p>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB>(To
open, lift here and pull)</span></span></p>

<p class=MsoNormal style='line-height:normal'><span class=MsoCommentReference><span
lang=EN-GB>CARTON HAS BEEN OPENED</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION
IN BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB>Liprolog
Basal</span></span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: </span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<p class=MsoEndnoteText><span class=MsoCommentReference><span style='font-size:
8.0pt'>&nbsp;</span></span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoEndnoteText style='border:none;padding:0in'><b><span lang=EN-GB>MINIMUM
PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS</span></b></p>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>LABEL TEXT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF THE
MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Basal
100&nbsp;units/ml suspension for injection in cartridge</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Insulin lispro
protamine suspension </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD OF
ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY DATE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BATCH NUMBER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CONTENTS BY WEIGHT,
BY VOLUME OR BY UNIT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'>3 ml (3.5 mg/ml)</p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<span style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=FR style='color:black'>OUTER CARTON &#8211; KwikPen. Pack of 5</span></b></p>

</div>

<p class=MsoNormal><span lang=FR>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog 100&nbsp;units/ml KwikPen solution
for injection in a pre-filled pen</span></p>

<p class=MsoEndnoteText><b><span lang=EN-GB>Insulin lispro </span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml solution contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Contains
glycerol, zinc oxide, dibasic sodium phosphate 7 H<sub>2</sub>0 with m-cresol
as a preservative in water for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Sodium
hydroxide and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Solution for injection..</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>5 pens of 3ml</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use. </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b><b><span
lang=EN-GB style='color:black'>SIGHT AND REACH </span><span lang=EN-GB
style='color:black'>OF CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the </span><span lang=EN-GB>sight
and </span><span lang=EN-GB>reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not freeze.
Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Once in use
pens may be used for up to 28 days. Pens in use should be stored below 30</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C and should
not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER<span style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/016</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=Logo-Unit style='line-height:13.0pt'><span class=MsoCommentReference><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>If seal
is broken before first use, contact pharmacist.</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN
BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=EN-GB>Liprolog
KwikPen</span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: </span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText><span class=MsoCommentReference><span style='font-size:
8.0pt'>&nbsp;</span></span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<b><u><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></u></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>INTERMEDIATE CARTON (without blue box) component
of a multipack - KwikPens</span></b></p>

</div>

<p class=MsoNormal><span lang=FR>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog 100&nbsp;units/ml KwikPen solution
for injection in a pre-filled pen</span></p>

<p class=MsoEndnoteText><b><span lang=EN-GB>Insulin lispro </span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml solution contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Contains
glycerol, zinc oxide, dibasic sodium phosphate 7 H<sub>2</sub>0 with m-cresol
as a preservative in water for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Sodium
hydroxide and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Solution for injection. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify;text-autospace:none'><span
lang=EN-GB style='color:black'>Multipack: 5 pens of 3&nbsp;ml. Component of a
multipack, can&#8217;t be sold separately.</span></p>

<p class=MsoNormal><span lang=EN-GB style='text-transform:uppercase'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='text-transform:uppercase'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use. </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b><b><span
lang=EN-GB style='color:black'>SIGHT AND REACH </span><span lang=EN-GB
style='color:black'>OF CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the </span><span lang=EN-GB>sight
and </span><span lang=EN-GB>reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not freeze.
Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Once in use
pens may be used for up to 28 days. Pens in use should be stored below 30</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C and should
not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER<span style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/017</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=Logo-Unit style='line-height:13.0pt'><span class=MsoCommentReference><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>If seal
is broken before first use, contact pharmacist.</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN
BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=EN-GB>Liprolog
KwikPen</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='background:white'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>PARTICULARS
TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>OUTER
CARTON (with blue box) multipack &#8211; KwikPen</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='text-align:justify;text-autospace:none'><span
lang=EN-GB style='color:#7030A0'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog 100&nbsp;units/ml KwikPen solution
for injection in a pre-filled pen</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Insulin lispro </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml solution contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Contains
glycerol, zinc oxide, dibasic sodium phosphate 7 H<sub>2</sub>0 with m-cresol
as a preservative in water for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Sodium
hydroxide and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Solution for injection. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='color:black'>Multipack: 10 (2 packs
of 5) pens of 3&nbsp;ml. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the sight and reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY DATE</span></b></p>

</div>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL STORAGE
CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>Store in a refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>Do not freeze. Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt;page-break-after:avoid'><span
lang=EN-GB>Once in use pens may be used for up to 28 days. Pens in use should
be stored below 30</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C and should not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER </span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/017</span><span lang=FR> </span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB
style='font-size:8.0pt'>&nbsp;</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN
BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span style='font-size:
8.0pt'>&nbsp;</span></span></p>

<p class=MsoEndnoteText>Liprolog KwikPen </p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: </span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>MINIMUM
PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS</span></b></p>

</div>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>LABEL
TEXT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog 100&nbsp;units/ml KwikPen solution
for injection</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin lispro</span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=EN-GB>Subcutaneous
use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CONTENTS
BY WEIGHT, BY VOLUME OR BY UNIT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal>3 ml (3.5 mg/ml)</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=FR style='color:black'>OUTER CARTON &#8211; KwikPen. Pack of 5</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog Mix25 100&nbsp;units/ml KwikPen
suspension for injection in a pre-filled pen</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>25% insulin lispro and 75% insulin
lispro protamine suspension </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml suspension contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Contains
protamine sulphate, glycerol, zinc oxide, dibasic sodium phosphate 7 H<sub>2</sub>0
with m-cresol and phenol as preservatives in water for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Sodium
hydroxide and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Suspension for injection. </span></p>

<p class=MsoNormal><span lang=EN-GB>5 pens of 3ml.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTE OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use. </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b><b><span
lang=EN-GB style='color:black'>SIGHT AND REACH </span><span lang=EN-GB
style='color:black'>OF CHILDREN</span></b></p>

</div>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the </span><span lang=EN-GB>sight
and </span><span lang=EN-GB>reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Resuspend
carefully. See enclosed package leaflet.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not freeze.
Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Once in use
pens may be used for up to 28 days. Pens in use should be stored below 30</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C and should
not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER<span style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/018</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoNormal><span class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=Logo-Unit style='line-height:13.0pt'><span class=MsoCommentReference><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>If seal
is broken before first use, contact pharmacist.</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=DE style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=DE>&nbsp;</span></span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=DE>Liprolog Mix25
KwikPen</span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: </span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<b><u><span style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></u></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>INTERMEDIATE CARTON (without blue box) component
of a multipack - KwikPen</span></b></p>

</div>

<p class=MsoNormal><span lang=FR>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog Mix25 100&nbsp;units/ml KwikPen
suspension for injection in a pre-filled pen</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>25% insulin lispro and 75% insulin
lispro protamine suspension </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml suspension contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Contains
protamine sulphate, glycerol, zinc oxide, dibasic sodium phosphate 7 H<sub>2</sub>0
with m-cresol and phenol as preservatives in water for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Sodium
hydroxide and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Suspension for injection.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify;text-autospace:none'><span
lang=EN-GB style='color:black'>Multipack: 5 pens of 3&nbsp;ml. Component of a
multipack, can&#8217;t be sold separately.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTE OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use. </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b><b><span
lang=EN-GB style='color:black'>SIGHT AND REACH </span><span lang=EN-GB
style='color:black'>OF CHILDREN</span></b></p>

</div>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the </span><span lang=EN-GB>sight
and </span><span lang=EN-GB>reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Resuspend
carefully. See enclosed package leaflet.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not freeze.
Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Once in use
pens may be used for up to 28 days. Pens in use should be stored below 30</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C and should
not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER<span style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/019</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoNormal><span class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=Logo-Unit style='line-height:13.0pt'><span class=MsoCommentReference><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>If seal
is broken before first use, contact pharmacist.</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=DE style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=DE>&nbsp;</span></span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=DE>Liprolog Mix25
KwikPen</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='background:white'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>PARTICULARS
TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>OUTER
CARTON (with blue box) multipack &#8211; KwikPen</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='text-align:justify;text-autospace:none'><span
lang=EN-GB style='color:#7030A0'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog Mix25 100&nbsp;units/ml KwikPen
suspension for injection in a pre-filled pen</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>25% insulin lispro and 75% insulin
lispro protamine suspension</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml suspension contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Contains
protamine sulphate, glycerol, zinc oxide, dibasic sodium phosphate 7 H<sub>2</sub>0
with m-cresol and phenol as preservatives in water for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Sodium
hydroxide and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Suspension for injection. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='color:black'>Multipack: 10 (2 packs
of 5) pens of 3&nbsp;ml. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the sight and reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Resuspend
carefully. See enclosed package leaflet.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY DATE</span></b></p>

</div>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL STORAGE
CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>Store in a refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>Do not freeze. Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt;page-break-after:avoid'><span
lang=EN-GB>Once in use pens may be used for up to 28 days. Pens in use should
be stored below 30</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C and should not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER </span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/019</span><span lang=FR> </span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB
style='font-size:8.0pt'>&nbsp;</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN
BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span style='font-size:
8.0pt'>&nbsp;</span></span></p>

<p class=MsoEndnoteText>Liprolog Mix25 KwikPen </p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: </span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<b><span style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>MINIMUM
PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS</span></b></p>

</div>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>LABEL
TEXT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog Mix25 100&nbsp;units/ml KwikPen
suspension for injection</span></p>

<p class=MsoNormal><span lang=EN-GB>25% insulin lispro and 75% insulin lispro
protamine suspension</span></p>

<p class=MsoNormal><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CONTENTS
BY WEIGHT, BY VOLUME OR BY UNIT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal>3 ml (3.5 mg/ml)</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white;margin-left:-4.5pt;margin-right:0in'>

<p class=MsoNormal style='text-indent:4.5pt;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>PARTICULARS TO APPEAR ON
THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='text-indent:4.5pt;background:white;border:none;
padding:0in'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='text-indent:4.5pt;background:white;border:none;
padding:0in'><b><span lang=FR style='color:black'>OUTER CARTON &#8211; KwikPen.
Pack of 5</span></b></p>

<p class=MsoNormal style='text-indent:4.5pt;background:white;border:none;
padding:0in'><b><span lang=EN-GB>&nbsp;</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white;margin-left:-4.5pt;margin-right:0in'>

<p class=MsoNormal style='text-indent:4.5pt;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog Mix50 100&nbsp;units/ml KwikPen
suspension for injection in a pre-filled pen</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>50% insulin lispro and 50% insulin
lispro protamine suspension </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white;margin-left:-4.5pt;margin-right:0in'>

<p class=MsoNormal style='text-indent:4.5pt;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml suspension contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white;margin-left:-4.5pt;margin-right:0in'>

<p class=MsoNormal style='text-indent:4.5pt;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Contains
protamine sulphate, glycerol, zinc oxide, dibasic sodium phosphate 7 H<sub>2</sub>0
with m-cresol and phenol as preservatives in water for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Sodium
hydroxide and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white;margin-left:-4.5pt;margin-right:0in'>

<p class=MsoNormal style='text-indent:4.5pt;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Suspension for injection..</span></p>

<p class=MsoNormal><span lang=EN-GB>5 pens of 3ml.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white;margin-left:-4.5pt;margin-right:0in'>

<p class=MsoNormal style='text-indent:4.5pt;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTE OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use. </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b><b><span
lang=EN-GB style='color:black'>SIGHT AND REACH </span><span lang=EN-GB
style='color:black'>OF CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the </span><span lang=EN-GB>sight
and </span><span lang=EN-GB>reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Resuspend
carefully. See enclosed package leaflet.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not freeze.
Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Once in use
pens may be used for up to 28 days. Pens in use should be stored below 30</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C and should
not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoBodyTextIndent align=left style='text-align:left'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyTextIndent align=left style='text-align:left'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER<span style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/020</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoNormal><span class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=Logo-Unit style='line-height:13.0pt'><span class=MsoCommentReference><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>If seal
is broken before first use, contact pharmacist.</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=DE style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=DE>&nbsp;</span></span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=DE>Liprolog Mix50
KwikPen</span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: </span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<b><u><span style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></u></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white;margin-left:-4.5pt;margin-right:0in'>

<p class=MsoNormal style='text-indent:4.5pt;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>PARTICULARS TO APPEAR ON
THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='text-indent:4.5pt;background:white;border:none;
padding:0in'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='text-indent:4.5pt;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>INTERMEDIATE CARTON
(without blue box) component of a multipack - KwikPen</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white;margin-left:-4.5pt;margin-right:0in'>

<p class=MsoNormal style='text-indent:4.5pt;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog Mix50 100&nbsp;units/ml KwikPen
suspension for injection in a pre-filled pen</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>50% insulin lispro and 50% insulin
lispro protamine suspension </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white;margin-left:-4.5pt;margin-right:0in'>

<p class=MsoNormal style='text-indent:4.5pt;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml suspension contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white;margin-left:-4.5pt;margin-right:0in'>

<p class=MsoNormal style='text-indent:4.5pt;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Contains
protamine sulphate, glycerol, zinc oxide, dibasic sodium phosphate 7 H<sub>2</sub>0
with m-cresol and phenol as preservatives in water for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Sodium
hydroxide and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white;margin-left:-4.5pt;margin-right:0in'>

<p class=MsoNormal style='text-indent:4.5pt;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Suspension for injection.&nbsp; </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify;text-autospace:none'><span
lang=EN-GB style='color:black'>Multipack: 5 pens of 3&nbsp;ml. Component of a
multipack, can&#8217;t be sold separately.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white;margin-left:-4.5pt;margin-right:0in'>

<p class=MsoNormal style='text-indent:4.5pt;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTE OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use. </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b><b><span
lang=EN-GB style='color:black'>SIGHT AND REACH </span><span lang=EN-GB
style='color:black'>OF CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the </span><span lang=EN-GB>sight
and </span><span lang=EN-GB>reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Resuspend
carefully. See enclosed package leaflet.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Store in a
refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not freeze.
Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:13.0pt'><span
lang=EN-GB>Once in use pens may be used for up to 28 days. Pens in use should
be stored below 30</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C and should not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoBodyTextIndent align=left style='text-align:left'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyTextIndent align=left style='text-align:left'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=DA>Eli
Lilly Nederland B.V.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER<span style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/021</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoNormal><span class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=Logo-Unit style='line-height:13.0pt'><span class=MsoCommentReference><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>If seal
is broken before first use, contact pharmacist.</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=DE style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=DE>&nbsp;</span></span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span lang=DE>Liprolog Mix50
KwikPen</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='background:white'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>PARTICULARS
TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>OUTER
CARTON (with blue box) multipack &#8211; KwikPen</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='text-align:justify;text-autospace:none'><span
lang=EN-GB style='color:#7030A0'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog Mix50 100&nbsp;units/ml KwikPen
suspension for injection in a pre-filled pen</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>50% insulin lispro and 50% insulin
lispro protamine suspension</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml suspension contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Contains
protamine sulphate, glycerol, zinc oxide, dibasic sodium phosphate 7 H<sub>2</sub>0
with m-cresol and phenol as preservatives in water for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Sodium hydroxide
and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='background:yellow'>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Suspension for injection. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='color:black'>Multipack: 10 (2 packs
of 5) pens of 3&nbsp;ml. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='background:yellow'>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the sight and reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Resuspend
carefully. See enclosed package leaflet.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY DATE</span></b></p>

</div>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL STORAGE
CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>Store in a refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>Do not freeze. Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt;page-break-after:avoid'><span
lang=EN-GB>Once in use pens may be used for up to 28 days. Pens in use should
be stored below 30</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C and should not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER </span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/021</span><span lang=FR> </span></p>

<p class=MsoEndnoteText><span style='background:yellow'>&nbsp;</span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB
style='font-size:8.0pt'>&nbsp;</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN
BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span style='font-size:
8.0pt'>&nbsp;</span></span></p>

<p class=MsoEndnoteText>Liprolog Mix50 KwikPen </p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: </span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<p class=MsoEndnoteText style='line-height:13.0pt'><span
class=MsoCommentReference><span lang=DE>&nbsp;</span></span></p>

<b><span style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>MINIMUM
PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS</span></b></p>

</div>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>LABEL
TEXT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog Mix50 100&nbsp;units/ml KwikPen
suspension for injection</span></p>

<p class=MsoNormal><span lang=EN-GB>50% insulin lispro and 50% insulin lispro
protamine suspension</span></p>

<p class=MsoNormal><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CONTENTS
BY WEIGHT, BY VOLUME OR BY UNIT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal>3 ml (3.5 mg/ml)</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>PARTICULARS TO APPEAR ON
THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>OUTER CARTON &#8211;
KwikPen. Pack of 5</span></b></p>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB>&nbsp;</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DA>Liprolog Basal 100&nbsp;units/ml
KwikPen suspension for injection in a pre-filled pen</span></p>

<p class=MsoEndnoteText><span lang=DA>Insulin lispro protamine suspension </span></p>

<p class=MsoEndnoteText><span lang=DA>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=DA>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=DA style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=DA>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml suspension contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText><span lang=DA>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=DA>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Contains protamine sulphate, glycerol, zinc oxide, dibasic sodium
phosphate 7 H<sub>2</sub>0 with m-cresol and phenol as preservatives in water
for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Sodium hydroxide and/or hydrochloric acid may have been used to
adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Suspension for injection. </span></p>

<p class=MsoNormal><span lang=EN-GB>5 pens of 3ml.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTE OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use. </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL WARNING THAT
THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b><b><span lang=EN-GB
style='color:black'>SIGHT AND REACH </span><span lang=EN-GB style='color:black'>OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Keep out of the </span><span
lang=EN-GB>sight and </span><span lang=EN-GB>reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER SPECIAL WARNING,
IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Resuspend carefully. See enclosed package leaflet.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY DATE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>Store in a refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>Do not freeze. Do not expose to excessive heat or
direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>Once in use pens may be used for up to 21 days. Pens in
use should be stored below 30</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C and should not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL PRECAUTIONS FOR
DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH
MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white'><b><span lang=EN-GB style='background:silver'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white'><b><span lang=EN-GB style='background:silver'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME AND ADDRESS OF THE
MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span lang=DA>Eli
Lilly Nederland B.V.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING AUTHORISATION NUMBER<span
style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EU/1/01/195/026</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL CLASSIFICATION FOR
SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span class=MsoCommentReference><span
lang=EN-GB>&nbsp;</span></span></p>

<p class=Logo-Unit><span class=MsoCommentReference><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>If seal is broken
before first use, contact pharmacist.</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION
IN BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Liprolog Basal KwikPen</span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: {</span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<b><u><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></u></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>PARTICULARS TO APPEAR ON
THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>INTERMEDIATE CARTON
(without blue box) component of a multipack - KwikPen</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Basal
100&nbsp;units/ml KwikPen suspension for injection in a pre-filled pen</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Insulin lispro protamine suspension </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml suspension contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Contains protamine sulphate, glycerol, zinc oxide, dibasic sodium
phosphate 7 H<sub>2</sub>0 with m-cresol and phenol as preservatives in water
for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Sodium hydroxide and/or hydrochloric acid may have been used to
adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Suspension for injection.&nbsp; </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify;text-autospace:none'><span
lang=EN-GB style='color:black'>Multipack: 5 pens of 3&nbsp;ml. Component of a
multipack, can&#8217;t be sold separately.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTE OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use. </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL WARNING THAT
THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b><b><span lang=EN-GB
style='color:black'>SIGHT AND REACH </span><span lang=EN-GB style='color:black'>OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Keep out of the sight
and reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER SPECIAL
WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Resuspend carefully. See enclosed package leaflet.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY DATE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>Store in a refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>Do not freeze. Do not expose to excessive heat or
direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>Once in use pens may be used for up to 21 days. Pens in
use should be stored below 30</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C and should not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL PRECAUTIONS FOR
DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH
MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white'><b><span lang=EN-GB style='background:silver'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white'><b><span lang=EN-GB style='background:silver'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME AND ADDRESS OF THE
MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span lang=DA>Eli
Lilly Nederland B.V.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING AUTHORISATION NUMBER<span
style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EU/1/01/195/027</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL CLASSIFICATION FOR
SUPPLY</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span class=MsoCommentReference><span
lang=EN-GB>&nbsp;</span></span></p>

<p class=Logo-Unit><span class=MsoCommentReference><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>If seal is broken
before first use, contact pharmacist.</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION
IN BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Liprolog Basal KwikPen</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='background:white'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>PARTICULARS
TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>OUTER
CARTON (with blue box) multipack &#8211; KwikPen</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='text-align:justify;text-autospace:none'><span
lang=EN-GB style='color:#7030A0'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Basal
100&nbsp;units/ml KwikPen suspension for injection in a pre-filled pen</span></p>

<p class=MsoEndnoteText><span lang=DA>Insulin lispro protamine suspension</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>One ml suspension contains 100 units of
insulin lispro (equivalent to 3.5mg).</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Contains
protamine sulphate, glycerol, zinc oxide, dibasic sodium phosphate 7 H<sub>2</sub>0
with m-cresol and phenol as preservatives in water for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Sodium
hydroxide and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Suspension for injection.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='color:black'>Multipack: 10 (2 packs
of 5) pens of 3&nbsp;ml. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the sight and reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Resuspend
carefully. See enclosed package leaflet.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY DATE</span></b></p>

</div>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL STORAGE
CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>Store in a refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>Do not freeze. Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt;page-break-after:avoid'><span
lang=EN-GB>Once in use pens may be used for up to 21 days. Pens in use should
be stored below 30</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C and should not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER </span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/027</span><span lang=FR> </span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS ON
USE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB
style='font-size:8.0pt'>&nbsp;</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION
IN BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span style='font-size:
8.0pt'>&nbsp;</span></span></p>

<p class=MsoEndnoteText>Liprolog Basal KwikPen </p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: </span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<b><u><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></u></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING
UNITS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>LABEL TEXT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF THE
MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DA>Liprolog Basal 100&nbsp;units/ml
KwikPen suspension for injection</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Insulin lispro
protamine suspension</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD OF
ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY DATE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BATCH NUMBER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CONTENTS BY WEIGHT,
BY VOLUME OR BY UNIT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'>3 ml (3.5 mg/ml)</p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='line-height:normal;background:white;border:none;
padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='background:white'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>PARTICULARS
TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>OUTER
CARTON &#8211; KwikPen. Pack of 5</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog 200&nbsp;units/ml KwikPen solution
for injection in a pre&#8209;filled pen</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Insulin lispro </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>One ml solution
contains 200 units of insulin lispro (equivalent to 6.9 mg)</span><span
lang=IT> </span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Contains
glycerol, zinc oxide, trometamol, metacresol and water for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Sodium
hydroxide and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Solution for injection. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>5 pens of 3&nbsp;mL.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the sight and reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB>Use only in
this pen, or severe overdose can result.</span></b></p>

<p class=Logo-Unit><span class=MsoCommentReference><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>If seal is broken
before first use, contact pharmacist.</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL STORAGE
CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>Store in a refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>Do not freeze. Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt;page-break-after:avoid'><span
lang=EN-GB>Once in use pens may be used for up to 28 days. Pens in use should
be stored below 30</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C and should not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER<span style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=FR>EU/1/01/195/028</span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB
style='font-size:8.0pt'>&nbsp;</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN
BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span style='font-size:
8.0pt'>&nbsp;</span></span></p>

<p class=MsoEndnoteText>Liprolog 200&nbsp;units/ml </p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: </span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='background:white'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>PARTICULARS
TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>INTERMEDIATE
CARTON (without blue box) component of a multipack &#8211; KwikPen</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='text-align:justify;text-autospace:none'><b><span
lang=EN-GB style='color:#7030A0'>&nbsp;</span></b></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog 200&nbsp;units/ml KwikPen solution
for injection in a pre&#8209;filled pen</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Insulin lispro </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>One ml solution
contains 200 units of insulin lispro (equivalent to 6.9 mg)</span><span
lang=IT> </span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Contains
glycerol, zinc oxide, trometamol, metacresol and water for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Sodium
hydroxide and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Solution for injection.&nbsp; </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify;text-autospace:none'><span
lang=EN-GB style='color:black'>Multipack: 5 pens of 3&nbsp;ml. Component of a
multipack, can&#8217;t be sold separately.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the sight and reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB>Use only in
this pen, or severe overdose can result.</span></b></p>

<p class=Logo-Unit><span class=MsoCommentReference><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>If seal is broken
before first use, contact pharmacist.</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY DATE</span></b></p>

</div>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL STORAGE
CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>Store in a refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>Do not freeze. Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt;page-break-after:avoid'><span
lang=EN-GB>Once in use pens may be used for up to 28 days. Pens in use should
be stored below 30</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C and should not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER<span style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/029</span><span lang=EN-GB> </span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB
style='font-size:8.0pt'>&nbsp;</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN
BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span style='font-size:
8.0pt'>&nbsp;</span></span></p>

<p class=MsoEndnoteText>Liprolog 200&nbsp;units/ml </p>

<p class=MsoEndnoteText><span class=MsoCommentReference><span style='font-size:
8.0pt'>&nbsp;</span></span></p>

<span class=MsoCommentReference><span lang=EN-GB style='font-size:8.0pt;
font-family:"Times New Roman",serif;color:black'><br clear=all
style='page-break-before:always'>
</span></span>

<p class=MsoNormal style='background:white'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>PARTICULARS
TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>OUTER
CARTON (with blue box) multipack &#8211; KwikPen</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='text-align:justify;text-autospace:none'><span
lang=EN-GB style='color:#7030A0'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog 200&nbsp;units/ml KwikPen solution
for injection in a pre&#8209;filled pen</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Insulin lispro </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>One ml solution contains 200 units of
insulin lispro (equivalent to 6.9 mg)</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Contains glycerol,
zinc oxide, trometamol, metacresol and water for injections.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Sodium
hydroxide and/or hydrochloric acid may have been used to adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Solution for injection. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='color:black'>Multipack: 10 (2 packs
of 5) pens of 3&nbsp;ml. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the sight and reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB>Use only in
this pen, or severe overdose can result.</span></b></p>

<p class=Logo-Unit><span class=MsoCommentReference><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>If seal is broken
before first use, contact pharmacist.</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY DATE</span></b></p>

</div>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL STORAGE
CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>Store in a refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>Do not freeze. Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt;page-break-after:avoid'><span
lang=EN-GB>Once in use pens may be used for up to 28 days. Pens in use should
be stored below 30</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C and should not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER<span style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/029</span><span lang=EN-GB> </span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB
style='font-size:8.0pt'>&nbsp;</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN
BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span style='font-size:
8.0pt'>&nbsp;</span></span></p>

<p class=MsoEndnoteText>Liprolog 200&nbsp;units/ml </p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: </span></p>

<p class=MsoNormal><span lang=EN-GB>SN:</span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText><span class=MsoCommentReference><span style='font-size:
8.0pt'>&nbsp;</span></span></p>

<b><u><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></u></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE
PACKAGING UNITS</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>LABEL TEXT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=DA>Liprolog 200&nbsp;units/ml KwikPen, solution
for injection</span></p>

<p class=MsoNormal><span lang=EN-GB>Insulin lispro</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Subcutaneous use</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CONTENTS
BY WEIGHT, BY VOLUME OR BY UNIT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>3 ml</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB>USE ONLY IN
THIS PEN, OR</span></b><b><span lang=EN-GB> SEVERE OVERDOSE CAN RESULT.</span></b></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='background:white'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>PARTICULARS
TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>OUTER
CARTON &#8211; Junior KwikPen. Pack of 5</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog 100&nbsp;units/ml Junior KwikPen solution
for injection in a pre&#8209;filled pen.</span></p>

<p class=MsoEndnoteText><b><span lang=EN-GB>Insulin lispro </span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>One ml solution
contains 100&nbsp;units of insulin lispro (equivalent to 3.5 mg)</span><span
lang=IT>.</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Contains glycerol, zinc oxide, dibasic sodium phosphate7H</span><sub><span
lang=EN-GB style='font-family:Symbol'>2</span></sub><span lang=EN-GB>0,
metacresol and water for injections.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Sodium hydroxide and/or hydrochloric acid may have been used to
adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Solution for injection. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>5 pens of 3&nbsp;mL.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use.</span></p>

<p class=MsoEndnoteText><b><span lang=EN-GB>Subcutaneous use.</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the sight and reach of children.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>The pen delivers 0.5 &#8211; 30 units in
steps of 0.5 units</span></b><b><span lang=EN-GB>.</span></b></p>

<p class=MsoNormal><span class=MsoCommentReference><span lang=EN-GB>&nbsp;</span></span></p>

<p class=MsoNormal><span class=MsoCommentReference><span lang=EN-GB>If seal is
broken before first use, contact pharmacist.</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Store in a refrigerator
(2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not freeze.
Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Once in use
pens may be used for up to 28 days. Discard after 28 days even if some of the
solution remains. Pens in use should be stored below 30</span><span lang=EN-GB
style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C and should not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER<span style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/030</span><span lang=EN-GB> </span></p>

<p class=MsoEndnoteText><span lang=PT>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=PT>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB
style='font-size:8.0pt'>&nbsp;</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN
BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span style='font-size:
8.0pt'>&nbsp;</span></span></p>

<p class=MsoEndnoteText>Liprolog <span lang=EN-GB>100&nbsp;units</span>/ml
Junior KwikPen</p>

<p class=MsoNormal style='background:white'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: </span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=X-NONE>NN: </span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='background:white'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>PARTICULARS
TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>INTERMEDIATE
CARTON (without blue box) component of a multipack &#8211; Junior KwikPen</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog 100&nbsp;units/ml Junior KwikPen
solution for injection in a pre&#8209;filled pen.</span></p>

<p class=MsoEndnoteText><b><span lang=EN-GB>Insulin lispro </span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>One ml solution
contains 100 units of insulin lispro (equivalent to 3.5 mg).</span><span
lang=IT> </span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Contains glycerol, zinc oxide, dibasic sodium phosphate7H</span><sub><span
lang=EN-GB style='font-family:Symbol'>2</span></sub><span lang=EN-GB>0,
metacresol and water for injections.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Sodium hydroxide and/or hydrochloric acid may have been used to
adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Solution for injection.&nbsp; </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify;text-autospace:none'><span
lang=EN-GB style='color:black'>Multipack: 5 pens of 3&nbsp;ml. Component of a
multipack, can&#8217;t be sold separately.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use.</span></p>

<p class=MsoEndnoteText><b><span lang=EN-GB>Subcutaneous use.</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the sight and reach of children.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>The pen delivers 0.5 &#8211; 30 units in
steps of 0.5 units</span></b><b><span lang=EN-GB>.</span></b></p>

<p class=Logo-Unit><span class=MsoCommentReference><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>&nbsp;</span></span></p>

<p class=Logo-Unit><span class=MsoCommentReference><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>If seal is broken
before first use, contact pharmacist.</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY DATE</span></b></p>

</div>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white;margin-left:0in;margin-right:.55pt'>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>Store in a refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not freeze.
Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Once in use
pens may be used for up to 28 days. Discard after 28 days even if some of the
solution remains. Pens in use should be stored below 30</span><span lang=EN-GB
style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C and should not be
refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER<span style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/31</span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB
style='font-size:8.0pt'>&nbsp;</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN
BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span style='font-size:
8.0pt'>&nbsp;</span></span></p>

<p class=MsoEndnoteText>Liprolog <span lang=EN-GB>100&nbsp;units</span>/ml
Junior KwikPen</p>

<p class=MsoEndnoteText><span class=MsoCommentReference><span style='font-size:
8.0pt'>&nbsp;</span></span></p>

<span class=MsoCommentReference><span lang=EN-GB style='font-size:8.0pt;
font-family:"Times New Roman",serif;color:black'><br clear=all
style='page-break-before:always'>
</span></span>

<p class=MsoNormal style='background:white'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>PARTICULARS
TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB>OUTER
CARTON (with blue box) multipack &#8211; Junior KwikPen</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF
THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='text-align:justify;text-autospace:none'><span
lang=EN-GB style='color:#7030A0'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog 100&nbsp;units/ml Junior KwikPen solution
for injection in a pre&#8209;filled pen.</span></p>

<p class=MsoEndnoteText><b><span lang=EN-GB>Insulin lispro </span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>One ml solution
contains 100 units of insulin lispro (equivalent to 3.5 mg).</span><span
lang=IT> </span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=IT>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Contains glycerol, zinc oxide, dibasic sodium phosphate7H</span><sub><span
lang=EN-GB style='font-family:Symbol'>2</span></sub><span lang=EN-GB>0,
metacresol and water for injections.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Sodium hydroxide and/or hydrochloric acid may have been used to
adjust acidity.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Solution for injection. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='color:black'>Multipack: 10 (2 packs
of 5) pens of 3&nbsp;ml. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Read the package leaflet before use.</span></p>

<p class=MsoEndnoteText><b><span lang=EN-GB>Subcutaneous use.</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Keep out of the sight and reach of children</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING, IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>The pen delivers 0.5 &#8211; 30 units in
steps of 0.5 units</span></b><b><span lang=EN-GB>.</span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;background:white;border:none;padding:0in'><b><span lang=EN-GB
style='color:black'>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY DATE</span></b></p>

</div>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white;margin-left:0in;margin-right:.55pt'>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>Store in a refrigerator (2&deg;C - 8&deg;C).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Do not freeze.
Do not expose to excessive heat or direct sunlight. </span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Once in use
pens may be used for up to 28 days. Discard after 28 days even if some of the
solution remains. &nbsp;Pens in use should be stored below 30</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C and should
not be refrigerated.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white'><span lang=EN-GB style='background:silver'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=DA>Eli Lilly Nederland
B.V.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>Papendorpseweg 83, 3528 BJ Utrecht </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>The Netherlands</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER<span style='background:silver'> </span></span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>EU/1/01/195/031</span></p>

<p class=MsoEndnoteText>&nbsp;</p>

<p class=MsoEndnoteText>&nbsp;</p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span lang=EN-GB
style='font-size:8.0pt'>&nbsp;</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION IN
BRAILLE</span></b></p>

</div>

<p class=MsoEndnoteText><span class=MsoCommentReference><span style='font-size:
8.0pt'>&nbsp;</span></span></p>

<p class=MsoEndnoteText>Liprolog <span lang=EN-GB>100&nbsp;units</span>/ml
Junior KwikPen</p>

<p class=MsoEndnoteText><span class=MsoCommentReference><span style='font-size:
8.0pt'>&nbsp;</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:silver'>2D barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC: </span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=X-NONE>NN: </span></p>

<b><u><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></u></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE
PACKAGING UNITS</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>LABEL TEXT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT AND ROUTES OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=DA>Liprolog 100&nbsp;units/ml Junior KwikPen
solution for injection</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Insulin lispro</span></b></p>

<p class=MsoEndnoteText><b><span lang=EN-GB>Subcutaneous use</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>EXP </span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;
background:white'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;background:
white;border:none;padding:0in'><b><span lang=EN-GB style='color:black'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CONTENTS
BY WEIGHT, BY VOLUME OR BY UNIT</span></b></p>

</div>

<p class=MsoEndnoteText><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>3 ml</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=MsoNormal style='background:white;border:none;padding:0in'><b><span
lang=EN-GB style='color:black'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='background:white'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=TitleA>B. PACKAGE LEAFLET</p>

<span style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>PACKAGE LEAFLET: INFORMATION FOR THE USER</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>Liprolog 100&nbsp;units/ml solution for injection in vial</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>insulin lispro</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Read all of
this leaflet carefully before you start using this medicine because it contains
important information for you.</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>Keep this leaflet. You may need to read it again.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of illness
are the same as yours.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you get any side effects, talk to your doctor
or pharmacist.</span><span lang=EN-GB> This includes any possible side effects
not listed in this leaflet. See section 4.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What is in this leaflet</span></b><span lang=EN-GB>: </span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Liprolog is and what it
is used for</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you use Liprolog</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to use Liprolog</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible side effects</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>How to store Liprolog</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:normal'><b><span
lang=EN-GB>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB>What Liprolog is and what it is used for</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Liprolog is used to treat diabetes. Liprolog works more quickly than
normal human insulin because the insulin molecule has been changed slightly.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>You get diabetes if your pancreas does not make enough insulin to
control the level of glucose in your blood. Liprolog is a substitute for your
own insulin and is used to control glucose in the long term. It works very
quickly and lasts a shorter time than soluble insulin (2 to 5 hours). You should
normally use Liprolog within 15 minutes of a meal.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Your doctor may tell you to use Liprolog as well as a longer-acting
insulin. Each kind of insulin comes with another patient information leaflet to
tell you about it. Do not change your insulin unless your doctor tells you to.
Be very careful if you do change insulin.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog is
suitable for use in adults and children. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:normal'><b><span
lang=EN-GB>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB>What you need to know before you use
Liprolog</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Do NOT use
Liprolog</span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you think <b>hypoglycaemia</b> (low blood
sugar) is starting. Further in this leaflet it tells you how to deal with mild
hypoglycaemia (see Section 3: If you take more Liprolog than you </span><span
lang=EN-GB>need</span><span lang=EN-GB>).</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you are <b>allergic</b> (hypersensitive) to
insulin lispro or any of the other ingredients of this medicine (listed in
section 6).</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoHeader><b><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>Warnings and precautions </span></b></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>If your blood sugar levels are well controlled by your current
insulin therapy, you may not feel the warning symptoms when your blood sugar is
falling too low. Warning signs are listed later in this leaflet. You must think
carefully about when to have your meals, how often to exercise and how much to
do. You must also keep a close watch on your blood sugar levels by testing your
blood glucose often.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>A few people who have had hypoglycaemia after switching from animal
insulin to human insulin have reported that the early warning symptoms were
less obvious or different. If you often have hypoglycaemia or have difficulty
recognising it, please discuss this with your doctor.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>If you answer YES to any of the following questions, tell your doctor,
pharmacist or diabetes nurse</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have
you recently become ill?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do
you have trouble with your kidneys or liver?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are you exercising more than usual?</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>The amount of insulin you need may also change if you drink alcohol.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>You should also tell your doctor, pharmacist or diabetes nurse if
you are planning to go abroad. The time difference between countries may mean
that you have to have your injections and meals at different times from when
you are at home.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>Some patients with long-standing type 2 diabetes mellitus and heart
disease or previous stroke who were treated with pioglitazone and insulin
experienced the development of heart failure. Inform your doctor as soon as
possible if you experience signs of heart failure such as unusual shortness of
breath or rapid increase in weight or localised swelling (oedema).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Other medicines and Liprolog</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Your insulin needs may change if you are taking </span></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>the contraceptive pill, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>steroids, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>thyroid hormone replacement therapy, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>oral hypoglycaemics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>acetyl salicylic acid, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>sulpha antibiotics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>octreotide, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>&#8220;beta<sub>2</sub> stimulants&#8221; (for example
     ritodrine, salbutamol or terbutaline), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>beta-blockers, or </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some antidepressants (monoamine oxidase inhibitors or selective
     serotonin reuptake inhibitors), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>danazol, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some angiotensin converting enzyme (ACE) inhibitors (for
     example captopril, enalapril), and </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>angiotensin II receptor blockers.</span></li>
</ul>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Please tell your doctor, if you are taking or have recently taken
any other medicines, including medicines obtained without a prescription </span>(see
section &#8220;<span lang=EN-GB>Warnings and precautions</span>&#8221;)<span
lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Pregnancy and breast-feeding</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Are you pregnant or thinking about becoming pregnant, or are you
breast-feeding? The amount of insulin you need usually falls during the first
three months of pregnancy and increases for the remaining six months. If you
are breast-feeding, you may need to alter your insulin intake or diet.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Ask your doctor
for advice.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Driving and using machines</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Your ability to concentrate and react may be reduced if you have
hypoglycaemia. Please keep this possible problem in mind in all situations
where you might put yourself and others at risk (e.g. driving a car or
operating machinery). You should contact your doctor about the advisability of
driving if you have:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>frequent episodes of hypoglycaemia</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>reduced or absent warning signs of hypoglycaemia</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:normal'><b><span
lang=EN-GB>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB>How to use Liprolog</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Always check the pack and the vial label for the name and type of
the insulin when you get it from your pharmacy. Make sure you get the Liprolog
that your doctor has told you to use.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Always use Liprolog exactly as your doctor has told you. You should
check with your doctor if you are not sure.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Dosage</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You should normally inject Liprolog within 15
minutes of a meal. If you need to, you can inject soon after a meal. But your
doctor will have told you exactly how much to use, when to use it, and how
often. These instructions are only for you. Follow them exactly and visit your
diabetes clinic regularly.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you change the type of insulin you use (for
example from a human or animal insulin to a Liprolog product), you may have to
take more or less than before. This might just be for the first injection or it
may be a gradual change over several weeks or months. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Inject Liprolog under the skin. You should only
inject it into a muscle if your doctor has told you to.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Preparing Liprolog</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Liprolog is already dissolved in water, so you
do not need to mix it. But you must use it <b>only </b>if it looks like water.
It must be clear, have no colour and no solid pieces in it. Check each time you
inject yourself.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Injecting Liprolog</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>First wash your hands.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Before you make an injection, clean your skin as
you have been instructed. Clean the rubber stopper on the vial, but do not
remove the stopper.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Use a clean, sterile syringe and needle to
pierce the rubber stopper and draw in the amount of Liprolog you want. Your
doctor or clinic will tell you how to do this. <b>Do not share your needles and
syringes.</b></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Inject under the skin, as you were taught. Do
not inject directly into a vein. After your injection, leave the needle in the
skin for five seconds to make sure you have taken the whole dose. Do not rub
the area you have just injected. Make sure you inject at least half an inch
(1&nbsp;cm) from the last injection and that you &#8216;rotate&#8217; the
places you inject, as you have been taught. It doesn&#8217;t matter which
injection site you use, either upper arm, thigh, buttock or abdomen, your
Liprolog injection will still work quicker than soluble human insulin.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Your doctor will tell you if you have to mix
Liprolog with one of the human insulins. For example if you do need to inject a
mixture, draw the Liprolog into the syringe before the long acting insulin.
Inject the liquid as soon as you have mixed it. Do the same thing every time.
You should not normally mix Liprolog with one of the mixtures of human insulins.
You should never mix Liprolog with insulins produced by other manufacturers or
animal insulins.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You must not administer Liprolog by the
intravenous route. Inject Liprolog as your physician or nurse has taught you.
Only your physician can administer Liprolog by the intravenous route. He will
only do this under special circumstances such as surgery or if you are ill and
your glucose levels are too high.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Using Liprolog in an infusion pump</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Only certain CE-marked insulin infusion pumps
may be used to infuse insulin lispro. Before infusing insulin lispro, the
manufacturers instructions should be studied to ascertain the suitability or
otherwise for the particular pump. Read and follow the instructions in the
product literature supplied with the infusion pump.</span></p>

<p class=MsoBlockText align=left style='text-align:left'><span lang=EN-GB
style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Be sure to use the correct reservoir and
catheter for your pump.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><u>Changing of the infusion set (tubing and needle) must be done
according to the instructions in the product information supplied with the
infusion set.</u></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>In the event of a hypoglycaemic episode, the
infusion should be stopped until the episode is resolved. If repeated or severe
low blood glucose levels occur, notify your doctor or clinic and consider the
need to reduce or stop your insulin infusion.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>A pump malfunction or obstruction of the infusion
set can result in a rapid rise in glucose levels. If an interruption to insulin
flow is suspected, follow the instructions in the product literature and if
appropriate, notify your doctor or clinic.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>When used with an insulin infusion pump,
Liprolog should not be mixed with any other insulin.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you take more Liprolog than you need</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>If
you take more Liprolog than you need, a low blood sugar may occur.&nbsp; </span>Check
your blood sugar. </p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>If
your blood sugar is low <b>(mild hypoglycaemia)</b>, eat glucose tablets, sugar
or drink a sugary drink. Then eat fruit, biscuits, or a sandwich, as your
doctor has advised you and have some rest. This will often get you over mild
hypoglycaemia or a minor insulin overdose. If you get worse and your breathing
is shallow and your skin gets pale, tell your doctor at once. A glucagon
injection can treat quite severe hypoglycaemia. Eat glucose or sugar after the
glucagon injection. If you do not respond to glucagon, you will have to go to
hospital. Ask your doctor to tell you about glucagon.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you forget to use Liprolog</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog than you need, a high blood sugar may
occur.&nbsp; </span>Check your blood sugar<span class=MsoCommentReference><span
lang=EN-GB style='display:none'>..</span></span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If hypoglycaemia (low blood sugar) or hyperglycaemia (high blood
sugar) is not treated they can be very serious and cause headaches, nausea,
vomiting, dehydration, unconsciousness, coma or even death (see A and B in
section 4 &#8220;Possible Side Effects&#8221;).</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><b><span
lang=EN-GB>Three simple steps </span></b><span lang=EN-GB>to avoid
hypoglycaemia or hyperglycaemia are:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always keep spare
syringes and a spare vial of Liprolog.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always carry
something to show you are diabetic.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always carry sugar
with you.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you stop using Liprolog.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog than you need, a high blood sugar may
occur. Do not change your insulin unless your doctor tells you to.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you have any further questions on the use of this product, ask
your doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible side effects </span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-1.45pt'><span lang=EN-GB>Like all
medicines, Liprolog can cause side effects, although not everybody gets them.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Local allergy</span><span
lang=EN-GB style='layout-grid-mode:line'> is common (</span><span lang=EN-GB
style='font-family:Symbol;layout-grid-mode:line'>&sup3;</span><span lang=EN-GB
style='layout-grid-mode:line'> 1/100 to &lt;1/10).</span><span lang=EN-GB>&nbsp;
Some people get redness, swelling or itching around the area of the insulin
injection. This usually clears up in anything from a few days to a few weeks.
If this happens to you, tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Systemic allergy
</span><span lang=EN-GB style='layout-grid-mode:line'>is rare (</span><span
lang=EN-GB style='font-family:Symbol;layout-grid-mode:line'>&sup3;</span><span
lang=EN-GB style='layout-grid-mode:line'> 1/10,000 to &lt;1/1,000)</span><span
lang=EN-GB>.</span><span lang=EN-GB> The symptoms are as follows:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash over the
whole body &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood pressure
dropping</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty in
breathing&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart
beating fast</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; wheezing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sweating.</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>If you think
you are having this sort of insulin allergy with Liprolog, tell your doctor at
once.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Lipodystrophy
(thickening or pitting of the skin)<span style='layout-grid-mode:line'> is
uncommon (</span></span><span lang=EN-GB style='font-family:Symbol;layout-grid-mode:
line'>&sup3;</span><span lang=EN-GB style='layout-grid-mode:line'> 1/1,000 to
&lt;1/100)</span><span lang=EN-GB>. If you notice your skin thickening or
pitting at the injection site, tell your doctor.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Oedema (e.g. swelling in arms,
ankles; fluid retention) has been reported, particularly at the start of insulin
therapy or during a change in therapy to improve control of your blood glucose.</p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><b><span lang=EN-GB>Reporting
of side effects</span></b></p>

<p class=BodytextAgency style='margin-bottom:0in;page-break-after:avoid'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>If you
get any side effects, talk to your doctor or pharmacist.</span><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'> This
includes any possible side effects not listed in this leaflet.</span><span
lang=EN-GB style='font-family:"Times New Roman",serif'> </span><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>You can
also report side effects directly via <span style='background:silver'>the
national reporting system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>.
By reporting side effects you can help provide more information on the safety
of this medicine.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Common problems of diabetes</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>A. &nbsp;&nbsp;&nbsp;&nbsp; Hypoglycaemia</span></b><span
lang=EN-GB> </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hypoglycaemia (low blood sugar) means there is not enough sugar in
the blood. This can be caused if:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you take too much
Liprolog or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you miss or delay
meals or change your diet;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you exercise or
work too hard just before or after a meal;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have an
infection or illness (especially diarrhoea or vomiting);</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; there is a change
in your need for insulin; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have trouble
with your kidneys or liver which gets worse.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Alcohol and some medicines can affect your blood sugar levels.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>The first symptoms of low blood sugar usually come on quickly and
include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tiredness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rapid
heartbeat</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nervousness or
shakiness &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sick</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cold
sweat.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>While you are not confident about recognising your warning symptoms,
avoid situations, e.g. driving a car, in which you or others would be put at
risk by hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>B. &nbsp;&nbsp;&nbsp;&nbsp; Hyperglycaemia and diabetic ketoacidosis</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia (too much sugar in the blood) means that your body
does not have enough insulin. Hyperglycaemia can be brought about by:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not taking your
Liprolog or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; taking less
insulin than your doctor tells you to;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eating a lot more
than your diet allows; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever, infection
or emotional stress.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia can lead to diabetic ketoacidosis. The first symptoms
come on slowly over many hours or days. The symptoms include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sleepy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; no
appetite</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flushed face&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fruity
smell on the breath</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thirst&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
or being sick.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Severe symptoms are heavy breathing and a rapid pulse.&nbsp; <b>Get
medical help immediately.</b></span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>C. &nbsp;&nbsp;&nbsp;&nbsp; Illness</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If you are ill, especially if you feel sick or are sick, the amount
of insulin you need may change. <b>Even when you are not eating normally, you
still need insulin.</b> Test your urine or blood, follow your &#8216;sick
rules&#8217;, and tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store
Liprolog</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Before the first use store your Liprolog in a refrigerator (2</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C &#8211; 8</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C). Do not
freeze. Keep your vial in use in a refrigerator (2&deg;C &#8211; 8&deg;C) or at
room temperature up to 30&deg;C and discard after 28 days. Do not put it near
heat or in the sun. </span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep out of the reach and sight of children.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog after the expiry date which is stated on the
label and the carton. The expiry date refers to the last day of that month. </span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog, if it is coloured or it has solid pieces in it.
</span><span lang=EN-GB>You must use it <b>only</b> if it looks like water. Check
this each time you inject yourself.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Medicines should not be disposed of via wastewater or household
waste. Ask your pharmacist how to dispose of medicines no longer required.
These measures will help to protect the environment.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What </span></b><b><span lang=EN-GB>Liprolog 100&nbsp;units/ml
solution for injection in vial contains</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The active substance is insulin lispro. </span><span
lang=EN-GB>Insulin lispro is made in the laboratory by a &#8216;recombinant DNA
technology&#8217; process. It is a changed form of human insulin and so is
different from other human and animal insulins. Insulin lispro is closely
related to human insulin which is a natural hormone made by the pancreas.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The other ingredients are</span><span
lang=EN-GB> m-cresol, glycerol, dibasic sodium phosphate 7 H<sub>2</sub>O, zinc
oxide and water for injection. Sodium hydroxide or hydrochloric acid may have
been used to adjust the acidity.<i> </i></span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What Liprolog looks like and contents of the pack</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Liprolog 100&nbsp;units/ml, solution for injection is a sterile,
clear, colourless, aqueous solution and contains 100 units of insulin lispro in
each millilitre (100&nbsp;units/ml) solution for injection. Each vial contains
1000&nbsp;units (10&nbsp;millilitres). Liprolog 100&nbsp;units/ml, solution for
injection in vial comes in a pack of 1 vial, 2 vials or a multipack of 5 x 1
vial. </span>Not all pack sizes may be marketed.</p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Marketing Authorisation Holder and Manufacturer</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Liprolog 100&nbsp;units/ml, solution for injection in vial</span><span
lang=EN-GB> is made by:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=ES-TRAD>Lilly S.A., Avda. de la Industria 30, 28108
Alcobendas, Madrid, Spain.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=ES>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The product
licence is held by: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ
Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>For any information about this medicinal product, please contact the
local representative of the Marketing Authorisation Holder:</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=624
 style='margin-left:-1.7pt;border-collapse:collapse'>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>Belgique/Belgi&euml;/Belgien</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Lietuva</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited atstovyb&#279;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel. +370 (5) 2649600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=BG>&#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1058;&#1055;
  &quot;&#1045;&#1083;&#1080; &#1051;&#1080;&#1083;&#1080;
  &#1053;&#1077;&#1076;&#1077;&#1088;&#1083;&#1072;&#1085;&#1076;&quot;
  &#1041;.&#1042;. - &#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1090;&#1077;&#1083;.
  + 359 2 491 41 40</span></p>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>&nbsp;</span></b></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Luxembourg/Luxemburg</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#268;esk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>ELI
  LILLY &#268;R, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 420 234 664 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Magyarorsz&aacute;g</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Lilly
  Hung&aacute;ria Kft.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 36 1 328 5100</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Danmark</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Danmark A/S </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  +45 45 26 6000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Malta</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Charles de Giorgio Ltd.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 356 25600 500</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Deutschland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Berlin-Chemie AG</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Postfach
  1108,&nbsp; 12474 Berlin</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=DE>Tel.: 030/6707-0</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DA
  style='color:black'>Nederland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DA
  style='color:black'>Eli Lilly Nederland B.V. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 31-(0) 30 60 25 800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  style='color:black'>Eesti</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Eli Lilly Holdings Limited Eesti filiaal </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>372 6817 280</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=NO-BOK
  style='color:black'>Norge</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=NO-BOK
  style='color:black'>Eli Lilly Norge A.S. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  + 47 22 88 18 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#917;&#955;&#955;&#940;&#948;&#945;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#934;&#913;&#929;&#924;&#913;&#931;&#917;&#929;&#914;-&#923;&#921;&#923;&#923;&#933;
  &#913;.&#917;.&#914;.&#917;. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +30 210 629 4600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>&Ouml;sterreich</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Ges. m.b.H. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 43-(0) 1 711 780</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Espa&ntilde;a</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Lilly S.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Tel: + 34-91 663 50 00</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=SV style='color:black'>Polska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Eli Lilly Polska Sp. z o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  +48 22 440 33 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=FR style='color:black'>France</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=FR style='color:black'>Lilly France S.A.S.</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=FR style='color:black'>T&eacute;l: +33-(0) 1 55 49 34 34</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=PT-BR style='color:black'>Portugal</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=PT-BR style='color:black'>Lilly Portugal - Produtos Farmac&ecirc;uticos,
  Lda</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Tel: + 351-21-4126600</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=ES>Hrvatska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Eli Lilly
  Hrvatska d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Tel: +385 1
  2350 999</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=IT>Rom&acirc;nia</span></b></p>
  <p class=MsoNormal><span lang=RO>Eli Lilly Rom&acirc;nia S.R.L.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=RO>Tel: + 40 21
  4023000</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b>Ireland</b></p>
  <p class=MsoNormal style='text-autospace:none'>Eli Lilly and Company (Ireland) Limited</p>
  <p class=MsoNormal style='text-autospace:none'>Tel: + 353-(0) 1 661 4377</p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR>Slovenija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR>Eli Lilly
  farmacevtska dru&#382;ba, d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Tel: +386 (0) 1
  580 00 10</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&Iacute;sland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Icepharma
  hf. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>S&iacute;mi
  + 354 540 8000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Slovensk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Slovakia, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 421 220 663 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=IT
  style='color:black'>Italia</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=IT
  style='color:black'>Eli Lilly Italia S.p.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 39- 055 42571</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=SV
  style='color:black'>Suomi/Finland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Oy Eli Lilly Finland Ab </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Puh/Tel:
  + 358-(0) 9 85 45 250</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#922;&#973;&#960;&#961;&#959;&#962;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Phadisco
  Ltd </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +357 22 715000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Sverige</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Sweden AB</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Tel: + 46-(0) 8 7378800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Latvija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited p&#257;rst&#257;vniec&#299;ba Latvij&#257;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>371 67364000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>United
    Kingdom</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly and Company Limited</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 44-(0) 1256 315000</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>This leaflet was last revised in </span></b><span lang=EN-GB>{MM/YYYY}.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Detailed information on this medicine is available on the European
Medicines Agency web site: http://www.ema.europa.eu/</span><span lang=EN-GB>.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>PACKAGE LEAFLET: INFORMATION FOR THE USER</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>Liprolog 100&nbsp;units/ml solution for injection in cartridge</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>insulin lispro</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>Read all of this leaflet carefully before you start
using this medicine because it contains important information for you.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Keep this leaflet. You may need to read it
again.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of illness
are the same as yours.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you get any side effects, talk to your doctor
or pharmacist.</span><span lang=EN-GB> This includes any possible side effects
not listed in this leaflet. See section 4.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What is in this leaflet</span></b><span lang=EN-GB>: </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>What Liprolog is and what it is used for</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>What you need to know before you use Liprolog</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>How to use Liprolog</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Possible side effects</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>How to store Liprolog</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Contents of the pack and other information</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Liprolog is and what it
is used for</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Liprolog is used to treat diabetes. Liprolog works more quickly than
normal human insulin because the insulin molecule has been changed slightly. </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>You get diabetes if your pancreas does not make enough insulin to
control the level of glucose in your blood. Liprolog is a substitute for your
own insulin and is used to control glucose in the long term. It works very
quickly and lasts a shorter time than soluble insulin (2 to 5 hours). You
should normally use Liprolog within 15 minutes of a meal. </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Your doctor may tell you to use Liprolog as well as a longer-acting
insulin. Each kind of insulin comes with another patient information leaflet to
tell you about it. Do not change your insulin unless your doctor tells you to.
Be very careful if you do change insulin.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog is
suitable for use in adults and children. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you use Liprolog</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Do NOT use
Liprolog</span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you think <b>hypoglycaemia</b> (low blood
sugar) is starting. Further in this leaflet it tells you how to deal with mild
hypoglycaemia&nbsp; (see Section 3: If you take more Liprolog than you need).</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you are <b>allergic</b> (hypersensitive) to
insulin lispro or any of the other ingredients of this medicine (listed in
section 6).</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoHeader><b><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>Warnings and precautions </span></b></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>If your blood sugar levels are well controlled by your current
insulin therapy, you may not feel the warning symptoms when your blood sugar is
falling too low. Warning signs are listed later in this leaflet. You must think
carefully about when to have your meals, how often to exercise and how much to
do. You must also keep a close watch on your blood sugar levels by testing your
blood glucose often.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>A few people who have had hypoglycaemia after switching from animal
insulin to human insulin have reported that the early warning symptoms were
less obvious or different. If you often have hypoglycaemia or have difficulty
recognising it, please discuss this with your doctor.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>If you answer YES to any of the following questions, tell your
doctor, pharmacist or diabetes nurse</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have
you recently become ill?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do
you have trouble with your kidneys or liver?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are you exercising more than usual?</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>The amount of insulin you need may also change if you drink alcohol.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>You should also tell your doctor, pharmacist or diabetes nurse if
you are planning to go abroad. The time difference between countries may mean
that you have to have your injections and meals at different times from when
you are at home.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>If the 40&nbsp;units/ml vial is the product normally prescribed, do
not take insulin from a 100&nbsp;units/ml cartridge using a 40&nbsp;units/ml
syringe.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>Some patients with long-standing type 2 diabetes mellitus and heart
disease or previous stroke who were treated with pioglitazone and insulin
experienced the development of heart failure. Inform your doctor as soon as
possible if you experience signs of heart failure such as unusual shortness of
breath or rapid increase in weight or localised swelling (oedema).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Other medicines and Liprolog</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Your insulin needs may change if you are taking </span></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>the contraceptive pill, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>steroids, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>thyroid hormone replacement therapy, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>oral hypoglycaemics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>acetyl salicylic acid, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>sulpha antibiotics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>octreotide, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>&#8220;beta<sub>2</sub> stimulants&#8221; (for example
     ritodrine, salbutamol or terbutaline), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>beta-blockers, or </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some antidepressants (monoamine oxidase inhibitors or selective
     serotonin reuptake inhibitors), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>danazol, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some angiotensin converting enzyme (ACE) inhibitors (for
     example captopril, enalapril), and </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>angiotensin II receptor blockers.</span></li>
</ul>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Please tell your doctor, if you are taking or have recently taken
any other medicines, including medicines obtained without a prescription </span>(see
section &#8220;<span lang=EN-GB>Warnings and precautions</span>&#8221;)<span
lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Pregnancy and breast-feeding</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Are you pregnant or thinking about becoming pregnant, or are you
breast-feeding? The amount of insulin you need usually falls during the first
three months of pregnancy and increases for the remaining six months. If you
are breast-feeding, you may need to alter your insulin intake or diet.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Ask your doctor
for advice.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Driving and using machines</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Your ability to concentrate and react may be reduced if you have
hypoglycaemia. Please keep this possible problem in mind in all situations
where you might put yourself and others at risk (e.g. driving a car or
operating machinery). You should contact your doctor about the advisability of
driving if you have:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>frequent episodes of hypoglycaemia</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>reduced or absent warning signs of hypoglycaemia</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to use Liprolog</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>The 3 ml
cartridge is only for use in 3ml pens. It is not for use in 1.5 ml pens.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Always check the pack and the cartridge label for the name and type
of the insulin when you get it from your pharmacy. Make sure you get the
Liprolog that your doctor has told you to use.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Always use Liprolog exactly as your doctor has told you. You should
check with your doctor if you are not sure.</span> To prevent the possible
transmission of disease, each cartridge must be used by you only, even if the
needle on the delivery device is changed.</p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>Dosage</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You should normally inject Liprolog within 15
minutes of a meal. If you need to, you can inject soon after a meal. But your
doctor will have told you exactly how much to use, when to use it, and how
often. These instructions are only for you. Follow them exactly and visit your
diabetes clinic regularly.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you change the type of insulin you use (for
example from a human or animal insulin to a Liprolog product), you may have to
take more or less than before. This might just be for the first injection or it
may be a gradual change over several weeks or months. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Inject Liprolog under the skin. You should only
inject it into a muscle if your doctor has told you to.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Preparing Liprolog</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Liprolog is already dissolved in water, so you
do not need to mix it. But you must use it <b>only </b>if it looks like water.
It must be clear, have no colour and no solid pieces in it. Check each time you
inject yourself.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Getting the
pen ready to use</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>First wash your hands. Disinfect the rubber
membrane of the cartridge.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB>You must only use Liprolog cartridges in
compatible CE marked pens. Please make sure that Liprolog is mentioned in the
leaflet accompanying your pen. The 3 ml&nbsp; cartridge only fits the 3 ml pen.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Follow the instructions that come with the pen.
Put the cartridge into the pen.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You will set the dose to 1 or 2 units. Then hold
the pen with the needle pointing up and tap the side of the pen so that any
bubbles float to the top. With the pen still pointing up, press the injection
mechanism. Do this until a drop of Liprolog comes out of the needle. There may
still be some small air bubbles left in the pen. These are harmless, but if the
air bubble is too big, it may make the dose of your injection less accurate.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Injecting Liprolog</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Before you make an injection, clean your skin as
you have been instructed. Inject under the skin, as you were taught. Do not
inject directly into a vein. After your injection, leave the needle in the skin
for five seconds to make sure you have taken the whole dose. Do not rub the
area you have just injected. Make sure you inject at least half an inch
(1&nbsp;cm) from the last injection and that you &#8216;rotate&#8217; the
places you inject, as you have been taught. It doesn&#8217;t matter which
injection site you use, either upper arm, thigh, buttock or abdomen, your
Liprolog injection will still work quicker than soluble human insulin.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You must not administer Liprolog by the
intravenous route. Inject Liprolog as your physician or nurse has taught you.
Only your physician can administer Liprolog by the intravenous route. He will
only do this under special circumstances such as surgery or if you are ill and
your glucose levels are too high.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>After
injecting</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>As soon as you have done the injection, take the
needle off the pen using the outer needle cap. This will keep the Liprolog sterile
and prevent leaking. It will also stop air going back into the pen and the
needle clogging up. <b>Do not share your needles<span style='background:white'>.</span>
</b><u>Do not share your pen<span style='background:white'>.</span> </u>Replace
the cap on your pen. Leave the cartridge in the pen.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Further
injections</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Before every injection, dial 1 or 2 units and
press the injection mechanism with the pen pointing up until a drop of Liprolog
comes out of the needle. You can see how much Liprolog is left by looking at
the gauge on the side of the cartridge. The distance between each mark on the
gauge is about 20 units. If there is not enough for your dose, change the
cartridge.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Do not mix
any other insulin in a Liprolog cartridge. Once the cartridge is empty, do not
use it again.</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Using Liprolog in an infusion pump</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Only certain CE-marked insulin infusion pumps
may be used to infuse insulin lispro. Before infusing insulin lispro, the
manufacturers instructions should be studied to ascertain the suitability or
otherwise for the particular pump. Read and follow the instructions in the
product literature supplied with the infusion pump.</span></p>

<p class=MsoBlockText align=left style='text-align:left'><span lang=EN-GB
style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Be sure to use the correct reservoir and
catheter for your pump.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><u>Changing of the infusion set (tubing and needle) must be done
according to the instructions in the product information supplied with the
infusion set.</u></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>In the event of a hypoglycaemic episode, the
infusion should be stopped until the episode is resolved. If repeated or severe
low blood glucose levels occur, notify your doctor or clinic and consider the
need to reduce or stop your insulin infusion.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>A pump malfunction or obstruction of the
infusion set can result in a rapid rise in glucose levels. If an interruption
to insulin flow is suspected, follow the instructions in the product literature
and if appropriate, notify your doctor or clinic.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>When used with an insulin infusion pump,
Liprolog should not be mixed with any other insulin.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you take more Liprolog than you need</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>If
you take more Liprolog than you need, a low blood sugar may occur.&nbsp; </span>Check
your blood sugar. </p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>If
your blood sugar is low <b>(mild hypoglycaemia)</b>, eat glucose tablets, sugar
or drink a sugary drink. Then eat fruit, biscuits, or a sandwich, as your
doctor has advised you and have some rest. This will often get you over mild
hypoglycaemia or a minor insulin overdose. If you get worse and your breathing
is shallow and your skin gets pale, tell your doctor at once. A glucagon
injection can treat quite severe hypoglycaemia. Eat glucose or sugar after the
glucagon injection. If you do not respond to glucagon, you will have to go to
hospital. Ask your doctor to tell you about glucagon.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you forget to use Liprolog</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog than you need, a high blood sugar may
occur.&nbsp; </span>Check your blood sugar<span class=MsoCommentReference><span
lang=EN-GB style='display:none'>.</span></span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If hypoglycaemia (low blood sugar) or hyperglycaemia (high blood
sugar) is not treated they can be very serious and cause headaches, nausea,
vomiting, dehydration, unconsciousness, coma or even death (see A and B in
section 4 &#8220;Possible Side Effects&#8221;).</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><b><span
lang=EN-GB>Three simple steps </span></b><span lang=EN-GB>to avoid
hypoglycaemia or hyperglycaemia are:</span></p>

<p class=MsoBlockText align=left style='text-align:left'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
keep spare syringes and a spare vial of Liprolog, or a spare pen and
cartridges, in case you lose your pen or cartridges or they get damaged.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always carry
something to show you are diabetic.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always carry sugar
with you.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you stop using Liprolog.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog than you need, a high blood sugar may
occur. Do not change your insulin unless your doctor tells you to.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you have any further questions on the use of this product, ask
your doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible side effects</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-1.45pt'><span lang=EN-GB>Like all
medicines, Liprolog can cause side effects, although not everybody gets them.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Local allergy</span><span
lang=EN-GB style='layout-grid-mode:line'> is common (</span><span lang=EN-GB
style='font-family:Symbol;layout-grid-mode:line'>&sup3;</span><span lang=EN-GB
style='layout-grid-mode:line'> 1/100 to &lt;1/10).</span><span lang=EN-GB>&nbsp;
Some people get redness, swelling or itching around the area of the insulin
injection. This usually clears up in anything from a few days to a few weeks.
If this happens to you, tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Systemic allergy
</span><span lang=EN-GB style='layout-grid-mode:line'>is rare (</span><span
lang=EN-GB style='font-family:Symbol;layout-grid-mode:line'>&sup3;</span><span
lang=EN-GB style='layout-grid-mode:line'> 1/10,000 to &lt;1/1,000)</span><span
lang=EN-GB>.</span><span lang=EN-GB> The symptoms are as follows:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash over the
whole body &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood pressure
dropping</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty in
breathing&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart
beating fast</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; wheezing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sweating.</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>If you think
you are having this sort of insulin allergy with Liprolog, tell your doctor at
once.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Lipodystrophy
(thickening or pitting of the skin)<span style='layout-grid-mode:line'> is
uncommon (</span></span><span lang=EN-GB style='font-family:Symbol;layout-grid-mode:
line'>&sup3;</span><span lang=EN-GB style='layout-grid-mode:line'> 1/1,000 to
&lt;1/100)</span><span lang=EN-GB>. If you notice your skin thickening or
pitting at the injection site, tell your doctor.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Oedema (e.g. swelling in arms,
ankles; fluid retention) has been reported, particularly at the start of
insulin therapy or during a change in therapy to improve control of your blood
glucose.</p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Reporting of side effects</span></b></p>

<p class=BodytextAgency style='margin-bottom:0in'><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>If you get any
side effects, talk to your doctor or pharmacist.</span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'> This includes any
possible side effects not listed in this leaflet.</span><span lang=EN-GB
style='font-family:"Times New Roman",serif'> </span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>You can also
report side effects directly via <span style='background:silver'>the national
reporting system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>.
By reporting side effects you can help provide more information on the safety
of this medicine.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Common problems of diabetes</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>A. &nbsp;&nbsp;&nbsp;&nbsp; Hypoglycaemia</span></b><span
lang=EN-GB> </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hypoglycaemia (low blood sugar) means there is not enough sugar in
the blood. This can be caused if:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you take too much
Liprolog or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you miss or delay
meals or change your diet;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you exercise or
work too hard just before or after a meal;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have an
infection or illness (especially diarrhoea or vomiting);</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; there is a change
in your need for insulin; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have trouble
with your kidneys or liver which gets worse.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Alcohol and some medicines can affect your blood sugar levels.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>The first symptoms of low blood sugar usually come on quickly and
include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tiredness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rapid
heartbeat</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nervousness or
shakiness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
sick</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cold
sweat.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>While you are not confident about recognising your warning symptoms,
avoid situations, e.g. driving a car, in which you or others would be put at
risk by hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>B. &nbsp;&nbsp;&nbsp;&nbsp; Hyperglycaemia and diabetic ketoacidosis</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia (too much sugar in the blood) means that your body
does not have enough insulin. Hyperglycaemia can be brought about by:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not taking your
Liprolog or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; taking less
insulin than your doctor tells you to;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eating a lot more
than your diet allows; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever, infection
or emotional stress.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia can lead to diabetic ketoacidosis. The first symptoms
come on slowly over many hours or days. The symptoms include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sleepy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; no
appetite</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flushed face&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fruity
smell on the breath</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thirst&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
or being sick.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Severe symptoms are heavy breathing and a rapid pulse.&nbsp; <b>Get
medical help immediately.</b></span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>C. &nbsp;&nbsp;&nbsp;&nbsp; Illness</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If you are ill, especially if you feel sick or are sick, the amount
of insulin you need may change. <b>Even when you are not eating normally, you
still need insulin.</b> Test your urine or blood, follow your &#8216;sick
rules&#8217;, and tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store
Liprolog</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Before the first use store your Liprolog in a refrigerator (2</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C &#8211; 8</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C). Do not
freeze. </span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep your cartridge in use at room temperature (15&deg; - 30&deg;C) and
discard after 28 days. Do not put it near heat or in the sun. Do not keep your
pen or the cartridges you are using in the fridge. The pen with the inserted
cartridge should not be stored with the needle attached.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep out of the reach and sight of children.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog after the expiry date which is stated on the
label and the carton. The expiry date refers to the last day of that month. </span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog, if it is coloured or it has solid pieces in it.
</span><span lang=EN-GB>You must use it <b>only</b> if it looks like water. Check
this each time you inject yourself.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Medicines should not be disposed of via wastewater or household
waste. Ask your pharmacist how to dispose of medicines no longer required.
These measures will help to protect the environment.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What </span></b><b><span lang=EN-GB>Liprolog 100&nbsp;units/ml
solution for injection in cartridge contains</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The active substance is insulin lispro. </span><span
lang=EN-GB>Insulin lispro is made in the laboratory by a &#8216;recombinant DNA
technology&#8217; process. It is a changed form of human insulin and so is
different from other human and animal insulins. Insulin lispro is closely
related to human insulin which is a natural hormone made by the pancreas.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The other ingredients are</span><span
lang=EN-GB> m-cresol, glycerol, dibasic sodium phosphate 7 H<sub>2</sub>O, zinc
oxide and water for injection. Sodium hydroxide or hydrochloric acid may have
been used to adjust the acidity.<i> </i></span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What Liprolog looks like and contents of the pack</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Liprolog 100&nbsp;units/ml, solution for injection is a sterile,
clear, colourless, aqueous solution and contains 100 units of insulin lispro in
each millilitre (100&nbsp;units/ml) solution for injection. Each cartridge
contains 300&nbsp;units (3&nbsp;millilitres). The cartridges come in packs of 5
or 10 cartridges. </span>Not all pack sizes may be marketed.</p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Marketing Authorisation Holder and Manufacturer</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Liprolog 100&nbsp;units/ml, solution for injection in cartridge</span><b><span
lang=EN-GB> </span></b><span lang=EN-GB>is made by:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Lilly France S.A.S., Rue du Colonel Lilly, 67640
  Fegersheim, France,</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=IT style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=IT>Eli Lilly Italia S.p.A., Via&nbsp; Gramsci 731-733,
50019 Sesto Fiorentino, (FI) Italy.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=IT>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The product
licence is held by: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht,
The Netherlands.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>For any information about this medicinal product, please contact the
local representative of the Marketing Authorisation Holder:</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=624
 style='margin-left:-1.7pt;border-collapse:collapse'>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>Belgique/Belgi&euml;/Belgien</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Lietuva</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited atstovyb&#279;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel. +370 (5) 2649600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=BG>&#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=BG>&#1058;&#1055; &quot;&#1045;&#1083;&#1080;
  &#1051;&#1080;&#1083;&#1080;
  &#1053;&#1077;&#1076;&#1077;&#1088;&#1083;&#1072;&#1085;&#1076;&quot;
  &#1041;.&#1042;. - &#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=BG>&#1090;&#1077;&#1083;. + 359 2 491 41 40</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=EN-GB style='color:black'>&nbsp;</span></b></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=DE style='color:black'>Luxembourg/Luxemburg</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=DE style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#268;esk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>ELI
  LILLY &#268;R, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 420 234 664 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Magyarorsz&aacute;g</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Lilly
  Hung&aacute;ria Kft.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 36 1 328 5100</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Danmark</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Danmark A/S </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  +45 45 26 6000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Malta</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Charles de Giorgio Ltd.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 356 25600 500</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Deutschland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Berlin-Chemie AG</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Postfach
  1108,&nbsp; 12474 Berlin</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=DE>Tel.: 030/6707-0</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DA
  style='color:black'>Nederland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DA
  style='color:black'>Eli Lilly Nederland B.V. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 31-(0) 30 60 25 800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  style='color:black'>Eesti</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Eli Lilly Holdings Limited Eesti filiaal </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>372 6817 280</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=NO-BOK
  style='color:black'>Norge</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=NO-BOK
  style='color:black'>Eli Lilly Norge A.S. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  + 47 22 88 18 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#917;&#955;&#955;&#940;&#948;&#945;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#934;&#913;&#929;&#924;&#913;&#931;&#917;&#929;&#914;-&#923;&#921;&#923;&#923;&#933;
  &#913;.&#917;.&#914;.&#917;. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +30 210 629 4600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>&Ouml;sterreich</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Ges. m.b.H. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 43-(0) 1 711 780</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Espa&ntilde;a</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Lilly S.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Tel: + 34-91 663 50 00</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=SV style='color:black'>Polska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Eli Lilly Polska Sp. z o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  +48 22 440 33 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>France</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Lilly France S.A.S.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>T&eacute;l: +33-(0) 1 55 49 34 34</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=PT-BR
  style='color:black'>Portugal</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=PT-BR
  style='color:black'>Lilly Portugal - Produtos Farmac&ecirc;uticos, Lda</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 351-21-4126600</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=ES>Hrvatska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Eli Lilly
  Hrvatska d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Tel: +385 1
  2350 999</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=IT>Rom&acirc;nia</span></b></p>
  <p class=MsoNormal><span lang=RO>Eli Lilly Rom&acirc;nia S.R.L.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=RO>Tel: + 40 21
  4023000</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b>Ireland</b></p>
  <p class=MsoNormal style='text-autospace:none'>Eli Lilly and Company (Ireland) Limited</p>
  <p class=MsoNormal style='text-autospace:none'>Tel: + 353-(0) 1 661 4377</p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR>Slovenija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR>Eli Lilly
  farmacevtska dru&#382;ba, d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Tel: +386 (0) 1
  580 00 10</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&Iacute;sland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Icepharma
  hf. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>S&iacute;mi
  + 354 540 8000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Slovensk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Slovakia, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 421 220 663 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=IT
  style='color:black'>Italia</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=IT
  style='color:black'>Eli Lilly Italia S.p.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 39- 055 42571</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=SV
  style='color:black'>Suomi/Finland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Oy Eli Lilly Finland Ab </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Puh/Tel:
  + 358-(0) 9 85 45 250</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#922;&#973;&#960;&#961;&#959;&#962;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Phadisco
  Ltd </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +357 22 715000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Sverige</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Sweden AB</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Tel: + 46-(0) 8 7378800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Latvija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited p&#257;rst&#257;vniec&#299;ba Latvij&#257;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>371 67364000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>United
    Kingdom</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly and Company Limited</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 44-(0) 1256 315000</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>This leaflet was last revised in </span></b><span lang=EN-GB>{MM/YYYY}.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Detailed information on this medicine is available on the European
Medicines Agency web site: http://www.ema.europa.eu/</span><span lang=EN-GB>.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>PACKAGE LEAFLET: INFORMATION FOR THE USER</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>Liprolog Mix25 100&nbsp;units/ml suspension for injection in
cartridge</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>insulin lispro</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>Read all of this leaflet carefully before you start
using this medicine because it contains important information for you.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Keep this leaflet. You may need to read it
again.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of illness
are the same as yours.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you get any side effects, talk to your doctor
or pharmacist.</span><span lang=EN-GB> This includes any possible side effects
not listed in this leaflet. See section 4.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What is in this leaflet</span></b><span lang=EN-GB>: </span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Liprolog Mix25 is and
what it is used for</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you use Liprolog Mix25</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to use Liprolog Mix25</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible side effects</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store Liprolog Mix25</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Liprolog Mix25 is and
what it is used for</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Mix25
is used to treat diabetes.&nbsp; Liprolog Mix25 is a premixed suspension. Its
active substance is insulin lispro.&nbsp; 25% of the insulin lispro in Liprolog
Mix25 is dissolved in water and it works more quickly than normal human insulin
because the insulin molecule has been changed slightly.&nbsp; 75% of the
insulin lispro in Liprolog Mix25 is available in a suspension together with
protamine sulphate, so that its action is prolonged.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>You get diabetes if your pancreas does not make enough insulin to
control the level of glucose in your blood. Liprolog Mix25 is a substitute for
your own insulin and is used to control glucose in the long term. Liprolog
Mix25 works very quickly and longer than soluble insulin. You should normally
use Liprolog Mix25 within 15 minutes of a meal.</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>Your doctor may tell you to use Liprolog Mix25 as well as a
longer-acting insulin. Each kind of insulin comes with another patient
information leaflet to tell you about it. Do not change your insulin unless
your doctor tells you to. Be very careful if you do change insulin.</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you use Liprolog<span style='text-transform:uppercase'> </span>Mix25</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Do NOT use
Liprolog Mix25</span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you think <b>hypoglycaemia</b> (low blood
sugar) is starting. Further in this leaflet it tells you how to deal with mild
hypoglycaemia (see Section 3: If you take more Liprolog Mix25 than you need).</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you are <b>allergic</b> (hypersensitive) to
insulin lispro or any of the other ingredients of this medicine (listed in
section 6).</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Warnings and precautions</span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If your blood sugar levels are well controlled
by your current insulin therapy, you may not feel the warning symptoms when
your blood sugar is falling too low. Warning signs are listed later in this
leaflet.&nbsp; You must think carefully about when to have your meals, how
often to exercise and how much to do. You must also keep a close watch on your
blood sugar levels by testing your blood glucose often.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>A few people who have had hypoglycaemia after
switching from animal insulin to human insulin have reported that the early
warning symptoms were less obvious or different. If you often have<b> </b>hypoglycaemia
or have difficulty recognising them, please discuss this with your doctor.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you answer YES to any of the following
questions, tell your doctor, pharmacist or diabetes nurse</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have
you recently become ill?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do
you have trouble with your kidneys or liver?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are you exercising more than usual?</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The amount of insulin you need may also change
if you drink alcohol.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You should also tell your doctor, pharmacist or
diabetes nurse if you are planning to go abroad.&nbsp; The time difference
between countries may mean that you have to have your injections and meals at
different times from when you are at home.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Some patients with long-standing type 2 diabetes
mellitus and heart disease or previous stroke who were treated with
pioglitazone and insulin experienced the development of heart failure. Inform your
doctor as soon as possible if you experience signs of heart failure such as
unusual shortness of breath or rapid increase in weight or localised swelling
(oedema).</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Other medicines and Liprolog Mix25</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Your insulin needs may change if you are taking </span></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>the contraceptive pill, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>steroids, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>thyroid hormone replacement therapy, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>oral hypoglycaemics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>acetyl salicylic acid, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>sulpha antibiotics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>octreotide, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>&#8220;beta<sub>2</sub> stimulants&#8221; (for example
     ritodrine, salbutamol or terbutaline), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>beta-blockers, or </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some antidepressants (monoamine oxidase inhibitors or selective
     serotonin reuptake inhibitors), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>danazol, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some angiotensin converting enzyme (ACE) inhibitors (for
     example captopril, enalapril), and </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>angiotensin II receptor blockers.</span></li>
</ul>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Please tell your doctor, if you are taking or have recently taken
any other medicines, including medicines obtained without a prescription </span>(see
section &#8220;<span lang=EN-GB>Warnings and precautions</span>&#8221;)<span
lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Pregnancy and breast-feeding</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Are you pregnant or thinking about becoming pregnant, or are you
breast-feeding? The amount of insulin you need usually falls during the first
three months of pregnancy and increases for the remaining six months. If you
are breast-feeding, you may need to alter your insulin intake or diet.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Ask your doctor
for advice.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Driving and using machines</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Your ability
to concentrate and react may be reduced if you have hypoglycaemia. Please keep
this possible problem in mind in all situations where you might put yourself
and others at risk (e.g. driving a car or operating machinery). You should
contact your doctor about the advisability of driving if you have:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>frequent episodes of hypoglycaemia</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>reduced or absent warning signs of hypoglycaemia</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to use Liprolog Mix25</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>The 3 ml
cartridge is only for use in 3ml pens. It is not for use in 1.5 ml pens.</span></b></p>

<p class=MsoNormal style='margin-right:5.65pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:5.65pt'><b><span lang=EN-GB>Always check
the pack and the cartridge label for the name and type of the insulin when you
get it from your pharmacy. Make sure you get the Liprolog Mix25 that your
doctor has told you to use.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Always use Liprolog Mix25 exactly as your doctor has told you. You
should check with your doctor if you are not sure.</span> To prevent the
possible transmission of disease, each cartridge must be used by you only, even
if the needle on the delivery device is changed.</p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;page-break-after:avoid'><b><span
lang=EN-GB>Dosage</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;page-break-after:
avoid'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You
should normally inject Liprolog Mix25 within 15 minutes of a meal.&nbsp; If you
need to, you can inject soon after a meal.&nbsp; But your doctor will have told
you exactly how much to use, when to use it, and how often.&nbsp; These
instructions are only for you.&nbsp; Follow them exactly and visit your
diabetes clinic regularly.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you change the
type of insulin you use (for example from a human or animal insulin to a
Liprolog product), you may have to take more or less than before.&nbsp; This
might just be for the first injection or it may be a gradual change over several
weeks or months. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inject Liprolog
Mix25 under the skin. You should not administer it using a different
administration route. Under no circumstances should Liprolog Mix25 be given
intravenously.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><b><span lang=EN-GB>Preparing
Liprolog Mix25</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cartridges
containing Liprolog Mix25 should be rotated in the palms of the hands ten times
and inverted 180&deg; ten times immediately before use to resuspend insulin
until it appears uniformly cloudy or milky. If not, repeat the above procedure
until contents are mixed. Cartridges contain a small glass bead to assist
mixing. Do not shake vigorously as this may cause frothing which may interfere
with the correct measurement of the dose. The cartridges should be examined
frequently and should not be used if clumps of material are present or if solid
white particles stick to the bottom or wall of the cartridge, giving it a
frosted appearance. Check each time you inject yourself.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Getting the
pen ready to use</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>First wash your hands. Disinfect the rubber
membrane of the cartridge.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB>You must only use Liprolog Mix25 cartridges
in compatible CE marked pens. Please make sure that Liprolog is mentioned in
the leaflet accompanying your pen. The 3 ml&nbsp; cartridge only fits the 3 ml
pen.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Follow the instructions that come with the pen.
Put the cartridge into the pen.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You will set the dose to 1 or 2 units. Then hold
the pen with the needle pointing up and tap the side of the pen so that any
bubbles float to the top. With the pen still pointing up, press the injection
mechanism. Do this until a drop of Liprolog Mix25 comes out of the needle.
There may still be some small air bubbles left in the pen. These are harmless,
but if the air bubble is too big, it may make the dose of your injection less
accurate.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Injecting Liprolog Mix25</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Before you make an injection, clean your skin as
you have been instructed. Inject under the skin, as you were taught. Do not
inject directly into a vein. After your injection, leave the needle in the skin
for five seconds to make sure you have taken the whole dose. Do not rub the
area you have just injected. Make sure you inject at least half an inch (1 cm)
from the last injection and that you &#8216;rotate&#8217; the places you
inject, as you have been taught.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>After
injecting</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>As soon as you have done the injection, take the
needle off the pen using the outer needle cap. This will keep the Liprolog
Mix25 sterile and prevent leaking. It will also stop air going back into the
pen and the needle clogging up. <b>Do not share your needles<span
style='background:white'>.</span> </b><u>Do not share your pen<span
style='background:white'>.</span> </u>Replace the cap on your pen. Leave the
cartridge in the pen.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><b><span
lang=EN-GB>Further injections</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;page-break-after:
avoid'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Before every injection, dial 1 or 2 units and
press the injection mechanism with the pen pointing up until a drop of Liprolog
Mix25 comes out of the needle. You can see how much Liprolog is left by looking
at the gauge on the side of the cartridge. The distance between each mark on
the gauge is about 20 units. If there is not enough for your dose, change the
cartridge.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Do not mix
any other insulin in a Liprolog Mix25 cartridge. Once the cartridge is empty,
do not use it again.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you take more Liprolog Mix25 than you need</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>If
you take more Liprolog Mix25 than you need, a low blood sugar may occur.&nbsp; </span>Check
your blood sugar. </p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>If
your blood sugar is low <b>(mild hypoglycaemia)</b>, eat glucose tablets, sugar
or drink a sugary drink. Then eat fruit, biscuits, or a sandwich, as your
doctor has advised you and have some rest. This will often get you over mild
hypoglycaemia or a minor insulin overdose. If you get worse and your breathing
is shallow and your skin gets pale, tell your doctor at once. A glucagon
injection can treat quite severe hypoglycaemia. Eat glucose or sugar after the
glucagon injection. If you do not respond to glucagon, you will have to go to
hospital. Ask your doctor to tell you about glucagon.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you forget to use Liprolog Mix25</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog Mix25 than you need, a high blood sugar
may occur.&nbsp; </span>Check your blood sugar<span class=MsoCommentReference><span
lang=EN-GB style='display:none'>.</span></span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If hypoglycaemia (low blood sugar) or hyperglycaemia (high blood
sugar) is not treated they can be very serious and cause headaches, nausea,
vomiting, dehydration, unconsciousness, coma or even death (see A and B in
section 4 &#8220;Possible Side Effects&#8221;). </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><b><span
lang=EN-GB>Three simple steps </span></b><span lang=EN-GB>to avoid
hypoglycaemia or hyperglycaemia are:</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
keep a spare pen and cartridges&nbsp; of Liprolog Mix25, in case you lose your
pen or cartridges or they get damaged.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
carry something to show you are diabetic.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
carry sugar with you.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you stop using Liprolog Mix25.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog Mix25 than you need, a high blood sugar
may occur. Do not change your insulin unless your doctor tells you to.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you have any further questions on the use of this product, ask
your doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible
side effects</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-1.45pt'><span lang=EN-GB>Like all
medicines, Liprolog Mix25 can cause side effects, although not everybody gets
them.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Local allergy</span><span
lang=EN-GB style='layout-grid-mode:line'> is common (</span><span lang=EN-GB
style='font-family:Symbol;layout-grid-mode:line'>&sup3;</span><span lang=EN-GB
style='layout-grid-mode:line'> 1/100 to &lt;1/10).</span><span lang=EN-GB>&nbsp;
Some people get redness, swelling or itching around the area of the insulin
injection. This usually clears up in anything from a few days to a few weeks.
If this happens to you, tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Systemic allergy
</span><span lang=EN-GB style='layout-grid-mode:line'>is rare (</span><span
lang=EN-GB style='font-family:Symbol;layout-grid-mode:line'>&sup3;</span><span
lang=EN-GB style='layout-grid-mode:line'> 1/10,000 to &lt;1/1,000)</span><span
lang=EN-GB>.</span><span lang=EN-GB> The symptoms are as follows:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash over the
whole body&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood
pressure dropping</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty in
breathing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart
beating fast</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; wheezing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sweating.</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>If you think
you are having this sort of insulin allergy with Liprolog Mix25, tell your
doctor at once.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Lipodystrophy
(thickening or pitting of the skin)<span style='layout-grid-mode:line'> is
uncommon (</span></span><span lang=EN-GB style='font-family:Symbol;layout-grid-mode:
line'>&sup3;</span><span lang=EN-GB style='layout-grid-mode:line'> 1/1,000 to
&lt;1/100)</span><span lang=EN-GB>. If you notice your skin thickening or
pitting at the injection site, tell your doctor.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Oedema (e.g. swelling in arms,
ankles; fluid retention) has been reported, particularly at the start of
insulin therapy or during a change in therapy to improve control of your blood
glucose.</p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Reporting of side effects</span></b></p>

<p class=BodytextAgency style='margin-bottom:0in'><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>If you get any
side effects, talk to your doctor or pharmacist.</span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'> This includes any
possible side effects not listed in this leaflet.</span><span lang=EN-GB
style='font-family:"Times New Roman",serif'> </span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>You can also
report side effects directly via <span style='background:silver'>the national
reporting system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>.
By reporting side effects you can help provide more information on the safety
of this medicine.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Common problems of diabetes</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>A. &nbsp;&nbsp;&nbsp;&nbsp; Hypoglycaemia</span></b><span
lang=EN-GB> </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hypoglycaemia (low blood sugar) means there is not enough sugar in
the blood. This can be caused if:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you take too much
Liprolog Mix25 or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you miss or delay
meals or change your diet;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you exercise or
work too hard just before or after a meal;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have an
infection or illness (especially diarrhoea or vomiting);</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; there is a change
in your need for insulin; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have trouble
with your kidneys or liver which gets worse.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Alcohol and some medicines can affect your blood sugar levels.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>The first symptoms of low blood sugar usually come on quickly and
include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tiredness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rapid
heartbeat</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nervousness or
shakiness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
sick</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cold
sweat.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>While you are not confident about recognising your warning symptoms,
avoid situations, e.g. driving a car, in which you or others would be put at
risk by hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>B. &nbsp;&nbsp;&nbsp;&nbsp; Hyperglycaemia and diabetic ketoacidosis</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia (too much sugar in the blood) means that your body
does not have enough insulin. Hyperglycaemia can be brought about by:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not taking your
Liprolog or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; taking less
insulin than your doctor tells you to;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eating a lot more
than your diet allows; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever, infection
or emotional stress.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia can lead to diabetic ketoacidosis. The first symptoms
come on slowly over many hours or days. The symptoms include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sleepy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; no
appetite</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flushed face&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fruity
smell on the breath</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thirst&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
or being sick.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Severe symptoms are heavy breathing and a rapid pulse.&nbsp; <b>Get
medical help immediately.</b></span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>C. &nbsp;&nbsp;&nbsp;&nbsp; Illness</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If you are ill, especially if you feel sick or are sick, the amount
of insulin you need may change. <b>Even when you are not eating normally, you
still need insulin.</b> Test your urine or blood, follow your &#8216;sick
rules&#8217;, and tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How
to store Liprolog Mix25</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Before the first use store your Liprolog Mix25 in a refrigerator (2</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C &#8211; 8</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C). Do not
freeze. </span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep your cartridge in use at room temperature (15&deg; - 30&deg;C) and
discard after 28 days. Do not put it near heat or in the sun. Do not keep your
pen or the cartridges you are using in the fridge. The pen with the inserted
cartridge should not be stored with the needle attached.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep out of the reach and sight of children.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog </span><span lang=EN-GB>Mix25 after the expiry
date which is stated on the label and the carton. The expiry date refers to the
last day of that month. </span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog</span><span lang=EN-GB> Mix25, if clumps of
material are present or if solid white particles stick to the bottom or wall of
the cartridge, giving it a frosted appearance. Check each time you inject
yourself.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Medicines should not be disposed of via wastewater or household
waste. Ask your pharmacist how to dispose of medicines no longer required.
These measures will help to protect the environment.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What </span></b><b><span lang=EN-GB>Liprolog Mix25 100&nbsp;units/ml
suspension for injection in cartridge contains</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The active substance is insulin lispro. </span><span
lang=EN-GB>Insulin lispro is made in the laboratory by a &#8216;recombinant DNA
technology&#8217; process. It is a changed form of human insulin and so is
different from other human and animal insulins. Insulin lispro is closely
related to human insulin which is a natural hormone made by the pancreas.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The other ingredients are</span><span
lang=EN-GB> protamine sulphate, m-cresol, phenol, glycerol, dibasic sodium
phosphate&nbsp;7H<span style='position:relative;top:2.0pt'>2</span>O, zinc
oxide and water for injection.&nbsp; Sodium hydroxide or hydrochloric acid may
have been used to adjust the acidity.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What </span></b><b><span lang=EN-GB>Liprolog Mix25 100&nbsp;units/ml
suspension for injection in cartridge looks like and contents of the pack</span></b></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>Liprolog Mix25
100&nbsp;units/ml suspension for injection </span><span lang=EN-GB>is a white,
sterile suspension and contains 100 units of insulin lispro in each millilitre
(100&nbsp;units/ml) suspension for injection.&nbsp; 25% of the insulin lispro
in Liprolog Mix25 is dissolved in water.&nbsp; 75% of the insulin lispro in
Liprolog Mix25 is available in a suspension together with protamine sulphate.
Each cartridge contains 300 units (3 millilitres). The cartridges come in packs
of 5 or 10 cartridges. </span>Not all pack sizes may be marketed.</p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Marketing Authorisation Holder and Manufacturer</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Liprolog Mix25 100&nbsp;units/ml suspension for injection in
cartridge</span><span lang=EN-GB> is made by:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Lilly France S.A.S., Rue du Colonel Lilly, 67640
  Fegersheim, France,</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=IT style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=IT>Eli Lilly Italia S.p.A., Via&nbsp; Gramsci 731-733,
50019 Sesto Fiorentino, (FI) Italy.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=IT>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The product
licence is held by: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ
Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>For any information about this medicinal product, please contact the
local representative of the Marketing Authorisation Holder:</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=624
 style='margin-left:-1.7pt;border-collapse:collapse'>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>Belgique/Belgi&euml;/Belgien</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Lietuva</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited atstovyb&#279;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel. +370 (5) 2649600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=BG>&#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1058;&#1055;
  &quot;&#1045;&#1083;&#1080; &#1051;&#1080;&#1083;&#1080;
  &#1053;&#1077;&#1076;&#1077;&#1088;&#1083;&#1072;&#1085;&#1076;&quot;
  &#1041;.&#1042;. - &#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1090;&#1077;&#1083;.
  + 359 2 491 41 40</span></p>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>&nbsp;</span></b></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Luxembourg/Luxemburg</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#268;esk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>ELI
  LILLY &#268;R, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 420 234 664 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Magyarorsz&aacute;g</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Lilly
  Hung&aacute;ria Kft.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 36 1 328 5100</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Danmark</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Danmark A/S </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  +45 45 26 6000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Malta</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Charles de Giorgio Ltd.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 356 25600 500</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=DE style='color:black'>Deutschland</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=DE>Berlin-Chemie AG</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=DE>Postfach 1108,&nbsp; 12474 Berlin</span></p>
  <p class=MsoNormal style='line-height:normal;page-break-after:avoid;
  text-autospace:none'><span lang=DE>Tel.: 030/6707-0</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=DE style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=DA style='color:black'>Nederland</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=DA style='color:black'>Eli Lilly Nederland B.V. </span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Tel: + 31-(0) 30 60 25 800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  style='color:black'>Eesti</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Eli Lilly Holdings Limited Eesti filiaal </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>372 6817 280</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=NO-BOK
  style='color:black'>Norge</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=NO-BOK
  style='color:black'>Eli Lilly Norge A.S. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  + 47 22 88 18 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#917;&#955;&#955;&#940;&#948;&#945;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#934;&#913;&#929;&#924;&#913;&#931;&#917;&#929;&#914;-&#923;&#921;&#923;&#923;&#933;
  &#913;.&#917;.&#914;.&#917;. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +30 210 629 4600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>&Ouml;sterreich</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Ges. m.b.H. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 43-(0) 1 711 780</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Espa&ntilde;a</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Lilly S.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Tel: + 34-91 663 50 00</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=SV style='color:black'>Polska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Eli Lilly Polska Sp. z o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  +48 22 440 33 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>France</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Lilly France S.A.S.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>T&eacute;l: +33-(0) 1 55 49 34 34</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=PT-BR
  style='color:black'>Portugal</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=PT-BR
  style='color:black'>Lilly Portugal - Produtos Farmac&ecirc;uticos, Lda</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 351-21-4126600</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=ES>Hrvatska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Eli Lilly
  Hrvatska d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Tel: +385 1
  2350 999</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=IT>Rom&acirc;nia</span></b></p>
  <p class=MsoNormal><span lang=RO>Eli Lilly Rom&acirc;nia S.R.L.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=RO>Tel: + 40 21
  4023000</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b>Ireland</b></p>
  <p class=MsoNormal style='text-autospace:none'>Eli Lilly and Company (Ireland) Limited</p>
  <p class=MsoNormal style='text-autospace:none'>Tel: + 353-(0) 1 661 4377</p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR>Slovenija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR>Eli Lilly
  farmacevtska dru&#382;ba, d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Tel: +386 (0) 1
  580 00 10</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&Iacute;sland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Icepharma
  hf. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>S&iacute;mi
  + 354 540 8000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Slovensk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Slovakia, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 421 220 663 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=IT
  style='color:black'>Italia</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=IT
  style='color:black'>Eli Lilly Italia S.p.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 39- 055 42571</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=SV
  style='color:black'>Suomi/Finland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Oy Eli Lilly Finland Ab </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Puh/Tel:
  + 358-(0) 9 85 45 250</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#922;&#973;&#960;&#961;&#959;&#962;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Phadisco
  Ltd </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +357 22 715000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Sverige</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Sweden AB</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Tel: + 46-(0) 8 7378800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Latvija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited p&#257;rst&#257;vniec&#299;ba Latvij&#257;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>371 67364000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>United
    Kingdom</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly and Company Limited</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 44-(0) 1256 315000</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>This leaflet was last revised in </span></b><span lang=EN-GB>{MM/YYYY}.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Detailed information on this medicine is available on the European
Medicines Agency web site: http://www.ema.europa.eu/</span><span lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>PACKAGE LEAFLET: INFORMATION FOR THE USER</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>Liprolog Mix50 100&nbsp;units/ml suspension for injection in
cartridge</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>insulin lispro</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>Read all of this leaflet carefully before you start
using this medicine because it contains important information for you.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Keep this leaflet. You may need to read it
again.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of illness are
the same as yours.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you get any side effects, talk to your doctor
or pharmacist.</span><span lang=EN-GB> This includes any possible side effects
not listed in this leaflet. See section 4.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What is in this leaflet</span></b><span lang=EN-GB>: </span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Liprolog Mix50 is and
what it is used for</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you use Liprolog Mix50</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to use Liprolog Mix50</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible side effects</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store Liprolog Mix50</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Liprolog Mix50 is and
what it is used for</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Mix50
is used to treat diabetes.&nbsp; Liprolog Mix50 is a premixed suspension. Its
active substance is insulin lispro.&nbsp; 50% of the insulin lispro in Liprolog
Mix50 is dissolved in water and it works more quickly than normal human insulin
because the insulin molecule has been changed slightly.&nbsp; 50% of the
insulin lispro in Liprolog Mix50 is available in a suspension together with
protamine sulphate, so that its action is prolonged.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>You get diabetes if your pancreas does not make enough insulin to
control the level of glucose in your blood. Liprolog Mix50 is a substitute for
your own insulin and is used to control glucose in the long term. Liprolog
Mix50 works very quickly and longer than soluble insulin. You should normally
use Liprolog Mix50 within 15 minutes of a meal.</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>Your doctor may tell you to use Liprolog Mix50 as well as a
longer-acting insulin. Each kind of insulin comes with another patient
information leaflet to tell you about it. Do not change your insulin unless
your doctor tells you to. Be very careful if you do change insulin.</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you use Liprolog<span style='text-transform:uppercase'> </span>Mix50</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Do NOT use
Liprolog Mix50</span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you think <b>hypoglycaemia</b> (low blood
sugar) is starting. Further in this leaflet it tells you how to deal with mild
hypoglycaemia (see Section 3: If you take more Liprolog Mix50 than you need).</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you are <b>allergic</b> (hypersensitive) to
insulin lispro or any of the other ingredients of this medicine (listed in
section 6).</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB>Warnings and precautions </span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If your blood sugar levels are well controlled
by your current insulin therapy, you may not feel the warning symptoms when
your blood sugar is falling too low. Warning signs are listed later in this
leaflet.&nbsp; You must think carefully about when to have your meals, how
often to exercise and how much to do. You must also keep a close watch on your
blood sugar levels by testing your blood glucose often.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>A few people who have had hypoglycaemia after
switching from animal insulin to human insulin have reported that the early
warning symptoms were less obvious or different. If you often have<b> </b>hypoglycaemia
or have difficulty recognising them, please discuss this with your doctor.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you answer YES to any of the following
questions, tell your doctor, pharmacist or diabetes nurse</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have
you recently become ill?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do
you have trouble with your kidneys or liver?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are you exercising more than usual?</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The amount of insulin you need may also change
if you drink alcohol.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You should also tell your doctor, pharmacist or
diabetes nurse if you are planning to go abroad.&nbsp; The time difference
between countries may mean that you have to have your injections and meals at
different times from when you are at home.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Some patients with long-standing type 2 diabetes
mellitus and heart disease or previous stroke who were treated with
pioglitazone and insulin experienced the development of heart failure. Inform your
doctor as soon as possible if you experience signs of heart failure such as
unusual shortness of breath or rapid increase in weight or localised swelling
(oedema).</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Other medicines and Liprolog Mix50</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Your insulin needs may change if you are taking </span></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>the contraceptive pill, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>steroids, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>thyroid hormone replacement therapy, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>oral hypoglycaemics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>acetyl salicylic acid, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>sulpha antibiotics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>octreotide, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>&#8220;beta<sub>2</sub> stimulants&#8221; (for example
     ritodrine, salbutamol or terbutaline), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>beta-blockers, or </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some antidepressants (monoamine oxidase inhibitors or selective
     serotonin reuptake inhibitors), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>danazol, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some angiotensin converting enzyme (ACE) inhibitors (for
     example captopril, enalapril), and </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>angiotensin II receptor blockers.</span></li>
</ul>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Please tell your doctor, if you are taking or have recently taken
any other medicines, including medicines obtained without a prescription </span>(see
section &#8220;<span lang=EN-GB>Warnings and precautions</span>&#8221;)<span
lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Pregnancy and breast-feeding</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Are you pregnant or thinking about becoming pregnant, or are you
breast-feeding? The amount of insulin you need usually falls during the first
three months of pregnancy and increases for the remaining six months. If you
are breast-feeding, you may need to alter your insulin intake or diet.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Ask your doctor
for advice.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Driving and using machines</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Your ability
to concentrate and react may be reduced if you have hypoglycaemia. Please keep
this possible problem in mind in all situations where you might put yourself
and others at risk (e.g. driving a car or operating machinery). You should
contact your doctor about the advisability of driving if you have:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>frequent episodes of hypoglycaemia</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>reduced or absent warning signs of hypoglycaemia</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to use Liprolog Mix50</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>The 3 ml
cartridge is only for use in 3ml pens. It is not for use in 1.5 ml pens.</span></b></p>

<p class=MsoNormal style='margin-right:5.65pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:5.65pt'><b><span lang=EN-GB>Always check
the pack and the cartridge label for the name and type of the insulin when you
get it from your pharmacy. Make sure you get the Liprolog Mix50 that your
doctor has told you to use.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Always use Liprolog Mix50 exactly as your doctor has told you. You
should check with your doctor if you are not sure.</span> To prevent the
possible transmission of disease, each cartridge must be used by you only, even
if the needle on the delivery device is changed.</p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><b><span lang=EN-GB>Dosage</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You should
normally inject Liprolog Mix50 within 15 minutes of a meal. &nbsp;If you need
to, you can inject soon after a meal.&nbsp; But your doctor will have told you
exactly how much to use, when to use it, and how often.&nbsp; These
instructions are only for you.&nbsp; Follow them exactly and visit your
diabetes clinic regularly.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you change the
type of insulin you use (for example from a human or animal insulin to a
Liprolog product), you may have to take more or less than before.&nbsp; This
might just be for the first injection or it may be a gradual change over
several weeks or months. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inject Liprolog
Mix50 under the skin. You should not administer it using a different
administration route. Under no circumstances should Liprolog Mix50 be given
intravenously.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><b><span lang=EN-GB>Preparing
Liprolog Mix50</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cartridges
containing Liprolog Mix50 should be rotated in the palms of the hands ten times
and inverted 180&deg; ten times immediately before use to resuspend insulin
until it appears uniformly cloudy or milky. If not, repeat the above procedure
until contents are mixed. Cartridges contain a small glass bead to assist
mixing. Do not shake vigorously as this may cause frothing which may interfere
with the correct measurement of the dose. The cartridges should be examined
frequently and should not be used if clumps of material are present or if solid
white particles stick to the bottom or wall of the cartridge, giving it a
frosted appearance. Check each time you inject yourself.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Getting the
pen ready to use</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>First wash your hands. Disinfect the rubber
membrane of the cartridge.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB>You must only use Liprolog Mix50 cartridges
in compatible CE marked pens. Please make sure that Liprolog is mentioned in
the leaflet accompanying your pen. The 3 ml&nbsp; cartridge only fits the 3 ml
pen.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Follow the instructions that come with the pen.
Put the cartridge into the pen.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You will set the dose to 1 or 2 units. Then hold
the pen with the needle pointing up and tap the side of the pen so that any
bubbles float to the top. With the pen still pointing up, press the injection
mechanism. Do this until a drop of Liprolog Mix50 comes out of the needle.
There may still be some small air bubbles left in the pen. These are harmless,
but if the air bubble is too big, it may make the dose of your injection less
accurate.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Injecting Liprolog Mix50</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Before you make an injection, clean your skin as
you have been instructed. Inject under the skin, as you were taught. Do not
inject directly into a vein. After your injection, leave the needle in the skin
for five seconds to make sure you have taken the whole dose. Do not rub the
area you have just injected. Make sure you inject at least half an inch (1 cm)
from the last injection and that you &#8216;rotate&#8217; the places you
inject, as you have been taught.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>After
injecting</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>As soon as you have done the injection, take the
needle off the pen using the outer needle cap. This will keep the Liprolog
Mix50 sterile and prevent leaking. It will also stop air going back into the
pen and the needle clogging up. <b>Do not share your needles<span
style='background:white'>.</span> </b><u>Do not share your pen<span
style='background:white'>.</span> </u>Replace the cap on your pen. Leave the
cartridge in the pen.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><b><span
lang=EN-GB>Further injections</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;page-break-after:
avoid'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Before every injection, dial 1 or 2 units and
press the injection mechanism with the pen pointing up until a drop of Liprolog
Mix50 comes out of the needle. You can see how much Liprolog is left by looking
at the gauge on the side of the cartridge. The distance between each mark on
the gauge is about 20 units. If there is not enough for your dose, change the
cartridge.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Do not mix
any other insulin in a Liprolog Mix50 cartridge. Once the cartridge is empty,
do not use it again.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you take more Liprolog Mix50 than you need</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>If
you take more Liprolog Mix50 than you need, a low blood sugar may occur.&nbsp; </span>Check
your blood sugar. </p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>If
your blood sugar is low <b>(mild hypoglycaemia)</b>, eat glucose tablets, sugar
or drink a sugary drink. Then eat fruit, biscuits, or a sandwich, as your
doctor has advised you and have some rest. This will often get you over mild
hypoglycaemia or a minor insulin overdose. If you get worse and your breathing
is shallow and your skin gets pale, tell your doctor at once. A glucagon injection
can treat quite severe hypoglycaemia. Eat glucose or sugar after the glucagon
injection. If you do not respond to glucagon, you will have to go to hospital.
Ask your doctor to tell you about glucagon.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you forget to use Liprolog Mix50</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog Mix50 than you need, a high blood sugar
may occur.&nbsp; </span>Check your blood sugar<span class=MsoCommentReference><span
lang=EN-GB style='display:none'>.</span></span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If hypoglycaemia (low blood sugar) or hyperglycaemia (high blood
sugar) is not treated they can be very serious and cause headaches, nausea,
vomiting, dehydration, unconsciousness, coma or even death (see A and B in
section 4 &#8220;Possible Side Effects&#8221;). </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><b><span
lang=EN-GB>Three simple steps </span></b><span lang=EN-GB>to avoid
hypoglycaemia or hyperglycaemia are:</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
keep a spare pen and cartridges of Liprolog Mix50, in case you lose your pen or
cartridges or they get damaged.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
carry something to show you are diabetic.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
carry sugar with you.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you stop using Liprolog Mix50.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog Mix50 than you need, a high blood sugar
may occur. Do not change your insulin unless your doctor tells you to.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you have any further questions on the use of this product, ask
your doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible
side effects</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>Like all medicines, Liprolog Mix50 can cause side effects, although
not everybody gets them.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><span
lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Local allergy</span><span
lang=EN-GB style='layout-grid-mode:line'> is common (</span><span lang=EN-GB
style='font-family:Symbol;layout-grid-mode:line'>&sup3;</span><span lang=EN-GB
style='layout-grid-mode:line'> 1/100 to &lt;1/10).</span><span lang=EN-GB>&nbsp;
Some people get redness, swelling or itching around the area of the insulin
injection. This usually clears up in anything from a few days to a few weeks.
If this happens to you, tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Systemic allergy
</span><span lang=EN-GB style='layout-grid-mode:line'>is rare (</span><span
lang=EN-GB style='font-family:Symbol;layout-grid-mode:line'>&sup3;</span><span
lang=EN-GB style='layout-grid-mode:line'> 1/10,000 to &lt;1/1,000)</span><span
lang=EN-GB>.</span><span lang=EN-GB> The symptoms are as follows:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash over the
whole body&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood
pressure dropping</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty in
breathing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart
beating fast</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; wheezing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sweating.</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>If you think
you are having this sort of insulin allergy with Liprolog Mix50, tell your
doctor at once.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Lipodystrophy
(thickening or pitting of the skin)<span style='layout-grid-mode:line'> is
uncommon (</span></span><span lang=EN-GB style='font-family:Symbol;layout-grid-mode:
line'>&sup3;</span><span lang=EN-GB style='layout-grid-mode:line'> 1/1,000 to
&lt;1/100)</span><span lang=EN-GB>. If you notice your skin thickening or
pitting at the injection site, tell your doctor.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Oedema (e.g. swelling in arms,
ankles; fluid retention) has been reported, particularly at the start of
insulin therapy or during a change in therapy to improve control of your blood
glucose.</p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Reporting of side effects</span></b></p>

<p class=BodytextAgency style='margin-bottom:0in'><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>If you get any
side effects, talk to your doctor or pharmacist.</span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'> This includes any
possible side effects not listed in this leaflet.</span><span lang=EN-GB
style='font-family:"Times New Roman",serif'> </span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>You can also
report side effects directly via <span style='background:silver'>the national
reporting system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>.
By reporting side effects you can help provide more information on the safety
of this medicine.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Common problems of diabetes</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>A. &nbsp;&nbsp;&nbsp;&nbsp; Hypoglycaemia</span></b><span
lang=EN-GB> </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hypoglycaemia (low blood sugar) means there is not enough sugar in
the blood. This can be caused if:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you take too much
Liprolog Mix50 or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you miss or delay
meals or change your diet;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you exercise or
work too hard just before or after a meal;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have an
infection or illness (especially diarrhoea or vomiting);</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; there is a change
in your need for insulin; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have trouble
with your kidneys or liver which gets worse.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Alcohol and some medicines can affect your blood sugar levels.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>The first symptoms of low blood sugar usually come on quickly and
include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tiredness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rapid
heartbeat</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nervousness or
shakiness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
sick</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cold
sweat.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>While you are not confident about recognising your warning symptoms,
avoid situations, e.g. driving a car, in which you or others would be put at
risk by hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>B. &nbsp;&nbsp;&nbsp;&nbsp; Hyperglycaemia and diabetic ketoacidosis</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia (too much sugar in the blood) means that your body
does not have enough insulin. Hyperglycaemia can be brought about by:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not taking your
Liprolog or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; taking less
insulin than your doctor tells you to;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eating a lot more
than your diet allows; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever, infection
or emotional stress.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia can lead to diabetic ketoacidosis. The first symptoms
come on slowly over many hours or days. The symptoms include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sleepy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; no
appetite</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flushed face &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fruity
smell on the breath</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thirst&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
or being sick.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Severe symptoms are heavy breathing and a rapid pulse.&nbsp; <b>Get
medical help immediately.</b></span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>C. &nbsp;&nbsp;&nbsp;&nbsp; Illness</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If you are ill, especially if you feel sick or are sick, the amount of
insulin you need may change. <b>Even when you are not eating normally, you
still need insulin.</b> Test your urine or blood, follow your &#8216;sick
rules&#8217;, and tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How
to store Liprolog Mix50</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Before the first use store your Liprolog Mix50 in a refrigerator (2</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C &#8211; 8</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C). Do not
freeze. </span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Keep your cartridge in use at room temperature (15&deg; - 30&deg;C) and
discard after 28 days. Do not put it near heat or in the sun. Do not keep your
pen or the cartridges you are using in the fridge. The pen with the inserted
cartridge should not be stored with the needle attached.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep out of the reach and sight of children.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog </span><span lang=EN-GB>Mix50 after the expiry
date which is stated on the label and the carton. The expiry date refers to the
last day of that month. </span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog</span><span lang=EN-GB> Mix50, if clumps of
material are present or if solid white particles stick to the bottom or wall of
the cartridge, giving it a frosted appearance. Check each time you inject
yourself.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Medicines should not be disposed of via wastewater or household
waste. Ask your pharmacist how to dispose of medicines no longer required.
These measures will help to protect the environment.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What </span></b><b><span lang=EN-GB>Liprolog Mix50 100&nbsp;units/ml
suspension for injection in cartridge contains</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The active substance is insulin lispro. </span><span
lang=EN-GB>Insulin lispro is made in the laboratory by a &#8216;recombinant DNA
technology&#8217; process. It is a changed form of human insulin and so is
different from other human and animal insulins. Insulin lispro is closely
related to human insulin which is a natural hormone made by the pancreas.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The other ingredients are</span><span
lang=EN-GB> protamine sulphate, m-cresol, phenol, glycerol, dibasic sodium
phosphate&nbsp;7H<span style='position:relative;top:2.0pt'>2</span>O, zinc
oxide and water for injection.&nbsp; Sodium hydroxide or hydrochloric acid may
have been used to adjust the acidity.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What </span></b><b><span lang=EN-GB>Liprolog Mix50 100&nbsp;units/ml
suspension for injection in cartridge looks like and contents of the pack</span></b></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>Liprolog Mix50
100&nbsp;units/ml suspension for injection </span><span lang=EN-GB>is a white,
sterile suspension and contains 100 units of insulin lispro in each millilitre
(100&nbsp;units/ml) suspension for injection.&nbsp; 50% of the insulin lispro
in Liprolog Mix50 is dissolved in water.&nbsp; 50% of the insulin lispro in
Liprolog Mix50 is available in a suspension together with protamine sulphate.
Each cartridge contains 300 units (3 millilitres). The cartridges come in packs
of 5 or 10 cartridges. </span>Not all pack sizes may be marketed.</p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Marketing Authorisation Holder and Manufacturer</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Liprolog Mix50 100&nbsp;units/ml suspension for injection in
cartridge</span><span lang=EN-GB> is made by:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Lilly France S.A.S., Rue du Colonel Lilly, 67640
  Fegersheim, France,</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=IT style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=IT>Eli Lilly Italia S.p.A., Via&nbsp; Gramsci 731-733,
50019 Sesto Fiorentino, (FI) Italy.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=IT>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The product
licence is held by: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht,
The Netherlands.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>For any information about this medicinal product, please contact the
local representative of the Marketing Authorisation Holder:</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=624
 style='margin-left:-1.7pt;border-collapse:collapse'>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>Belgique/Belgi&euml;/Belgien</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Lietuva</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited atstovyb&#279;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel. +370 (5) 2649600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=BG>&#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1058;&#1055;
  &quot;&#1045;&#1083;&#1080; &#1051;&#1080;&#1083;&#1080;
  &#1053;&#1077;&#1076;&#1077;&#1088;&#1083;&#1072;&#1085;&#1076;&quot;
  &#1041;.&#1042;. - &#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1090;&#1077;&#1083;.
  + 359 2 491 41 40</span></p>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>&nbsp;</span></b></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Luxembourg/Luxemburg</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#268;esk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>ELI
  LILLY &#268;R, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 420 234 664 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Magyarorsz&aacute;g</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Lilly
  Hung&aacute;ria Kft.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 36 1 328 5100</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Danmark</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Danmark A/S </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  +45 45 26 6000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Malta</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Charles de Giorgio Ltd.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 356 25600 500</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=DE style='color:black'>Deutschland</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=DE>Berlin-Chemie AG</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=DE>Postfach 1108,&nbsp; 12474 Berlin</span></p>
  <p class=MsoNormal style='line-height:normal;page-break-after:avoid;
  text-autospace:none'><span lang=DE>Tel.: 030/6707-0</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=DE style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=DA style='color:black'>Nederland</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=DA style='color:black'>Eli Lilly Nederland B.V. </span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Tel: + 31-(0) 30 60 25 800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  style='color:black'>Eesti</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Eli Lilly Holdings Limited Eesti filiaal </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>372 6817 280</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=NO-BOK
  style='color:black'>Norge</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=NO-BOK
  style='color:black'>Eli Lilly Norge A.S. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  + 47 22 88 18 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#917;&#955;&#955;&#940;&#948;&#945;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#934;&#913;&#929;&#924;&#913;&#931;&#917;&#929;&#914;-&#923;&#921;&#923;&#923;&#933;
  &#913;.&#917;.&#914;.&#917;. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +30 210 629 4600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>&Ouml;sterreich</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Ges. m.b.H. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 43-(0) 1 711 780</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Espa&ntilde;a</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Lilly S.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Tel: + 34-91 663 50 00</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=SV style='color:black'>Polska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Eli Lilly Polska Sp. z o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  +48 22 440 33 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>France</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Lilly France S.A.S.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>T&eacute;l: +33-(0) 1 55 49 34 34</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=PT-BR
  style='color:black'>Portugal</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=PT-BR
  style='color:black'>Lilly Portugal - Produtos Farmac&ecirc;uticos, Lda</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 351-21-4126600</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=ES>Hrvatska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Eli Lilly
  Hrvatska d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Tel: +385 1
  2350 999</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=IT>Rom&acirc;nia</span></b></p>
  <p class=MsoNormal><span lang=RO>Eli Lilly Rom&acirc;nia S.R.L.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=RO>Tel: + 40 21
  4023000</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b>Ireland</b></p>
  <p class=MsoNormal style='text-autospace:none'>Eli Lilly and Company (Ireland) Limited</p>
  <p class=MsoNormal style='text-autospace:none'>Tel: + 353-(0) 1 661 4377</p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR>Slovenija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR>Eli Lilly farmacevtska
  dru&#382;ba, d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Tel: +386 (0) 1
  580 00 10</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&Iacute;sland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Icepharma
  hf. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>S&iacute;mi
  + 354 540 8000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Slovensk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Slovakia, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 421 220 663 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=IT
  style='color:black'>Italia</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=IT
  style='color:black'>Eli Lilly Italia S.p.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 39- 055 42571</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=SV
  style='color:black'>Suomi/Finland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Oy Eli Lilly Finland Ab </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Puh/Tel:
  + 358-(0) 9 85 45 250</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#922;&#973;&#960;&#961;&#959;&#962;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Phadisco
  Ltd </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +357 22 715000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Sverige</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Sweden AB</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Tel: + 46-(0) 8 7378800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Latvija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited p&#257;rst&#257;vniec&#299;ba Latvij&#257;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>371 67364000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>United
    Kingdom</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly and Company Limited</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 44-(0) 1256 315000</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>This leaflet was last revised in </span></b><span lang=EN-GB>{MM/YYYY}.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Detailed information on this medicine is available on the European
Medicines Agency web site: http://www.ema.europa.eu/</span><span lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>PACKAGE LEAFLET: INFORMATION FOR THE USER</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>Liprolog Basal 100&nbsp;units/ml suspension for injection in
cartridge</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>insulin lispro</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>Read all of this leaflet carefully before you start
using this medicine because it contains important information for you.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Keep this leaflet. You may need to read it
again.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of illness
are the same as yours.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you get any side effects, talk to your doctor
or pharmacist.</span><span lang=EN-GB> This includes any possible side effects
not listed in this leaflet. See section 4.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What is in this leaflet</span></b><span lang=EN-GB>: </span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Liprolog Basal is and
what it is used for</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you use Liprolog Basal</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to use Liprolog Basal</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible side effects</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store Liprolog Basal</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Liprolog Basal is and
what it is used for</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Basal
is used to treat diabetes. Its active substance is insulin lispro. The insulin
lispro in Liprolog Basal is available in a suspension together with protamine
sulphate, so that its action is prolonged.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>You get diabetes if your pancreas does not make enough insulin to
control the level of glucose in your blood. Liprolog Basal is a substitute for
your own insulin and is used to control glucose in the long term. Liprolog
Basal has a prolonged mode of action compared to soluble insulin.</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>Your doctor may tell you to use Liprolog Basal as well as a
fast-acting insulin. Each kind of insulin comes with another patient
information leaflet to tell you about it. Do not change your insulin unless
your doctor tells you to. Be very careful if you do change insulin.</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you use Liprolog<span style='text-transform:uppercase'> </span>Basal</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Do NOT use
Liprolog Basal</span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you think <b>hypoglycaemia</b> (low blood
sugar) is starting. Further in this leaflet it tells you how to deal with mild
hypoglycaemia&nbsp; (see Section 3: If you take more Liprolog Basal than you
need).</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you are <b>allergic</b> (hypersensitive) to
insulin lispro or any of the other ingredients of this medicine (listed in
section 6).</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:.25in;line-height:normal'><b><span
lang=EN-GB>Warnings and precautions </span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If your blood sugar levels are well controlled
by your current insulin therapy, you may not feel the warning symptoms when
your blood sugar is falling too low. Warning signs are listed later in this
leaflet.&nbsp; You must think carefully about when to have your meals, how
often to exercise and how much to do. You must also keep a close watch on your
blood sugar levels by testing your blood glucose often.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>A few people who have had hypoglycaemia after
switching from animal insulin to human insulin have reported that the early
warning symptoms were less obvious or different. If you often have<b> </b>hypoglycaemia
or have difficulty recognising them, please discuss this with your doctor.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you answer YES to any of the following
questions, tell your doctor, pharmacist or diabetes nurse</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have
you recently become ill?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do
you have trouble with your kidneys or liver?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are
you exercising more than usual?</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The amount of insulin you need may also change
if you drink alcohol.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You should also tell your doctor, pharmacist or
diabetes nurse if you are planning to go abroad.&nbsp; The time difference
between countries may mean that you have to have your injections and meals at
different times from when you are at home.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Some patients with long-standing type 2 diabetes
mellitus and heart disease or previous stroke who were treated with
pioglitazone and insulin experienced the development of heart failure. Inform your
doctor as soon as possible if you experience signs of heart failure such as
unusual shortness of breath or rapid increase in weight or localised swelling
(oedema).</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Other medicines and Liprolog Basal</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Your insulin needs may change if you are taking </span></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>the contraceptive pill, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>steroids, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>thyroid hormone replacement therapy, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>oral hypoglycaemics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>acetyl salicylic acid, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>sulpha antibiotics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>octreotide, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>&#8220;beta<sub>2</sub> stimulants&#8221; (for example
     ritodrine, salbutamol or terbutaline), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>beta-blockers, or </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some antidepressants (monoamine oxidase inhibitors or selective
     serotonin reuptake inhibitors), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>danazol, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some angiotensin converting enzyme (ACE) inhibitors (for
     example captopril, enalapril), and </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>angiotensin II receptor blockers.</span></li>
</ul>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Please tell your doctor, if you are taking or have recently taken
any other medicines, including medicines obtained without a prescription </span>(see
section &#8220;<span lang=EN-GB>Warnings and precautions</span>&#8221;)<span
lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Pregnancy and breast-feeding</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Are you pregnant or thinking about becoming pregnant, or are you
breast-feeding? The amount of insulin you need usually falls during the first
three months of pregnancy and increases for the remaining six months. If you
are breast-feeding, you may need to alter your insulin intake or diet.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Ask your doctor
for advice.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Driving and using machines</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Your ability to concentrate and react may be reduced if you have
hypoglycaemia. Please keep this possible problem in mind in all situations
where you might put yourself and others at risk (e.g. driving a car or
operating machinery). You should contact your doctor about the advisability of
driving if you have:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>frequent episodes of hypoglycaemia</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>reduced or absent warning signs of hypoglycaemia</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to use Liprolog Basal</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>The 3 ml cartridge is only for use in 3ml pens. It is not for use in
1.5 ml pens.</span></b></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><b><span
lang=EN-GB>Always check the pack and the cartridge label for the name and type
of the insulin when you get it from your pharmacy. Make sure you get the
Liprolog Basal that your doctor has told you to use.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Always use Liprolog Basal exactly as your doctor has told you. You
should check with your doctor if you are not sure.</span> To prevent the
possible transmission of disease, each cartridge must be used by you only, even
if the needle on the delivery device is changed.</p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><b><span
lang=EN-GB>Dosage</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You
should normally inject Liprolog Basal as your basal insulin.&nbsp; Your doctor
will have told you exactly how much to use, when to use it, and how
often.&nbsp; These instructions are only for you.&nbsp; Follow them exactly and
visit your diabetes clinic regularly.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If
you change the type of insulin you use (for example from a human or animal
insulin to a Liprolog product), you may have to take more or less than
before.&nbsp; This might just be for the first injection or it may be a gradual
change over several weeks or months. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inject
Liprolog Basal under the skin. You should not administer it using a different
administration route. Under no circumstances should Liprolog Basal be given
intravenously.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Preparing Liprolog Basal</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cartridges
containing Liprolog Basal should be rotated in the palms of the hands ten times
and inverted 180&deg; ten times immediately before use to resuspend insulin
until it appears uniformly cloudy or milky. If not, repeat the above procedure
until contents are mixed. Cartridges contain a small glass bead to assist
mixing. Do not shake vigorously as this may cause frothing which may interfere
with the correct measurement of the dose. The cartridges should be examined
frequently and should not be used if clumps of material are present or if solid
white particles stick to the bottom or wall of the cartridge, giving it a
frosted appearance. Check each time you inject yourself.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Getting the pen ready to use</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>First wash your hands. Disinfect the rubber
membrane of the cartridge.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB>You must only use Liprolog Basal cartridges
in compatible CE marked pens. Please make sure that Liprolog or Lilly cartridges
are mentioned in the leaflet accompanying your pen. The 3 ml cartridge only
fits the 3 ml pen.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Follow the instructions that come with the pen.
Put the cartridge into the pen.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You will set the dose to 1 or 2 units. Then hold
the pen with the needle pointing up and tap the side of the pen so that any
bubbles float to the top. With the pen still pointing up, press the injection
mechanism. Do this until a drop of Liprolog Basal comes out of the needle.
There may still be some small air bubbles left in the pen. These are harmless,
but if the air bubble is too big, it may make the dose of your injection less
accurate.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Injecting Liprolog Basal</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Before you make an injection, clean your skin as
you have been instructed. Inject under the skin, as you were taught. Do not
inject directly into a vein. After your injection, leave the needle in the skin
for five seconds to make sure you have taken the whole dose. Do not rub the
area you have just injected. Make sure you inject at least half an inch (1 cm)
from the last injection and that you &#8216;rotate&#8217; the places you
inject, as you have been taught.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>After injecting</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>As soon as you have done the injection, take the
needle off the pen using the outer needle cap. This will keep the Liprolog
Basal sterile and prevent leaking. It will also stop air going back into the
pen and the needle clogging up. <b>Do not share your needles<span
style='background:white'>.</span> </b><u>Do not share your pen<span
style='background:white'>.</span> </u>Replace the cap on your pen. Leave the
cartridge in the pen.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Further injections</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Before every injection, dial 1 or 2 units and
press the injection mechanism with the pen pointing up until a drop of Liprolog
Basal comes out of the needle. You can see how much Liprolog is left by looking
at the gauge on the side of the cartridge. The distance between each mark on
the gauge is about 20 units. If there is not enough for your dose, change the
cartridge.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Do not mix any other insulin in a Liprolog Basal cartridge. Once the
cartridge is empty, do not use it again.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you take more Liprolog Basal than you need</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>If you take more Liprolog Basal than you need, a low blood sugar may
occur.&nbsp; </span>Check your blood sugar. </p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>If your blood sugar is low <b>(mild hypoglycaemia)</b>, eat glucose
tablets, sugar or drink a sugary drink. Then eat fruit, biscuits, or a
sandwich, as your doctor has advised you and have some rest. This will often
get you over mild hypoglycaemia or a minor insulin overdose. If you get worse
and your breathing is shallow and your skin gets pale, tell your doctor at
once. A glucagon injection can treat quite severe hypoglycaemia. Eat glucose or
sugar after the glucagon injection. If you do not respond to glucagon, you will
have to go to hospital. Ask your doctor to tell you about glucagon.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you forget to use Liprolog Basal</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog Basal than you need, a high blood sugar may
occur.&nbsp; </span>Check your blood sugar<span class=MsoCommentReference><span
lang=EN-GB style='display:none'>.</span></span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If hypoglycaemia (low blood sugar) or hyperglycaemia (high blood
sugar) is not treated they can be very serious and cause headaches, nausea,
vomiting, dehydration, unconsciousness, coma or even death (see A and B in section
4 &#8220;Possible Side Effects&#8221;).</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><b><span
lang=EN-GB>Three simple steps </span></b><span lang=EN-GB>to avoid
hypoglycaemia or hyperglycaemia are:</span></p>

<p class=MsoBlockText align=left style='text-align:left'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
keep spare syringes and a spare vial of Liprolog Basal, or a spare pen and
cartridges, in case you lose your pen or cartridges or they get damaged.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always carry
something to show you are diabetic.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always carry sugar
with you.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you stop using Liprolog Basal.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog Basal than you need, a high blood sugar
may occur. Do not change your insulin unless your doctor tells you to.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you have any further questions on the use of this product, ask
your doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible
side effects</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>Like all medicines, Liprolog Basal can cause side effects, although
not everybody gets them.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><span
lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Local allergy</span><span lang=EN-GB style='layout-grid-mode:line'>
is common (</span><span lang=EN-GB style='font-family:Symbol;layout-grid-mode:
line'>&sup3;</span><span lang=EN-GB style='layout-grid-mode:line'> 1/100 to
&lt;1/10).</span><span lang=EN-GB>&nbsp; Some people get redness, swelling or
itching around the area of the insulin injection. This usually clears up in
anything from a few days to a few weeks. If this happens to you, tell your
doctor.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><span
lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Systemic allergy </span><span lang=EN-GB style='layout-grid-mode:
line'>is rare (</span><span lang=EN-GB style='font-family:Symbol;layout-grid-mode:
line'>&sup3;</span><span lang=EN-GB style='layout-grid-mode:line'> 1/10,000 to
&lt;1/1,000)</span><span lang=EN-GB>.</span><span lang=EN-GB> The symptoms are
as follows:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash over the
whole body&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood
pressure dropping</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty in
breathing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart
beating fast</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; wheezing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sweating</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>If you think you are having this sort of insulin allergy with
Liprolog Basal, tell your doctor at once.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Lipodystrophy (thickening or pitting of the skin)<span
style='layout-grid-mode:line'> is uncommon (</span></span><span lang=EN-GB
style='font-family:Symbol;layout-grid-mode:line'>&sup3;</span><span lang=EN-GB
style='layout-grid-mode:line'> 1/1,000 to &lt;1/100)</span><span lang=EN-GB>.
If you notice your skin thickening or pitting at the injection site, tell your
doctor.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Oedema (e.g. swelling in arms,
ankles; fluid retention) has been reported, particularly at the start of
insulin therapy or during a change in therapy to improve control of your blood
glucose.</p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Reporting of side effects</span></b></p>

<p class=BodytextAgency style='margin-bottom:0in'><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>If you get any
side effects, talk to your doctor or pharmacist.</span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'> This includes any
possible side effects not listed in this leaflet.</span><span lang=EN-GB
style='font-family:"Times New Roman",serif'> </span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>You can also
report side effects directly via <span style='background:silver'>the national
reporting system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>.
By reporting side effects you can help provide more information on the safety
of this medicine.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Common problems of diabetes</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>A. &nbsp;&nbsp;&nbsp;&nbsp; Hypoglycaemia</span></b><span
lang=EN-GB> </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hypoglycaemia (low blood sugar) means there is not enough sugar in
the blood. This can be caused if:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you take too much
Liprolog Basal or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you miss or delay
meals or change your diet;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you exercise or
work too hard just before or after a meal;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have an
infection or illness (especially diarrhoea or vomiting);</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; there is a change
in your need for insulin; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have trouble with
your kidneys or liver which gets worse.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Alcohol and some medicines can affect your blood sugar levels.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>The first symptoms of low blood sugar usually come on quickly and
include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tiredness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rapid
heartbeat</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nervousness or
shakiness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
sick</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cold sweat</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>While you are not confident about recognising your warning symptoms,
avoid situations, e.g. driving a car, in which you or others would be put at
risk by hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>B. &nbsp;&nbsp;&nbsp;&nbsp; Hyperglycaemia and diabetic ketoacidosis</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia (too much sugar in the blood) means that your body
does not have enough insulin. Hyperglycaemia can be brought about by:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not taking your
Liprolog or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; taking less
insulin than your doctor tells you to;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eating a lot more
than your diet allows; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever, infection
or emotional stress.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia can lead to diabetic ketoacidosis. The first symptoms
come on slowly over many hours or days. The symptoms include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sleepy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; no
appetite</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flushed face&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fruity
smell on the breath</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thirst&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
or being sick</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Severe symptoms are heavy breathing and a rapid pulse.&nbsp; <b>Get
medical help immediately.</b></span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>C. &nbsp;&nbsp;&nbsp;&nbsp; Illness</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If you are ill, especially if you feel sick or are sick, the amount
of insulin you need may change. <b>Even when you are not eating normally, you
still need insulin.</b> Test your urine or blood, follow your &#8216;sick
rules&#8217;, and tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store
Liprolog Basal</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Before the first use store your Liprolog Basal in a refrigerator (2</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C &#8211; 8</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C). Do not
freeze. </span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep your cartridge in use at room temperature (15&deg; - 30&deg;C) and
discard after 21 days. Do not put it near heat or in the sun. Do not keep your
pen or the cartridges you are using in the fridge. The pen with the inserted cartridge
should not be stored with the needle attached.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep out of the reach and sight of children.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog </span><span lang=EN-GB>Basal after the expiry
date which is stated on the label and the carton. The expiry date refers to the
last day of that month. </span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog</span><span lang=EN-GB> Basal, if clumps of
material are present or if solid white particles stick to the bottom or wall of
the cartridge, giving it a frosted appearance. Check each time you inject
yourself.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Medicines should not be disposed of via wastewater or household
waste. Ask your pharmacist how to dispose of medicines no longer required.
These measures will help to protect the environment.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>What </span></b><b><span lang=EN-GB>Liprolog Basal 100&nbsp;units/ml
suspension for injection in cartridge contains</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The active substance is insulin lispro. </span><span
lang=EN-GB>Insulin lispro is made in the laboratory by a &#8216;recombinant DNA
technology&#8217; process. It is a changed form of human insulin and so is
different from other human and animal insulins. Insulin lispro is closely related
to human insulin which is a natural hormone made by the pancreas.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The other ingredients are</span><span
lang=EN-GB> protamine sulphate, m-cresol, phenol, glycerol, dibasic sodium
phosphate&nbsp;7H<span style='position:relative;top:2.0pt'>2</span>O, zinc
oxide and water for injection.&nbsp; Sodium hydroxide or hydrochloric acid may
have been used to adjust the acidity.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What </span></b><b><span lang=EN-GB>Liprolog Basal 100&nbsp;units/ml
suspension for injection in cartridge looks like and contents of the pack</span></b></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>Liprolog Basal 100&nbsp;units/ml suspension for injection </span><span
lang=EN-GB>is a white, sterile suspension and contains 100 units of insulin
lispro in each millilitre (100&nbsp;units/ml) suspension for injection.&nbsp;
The insulin lispro in Liprolog Basal is available in a suspension together with
protamine sulphate. Each cartridge contains 300 units (3 millilitres). The
cartridges come in packs of 5 or 10 cartridges. </span>Not all pack sizes may
be marketed.</p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Marketing Authorisation Holder and Manufacturer</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Liprolog Basal 100&nbsp;units/ml suspension for injection in
cartridge is</span><span lang=EN-GB> made by:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Lilly France S.A.S., Rue du Colonel Lilly, 67640
  Fegersheim, France,</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=ES>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The product
licence is held by: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ
Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>For any information about this medicinal product, please contact the
local representative of the Marketing Authorisation Holder:</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=624
 style='margin-left:-1.7pt;border-collapse:collapse'>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>Belgique/Belgi&euml;/Belgien</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Lietuva</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited atstovyb&#279;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel. +370 (5) 2649600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=BG>&#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1058;&#1055;
  &quot;&#1045;&#1083;&#1080; &#1051;&#1080;&#1083;&#1080;
  &#1053;&#1077;&#1076;&#1077;&#1088;&#1083;&#1072;&#1085;&#1076;&quot;
  &#1041;.&#1042;. - &#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1090;&#1077;&#1083;.
  + 359 2 491 41 40</span></p>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>&nbsp;</span></b></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Luxembourg/Luxemburg</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#268;esk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>ELI
  LILLY &#268;R, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 420 234 664 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Magyarorsz&aacute;g</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Lilly
  Hung&aacute;ria Kft.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 36 1 328 5100</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Danmark</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Danmark A/S </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  +45 45 26 6000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Malta</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Charles de Giorgio Ltd.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 356 25600 500</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Deutschland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Berlin-Chemie AG</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Postfach
  1108,&nbsp; 12474 Berlin</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=DE>Tel.: 030/6707-0</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DA
  style='color:black'>Nederland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DA
  style='color:black'>Eli Lilly Nederland B.V. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 31-(0) 30 60 25 800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  style='color:black'>Eesti</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Eli Lilly Holdings Limited Eesti filiaal </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>372 6817 280</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=NO-BOK
  style='color:black'>Norge</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=NO-BOK
  style='color:black'>Eli Lilly Norge A.S. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  + 47 22 88 18 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  style='color:black'>&#917;&#955;&#955;&#940;&#948;&#945;</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>&#934;&#913;&#929;&#924;&#913;&#931;&#917;&#929;&#914;-&#923;&#921;&#923;&#923;&#933;
  &#913;.&#917;.&#914;.&#917;. </span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>&#932;&#951;&#955;</span><span lang=EN-GB
  style='color:black'>: +30 210 629 4600</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=ES style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=DE style='color:black'>&Ouml;sterreich</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=DE style='color:black'>Eli Lilly Ges. m.b.H. </span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Tel: + 43-(0) 1 711 780</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Espa&ntilde;a</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Lilly S.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Tel: + 34-91 663 50 00</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=SV style='color:black'>Polska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Eli Lilly Polska Sp. z o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  +48 22 440 33 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>France</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Lilly France S.A.S.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>T&eacute;l: +33-(0) 1 55 49 34 34</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=PT-BR
  style='color:black'>Portugal</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=PT-BR
  style='color:black'>Lilly Portugal - Produtos Farmac&ecirc;uticos, Lda</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 351-21-4126600</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=ES>Hrvatska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Eli Lilly
  Hrvatska d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Tel: +385 1
  2350 999</span></p>
  <p class=MsoNormal style='text-indent:28.35pt;text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=IT>Rom&acirc;nia</span></b></p>
  <p class=MsoNormal><span lang=RO>Eli Lilly Rom&acirc;nia S.R.L.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=RO>Tel: + 40 21
  4023000</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b>Ireland</b></p>
  <p class=MsoNormal style='text-autospace:none'>Eli Lilly and Company (Ireland) Limited</p>
  <p class=MsoNormal style='text-autospace:none'>Tel: + 353-(0) 1 661 4377</p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR>Slovenija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR>Eli Lilly
  farmacevtska dru&#382;ba, d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Tel: +386 (0) 1
  580 00 10</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&Iacute;sland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Icepharma
  hf. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>S&iacute;mi
  + 354 540 8000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Slovensk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Slovakia, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 421 220 663 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=IT
  style='color:black'>Italia</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=IT
  style='color:black'>Eli Lilly Italia S.p.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 39- 055 42571</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=SV
  style='color:black'>Suomi/Finland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Oy Eli Lilly Finland Ab </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Puh/Tel:
  + 358-(0) 9 85 45 250</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#922;&#973;&#960;&#961;&#959;&#962;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Phadisco
  Ltd </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +357 22 715000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Sverige</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Sweden AB</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Tel: + 46-(0) 8 7378800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Latvija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited p&#257;rst&#257;vniec&#299;ba Latvij&#257;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>371 67364000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>United
    Kingdom</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly and Company Limited</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 44-(0) 1256 315000</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>This leaflet was last revised in </span></b><span lang=EN-GB>{MM/YYYY}.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Detailed information on this medicine is available on the European
Medicines Agency web site: http://www.ema.europa.eu/</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=center style='margin-right:-2.25pt;text-align:center;
line-height:normal'><b><span lang=EN-GB>&nbsp;PACKAGE LEAFLET: INFORMATION FOR
THE USER</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>Liprolog 100&nbsp;units/ml KwikPen, solution for injection in a pre-filled
pen</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>insulin lispro</span></b></p>

<p class=MsoNormal align=center style='margin-right:-2.25pt;text-align:center;
line-height:normal'><b><span lang=EN-GB>Each </span><span lang=EN-GB>KwikPen </span></b><b><span
lang=EN-GB>delivers 1 &#8211; 60 units in steps of 1 units.</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>Read all of this leaflet carefully before you start
using this medicine because it contains important information for you.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Keep this leaflet. You may need to read it
again.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of illness
are the same as yours.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you get any side effects, talk to your doctor
or pharmacist.</span><span lang=EN-GB> This includes any possible side effects
not listed in this leaflet. See section 4.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What is in this leaflet</span></b><span lang=EN-GB>: </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>What Liprolog KwikPen is and what it is used for</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>What you need to know before you use Liprolog
KwikPen</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>How to use Liprolog KwikPen</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Possible side effects</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>How to store Liprolog KwikPen</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Contents of the pack and other information</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Liprolog KwikPen is and
what it is used for</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Liprolog KwikPen is used to treat diabetes. It works more quickly
than normal human insulin because the insulin molecule has been changed
slightly.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>You get diabetes if your pancreas does not make enough insulin to
control the level of glucose in your blood. Liprolog is a substitute for your
own insulin and is used to control glucose in the long term. It works very
quickly and lasts a shorter time than soluble insulin (2 to 5 hours). You
should normally use Liprolog within 15 minutes of a meal. </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Your doctor may tell you to use Liprolog KwikPen as well as a
longer-acting insulin. Each kind of insulin comes with another patient
information leaflet to tell you about it. Do not change your insulin unless
your doctor tells you to. Be very careful if you do change insulin.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog is
suitable for use in adults and children. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The KwikPen is a
disposable pre-filled pen containing 3 ml (300 units, 100 units/ml) of insulin
lispro.&nbsp; One KwikPen contains multiple doses of insulin.&nbsp; The KwikPen
dials 1 unit at a time. <b>The number of units are displayed in the dose
window, always check this before your injection. </b>You can give from 1 to 60
units in a single injection.&nbsp; <b>If your dose is more than 60 units, you
will need to give yourself more than one injection. </b></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you use Liprolog<span style='text-transform:uppercase'> </span>KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Do NOT use
Liprolog KwikPen </span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you think <b>hypoglycaemia</b> (low blood
sugar) is starting. Further in this leaflet it tells you how to deal with mild
hypoglycaemia (see Section 3: If you take more Liprolog than you need).</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you are <b>allergic</b> (hypersensitive) to
insulin lispro or any of the other ingredients of this medicine (listed in
section 6).</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Warnings and precautions</span></b></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>If your blood sugar levels are well controlled by your current
insulin therapy, you may not feel the warning symptoms when your blood sugar is
falling too low. Warning signs are listed later in this leaflet. You must think
carefully about when to have your meals, how often to exercise and how much to
do. You must also keep a close watch on your blood sugar levels by testing your
blood glucose often.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>A few people who have had hypoglycaemia after switching from animal
insulin to human insulin have reported that the early warning symptoms were
less obvious or different. If you often have hypoglycaemia or have difficulty
recognising it, please discuss this with your doctor.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>If you answer YES to any of the following questions, tell your
doctor, pharmacist or diabetes nurse</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have
you recently become ill?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do
you have trouble with your kidneys or liver?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are you exercising more than usual?</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>The amount of insulin you need may also change if you drink alcohol.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>You should also tell your doctor, pharmacist or diabetes nurse if
you are planning to go abroad. The time difference between countries may mean
that you have to have your injections and meals at different times from when
you are at home.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>Some patients with long-standing type 2 diabetes mellitus and heart
disease or previous stroke who were treated with pioglitazone and insulin
experienced the development of heart failure. Inform your doctor as soon as
possible if you experience signs of heart failure such as unusual shortness of
breath or rapid increase in weight or localised swelling (oedema).</span></p>

<p class=PPILabelingBodyText style='margin-left:14.15pt;text-indent:-14.15pt'><span
style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-family:"Times New Roman",serif'>This Pen is not
recommended for use by the blind or visually impaired without the help of
someone trained to use the Pen.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Other medicines and Liprolog KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Your insulin needs may change if you are taking </span></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>the contraceptive pill, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>steroids, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>thyroid hormone replacement therapy, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>oral hypoglycaemics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>acetyl salicylic acid, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>sulpha antibiotics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>octreotide, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>&#8220;beta<sub>2</sub> stimulants&#8221; (for example
     ritodrine, salbutamol or terbutaline), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>beta-blockers, or </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some antidepressants (monoamine oxidase inhibitors or selective
     serotonin reuptake inhibitors), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>danazol, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some angiotensin converting enzyme (ACE) inhibitors (for
     example captopril, enalapril), and </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>angiotensin II receptor blockers.</span></li>
</ul>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Please tell your doctor, if you are taking or have recently taken
any other medicines, including medicines obtained without a prescription </span>(see
section &#8220;<span lang=EN-GB>Warnings and precautions</span>&#8221;)<span
lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Pregnancy and breast-feeding</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Are you pregnant or thinking about becoming pregnant, or are you
breast-feeding? The amount of insulin you need usually falls during the first
three months of pregnancy and increases for the remaining six months. If you
are breast-feeding, you may need to alter your insulin intake or diet.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Ask your doctor
for advice.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Driving and using machines</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Your ability to concentrate and react may be reduced if you have
hypoglycaemia. Please keep this possible problem in mind in all situations
where you might put yourself and others at risk (e.g. driving a car or
operating machinery). You should contact your doctor about the advisability of
driving if you have:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>frequent episodes of hypoglycaemia</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>reduced or absent warning signs of hypoglycaemia</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to use
Liprolog KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>Always check the pack and the label of the
pre-filled pen for the name and type of the insulin when you get it from your
pharmacy. Make sure you get the Liprolog KwikPen that your doctor has told you
to use.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Always use Liprolog KwikPen exactly as your doctor has told you. You
should check with your doctor if you are not sure.</span> To prevent the
possible transmission of disease, each pen must be used by you only, even if
the needle is changed.</p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Dosage</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You should normally inject Liprolog within 15
minutes of a meal. If you need to, you can inject soon after a meal. But your
doctor will have told you exactly how much to use, when to use it, and how
often. These instructions are only for you. Follow them exactly and visit your
diabetes clinic regularly.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you change the type of insulin you use (for
example from a human or animal insulin to a Liprolog product), you may have to
take more or less than before. This might just be for the first injection or it
may be a gradual change over several weeks or months. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Inject Liprolog under the skin. You should only
inject it into a muscle if your doctor has told you to.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Preparing Liprolog KwikPen </span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Liprolog is already dissolved in water, so you
do not need to mix it. But you must use it <b>only </b>if it looks like water.
It must be clear, have no colour and no solid pieces in it. Check each time you
inject yourself.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Getting the
KwikPen ready to use (Please see user manual)</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>First wash your hands.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Read the instructions on how to use your pre-filled
insulin pen. Please follow the instructions carefully. Here are some reminders.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Use a clean needle. (Needles are not included).</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Prime your KwikPen before each use. This checks
that insulin comes out and clears the air bubbles from your KwikPen. There may
still be some small air bubbles left in the pen - these are harmless. But if
the air bubbles are too large it may affect the insulin dose.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Injecting Liprolog KwikPen</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Before you make an injection, clean your skin as
you have been instructed. Inject under the skin, as you were taught. Do not
inject directly into a vein. After your injection, leave the needle in the skin
for five seconds to make sure you have taken the whole dose. Do not rub the
area you have just injected. Make sure you inject at least half an inch
(1&nbsp;cm) from the last injection and that you &#8216;rotate&#8217; the
places you inject, as you have been taught. It doesn&#8217;t matter which
injection site you use, either upper arm, thigh, buttock or abdomen, your
Liprolog injection will still work quicker than soluble human insulin.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You must not administer Liprolog by the
intravenous route. Inject Liprolog as your physician or nurse has taught you.
Only your physician can administer Liprolog by the intravenous route. He will
only do this under special circumstances such as surgery or if you are ill and
your glucose levels are too high.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>After
injecting</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>As soon as you have done the injection, unscrew
the needle from the KwikPen using the outer needle cap. This will keep the
insulin sterile and stop it leaking. It also stops air entering the pen and
your needle clogging. <b>Do not share your needles</b>. <u>Do not share your
pen.</u> Replace the cap on your pen.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><b><span
lang=EN-GB>Further injections</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;page-break-after:
avoid'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Every time you use a KwikPen you must use a new
needle. Before every injection, clear any air bubbles. You can see how much
insulin is left by holding the KwikPen with the needle pointing up. The scale
on the cartridge shows about how many units you have left.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;page-break-after:
avoid'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Do not mix any other insulin in your disposable
pen. Once the KwikPen is empty, do not use it again. Please get rid of it
carefully - your pharmacist or diabetes nurse will tell you how to do this.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Using Liprolog in an infusion pump</span></b></p>

<p class=BodytextAgency style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>KwikPen
is only suitable for injecting just under the skin.&nbsp; Do not use the pen to
administer Liprolog by a different way.&nbsp; Other forms of Liprolog </span><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>100&nbsp;units</span><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>/ml are
available if this is necessary.&nbsp; Speak to your doctor if this applies to
you.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you take more Liprolog than you need</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>If
you take more Liprolog than you need, a low blood sugar may occur.&nbsp; </span>Check
your blood sugar. </p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>If
your blood sugar is low <b>(mild hypoglycaemia)</b>, eat glucose tablets, sugar
or drink a sugary drink. Then eat fruit, biscuits, or a sandwich, as your
doctor has advised you and have some rest. This will often get you over mild
hypoglycaemia or a minor insulin overdose. If you get worse and your breathing
is shallow and your skin gets pale, tell your doctor at once. A glucagon
injection can treat quite severe hypoglycaemia. Eat glucose or sugar after the
glucagon injection. If you do not respond to glucagon, you will have to go to
hospital. Ask your doctor to tell you about glucagon.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you forget to use Liprolog</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog than you need, a high blood sugar may
occur.&nbsp; </span>Check your blood sugar<span class=MsoCommentReference><span
lang=EN-GB style='display:none'>.</span></span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If hypoglycaemia (low blood sugar) or hyperglycaemia (high blood
sugar) is not treated they can be very serious and cause headaches, nausea,
vomiting, dehydration, unconsciousness, coma or even death (see A and B in
section 4 &#8220;Possible Side Effects&#8221;). </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><b><span
lang=EN-GB>Three simple steps </span></b><span lang=EN-GB>to avoid hypoglycaemia
or hyperglycaemia are:</span></p>

<p class=MsoBlockText align=left style='text-align:left'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
keep spare syringes and a spare vial of Liprolog, or a spare pen and
cartridges, in case you lose your KwikPen or it gets damaged.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always carry
something to show you are diabetic.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always carry sugar
with you.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you stop using Liprolog.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog than you need, a high blood sugar may
occur. Do not change your insulin unless your doctor tells you to.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you have any further questions on the use of this product, ask
your doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible side
effects</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>Like all medicines, Liprolog can cause side effects,
although not everybody gets them.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal;page-break-after:
avoid'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>Local allergy</span><span lang=EN-GB style='layout-grid-mode:line'>
is common (</span><span lang=EN-GB style='font-family:Symbol;layout-grid-mode:
line'>&sup3;</span><span lang=EN-GB style='layout-grid-mode:line'> 1/100 to
&lt;1/10).</span><span lang=EN-GB>&nbsp; Some people get redness, swelling or
itching around the area of the insulin injection. This usually clears up in
anything from a few days to a few weeks. If this happens to you, tell your
doctor.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Systemic allergy
</span><span lang=EN-GB style='layout-grid-mode:line'>is rare (</span><span
lang=EN-GB style='font-family:Symbol;layout-grid-mode:line'>&sup3;</span><span
lang=EN-GB style='layout-grid-mode:line'> 1/10,000 to &lt;1/1,000)</span><span
lang=EN-GB>.</span><span lang=EN-GB> The symptoms are as follows:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash over the
whole body &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood pressure
dropping</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty in
breathing&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart
beating fast</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; wheezing&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sweating.</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>If you think
you are having this sort of insulin allergy with Liprolog, tell your doctor at
once.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Lipodystrophy
(thickening or pitting of the skin)<span style='layout-grid-mode:line'> is
uncommon (</span></span><span lang=EN-GB style='font-family:Symbol;layout-grid-mode:
line'>&sup3;</span><span lang=EN-GB style='layout-grid-mode:line'> 1/1,000 to
&lt;1/100)</span><span lang=EN-GB>. If you notice your skin thickening or
pitting at the injection site, tell your doctor.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Oedema (e.g. swelling in arms,
ankles; fluid retention) has been reported, particularly at the start of
insulin therapy or during a change in therapy to improve control of your blood
glucose.</p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Reporting of side effects</span></b></p>

<p class=BodytextAgency style='margin-bottom:0in'><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>If you get any
side effects, talk to your doctor or pharmacist.</span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'> This includes any
possible side effects not listed in this leaflet.</span><span lang=EN-GB
style='font-family:"Times New Roman",serif'> </span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>You can also
report side effects directly via <span style='background:silver'>the national
reporting system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>.
By reporting side effects you can help provide more information on the safety
of this medicine.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Common problems of diabetes</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>A. &nbsp;&nbsp;&nbsp;&nbsp; Hypoglycaemia</span></b><span
lang=EN-GB> </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hypoglycaemia (low blood sugar) means there is not enough sugar in
the blood. This can be caused if:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you take too much
Liprolog or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you miss or delay
meals or change your diet;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you exercise or
work too hard just before or after a meal;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have an
infection or illness (especially diarrhoea or vomiting);</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; there is a change
in your need for insulin; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have trouble
with your kidneys or liver which gets worse.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Alcohol and some medicines can affect your blood sugar levels.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>The first symptoms of low blood sugar usually come on quickly and
include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tiredness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rapid
heartbeat</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nervousness or
shakiness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
sick</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cold
sweat.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>While you are not confident about recognising your warning symptoms,
avoid situations, e.g. driving a car, in which you or others would be put at
risk by hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>B. &nbsp;&nbsp;&nbsp;&nbsp; Hyperglycaemia and diabetic ketoacidosis</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia (too much sugar in the blood) means that your body
does not have enough insulin. Hyperglycaemia can be brought about by:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not taking your
Liprolog or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; taking less
insulin than your doctor tells you to;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eating a lot more
than your diet allows; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever, infection
or emotional stress.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia can lead to diabetic ketoacidosis. The first symptoms
come on slowly over many hours or days. The symptoms include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sleepy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; no
appetite</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flushed face&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fruity
smell on the breath</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thirst&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
or being sick.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Severe symptoms are heavy breathing and a rapid pulse.&nbsp; <b>Get
medical help immediately.</b></span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>C. &nbsp;&nbsp;&nbsp;&nbsp; Illness</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If you are ill, especially if you feel sick or are sick, the amount
of insulin you need may change. <b>Even when you are not eating normally, you
still need insulin.</b> Test your urine or blood, follow your &#8216;sick
rules&#8217;, and tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store
Liprolog KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Before the first use store your Liprolog KwikPen in a refrigerator
(2</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C &#8211; 8</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C). Do not freeze. </span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep your Liprolog KwikPen in use at room temperature (15&deg; - 30&deg;C)
and discard after 28 days. Do not put it near heat or in the sun. Do not keep
the KwikPen that you are using in the fridge. The KwikPen should not be stored
with the needle attached.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep out of the reach and sight of children.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog KwikPen after the expiry date which is stated on
the label and the carton. The expiry date refers to the last day of that month.
</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog KwikPen, if the solution is coloured or it has
solid pieces in it. </span><span lang=EN-GB>You must use it <b>only</b> if it
looks like water. Check this each time you inject yourself.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Medicines should not be disposed of via wastewater or household
waste. Ask your pharmacist how to dispose of medicines no longer required.
These measures will help to protect the environment.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What Liprolog KwikPen</span></b><b><span lang=EN-GB> 100&nbsp;units/ml
solution for injection contains</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The active substance is insulin lispro. </span><span
lang=EN-GB>Insulin lispro is made in the laboratory by a &#8216;recombinant DNA
technology&#8217; process. It is a changed form of human insulin and so is
different from other human and animal insulins. Insulin lispro is closely
related to human insulin which is a natural hormone made by the pancreas.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The other ingredients are</span><span
lang=EN-GB> m-cresol, glycerol, dibasic sodium phosphate 7 H<sub>2</sub>O, zinc
oxide and water for injection. Sodium hydroxide or hydrochloric acid may have
been used to adjust the acidity.<i> </i></span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What Liprolog KwikPen looks like and contents of the pack</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Liprolog KwikPen 100&nbsp;units/ml, solution for injection is a
sterile, clear, colourless, aqueous solution and contains 100 units of insulin
lispro in each millilitre (100&nbsp;units/ml) solution for injection. Each
Liprolog KwikPen contains 300&nbsp;units (3&nbsp;millilitres). The Liprolog
KwikPen comes in a pack of 5 pre-filled pens or a multipack of 2 x 5 pre-filled
pens. </span>Not all pack sizes may be marketed.<span lang=EN-GB> The Liprolog
in your pre-filled pen is the same as the Liprolog, which comes in separate
Liprolog cartridges. The KwikPen simply has a built in cartridge. When the
pre-filled pen is empty you cannot use it again.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Marketing Authorisation Holder and Manufacturer</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Liprolog KwikPen 100&nbsp;units/ml, solution for injection</span><span
lang=EN-GB> is made by:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Lilly France S.A.S., Rue du Colonel Lilly, 67640
  Fegersheim, France,</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=IT>Eli Lilly Italia S.p.A., Via&nbsp; Gramsci 731-733,
50019 Sesto Fiorentino, (FI) Italy.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The product
licence is held by: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ
Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>For any information about this medicinal product, please contact the
local representative of the Marketing Authorisation Holder:</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=624
 style='margin-left:-1.7pt;border-collapse:collapse'>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>Belgique/Belgi&euml;/Belgien</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Lietuva</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited atstovyb&#279;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel. +370 (5) 2649600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=BG>&#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1058;&#1055;
  &quot;&#1045;&#1083;&#1080; &#1051;&#1080;&#1083;&#1080;
  &#1053;&#1077;&#1076;&#1077;&#1088;&#1083;&#1072;&#1085;&#1076;&quot;
  &#1041;.&#1042;. - &#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1090;&#1077;&#1083;.
  + 359 2 491 41 40</span></p>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>&nbsp;</span></b></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Luxembourg/Luxemburg</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#268;esk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>ELI
  LILLY &#268;R, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 420 234 664 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Magyarorsz&aacute;g</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Lilly
  Hung&aacute;ria Kft.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 36 1 328 5100</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  style='color:black'>Danmark</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Eli Lilly Danmark A/S </span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Tlf: +45 45 26 6000</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=DE style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=ES style='color:black'>Malta</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=ES style='color:black'>Charles de Giorgio Ltd.</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>Tel: + 356 25600 500</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Deutschland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Berlin-Chemie AG</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Postfach
  1108,&nbsp; 12474 Berlin</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=DE>Tel.: 030/6707-0</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DA
  style='color:black'>Nederland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DA
  style='color:black'>Eli Lilly Nederland B.V. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 31-(0) 30 60 25 800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  style='color:black'>Eesti</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Eli Lilly Holdings Limited Eesti filiaal </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>372 6817 280</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=NO-BOK
  style='color:black'>Norge</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=NO-BOK
  style='color:black'>Eli Lilly Norge A.S. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  + 47 22 88 18 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#917;&#955;&#955;&#940;&#948;&#945;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#934;&#913;&#929;&#924;&#913;&#931;&#917;&#929;&#914;-&#923;&#921;&#923;&#923;&#933;
  &#913;.&#917;.&#914;.&#917;. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +30 210 629 4600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>&Ouml;sterreich</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Ges. m.b.H. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 43-(0) 1 711 780</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Espa&ntilde;a</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Lilly S.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Tel: + 34-91 663 50 00</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=SV style='color:black'>Polska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Eli Lilly Polska Sp. z o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  +48 22 440 33 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>France</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Lilly France S.A.S.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>T&eacute;l: +33-(0) 1 55 49 34 34</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=PT-BR
  style='color:black'>Portugal</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=PT-BR
  style='color:black'>Lilly Portugal - Produtos Farmac&ecirc;uticos, Lda</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 351-21-4126600</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=ES>Hrvatska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Eli Lilly
  Hrvatska d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Tel: +385 1
  2350 999</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=IT>Rom&acirc;nia</span></b></p>
  <p class=MsoNormal><span lang=RO>Eli Lilly Rom&acirc;nia S.R.L.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=RO>Tel: + 40 21
  4023000</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b>Ireland</b></p>
  <p class=MsoNormal style='text-autospace:none'>Eli Lilly and Company (Ireland) Limited</p>
  <p class=MsoNormal style='text-autospace:none'>Tel: + 353-(0) 1 661 4377</p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR>Slovenija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR>Eli Lilly
  farmacevtska dru&#382;ba, d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Tel: +386 (0) 1
  580 00 10</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&Iacute;sland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Icepharma
  hf. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>S&iacute;mi
  + 354 540 8000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Slovensk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Slovakia, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 421 220 663 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=IT
  style='color:black'>Italia</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=IT
  style='color:black'>Eli Lilly Italia S.p.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 39- 055 42571</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=SV
  style='color:black'>Suomi/Finland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Oy Eli Lilly Finland Ab </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Puh/Tel:
  + 358-(0) 9 85 45 250</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#922;&#973;&#960;&#961;&#959;&#962;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Phadisco
  Ltd </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +357 22 715000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Sverige</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Sweden AB</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Tel: + 46-(0) 8 7378800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Latvija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited p&#257;rst&#257;vniec&#299;ba Latvij&#257;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>371 67364000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>United
    Kingdom</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly and Company Limited</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 44-(0) 1256 315000</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>This leaflet was last revised in </span></b><span lang=EN-GB>{MM/YYYY}.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>USER MANUAL Please
see manual text later.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Detailed information on this medicine is available on the European
Medicines Agency web site: http://www.ema.europa.eu/</span><span lang=EN-GB>.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>PACKAGE LEAFLET: INFORMATION FOR THE USER</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>Liprolog Mix25 100&nbsp;units/ml KwikPen, suspension for injection
in a pre-filled pen</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>insulin lispro</span></b></p>

<p class=MsoNormal align=center style='margin-right:-2.25pt;text-align:center;
line-height:normal'><b><span lang=EN-GB>Each </span><span lang=EN-GB>KwikPen </span></b><b><span
lang=EN-GB>delivers 1 &#8211; 60 units in steps of 1 units.</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>Read all of this leaflet carefully before you start
using this medicine because it contains important information for you.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Keep this leaflet. You may need to read it
again.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of illness are
the same as yours.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you get any side effects, talk to your doctor
or pharmacist.</span><span lang=EN-GB> This includes any possible side effects
not listed in this leaflet. See section 4.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What is in this leaflet</span></b><span lang=EN-GB>: </span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Liprolog Mix25 KwikPen
is and what it is used for</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you use Liprolog Mix25 KwikPen </span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to use Liprolog Mix25
KwikPen</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible side effects</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store Liprolog Mix25
KwikPen</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Liprolog Mix25 KwikPen
is and what it is used for</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Mix25
KwikPen is used to treat diabetes.&nbsp; It is a premixed suspension. Its
active substance is insulin lispro.&nbsp; 25% of the insulin lispro in Liprolog
Mix25 KwikPen is dissolved in water and it works more quickly than normal human
insulin because the insulin molecule has been changed slightly.&nbsp; 75% of
the insulin lispro in Liprolog Mix25 KwikPen is available in a suspension
together with protamine sulphate, so that its action is prolonged.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>You get diabetes if your pancreas does not make enough insulin to
control the level of glucose in your blood. Liprolog Mix25 is a substitute for
your own insulin and is used to control glucose in the long term. Liprolog
Mix25 works very quickly and longer than soluble insulin. You should normally
use Liprolog Mix25 within 15 minutes of a meal.</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>Your doctor may tell you to use Liprolog Mix25 KwikPen as well as a
longer-acting insulin. Each kind of insulin comes with another patient
information leaflet to tell you about it. Do not change your insulin unless
your doctor tells you to. Be very careful if you do change insulin.</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The KwikPen is a
disposable pre-filled pen containing 3 ml (300 units, 100 units/ml) of insulin
lispro.&nbsp; One KwikPen contains multiple doses of insulin.&nbsp; The KwikPen
dials 1 unit at a time. <b>The number of units are displayed in the dose
window, always check this before your injection. </b>You can give from 1 to 60
units in a single injection.&nbsp; <b>If your dose is more than 60 units, you
will need to give yourself more than one injection. </b></span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you use Liprolog<span style='text-transform:uppercase'> </span>Mix25<span
style='text-transform:uppercase'> </span>KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Do NOT use
Liprolog Mix25 KwikPen</span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you think <b>hypoglycaemia</b> (low blood
sugar) is starting. Further in this leaflet it tells you how to deal with mild
hypoglycaemia&nbsp; (see Section 3: If you take more Liprolog Mix25 than you
need).</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you are <b>allergic</b> (hypersensitive) to
insulin lispro or any of the other ingredients of this medicine (listed in
section 6).</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Warnings and precautions</span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If your blood sugar levels are well controlled
by your current insulin therapy, you may not feel the warning symptoms when
your blood sugar is falling too low. Warning signs are listed later in this
leaflet.&nbsp; You must think carefully about when to have your meals, how often
to exercise and how much to do. You must also keep a close watch on your blood
sugar levels by testing your blood glucose often.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>A few people who have had hypoglycaemia after
switching from animal insulin to human insulin have reported that the early
warning symptoms were less obvious or different. If you often have<b> </b>hypoglycaemia
or have difficulty recognising them, please discuss this with your doctor.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you answer YES to any of the following
questions, tell your doctor, pharmacist or diabetes nurse</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have
you recently become ill?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do
you have trouble with your kidneys or liver?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are you exercising more than usual?</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The amount of insulin you need may also change
if you drink alcohol.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You should also tell your doctor, pharmacist or
diabetes nurse if you are planning to go abroad.&nbsp; The time difference
between countries may mean that you have to have your injections and meals at
different times from when you are at home.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Some patients with long-standing type 2 diabetes
mellitus and heart disease or previous stroke who were treated with
pioglitazone and insulin experienced the development of heart failure. Inform your
doctor as soon as possible if you experience signs of heart failure such as
unusual shortness of breath or rapid increase in weight or localised swelling
(oedema).</span></p>

<p class=PPILabelingBodyText style='margin-left:.25in;text-indent:-.25in'><span
style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-family:"Times New Roman",serif'>This Pen is not
recommended for use by the blind or visually impaired without the help of
someone trained to use the Pen.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Other medicines and Liprolog Mix25 KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Your insulin needs may change if you are taking </span></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>the contraceptive pill, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>steroids, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>thyroid hormone replacement therapy, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>oral hypoglycaemics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>acetyl salicylic acid, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>sulpha antibiotics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>octreotide, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>&#8220;beta<sub>2</sub> stimulants&#8221; (for example
     ritodrine, salbutamol or terbutaline), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>beta-blockers, or </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some antidepressants (monoamine oxidase inhibitors or selective
     serotonin reuptake inhibitors), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>danazol, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some angiotensin converting enzyme (ACE) inhibitors (for
     example captopril, enalapril), and </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>angiotensin II receptor blockers.</span></li>
</ul>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Please tell your doctor, if you are taking or have recently taken
any other medicines, including medicines obtained without a prescription </span>(see
section &#8220;<span lang=EN-GB>Warnings and precautions</span>&#8221;)<span
lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Pregnancy and breast-feeding</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Are you pregnant or thinking about becoming pregnant, or are you
breast-feeding? The amount of insulin you need usually falls during the first
three months of pregnancy and increases for the remaining six months. If you
are breast-feeding, you may need to alter your insulin intake or diet.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Ask your doctor
for advice.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Driving and using machines</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Your ability
to concentrate and react may be reduced if you have hypoglycaemia. Please keep
this possible problem in mind in all situations where you might put yourself
and others at risk (e.g. driving a car or operating machinery). You should
contact your doctor about the advisability of driving if you have:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>frequent episodes of hypoglycaemia</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>reduced or absent warning signs of hypoglycaemia</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to use
Liprolog Mix25 KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;page-break-after:avoid'><b><span
lang=EN-GB>Always check the pack and the label of the pre-filled pen for the
name and type of the insulin when you get it from your pharmacy. Make sure you
get the Liprolog Mix25 KwikPen that your doctor has told you to use.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Always use Liprolog Mix25 KwikPen exactly as your doctor has told
you. You should check with your doctor if you are not sure.</span><span
lang=EN-GB> </span>To prevent the possible transmission of disease, each pen
must be used by you only, even if the needle is changed.</p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><b><span lang=EN-GB>Dosage</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You should
normally inject Liprolog Mix25 within 15 minutes of a meal.&nbsp; If you need
to, you can inject soon after a meal.&nbsp; But your doctor will have told you
exactly how much to use, when to use it, and how often.&nbsp; These
instructions are only for you.&nbsp; Follow them exactly and visit your
diabetes clinic regularly.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you change the
type of insulin you use (for example from a human or animal insulin to a
Liprolog product), you may have to take more or less than before.&nbsp; This
might just be for the first injection or it may be a gradual change over
several weeks or months. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inject Liprolog
Mix25 under the skin. You should not administer it using a different
administration route. Under no circumstances should Liprolog Mix25 be given
intravenously.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><b><span lang=EN-GB>Preparing
Liprolog Mix25 KwikPen</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The KwikPen should
be rotated in the palms of the hands ten times and inverted 180&deg; ten times
immediately before use to resuspend insulin until it appears uniformly cloudy
or milky. If not, repeat the above procedure until contents are mixed.&nbsp;
Cartridges contain a small glass bead to assist mixing.&nbsp; Do not shake
vigorously as this may cause frothing which may interfere with the correct
measurement of the dose. The cartridges should be examined frequently and
should not be used if clumps of material are present or if solid white
particles stick to the bottom or wall of the cartridge, giving it a frosted
appearance. Check each time you inject yourself.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Getting the
KwikPen ready to use (Please see user manual)</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>First wash your hands.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Read the instructions on how to use your
pre-filled insulin pen.&nbsp; Please follow the instructions carefully. Here
are some reminders.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Use a clean needle.&nbsp; (Needles are not
included).</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Prime your KwikPen before each use. This checks
that insulin comes out and clears the air bubbles from your KwikPen.&nbsp;
There may still be some small air bubbles left in the pen - these are
harmless.&nbsp; But if the air bubbles are too large it may affect the insulin
dose.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Injecting Liprolog Mix25</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Before you make an injection, clean your skin as
you have been instructed.&nbsp; Inject under the skin, as you were
taught.&nbsp; Do not inject directly into a vein.&nbsp; After your injection,
leave the needle in the skin for five seconds to make sure you have taken the
whole dose.&nbsp; Do not rub the area you have just injected.&nbsp; Make sure
you inject at least half an inch (1&nbsp;cm) from where you last injected and
that you &#8216;rotate&#8217; the places you inject, as you have been taught.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>After
injecting</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>As soon as you have done the injection, unscrew
the needle from the KwikPen using the outer needle cap.&nbsp; This will keep
the insulin sterile and stop it leaking.&nbsp; It also stops air entering the
pen and your needle clogging<b>.&nbsp; Do not share your needles</b>.&nbsp; <u>Do
not share your pen.</u>&nbsp; Replace the cap on the pen.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><b><span
lang=EN-GB>Further injections</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;page-break-after:
avoid'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Every time you use a KwikPen you must use a new
needle.&nbsp; Before every injection, clear any air bubbles.&nbsp; You can see
how much insulin is left by holding the KwikPen with the needle pointing up.&nbsp;
The scale on the cartridge shows about how many units you have left.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;page-break-after:
avoid'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Do not mix any other insulin in your disposable
pen.&nbsp; Once the KwikPen is empty, do not use it again.&nbsp; Please get rid
of it carefully - your pharmacist or diabetes nurse will tell you how to do
this.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you take more Liprolog Mix25 than you need</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>If
you take more Liprolog Mix25 than you need, a low blood sugar may occur.&nbsp; </span>Check
your blood sugar. </p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>If
your blood sugar is low <b>(mild hypoglycaemia)</b>, eat glucose tablets, sugar
or drink a sugary drink. Then eat fruit, biscuits, or a sandwich, as your
doctor has advised you and have some rest. This will often get you over mild
hypoglycaemia or a minor insulin overdose. If you get worse and your breathing
is shallow and your skin gets pale, tell your doctor at once. A glucagon
injection can treat quite severe hypoglycaemia. Eat glucose or sugar after the
glucagon injection. If you do not respond to glucagon, you will have to go to
hospital. Ask your doctor to tell you about glucagon.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you forget to use Liprolog Mix25</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog Mix25 than you need, a high blood sugar
may occur.&nbsp; </span>Check your blood sugar<span class=MsoCommentReference><span
lang=EN-GB style='display:none'>.</span></span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If hypoglycaemia (low blood sugar) or hyperglycaemia (high blood
sugar) is not treated they can be very serious and cause headaches, nausea,
vomiting, dehydration, unconsciousness, coma or even death (see A and B in
section 4 &#8220;Possible Side Effects&#8221;). </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Three simple steps </span></b><span lang=EN-GB>to avoid
hypoglycaemia or hyperglycaemia are:</span></p>

<p class=MsoBlockText align=left style='text-align:left;line-height:13.0pt'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always keep a
spare pen and cartridges of Liprolog Mix25, in case you lose your KwikPen or it
gets damaged.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
carry something to show you are diabetic.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
carry sugar with you.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you stop using Liprolog Mix25.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog Mix25 than you need, a high blood sugar
may occur. Do not change your insulin unless your doctor tells you to.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you have any further questions on the use of this product, ask
your doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible
side effects</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>Like all medicines, Liprolog Mix25 can cause side effects, although
not everybody gets them.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><span
lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Local allergy</span><span
lang=EN-GB style='layout-grid-mode:line'> is common (</span><span lang=EN-GB
style='font-family:Symbol;layout-grid-mode:line'>&sup3;</span><span lang=EN-GB
style='layout-grid-mode:line'> 1/100 to &lt;1/10).</span><span lang=EN-GB>&nbsp;
Some people get redness, swelling or itching around the area of the insulin
injection. This usually clears up in anything from a few days to a few weeks.
If this happens to you, tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Systemic allergy
</span><span lang=EN-GB style='layout-grid-mode:line'>is rare (</span><span
lang=EN-GB style='font-family:Symbol;layout-grid-mode:line'>&sup3;</span><span
lang=EN-GB style='layout-grid-mode:line'> 1/10,000 to &lt;1/1,000)</span><span
lang=EN-GB>.</span><span lang=EN-GB> The symptoms are as follows:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash over the
whole body&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood
pressure dropping</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty in
breathing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart
beating fast</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; wheezing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sweating.</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>If you think
you are having this sort of insulin allergy with Liprolog Mix25, tell your
doctor at once.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Lipodystrophy
(thickening or pitting of the skin)<span style='layout-grid-mode:line'> is
uncommon (</span></span><span lang=EN-GB style='font-family:Symbol;layout-grid-mode:
line'>&sup3;</span><span lang=EN-GB style='layout-grid-mode:line'> 1/1,000 to
&lt;1/100)</span><span lang=EN-GB>. If you notice your skin thickening or
pitting at the injection site, tell your doctor.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Oedema (e.g. swelling in arms,
ankles; fluid retention) has been reported, particularly at the start of
insulin therapy or during a change in therapy to improve control of your blood
glucose.</p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Reporting of side effects</span></b></p>

<p class=BodytextAgency style='margin-bottom:0in'><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>If you get any side
effects, talk to your doctor or pharmacist.</span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'> This includes any
possible side effects not listed in this leaflet.</span><span lang=EN-GB
style='font-family:"Times New Roman",serif'> </span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>You can also
report side effects directly via <span style='background:silver'>the national
reporting system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>.
By reporting side effects you can help provide more information on the safety
of this medicine.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Common problems of diabetes</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>A. &nbsp;&nbsp;&nbsp;&nbsp; Hypoglycaemia</span></b><span
lang=EN-GB> </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hypoglycaemia (low blood sugar) means there is not enough sugar in
the blood. This can be caused if:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you take too much
Liprolog Mix25 or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you miss or delay
meals or change your diet;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you exercise or
work too hard just before or after a meal;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have an
infection or illness (especially diarrhoea or vomiting);</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; there is a change
in your need for insulin; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have trouble
with your kidneys or liver which gets worse.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Alcohol and some medicines can affect your blood sugar levels.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>The first symptoms of low blood sugar usually come on quickly and
include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tiredness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rapid
heartbeat</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nervousness or
shakiness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
sick</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cold
sweat.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>While you are not confident about recognising your warning symptoms,
avoid situations, e.g. driving a car, in which you or others would be put at
risk by hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>B. &nbsp;&nbsp;&nbsp;&nbsp; Hyperglycaemia and diabetic ketoacidosis</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia (too much sugar in the blood) means that your body
does not have enough insulin. Hyperglycaemia can be brought about by:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not taking your
Liprolog or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; taking less
insulin than your doctor tells you to;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eating a lot more
than your diet allows; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever, infection
or emotional stress.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia can lead to diabetic ketoacidosis. The first symptoms
come on slowly over many hours or days. The symptoms include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sleepy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; no
appetite</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flushed face&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fruity
smell on the breath</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thirst&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
or being sick.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Severe symptoms are heavy breathing and a rapid pulse.&nbsp; <b>Get
medical help immediately.</b></span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>C. &nbsp;&nbsp;&nbsp;&nbsp; Illness</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If you are ill, especially if you feel sick or are sick, the amount
of insulin you need may change. <b>Even when you are not eating normally, you
still need insulin.</b> Test your urine or blood, follow your &#8216;sick
rules&#8217;, and tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How
to store Liprolog Mix25 KwikPen</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Before the first use store your Liprolog Mix25 KwikPen in a
refrigerator (2</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C &#8211; 8</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C). Do not freeze. </span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep your Liprolog Mix25 KwikPen in use at room temperature (15&deg;
- 30&deg;C) and discard after 28 days. Do not put it near heat or in the sun.
Do not keep the KwikPen that you are using in the fridge. The KwikPen should
not be stored with the needle attached.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep out of the reach and sight of children.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog Mix25 KwikPen</span><span lang=EN-GB> after the
expiry date which is stated on the label and the carton. The expiry date refers
to the last day of that month. </span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog Mix25 KwikPen, </span><span lang=EN-GB>if clumps
of material are present or if solid white particles stick to the bottom or wall
of the cartridge, giving it a frosted appearance. Check each time you inject
yourself.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Medicines should not be disposed of via wastewater or household
waste. Ask your pharmacist how to dispose of medicines no longer required.
These measures will help to protect the environment.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What </span></b><b><span lang=EN-GB>Liprolog Mix25 100&nbsp;units/ml
KwikPen, suspension for injection contains</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The active substance is insulin lispro. </span><span
lang=EN-GB>Insulin lispro is made in the laboratory by a &#8216;recombinant DNA
technology&#8217; process. It is a changed form of human insulin and so is
different from other human and animal insulins. Insulin lispro is closely
related to human insulin which is a natural hormone made by the pancreas.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The other ingredients are</span><span
lang=EN-GB> protamine sulphate, m-cresol, phenol, glycerol, dibasic sodium
phosphate&nbsp;7H<span style='position:relative;top:2.0pt'>2</span>O, zinc
oxide and water for injection.&nbsp; Sodium hydroxide or hydrochloric acid may
have been used to adjust the acidity.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What </span></b><b><span lang=EN-GB>Liprolog Mix25 100&nbsp;units/ml
KwikPen, suspension for injection looks like and contents of the pack</span></b></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>Liprolog Mix25
100&nbsp;units/ml KwikPen, suspension for injection </span><span lang=EN-GB>is
a white, sterile suspension and contains 100 units of insulin lispro in each
millilitre (100&nbsp;units/ml) suspension for injection.&nbsp; 25% of the
insulin lispro in Liprolog Mix25 is dissolved in water.&nbsp; 75% of the
insulin lispro in Liprolog Mix25 is available in a suspension together with
protamine sulphate. Each Liprolog Mix25 KwikPen contains 300 units (3
millilitres). The Liprolog Mix25 KwikPen comes in a pack of 5 pre-filled pens
or a multipack of 2 x 5 pre-filled pens. </span>Not all pack sizes may be
marketed.<span lang=EN-GB> The Liprolog Mix25 in your pre-filled pen is the
same as the Liprolog Mix25, which comes in separate Liprolog Mix25 cartridges.
The KwikPen simply has a built in cartridge. When the pre-filled pen is empty
you cannot use it again.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><u><span
 style='text-decoration:none'>&nbsp;</span></u></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Marketing Authorisation Holder and Manufacturer</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Liprolog Mix25 100&nbsp;units/ml KwikPen, suspension for injection</span><span
lang=EN-GB> is made by:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Lilly France S.A.S., Rue du Colonel Lilly, 67640
  Fegersheim, France,</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=IT>Eli Lilly Italia S.p.A., Via&nbsp; Gramsci 731-733,
50019 Sesto Fiorentino, (FI) Italy.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The product
licence is held by: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ
Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>For any information about this medicinal product, please contact the
local representative of the Marketing Authorisation Holder:</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=624
 style='margin-left:-1.7pt;border-collapse:collapse'>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>Belgique/Belgi&euml;/Belgien</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Lietuva</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited atstovyb&#279;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel. +370 (5) 2649600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=BG>&#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1058;&#1055;
  &quot;&#1045;&#1083;&#1080; &#1051;&#1080;&#1083;&#1080;
  &#1053;&#1077;&#1076;&#1077;&#1088;&#1083;&#1072;&#1085;&#1076;&quot;
  &#1041;.&#1042;. - &#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1090;&#1077;&#1083;.
  + 359 2 491 41 40</span></p>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>&nbsp;</span></b></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Luxembourg/Luxemburg</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#268;esk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>ELI
  LILLY &#268;R, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 420 234 664 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Magyarorsz&aacute;g</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Lilly
  Hung&aacute;ria Kft.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 36 1 328 5100</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Danmark</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Danmark A/S </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  +45 45 26 6000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Malta</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Charles de Giorgio Ltd.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 356 25600 500</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Deutschland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Berlin-Chemie AG</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Postfach
  1108,&nbsp; 12474 Berlin</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=DE>Tel.: 030/6707-0</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DA
  style='color:black'>Nederland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DA
  style='color:black'>Eli Lilly Nederland B.V. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 31-(0) 30 60 25 800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  style='color:black'>Eesti</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Eli Lilly Holdings Limited Eesti filiaal </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>372 6817 280</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=NO-BOK
  style='color:black'>Norge</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=NO-BOK
  style='color:black'>Eli Lilly Norge A.S. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  + 47 22 88 18 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#917;&#955;&#955;&#940;&#948;&#945;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#934;&#913;&#929;&#924;&#913;&#931;&#917;&#929;&#914;-&#923;&#921;&#923;&#923;&#933;
  &#913;.&#917;.&#914;.&#917;. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +30 210 629 4600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>&Ouml;sterreich</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Ges. m.b.H. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 43-(0) 1 711 780</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Espa&ntilde;a</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Lilly S.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Tel: + 34-91 663 50 00</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=SV style='color:black'>Polska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Eli Lilly Polska Sp. z o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  +48 22 440 33 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>France</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Lilly France S.A.S.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>T&eacute;l: +33-(0) 1 55 49 34 34</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=PT-BR
  style='color:black'>Portugal</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=PT-BR
  style='color:black'>Lilly Portugal - Produtos Farmac&ecirc;uticos, Lda</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 351-21-4126600</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=ES>Hrvatska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Eli Lilly
  Hrvatska d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Tel: +385 1
  2350 999</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=IT>Rom&acirc;nia</span></b></p>
  <p class=MsoNormal><span lang=RO>Eli Lilly Rom&acirc;nia S.R.L.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=RO>Tel: + 40 21
  4023000</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b>Ireland</b></p>
  <p class=MsoNormal style='text-autospace:none'>Eli Lilly and Company (Ireland) Limited</p>
  <p class=MsoNormal style='text-autospace:none'>Tel: + 353-(0) 1 661 4377</p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR>Slovenija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR>Eli Lilly
  farmacevtska dru&#382;ba, d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Tel: +386 (0) 1
  580 00 10</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&Iacute;sland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Icepharma
  hf. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>S&iacute;mi
  + 354 540 8000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Slovensk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Slovakia, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 421 220 663 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=IT
  style='color:black'>Italia</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=IT
  style='color:black'>Eli Lilly Italia S.p.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 39- 055 42571</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=SV
  style='color:black'>Suomi/Finland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Oy Eli Lilly Finland Ab </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Puh/Tel:
  + 358-(0) 9 85 45 250</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#922;&#973;&#960;&#961;&#959;&#962;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Phadisco
  Ltd </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +357 22 715000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Sverige</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Sweden AB</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Tel: + 46-(0) 8 7378800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Latvija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited p&#257;rst&#257;vniec&#299;ba Latvij&#257;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>371 67364000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>United
    Kingdom</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly and Company Limited</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 44-(0) 1256 315000</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>This leaflet was last revised in </span></b><span lang=EN-GB>{MM/YYYY}.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>USER MANUAL</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Please see
manual text later.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Detailed information on this medicine is available on the European
Medicines Agency web site: http://www.ema.europa.eu/</span><span lang=EN-GB>.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>PACKAGE LEAFLET: INFORMATION FOR THE USER</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>Liprolog Mix50 100&nbsp;units/ml KwikPen, suspension for injection
in a pre-filled pen</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>insulin lispro</span></b></p>

<p class=MsoNormal align=center style='margin-right:-2.25pt;text-align:center;
line-height:normal'><b><span lang=EN-GB>Each </span><span lang=EN-GB>KwikPen </span></b><b><span
lang=EN-GB>delivers 1 &#8211; 60 units in steps of 1 units.</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>Read all of this leaflet carefully before you start
using this medicine because it contains important information for you.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Keep this leaflet. You may need to read it
again.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of illness
are the same as yours.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you get any side effects, talk to your doctor
or pharmacist.</span><span lang=EN-GB> This includes any possible side effects
not listed in this leaflet. See section 4.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What is in this leaflet</span></b><span lang=EN-GB>: </span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Liprolog Mix50 KwikPen
is and what it is used for</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you use Liprolog Mix50 KwikPen </span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to use Liprolog Mix50
KwikPen</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible side effects</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store Liprolog Mix50
KwikPen</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Liprolog Mix50 KwikPen
is and what it is used for</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Mix50
KwikPen is used to treat diabetes.&nbsp; It is a premixed suspension. Its
active substance is insulin lispro.&nbsp; 50% of the insulin lispro in Liprolog
Mix50 KwikPen is dissolved in water and it works more quickly than normal human
insulin because the insulin molecule has been changed slightly.&nbsp; 50% of
the insulin lispro in Liprolog Mix50 KwikPen is available in a suspension
together with protamine sulphate, so that its action is prolonged.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>You get diabetes if your pancreas does not make enough insulin to
control the level of glucose in your blood. Liprolog Mix50 is a substitute for
your own insulin and is used to control glucose in the long term. Liprolog
Mix50 works very quickly and longer than soluble insulin. You should normally
use Liprolog Mix50 within 15 minutes of a meal.</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>Your doctor may tell you to use Liprolog Mix50 KwikPen as well as a
longer-acting insulin. Each kind of insulin comes with another patient
information leaflet to tell you about it. Do not change your insulin unless
your doctor tells you to. Be very careful if you do change insulin.</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The KwikPen is a
disposable pre-filled pen containing 3 ml (300 units, 100 units/ml) of insulin
lispro.&nbsp; One KwikPen contains multiple doses of insulin.&nbsp; The KwikPen
dials 1 unit at a time. <b>The number of units are displayed in the dose
window, always check this before your injection. </b>You can give from 1 to 60
units in a single injection.&nbsp; <b>If your dose is more than 60 units, you
will need to give yourself more than one injection. </b></span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you use Liprolog<span style='text-transform:uppercase'> </span>Mix50 KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Do NOT use
Liprolog Mix50 KwikPen</span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you think <b>hypoglycaemia</b> (low blood
sugar) is starting. Further in this leaflet it tells you how to deal with mild
hypoglycaemia (see Section 3: If you take more Liprolog Mix50 than you need).</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you are <b>allergic</b> (hypersensitive) to
insulin lispro or any of the other ingredients of this medicine (listed in
section 6).</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Warnings and precautions</span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If your blood sugar levels are well controlled
by your current insulin therapy, you may not feel the warning symptoms when
your blood sugar is falling too low. Warning signs are listed later in this
leaflet.&nbsp; You must think carefully about when to have your meals, how often
to exercise and how much to do. You must also keep a close watch on your blood
sugar levels by testing your blood glucose often.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>A few people who have had hypoglycaemia after
switching from animal insulin to human insulin have reported that the early
warning symptoms were less obvious or different. If you often have<b> </b>hypoglycaemia
or have difficulty recognising them, please discuss this with your doctor.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you answer YES to any of the following
questions, tell your doctor, pharmacist or diabetes nurse</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have
you recently become ill?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do
you have trouble with your kidneys or liver?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are you exercising more than usual?</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The amount of insulin you need may also change
if you drink alcohol.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You should also tell your doctor, pharmacist or
diabetes nurse if you are planning to go abroad.&nbsp; The time difference
between countries may mean that you have to have your injections and meals at
different times from when you are at home.</span></p>

<p class=PPILabelingBodyText style='margin-left:14.15pt;text-indent:-14.15pt'><span
style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-family:"Times New Roman",serif'>Some patients
with long-standing type 2 diabetes mellitus and heart disease or previous stroke
who were treated with pioglitazone and insulin experienced the development of
heart failure. Inform your doctor as soon as possible if you experience signs
of heart failure such as unusual shortness of breath or rapid increase in
weight or localised swelling (oedema). </span></p>

<p class=PPILabelingBodyText style='margin-left:14.15pt;text-indent:-14.15pt'><span
style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-family:"Times New Roman",serif'>This Pen is not
recommended for use by the blind or visually impaired without the help of
someone trained to use the Pen.</span></p>

<p class=MsoNormal style='margin-left:.25in;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Other medicines and Liprolog Mix50 KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Your insulin needs may change if you are taking </span></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>the contraceptive pill, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>steroids, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>thyroid hormone replacement therapy, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>oral hypoglycaemics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>acetyl salicylic acid, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>sulpha antibiotics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>octreotide, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>&#8220;beta<sub>2</sub> stimulants&#8221; (for example
     ritodrine, salbutamol or terbutaline), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>beta-blockers, or </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some antidepressants (monoamine oxidase inhibitors or selective
     serotonin reuptake inhibitors), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>danazol, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some angiotensin converting enzyme (ACE) inhibitors (for
     example captopril, enalapril), and </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>angiotensin II receptor blockers.</span></li>
</ul>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Please tell your doctor, if you are taking or have recently taken
any other medicines, including medicines obtained without a prescription </span>(see
section &#8220;<span lang=EN-GB>Warnings and precautions</span>&#8221;)<span
lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Pregnancy and breast-feeding</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Are you pregnant or thinking about becoming pregnant, or are you
breast-feeding? The amount of insulin you need usually falls during the first
three months of pregnancy and increases for the remaining six months. If you
are breast-feeding, you may need to alter your insulin intake or diet.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Ask your doctor
for advice.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Driving and using machines</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Your ability
to concentrate and react may be reduced if you have hypoglycaemia. Please keep
this possible problem in mind in all situations where you might put yourself
and others at risk (e.g. driving a car or operating machinery). You should
contact your doctor about the advisability of driving if you have:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>frequent episodes of hypoglycaemia</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>reduced or absent warning signs of hypoglycaemia</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to use
Liprolog Mix50 KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;page-break-after:avoid'><b><span
lang=EN-GB>Always check the pack and the label of the pre-filled pen for the
name and type of the insulin when you get it from your pharmacy. Make sure you
get the Liprolog Mix50 KwikPen that your doctor has told you to use.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Always use Liprolog Mix50 KwikPen exactly as your doctor has told
you. You should check with your doctor if you are not sure.</span> To prevent
the possible transmission of disease, each pen must be used by you only, even
if the needle is changed.</p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><b><span lang=EN-GB>Dosage</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You should
normally inject Liprolog Mix50 within 15 minutes of a meal.&nbsp; If you need
to, you can inject soon after a meal.&nbsp; But your doctor will have told you
exactly how much to use, when to use it, and how often.&nbsp; These
instructions are only for you.&nbsp; Follow them exactly and visit your
diabetes clinic regularly.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you change the
type of insulin you use (for example from a human or animal insulin to a
Liprolog product), you may have to take more or less than before.&nbsp; This
might just be for the first injection or it may be a gradual change over
several weeks or months. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inject Liprolog
Mix50 under the skin. You should not administer it using a different
administration route. Under no circumstances should Liprolog Mix50 be given
intravenously.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><b><span lang=EN-GB>Preparing
Liprolog Mix50 KwikPen</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The KwikPen should
be rotated in the palms of the hands ten times and inverted 180&deg; ten times
immediately before use to resuspend insulin until it appears uniformly cloudy
or milky. If not, repeat the above procedure until contents are mixed.&nbsp;
Cartridges contain a small glass bead to assist mixing.&nbsp; Do not shake
vigorously as this may cause frothing which may interfere with the correct
measurement of the dose. The cartridges should be examined frequently and
should not be used if clumps of material are present or if solid white
particles stick to the bottom or wall of the cartridge, giving it a frosted appearance.
Check each time you inject yourself.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Getting the
KwikPen ready to use (Please see user manual)</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>First wash your hands.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Read the instructions on how to use your
pre-filled insulin pen.&nbsp; Please follow the instructions carefully. Here
are some reminders.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Use a clean needle.&nbsp; (Needles are not
included).</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Prime your KwikPen before each use. This checks
that insulin comes out and clears the air bubbles from your KwikPen.&nbsp;
There may still be some small air bubbles left in the pen - these are
harmless.&nbsp; But if the air bubbles are too large it may affect the insulin
dose.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Injecting Liprolog Mix50</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Before you make an injection, clean your skin as
you have been instructed.&nbsp; Inject under the skin, as you were
taught.&nbsp; Do not inject directly into a vein.&nbsp; After your injection,
leave the needle in the skin for five seconds to make sure you have taken the
whole dose.&nbsp; Do not rub the area you have just injected.&nbsp; Make sure
you inject at least half an inch (1&nbsp;cm) from where you last injected and
that you &#8216;rotate&#8217; the places you inject, as you have been taught.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>After
injecting</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>As soon as you have done the injection, unscrew
the needle from the KwikPen using the outer needle cap.&nbsp; This will keep
the insulin sterile and stop it leaking.&nbsp; It also stops air entering the
pen and your needle clogging<b>.&nbsp; Do not share your needles</b>.&nbsp; <u>Do
not share your pen.</u>&nbsp; Replace the cap on the pen.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><b><span
lang=EN-GB>Further injections</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;page-break-after:
avoid'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Every time you use a KwikPen you must use a new
needle.&nbsp; Before every injection, clear any air bubbles.&nbsp; You can see
how much insulin is left by holding the KwikPen with the needle pointing up.&nbsp;
The scale on the cartridge shows about how many units you have left.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;page-break-after:
avoid'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Do not mix any other insulin in your disposable
pen.&nbsp; Once the KwikPen is empty, do not use it again.&nbsp; Please get rid
of it carefully - your pharmacist or diabetes nurse will tell you how to do
this.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you take more Liprolog Mix50 than you need</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>If
you take more Liprolog Mix50 than you need, a low blood sugar may occur.&nbsp; </span>Check
your blood sugar. </p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>If
your blood sugar is low <b>(mild hypoglycaemia)</b>, eat glucose tablets, sugar
or drink a sugary drink. Then eat fruit, biscuits, or a sandwich, as your
doctor has advised you and have some rest. This will often get you over mild
hypoglycaemia or a minor insulin overdose. If you get worse and your breathing
is shallow and your skin gets pale, tell your doctor at once. A glucagon
injection can treat quite severe hypoglycaemia. Eat glucose or sugar after the
glucagon injection. If you do not respond to glucagon, you will have to go to
hospital. Ask your doctor to tell you about glucagon.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you forget to use Liprolog Mix50</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog Mix50 than you need, a high blood sugar
may occur.&nbsp; </span>Check your blood sugar<span class=MsoCommentReference><span
lang=EN-GB style='display:none'>.</span></span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If hypoglycaemia (low blood sugar) or hyperglycaemia (high blood sugar)
is not treated they can be very serious and cause headaches, nausea, vomiting,
dehydration, unconsciousness, coma or even death (see A and B in section 4
&#8220;Possible Side Effects&#8221;). </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><b><span
lang=EN-GB>Three simple steps </span></b><span lang=EN-GB>to avoid
hypoglycaemia or hyperglycaemia are:</span></p>

<p class=MsoBlockText align=left style='text-align:left;line-height:13.0pt'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always keep a
spare pen and cartridges of Liprolog Mix50, in case you lose your KwikPen or it
gets damaged.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
carry something to show you are diabetic.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
carry sugar with you.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you stop using Liprolog Mix50.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog Mix50 than you need, a high blood sugar
may occur. Do not change your insulin unless your doctor tells you to.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you have any further questions on the use of this product, ask
your doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible
side effects</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>Like all medicines, Liprolog Mix50 can cause side effects, although
not everybody gets them.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><span
lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Local allergy</span><span
lang=EN-GB style='layout-grid-mode:line'> is common (</span><span lang=EN-GB
style='font-family:Symbol;layout-grid-mode:line'>&sup3;</span><span lang=EN-GB
style='layout-grid-mode:line'> 1/100 to &lt;1/10).</span><span lang=EN-GB>&nbsp;
Some people get redness, swelling or itching around the area of the insulin
injection. This usually clears up in anything from a few days to a few weeks.
If this happens to you, tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Systemic allergy
</span><span lang=EN-GB style='layout-grid-mode:line'>is rare (</span><span
lang=EN-GB style='font-family:Symbol;layout-grid-mode:line'>&sup3;</span><span
lang=EN-GB style='layout-grid-mode:line'> 1/10,000 to &lt;1/1,000)</span><span
lang=EN-GB>.</span><span lang=EN-GB> The symptoms are as follows:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash over the
whole body&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood
pressure dropping</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty in
breathing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart
beating fast</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; wheezing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sweating.</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>If you think
you are having this sort of insulin allergy with Liprolog Mix50, tell your
doctor at once.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Lipodystrophy
(thickening or pitting of the skin)<span style='layout-grid-mode:line'> is
uncommon (</span></span><span lang=EN-GB style='font-family:Symbol;layout-grid-mode:
line'>&sup3;</span><span lang=EN-GB style='layout-grid-mode:line'> 1/1,000 to
&lt;1/100)</span><span lang=EN-GB>. If you notice your skin thickening or
pitting at the injection site, tell your doctor.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Oedema (e.g. swelling in arms,
ankles; fluid retention) has been reported, particularly at the start of
insulin therapy or during a change in therapy to improve control of your blood
glucose.</p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Reporting of side effects</span></b></p>

<p class=BodytextAgency style='margin-bottom:0in'><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>If you get any
side effects, talk to your doctor or pharmacist.</span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'> This includes any
possible side effects not listed in this leaflet.</span><span lang=EN-GB
style='font-family:"Times New Roman",serif'> </span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>You can also
report side effects directly via <span style='background:silver'>the national
reporting system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>.
By reporting side effects you can help provide more information on the safety
of this medicine.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Common problems of diabetes</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>A. &nbsp;&nbsp;&nbsp;&nbsp; Hypoglycaemia</span></b><span
lang=EN-GB> </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hypoglycaemia (low blood sugar) means there is not enough sugar in
the blood. This can be caused if:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you take too much
Liprolog Mix50 or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you miss or delay
meals or change your diet;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you exercise or
work too hard just before or after a meal;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have an
infection or illness (especially diarrhoea or vomiting);</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; there is a change
in your need for insulin; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have trouble
with your kidneys or liver which gets worse.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Alcohol and some medicines can affect your blood sugar levels.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>The first symptoms of low blood sugar usually come on quickly and
include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tiredness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rapid
heartbeat</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nervousness or
shakiness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
sick</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cold
sweat.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>While you are not confident about recognising your warning symptoms,
avoid situations, e.g. driving a car, in which you or others would be put at
risk by hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>B. &nbsp;&nbsp;&nbsp;&nbsp; Hyperglycaemia and diabetic ketoacidosis</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia (too much sugar in the blood) means that your body
does not have enough insulin. Hyperglycaemia can be brought about by:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not taking your
Liprolog or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; taking less
insulin than your doctor tells you to;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eating a lot more
than your diet allows; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever, infection
or emotional stress.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia can lead to diabetic ketoacidosis. The first symptoms
come on slowly over many hours or days. The symptoms include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sleepy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; no
appetite</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flushed face&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fruity
smell on the breath</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thirst&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
or being sick.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Severe symptoms are heavy breathing and a rapid pulse.&nbsp; <b>Get
medical help immediately.</b></span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>C. &nbsp;&nbsp;&nbsp;&nbsp; Illness</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If you are ill, especially if you feel sick or are sick, the amount
of insulin you need may change. <b>Even when you are not eating normally, you
still need insulin.</b> Test your urine or blood, follow your &#8216;sick
rules&#8217;, and tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How
to store Liprolog Mix50 KwikPen</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Before the first use store your Liprolog Mix50 KwikPen in a
refrigerator (2</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C &#8211; 8</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C). Do not freeze. </span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep your Liprolog Mix50 KwikPen in use at room temperature (15&deg;
- 30&deg;C) and discard after 28 days. Do not put it near heat or in the sun.
Do not keep the KwikPen that you are using in the fridge. The KwikPen should
not be stored with the needle attached.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep out of the reach and sight of children.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog Mix50 KwikPen</span><span lang=EN-GB> after the
expiry date which is stated on the label and the carton. The expiry date refers
to the last day of that month. </span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog Mix50 KwikPen, </span><span lang=EN-GB>if clumps
of material are present or if solid white particles stick to the bottom or wall
of the cartridge, giving it a frosted appearance. Check each time you inject
yourself.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Medicines should not be disposed of via wastewater or household
waste. Ask your pharmacist how to dispose of medicines no longer required.
These measures will help to protect the environment.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What </span></b><b><span lang=EN-GB>Liprolog Mix50 100&nbsp;units/ml
KwikPen, suspension for injection contains</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The active substance is insulin lispro. </span><span
lang=EN-GB>Insulin lispro is made in the laboratory by a &#8216;recombinant DNA
technology&#8217; process. It is a changed form of human insulin and so is
different from other human and animal insulins. Insulin lispro is closely
related to human insulin which is a natural hormone made by the pancreas.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The other ingredients are</span><span
lang=EN-GB> protamine sulphate, m-cresol, phenol, glycerol, dibasic sodium
phosphate&nbsp;7H<span style='position:relative;top:2.0pt'>2</span>O, zinc
oxide and water for injection.&nbsp; Sodium hydroxide or hydrochloric acid may
have been used to adjust the acidity.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What </span></b><b><span lang=EN-GB>Liprolog Mix50 100&nbsp;units/ml
KwikPen, suspension for injection looks like and contents of the pack</span></b></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>Liprolog Mix50
100&nbsp;units/ml KwikPen, suspension for injection </span><span lang=EN-GB>is
a white, sterile suspension and contains 100 units of insulin lispro in each
millilitre (100&nbsp;units/ml) suspension for injection.&nbsp; 50% of the
insulin lispro in Liprolog Mix50 is dissolved in water.&nbsp; 50% of the
insulin lispro in Liprolog Mix50 is available in a suspension together with
protamine sulphate. Each Liprolog Mix50 KwikPen contains 300 units (3
millilitres). The Liprolog Mix50 KwikPen comes in a pack of 5 pre-filled pens
or a multipack of 2 x 5 pre-filled pens. </span>Not all pack sizes may be
marketed.<span lang=EN-GB> The Liprolog Mix50 in your pre-filled pen is the
same as the Liprolog Mix50, which comes in separate Liprolog Mix50 cartridges.
The KwikPen simply has a built in cartridge. When the pre-filled pen is empty
you cannot use it again.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><u><span
 style='text-decoration:none'>&nbsp;</span></u></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Marketing Authorisation Holder and Manufacturer</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Liprolog Mix50 100&nbsp;units/ml KwikPen, suspension for injection</span><span
lang=EN-GB> is made by:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Lilly France S.A.S., Rue du Colonel Lilly, 67640
  Fegersheim, France,</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=IT>Eli Lilly Italia S.p.A., Via &nbsp;Gramsci 731-733,
50019 Sesto Fiorentino, (FI) Italy.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The product
licence is held by: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ
Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>For any information about this medicinal product, please contact the
local representative of the Marketing Authorisation Holder:</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=624
 style='margin-left:-1.7pt;border-collapse:collapse'>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>Belgique/Belgi&euml;/Belgien</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Lietuva</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited atstovyb&#279;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel. +370 (5) 2649600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=BG>&#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1058;&#1055;
  &quot;&#1045;&#1083;&#1080; &#1051;&#1080;&#1083;&#1080;
  &#1053;&#1077;&#1076;&#1077;&#1088;&#1083;&#1072;&#1085;&#1076;&quot;
  &#1041;.&#1042;. - &#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1090;&#1077;&#1083;.
  + 359 2 491 41 40</span></p>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>&nbsp;</span></b></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Luxembourg/Luxemburg</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#268;esk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>ELI
  LILLY &#268;R, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 420 234 664 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Magyarorsz&aacute;g</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Lilly
  Hung&aacute;ria Kft.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 36 1 328 5100</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Danmark</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Danmark A/S </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  +45 45 26 6000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Malta</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Charles de Giorgio Ltd.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 356 25600 500</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Deutschland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Berlin-Chemie AG</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Postfach
  1108,&nbsp; 12474 Berlin</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=DE>Tel.: 030/6707-0</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DA
  style='color:black'>Nederland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DA
  style='color:black'>Eli Lilly Nederland B.V. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 31-(0) 30 60 25 800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  style='color:black'>Eesti</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Eli Lilly Holdings Limited Eesti filiaal </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>372 6817 280</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=NO-BOK
  style='color:black'>Norge</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=NO-BOK
  style='color:black'>Eli Lilly Norge A.S. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  + 47 22 88 18 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#917;&#955;&#955;&#940;&#948;&#945;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#934;&#913;&#929;&#924;&#913;&#931;&#917;&#929;&#914;-&#923;&#921;&#923;&#923;&#933;
  &#913;.&#917;.&#914;.&#917;. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +30 210 629 4600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>&Ouml;sterreich</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Ges. m.b.H. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 43-(0) 1 711 780</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Espa&ntilde;a</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Lilly S.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Tel: + 34-91 663 50 00</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=SV style='color:black'>Polska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Eli Lilly Polska Sp. z o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  +48 22 440 33 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>France</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Lilly France S.A.S.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>T&eacute;l: +33-(0) 1 55 49 34 34</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=PT-BR
  style='color:black'>Portugal</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=PT-BR
  style='color:black'>Lilly Portugal - Produtos Farmac&ecirc;uticos, Lda</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 351-21-4126600</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=ES>Hrvatska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Eli Lilly
  Hrvatska d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Tel: +385 1
  2350 999</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=IT>Rom&acirc;nia</span></b></p>
  <p class=MsoNormal><span lang=RO>Eli Lilly Rom&acirc;nia S.R.L.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=RO>Tel: + 40 21
  4023000</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b>Ireland</b></p>
  <p class=MsoNormal style='text-autospace:none'>Eli Lilly and Company (Ireland) Limited</p>
  <p class=MsoNormal style='text-autospace:none'>Tel: + 353-(0) 1 661 4377</p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR>Slovenija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR>Eli Lilly
  farmacevtska dru&#382;ba, d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Tel: +386 (0) 1
  580 00 10</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&Iacute;sland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Icepharma
  hf. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>S&iacute;mi
  + 354 540 8000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Slovensk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Slovakia, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 421 220 663 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=IT
  style='color:black'>Italia</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=IT
  style='color:black'>Eli Lilly Italia S.p.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 39- 055 42571</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=SV
  style='color:black'>Suomi/Finland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Oy Eli Lilly Finland Ab </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Puh/Tel:
  + 358-(0) 9 85 45 250</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#922;&#973;&#960;&#961;&#959;&#962;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Phadisco
  Ltd </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +357 22 715000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Sverige</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Sweden AB</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Tel: + 46-(0) 8 7378800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Latvija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited p&#257;rst&#257;vniec&#299;ba Latvij&#257;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>371 67364000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>United
    Kingdom</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly and Company Limited</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 44-(0) 1256 315000</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>This leaflet was last revised in </span></b><span lang=EN-GB>{MM/YYYY}.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>USER MANUAL</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Please see
manual text later.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Detailed information on this medicine is available on the European
Medicines Agency web site: http://www.ema.europa.eu/</span><span lang=EN-GB>.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>PACKAGE LEAFLET: INFORMATION FOR THE USER</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=DA>Liprolog Basal 100&nbsp;units/ml KwikPen, suspension for injection in a
pre-filled pen</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>insulin lispro</span></b></p>

<p class=MsoNormal align=center style='margin-right:-2.25pt;text-align:center;
line-height:normal'><b><span lang=EN-GB>Each </span><span lang=EN-GB>KwikPen </span></b><b><span
lang=EN-GB>delivers 1 &#8211; 60 units in steps of 1 units.</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>Read all of this leaflet carefully before you start
using this medicine because it contains important information for you.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Keep this leaflet. You may need to read it
again.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of illness are
the same as yours.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you get any side effects, talk to your doctor
or pharmacist.</span><span lang=EN-GB> This includes any possible side effects
not listed in this leaflet. See section 4.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What is in this leaflet</span></b><span lang=EN-GB>: </span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Liprolog Basal KwikPen
is and what it is used for</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you use Liprolog Basal KwikPen </span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to use Liprolog Basal
KwikPen</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible side effects</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store Liprolog Basal
KwikPen</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Liprolog Basal KwikPen
is and what it is used for</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog Basal
KwikPen is used to treat diabetes. Its active substance is insulin lispro. The
insulin lispro in Liprolog Basal KwikPen is available in a suspension together
with protamine sulphate, so that its action is prolonged.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>You get diabetes if your pancreas does not make enough insulin to
control the level of glucose in your blood. Liprolog Basal is a substitute for
your own insulin and is used to control glucose in the long term. Liprolog
Basal has a prolonged mode of action compared to soluble insulin</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>Your doctor may tell you to use Liprolog Basal as well as a
fast-acting insulin. Each kind of insulin comes with another patient
information leaflet to tell you about it. Do not change your insulin unless
your doctor tells you to. Be very careful if you do change insulin.</span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The KwikPen is a
disposable pre-filled pen containing 3 ml (300 units, 100 units/ml) of insulin
lispro.&nbsp; One KwikPen contains multiple doses of insulin.&nbsp; The KwikPen
dials 1 unit at a time. <b>The number of units are displayed in the dose
window, always check this before your injection. </b>You can give from 1 to 60
units in a single injection.&nbsp; <b>If your dose is more than 60 units, you
will need to give yourself more than one injection. </b></span></p>

<p class=MsoNormal style='margin-right:8.5pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you use Liprolog<span style='text-transform:uppercase'> </span>Basal KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Do NOT use
Liprolog Basal KwikPen</span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you think <b>hypoglycaemia</b> (low blood
sugar) is starting. Further in this leaflet it tells you how to deal with mild
hypoglycaemia (see Section 3: If you take more Liprolog Basal than you need).</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you are <b>allergic</b> (hypersensitive) to
insulin lispro or any of the other ingredients of this medicine (listed in
section 6).</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Warnings and precautions</span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If your blood sugar levels are well controlled
by your current insulin therapy, you may not feel the warning symptoms when
your blood sugar is falling too low. Warning signs are listed later in this
leaflet.&nbsp; You must think carefully about when to have your meals, how
often to exercise and how much to do. You must also keep a close watch on your
blood sugar levels by testing your blood glucose often.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>A few people who have had hypoglycaemia after
switching from animal insulin to human insulin have reported that the early
warning symptoms were less obvious or different. If you often have<b> </b>hypoglycaemia
or have difficulty recognising them, please discuss this with your doctor.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you answer YES to any of the following
questions, tell your doctor, pharmacist or diabetes nurse</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have
you recently become ill?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do
you have trouble with your kidneys or liver?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are you exercising more than usual?</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The amount of insulin you need may also change
if you drink alcohol.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You should also tell your doctor, pharmacist or
diabetes nurse if you are planning to go abroad.&nbsp; The time difference
between countries may mean that you have to have your injections and meals at
different times from when you are at home.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Some patients with long-standing type 2 diabetes
mellitus and heart disease or previous stroke who were treated with pioglitazone
and insulin experienced the development of heart failure. Inform your doctor as
soon as possible if you experience signs of heart failure such as unusual
shortness of breath or rapid increase in weight or localised swelling (oedema).</span></p>

<p class=PPILabelingBodyText style='margin-left:.25in;text-indent:-.25in'><span
style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-family:"Times New Roman",serif'>This Pen is not
recommended for use by the blind or visually impaired without the help of
someone trained to use the Pen.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Other medicines and Liprolog Basal KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Your insulin needs may change if you are taking </span></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>the contraceptive pill, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>steroids, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>thyroid hormone replacement therapy, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>oral hypoglycaemics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>acetyl salicylic acid, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>sulpha antibiotics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>octreotide, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>&#8220;beta<sub>2</sub> stimulants&#8221; (for example
     ritodrine, salbutamol or terbutaline), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>beta-blockers, or </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some antidepressants (monoamine oxidase inhibitors or selective
     serotonin reuptake inhibitors), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>danazol, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some angiotensin converting enzyme (ACE) inhibitors (for
     example captopril, enalapril), and </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>angiotensin <span class=Heading5Char><span style='font-weight:
     normal'>II</span> </span>receptor blockers.</span></li>
</ul>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Please tell your doctor, if you are taking or have recently taken
any other medicines, including medicines obtained without a prescription </span>(see
section &#8220;<span lang=EN-GB>Warnings and precautions</span>&#8221;)<span
lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Pregnancy and breast-feeding</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Are you pregnant or thinking about becoming pregnant, or are you
breast-feeding? The amount of insulin you need usually falls during the first
three months of pregnancy and increases for the remaining six months. If you
are breast-feeding, you may need to alter your insulin intake or diet.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Ask your doctor
for advice.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Driving and using machines</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Your ability to concentrate and react may be reduced if you have
hypoglycaemia. Please keep this possible problem in mind in all situations
where you might put yourself and others at risk (e.g. driving a car or
operating machinery). You should contact your doctor about the advisability of
driving if you have:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>frequent episodes of hypoglycaemia</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>reduced or absent warning signs of hypoglycaemia</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to use Liprolog Basal
KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><b><span
lang=EN-GB>Always check the pack and the label of the pre-filled pen for the
name and type of the insulin when you get it from your pharmacy. Make sure you
get the Liprolog Basal KwikPen that your doctor has told you to use.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Always use Liprolog Basal KwikPen exactly as your doctor has told
you. You should check with your doctor if you are not sure.</span> To prevent
the possible transmission of disease, each pen must be used by you only, even
if the needle is changed.</p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><b><span
lang=EN-GB>Dosage</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You
should normally inject Liprolog Basal as your basal insulin.&nbsp; But your
doctor will have told you exactly how much to use, when to use it, and how
often.&nbsp; These instructions are only for you.&nbsp; Follow them exactly and
visit your diabetes clinic regularly.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If
you change the type of insulin you use (for example from a human or animal
insulin to a Liprolog product), you may have to take more or less than
before.&nbsp; This might just be for the first injection or it may be a gradual
change over several weeks or months. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inject
Liprolog Basal under the skin. You should not administer it using a different
administration route. Under no circumstances should Liprolog Basal be given
intravenously.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><b><span
lang=EN-GB>Preparing Liprolog Basal KwikPen</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
KwikPen should be rotated in the palms of the hands ten times and inverted
180&deg; ten times immediately before use to resuspend insulin until it appears
uniformly cloudy or milky. If not, repeat the above procedure until contents
are mixed.&nbsp; Cartridges contain a small glass bead to assist mixing.&nbsp;
Do not shake vigorously as this may cause frothing which may interfere with the
correct measurement of the dose. The cartridges should be examined frequently
and should not be used if clumps of material are present or if solid white
particles stick to the bottom or wall of the cartridge, giving it a frosted
appearance. Check each time you inject yourself.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:5.65pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Getting the KwikPen ready to use (Please see user manual)</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>First wash your hands.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Read the instructions on how to use your
pre-filled insulin pen.&nbsp; Please follow the instructions carefully. Here
are some reminders.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Use a clean needle.&nbsp; (Needles are not
included).</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Prime your KwikPen before each use. This checks
that insulin comes out and clears the air bubbles from your KwikPen.&nbsp;
There may still be some small air bubbles left in the pen - these are
harmless.&nbsp; But if the air bubbles are too large it may affect the insulin
dose.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Injecting Liprolog Basal</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Before you make an injection, clean your skin as
you have been instructed.&nbsp; Inject under the skin, as you were
taught.&nbsp; Do not inject directly into a vein.&nbsp; After your injection,
leave the needle in the skin for five seconds to make sure you have taken the
whole dose.&nbsp; Do not rub the area you have just injected.&nbsp; Make sure
you inject at least half an inch (1&nbsp;cm) from where you last injected and
that you &#8216;rotate&#8217; the places you inject, as you have been taught.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>After injecting</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>As soon as you have done the injection, unscrew
the needle from the KwikPen using the outer needle cap.&nbsp; This will keep
the insulin sterile and stop it leaking.&nbsp; It also stops air entering the
pen and your needle clogging<b>.&nbsp; Do not share your needles</b>.&nbsp; <u>Do
not share your pen</u>.&nbsp; Replace the cap on the pen.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Further injections</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Every time you use a KwikPen you must use a new
needle.&nbsp; Before every injection, clear any air bubbles.&nbsp; You can see
how much insulin is left by holding the KwikPen with the needle pointing up.&nbsp;
The scale on the cartridge shows about how many units you have left.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Do not mix any other insulin in your disposable
pen.&nbsp; Once the KwikPen is empty, do not use it again.&nbsp; Please get rid
of it carefully - your pharmacist or diabetes nurse will tell you how to do
this.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>If you take more Liprolog Basal than you need</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>If you take more Liprolog Basal than
you need, a low blood sugar may occur.&nbsp; </span>Check your blood sugar. </p>

<p class=MsoBodyText3 align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>If your blood sugar is low <b>(mild
hypoglycaemia)</b>, eat glucose tablets, sugar or drink a sugary drink. Then
eat fruit, biscuits, or a sandwich, as your doctor has advised you and have
some rest. This will often get you over mild hypoglycaemia or a minor insulin
overdose. If you get worse and your breathing is shallow and your skin gets
pale, tell your doctor at once. A glucagon injection can treat quite severe
hypoglycaemia. Eat glucose or sugar after the glucagon injection. If you do not
respond to glucagon, you will have to go to hospital. Ask your doctor to tell
you about glucagon.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you forget to use Liprolog Basal</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog Basal than you need, a high blood sugar
may occur.&nbsp; </span>Check your blood sugar<span class=MsoCommentReference><span
lang=EN-GB style='display:none'>.</span></span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If hypoglycaemia (low blood sugar) or hyperglycaemia (high blood
sugar) is not treated they can be very serious and cause headaches, nausea,
vomiting, dehydration, unconsciousness, coma or even death (see A and B in
section 4 &#8220;Possible Side Effects&#8221;). </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><b><span
lang=EN-GB>Three simple steps </span></b><span lang=EN-GB>to avoid
hypoglycaemia or hyperglycaemia are:</span></p>

<p class=MsoBlockText align=left style='text-align:left'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
keep spare syringes and a spare vial of Liprolog Basal, or a spare pen and
cartridges, in case you lose your KwikPen or it gets damaged.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always carry
something to show you are diabetic.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always carry sugar
with you.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you stop using Liprolog Basal.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog Basal than you need, a high blood sugar
may occur. Do not change your insulin unless your doctor tells you to.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you have any further questions on the use of this product, ask
your doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible
side effects</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>Like all medicines, Liprolog Basal can cause side effects, although
not everybody gets them.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><span
lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Local allergy</span><span lang=EN-GB style='layout-grid-mode:line'>
is common (</span><span lang=EN-GB style='font-family:Symbol;layout-grid-mode:
line'>&sup3;</span><span lang=EN-GB style='layout-grid-mode:line'> 1/100 to
&lt;1/10).</span><span lang=EN-GB>&nbsp; Some people get redness, swelling or
itching around the area of the insulin injection. This usually clears up in
anything from a few days to a few weeks. If this happens to you, tell your
doctor.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><i><span
lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Systemic allergy </span><span lang=EN-GB style='layout-grid-mode:
line'>is rare (</span><span lang=EN-GB style='font-family:Symbol;layout-grid-mode:
line'>&sup3;</span><span lang=EN-GB style='layout-grid-mode:line'> 1/10,000 to
&lt;1/1,000)</span><span lang=EN-GB>.</span><span lang=EN-GB> The symptoms are
as follows:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash over the
whole body&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood
pressure dropping</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty in
breathing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart
beating fast</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; wheezing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sweating</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>If you think you are having this sort of insulin allergy with
Liprolog Basal, tell your doctor at once.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Lipodystrophy (thickening or pitting of the skin)<span
style='layout-grid-mode:line'> is uncommon (</span></span><span lang=EN-GB
style='font-family:Symbol;layout-grid-mode:line'>&sup3;</span><span lang=EN-GB
style='layout-grid-mode:line'> 1/1,000 to &lt;1/100)</span><span lang=EN-GB>.
If you notice your skin thickening or pitting at the injection site, tell your
doctor.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'>&nbsp;</p>

<p class=MsoNormal style='line-height:normal'>Oedema (e.g. swelling in arms,
ankles; fluid retention) has been reported, particularly at the start of
insulin therapy or during a change in therapy to improve control of your blood
glucose.</p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Reporting of side effects</span></b></p>

<p class=BodytextAgency style='margin-bottom:0in'><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>If you get any
side effects, talk to your doctor or pharmacist.</span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'> This includes any
possible side effects not listed in this leaflet.</span><span lang=EN-GB
style='font-family:"Times New Roman",serif'> </span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>You can also
report side effects directly via <span style='background:silver'>the national
reporting system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>.
By reporting side effects you can help provide more information on the safety
of this medicine.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Common problems of diabetes</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>A. &nbsp;&nbsp;&nbsp;&nbsp; Hypoglycaemia</span></b><span
lang=EN-GB> </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hypoglycaemia (low blood sugar) means there is not enough sugar in
the blood. This can be caused if:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you take too much
Liprolog Basal or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you miss or delay
meals or change your diet;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you exercise or
work too hard just before or after a meal;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have an
infection or illness (especially diarrhoea or vomiting);</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; there is a change
in your need for insulin; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have trouble
with your kidneys or liver which gets worse.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Alcohol and some medicines can affect your blood sugar levels.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>The first symptoms of low blood sugar usually come on quickly and
include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tiredness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rapid
heartbeat</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nervousness or
shakiness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
sick</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cold
sweat</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>While you are not confident about recognising your warning symptoms,
avoid situations, e.g. driving a car, in which you or others would be put at
risk by hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>B. &nbsp;&nbsp;&nbsp;&nbsp; Hyperglycaemia and diabetic ketoacidosis</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia (too much sugar in the blood) means that your body
does not have enough insulin. Hyperglycaemia can be brought about by:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not taking your
Liprolog or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; taking less
insulin than your doctor tells you to;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eating a lot more
than your diet allows; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever, infection
or emotional stress.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia can lead to diabetic ketoacidosis. The first symptoms
come on slowly over many hours or days. The symptoms include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sleepy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; no
appetite</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flushed face&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fruity
smell on the breath</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thirst&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
or being sick</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Severe symptoms are heavy breathing and a rapid pulse.&nbsp; <b>Get
medical help immediately.</b></span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>C. &nbsp;&nbsp;&nbsp;&nbsp; Illness</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If you are ill, especially if you feel sick or are sick, the amount
of insulin you need may change. <b>Even when you are not eating normally, you
still need insulin.</b> Test your urine or blood, follow your &#8216;sick
rules&#8217;, and tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store
Liprolog Basal KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Before the first use store your Liprolog Basal KwikPen in a
refrigerator (2</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C &#8211; 8</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C). Do not freeze. </span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep your Liprolog Basal KwikPen in use at room temperature (15&deg;
- 30&deg;C) and discard after 21 days. Do not put it near heat or in the sun.
Do not keep the KwikPen that you are using in the fridge. The KwikPen should
not be stored with the needle attached.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep out of the reach and sight of children.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog Basal KwikPen</span><span lang=EN-GB> after the
expiry date which is stated on the label and the carton. The expiry date refers
to the last day of that month. </span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog Basal KwikPen, </span><span lang=EN-GB>if clumps
of material are present or if solid white particles stick to the bottom or wall
of the cartridge, giving it a frosted appearance. Check each time you inject
yourself.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Medicines should not be disposed of via wastewater or household
waste. Ask your pharmacist how to dispose of medicines no longer required.
These measures will help to protect the environment.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What </span></b><b><span lang=EN-GB>Liprolog Basal 100&nbsp;units/ml
KwikPen, suspension for injection contains</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The active substance is insulin lispro. </span><span
lang=EN-GB>Insulin lispro is made in the laboratory by a &#8216;recombinant DNA
technology&#8217; process. It is a changed form of human insulin and so is
different from other human and animal insulins. Insulin lispro is closely
related to human insulin which is a natural hormone made by the pancreas.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The other ingredients are</span><span
lang=EN-GB> protamine sulphate, m-cresol, phenol, glycerol, dibasic sodium
phosphate&nbsp;7H<span style='position:relative;top:2.0pt'>2</span>O, zinc
oxide and water for injection.&nbsp; Sodium hydroxide or hydrochloric acid may
have been used to adjust the acidity.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What </span></b><b><span lang=EN-GB>Liprolog Basal 100&nbsp;units/ml
KwikPen, suspension for injection looks like and contents of the pack</span></b></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>Liprolog Basal 100&nbsp;units/ml </span><span lang=EN-GB>KwikPen,
suspension for injection is a white, sterile suspension and contains 100 units
of insulin lispro in each millilitre (100&nbsp;units/ml) suspension for
injection.&nbsp; The insulin lispro in Liprolog Basal is available in a
suspension together with protamine sulphate.&nbsp; Each Liprolog Basal KwikPen contains
300 units (3 millilitres). The Liprolog Basal KwikPen comes in a pack of 5
pre-filled pens or a multipack of 2 x 5 pre-filled pens. </span>Not all pack
sizes may be marketed.<span lang=EN-GB> The Liprolog Basal in your KwikPen is
the same as the Liprolog Basal, which comes in separate Liprolog Basal
cartridges. The KwikPen simply has a built in cartridge. When the KwikPen is
empty you cannot use it again.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Marketing Authorisation Holder and Manufacturer</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Liprolog Basal 100&nbsp;units/ml KwikPen, suspension for injection</span><span
lang=EN-GB> is made by:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Lilly France S.A.S., Rue du Colonel Lilly, 67640
Fegersheim, France</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The product
licence is held by: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ
Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>For any information about this medicinal product, please contact the
local representative of the Marketing Authorisation Holder:</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=624
 style='margin-left:-1.7pt;border-collapse:collapse'>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>Belgique/Belgi&euml;/Belgien</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Lietuva</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited atstovyb&#279;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel. +370 (5) 2649600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=BG>&#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1058;&#1055;
  &quot;&#1045;&#1083;&#1080; &#1051;&#1080;&#1083;&#1080;
  &#1053;&#1077;&#1076;&#1077;&#1088;&#1083;&#1072;&#1085;&#1076;&quot;
  &#1041;.&#1042;. - &#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1090;&#1077;&#1083;.
  + 359 2 491 41 40</span></p>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>&nbsp;</span></b></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Luxembourg/Luxemburg</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#268;esk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>ELI
  LILLY &#268;R, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 420 234 664 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Magyarorsz&aacute;g</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Lilly
  Hung&aacute;ria Kft.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 36 1 328 5100</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Danmark</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Danmark A/S </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  +45 45 26 6000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Malta</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Charles de Giorgio Ltd.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 356 25600 500</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Deutschland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Berlin-Chemie AG</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Postfach
  1108,&nbsp; 12474 Berlin</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=DE>Tel.: 030/6707-0</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DA
  style='color:black'>Nederland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DA
  style='color:black'>Eli Lilly Nederland B.V. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 31-(0) 30 60 25 800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  style='color:black'>Eesti</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Eli Lilly Holdings Limited Eesti filiaal </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>372 6817 280</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=NO-BOK
  style='color:black'>Norge</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=NO-BOK
  style='color:black'>Eli Lilly Norge A.S. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  + 47 22 88 18 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  style='color:black'>&#917;&#955;&#955;&#940;&#948;&#945;</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>&#934;&#913;&#929;&#924;&#913;&#931;&#917;&#929;&#914;-&#923;&#921;&#923;&#923;&#933;
  &#913;.&#917;.&#914;.&#917;. </span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>&#932;&#951;&#955;</span><span lang=EN-GB
  style='color:black'>: +30 210 629 4600</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=ES style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=DE style='color:black'>&Ouml;sterreich</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=DE style='color:black'>Eli Lilly Ges. m.b.H. </span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Tel: + 43-(0) 1 711 780</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Espa&ntilde;a</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Lilly S.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Tel: + 34-91 663 50 00</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=SV style='color:black'>Polska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Eli Lilly Polska Sp. z o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  +48 22 440 33 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>France</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Lilly France S.A.S.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>T&eacute;l: +33-(0) 1 55 49 34 34</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=PT-BR
  style='color:black'>Portugal</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=PT-BR
  style='color:black'>Lilly Portugal - Produtos Farmac&ecirc;uticos, Lda</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 351-21-4126600</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=ES>Hrvatska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Eli Lilly
  Hrvatska d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Tel: +385 1
  2350 999</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=IT>Rom&acirc;nia</span></b></p>
  <p class=MsoNormal><span lang=RO>Eli Lilly Rom&acirc;nia S.R.L.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=RO>Tel: + 40 21
  4023000</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b>Ireland</b></p>
  <p class=MsoNormal style='text-autospace:none'>Eli Lilly and Company (Ireland) Limited</p>
  <p class=MsoNormal style='text-autospace:none'>Tel: + 353-(0) 1 661 4377</p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR>Slovenija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR>Eli Lilly
  farmacevtska dru&#382;ba, d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Tel: +386 (0) 1
  580 00 10</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&Iacute;sland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Icepharma
  hf. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>S&iacute;mi
  + 354 540 8000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Slovensk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Slovakia, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 421 220 663 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=IT
  style='color:black'>Italia</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=IT
  style='color:black'>Eli Lilly Italia S.p.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 39- 055 42571</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=SV
  style='color:black'>Suomi/Finland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Oy Eli Lilly Finland Ab </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Puh/Tel:
  + 358-(0) 9 85 45 250</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#922;&#973;&#960;&#961;&#959;&#962;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Phadisco
  Ltd </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +357 22 715000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Sverige</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Sweden AB</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Tel: + 46-(0) 8 7378800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Latvija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited p&#257;rst&#257;vniec&#299;ba Latvij&#257;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>371 67364000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>United
    Kingdom</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly and Company Limited</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 44-(0) 1256 315000</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=ES>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>This leaflet was last revised in </span></b><span lang=EN-GB>{MM/YYYY}.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>USER MANUAL</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Please see manual text later.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Detailed information on this medicine is available on the European
Medicines Agency web site: http://www.ema.europa.eu/.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB>USER
MANUAL</span></b></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB>KwikPen
pre-filled insulin pen</span></b></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB>100&nbsp;units/ml</span></b></p>

<p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal>

<table cellpadding=0 cellspacing=0 align=left>
 <tr>
  <td width=67 height=0></td>
 </tr>
 <tr>
  <td></td>
  <td><img width=470 height=1 src="Humalo_files/image011.jpg"></td>
 </tr>
</table>

<br clear=ALL>
</p>

<h1 style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:
0in;text-indent:0in'><span style='font-size:11.0pt;color:red;letter-spacing:
-.1pt'>PLEASE</span><span style='font-size:11.0pt;color:red;letter-spacing:
.15pt'> </span><span style='font-size:11.0pt;color:red;letter-spacing:-.15pt'>READ</span><span
style='font-size:11.0pt;color:red;letter-spacing:-.05pt'> THIS USER MANUAL
BEFORE USE</span></h1>

<h1 style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:
0in'><span style='font-size:11.0pt;font-weight:normal'>&nbsp;</span></h1>

<h3 style='margin-top:0in;background:white'><span style='font-size:11.0pt;
color:black;font-weight:normal'>Read<span style='letter-spacing:.05pt'> </span>the<span
style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>User
Manual before you start taking</span><span style='letter-spacing:.15pt'> </span><span
style='letter-spacing:-.05pt'>your</span><span style='letter-spacing:-.1pt'> </span><span
style='letter-spacing:-.05pt'>insulin</span><span style='letter-spacing:.15pt'>
</span><span style='letter-spacing:-.05pt'>and</span> each<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>time
you get</span><span style='letter-spacing:-.15pt'> </span>another<span
style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>KwikPen.</span><span
style='letter-spacing:1.85pt'> </span><span style='letter-spacing:-.05pt'>There
may be new information.</span><span style='letter-spacing:-.15pt'> </span><span
style='letter-spacing:-.05pt'>This information does not take the place of talking
to your</span><span style='letter-spacing:.05pt'> </span><span
style='letter-spacing:-.05pt'>healthcare</span> <span style='letter-spacing:
-.05pt'>professional</span><span style='letter-spacing:1.7pt'> </span><span
style='letter-spacing:-.05pt'>about your medical condition or your treatment.</span></span></h3>

<h3 style='margin-top:0in;background:white'><span style='font-size:11.0pt'>&nbsp;</span></h3>

<p class=MsoNormal><span lang=EN-GB style='letter-spacing:-.05pt'>KwikPen
(&#8220;Pen&#8221;) is </span><span lang=EN-GB>a <span style='letter-spacing:
-.05pt'>disposable</span><span style='letter-spacing:.15pt'> </span><span
style='letter-spacing:-.05pt'>pre-filled</span> <span style='letter-spacing:
-.05pt'>pen containing 3ml (300</span><span style='letter-spacing:-.1pt'>&nbsp;</span><span
style='letter-spacing:-.05pt'>units, 100&nbsp;units/ml)</span><span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:.1pt'> </span><span
style='letter-spacing:-.05pt'>insulin.</span><span style='letter-spacing:-.15pt'>
</span><span style='letter-spacing:-.05pt'>You can give yourself multiple</span><span
style='letter-spacing:1.8pt'> </span><span style='letter-spacing:-.05pt'>doses
using one Pen. The Pen dials</span> 1<span style='letter-spacing:-.1pt'> </span><span
style='letter-spacing:-.05pt'>unit</span><span style='letter-spacing:.05pt'> </span><span
style='letter-spacing:-.05pt'>at</span> a <span style='letter-spacing:-.05pt'>time.</span><span
style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>You
can</span><span style='letter-spacing:-.25pt'> </span>give<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.05pt'>from</span><span
style='letter-spacing:.05pt'> </span>1<span style='letter-spacing:-.1pt'> </span><span
style='letter-spacing:-.05pt'>to</span> <span style='letter-spacing:-.1pt'>60&nbsp;</span><span
style='letter-spacing:-.05pt'>units in </span>a<span style='letter-spacing:
-.05pt'> single</span><span style='letter-spacing:.15pt'> </span><span
style='letter-spacing:-.1pt'>injection.</span><span style='letter-spacing:.1pt'>
</span><b><span style='letter-spacing:-.15pt'>If</span><span style='letter-spacing:
2.4pt'> </span><span style='letter-spacing:-.05pt'>your</span><span
style='letter-spacing:-.1pt'> </span><span style='letter-spacing:-.05pt'>dose</span><span
style='letter-spacing:-.1pt'> </span><span style='letter-spacing:-.05pt'>is</span>
<span style='letter-spacing:-.05pt'>more than</span> <span style='letter-spacing:
.05pt'>60</span><span style='letter-spacing:.15pt'> </span><span
style='letter-spacing:-.1pt'>units,</span><span style='letter-spacing:-.05pt'>
you will need to give yourself more than one injection.</span><span
style='letter-spacing:.05pt'> </span></b><span style='letter-spacing:-.05pt'>The
plunger</span><span style='letter-spacing:1.7pt'> </span><span
style='letter-spacing:-.05pt'>only moves </span>a<span style='letter-spacing:
-.05pt'> little with each injection, and you may not notice that it moves. The
plunger will only reach the</span><span style='letter-spacing:1.9pt'> </span><span
style='letter-spacing:-.05pt'>end of the cartridge when you have used all</span><span
style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>300</span><span
style='letter-spacing:-.1pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>units
in the Pen.</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<h1 style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:
0in;text-indent:0in'><span style='font-size:11.0pt;text-transform:none;
letter-spacing:-.05pt'>Do not share your pen with</span><span style='font-size:
11.0pt'> </span><span style='font-size:11.0pt;text-transform:none;letter-spacing:
-.05pt'>other people, even if the needle has been </span><span
style='font-size:11.0pt;text-transform:none;letter-spacing:-.1pt'>changed.</span><span
style='font-size:11.0pt;letter-spacing:.1pt'> </span><span style='font-size:
11.0pt;text-transform:none;letter-spacing:-.05pt'>Do not reuse or share</span><span
style='font-size:11.0pt;letter-spacing:2.4pt'> </span><span style='font-size:
11.0pt;text-transform:none;letter-spacing:-.05pt'>needles with other people.</span><span
style='font-size:11.0pt'> </span><span style='font-size:11.0pt;text-transform:
none;letter-spacing:-.05pt'>You may give an infection to them or get an
infection from </span><span style='font-size:11.0pt;text-transform:none;
letter-spacing:-.1pt'>them.</span></h1>

<h3 style='margin-top:0in'><span style='font-size:11.0pt;letter-spacing:-.05pt;
font-weight:normal'>This Pen is not recommended for use by the blind or
visually impaired without the</span><span style='font-size:11.0pt;font-weight:
normal'> <span style='letter-spacing:-.05pt'>help of someone trained to</span><span
style='letter-spacing:1.9pt'> </span>use the <span style='letter-spacing:-.1pt'>Pen.&nbsp;
</span></span></h3>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;border-collapse:collapse'>
 <tr style='height:26.8pt'>
  <td width=619 nowrap colspan=10 valign=top style='width:464.35pt;padding:
  0in 5.4pt 0in 5.4pt;height:26.8pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  lang=EN-GB>KwikPen Parts</span></b></p>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  lang=EN-GB>&nbsp;</span></b></p>
  </td>
 </tr>
 <tr style='height:13.65pt'>
  <td width=187 nowrap valign=bottom style='width:140.15pt;padding:0in 5.4pt 0in 5.4pt;
  height:13.65pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>Cap
  Clip</span></p>
  </td>
  <td width=156 nowrap colspan=3 valign=bottom style='width:116.75pt;
  padding:0in 5.4pt 0in 5.4pt;height:13.65pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  Cartridge Holder</span></p>
  </td>
  <td width=100 nowrap colspan=3 valign=bottom style='width:75.15pt;padding:
  0in 5.4pt 0in 5.4pt;height:13.65pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>Label</span></p>
  </td>
  <td width=176 nowrap colspan=3 valign=bottom style='width:132.3pt;padding:
  0in 5.4pt 0in 5.4pt;height:13.65pt'>
  <p class=MsoNormal><span lang=EN-GB>&nbsp;&nbsp; Dose Indicator</span></p>
  </td>
 </tr>
 <tr style='height:55.5pt'>
  <td width=531 colspan=9 style='width:398.35pt;padding:0in 5.4pt 0in 5.4pt;
  height:55.5pt'>
  <p class=MsoNormal align=center style='text-align:center'><span
  style='position:relative;z-index:251648000'><span style='left:0px;position:
  absolute;left:32px;top:-159491px;width:492px;height:1px'><img width=492
  height=1 src="Humalo_files/image012.jpg"></span></span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=88 style='width:66.0pt;padding:0in 5.4pt 0in 5.4pt;height:55.5pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>Dose
  Knob</span></p>
  </td>
 </tr>
 <tr style='height:40.9pt'>
  <td width=196 nowrap colspan=2 valign=top style='width:147.15pt;padding:0in 5.4pt 0in 5.4pt;
  height:40.9pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:1.65pt;
  margin-bottom:0in;margin-left:99.25pt;margin-bottom:.0001pt;text-align:center'><span
  lang=EN-GB>&nbsp;&nbsp;&nbsp; Pen&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  Cap</span></p>
  </td>
  <td width=58 valign=top style='width:43.45pt;padding:0in 5.4pt 0in 5.4pt;
  height:40.9pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>Rubber
  Seal</span></p>
  </td>
  <td width=103 nowrap colspan=2 valign=top style='width:77.1pt;padding:0in 5.4pt 0in 5.4pt;
  height:40.9pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>Plunger</span></p>
  </td>
  <td width=45 nowrap valign=top style='width:34.1pt;padding:0in 5.4pt 0in 5.4pt;
  height:40.9pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=49 nowrap colspan=2 valign=top style='width:36.75pt;padding:0in 5.4pt 0in 5.4pt;
  height:40.9pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>Pen
  Body</span></p>
  </td>
  <td width=80 valign=top style='width:59.8pt;padding:0in 5.4pt 0in 5.4pt;
  height:40.9pt'>
  <p class=MsoNormal><span lang=EN-GB>Dose <br>
  Window</span></p>
  </td>
  <td width=88 nowrap valign=top style='width:66.0pt;padding:0in 5.4pt 0in 5.4pt;
  height:40.9pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr height=0>
  <td width=187 style='border:none'></td>
  <td width=9 style='border:none'></td>
  <td width=58 style='border:none'></td>
  <td width=88 style='border:none'></td>
  <td width=14 style='border:none'></td>
  <td width=45 style='border:none'></td>
  <td width=40 style='border:none'></td>
  <td width=9 style='border:none'></td>
  <td width=80 style='border:none'></td>
  <td width=88 style='border:none'></td>
 </tr>
</table>

<p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>

<div align=center>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse'>
 <tr>
  <td width=360 colspan=6 valign=top style='width:3.75in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  lang=EN-GB>Pen Needle Parts<br>
  </span></b><span lang=EN-GB>(Needles Not Included)</span></p>
  </td>
 </tr>
 <tr style='height:11.2pt'>
  <td width=156 colspan=2 valign=bottom style='width:117.0pt;padding:0in 5.4pt 0in 5.4pt;
  height:11.2pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=72 valign=bottom style='width:.75in;padding:0in 5.4pt 0in 5.4pt;
  height:11.2pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=78 colspan=2 valign=bottom style='width:58.5pt;padding:0in 5.4pt 0in 5.4pt;
  height:11.2pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>Paper
  Tab</span></p>
  </td>
  <td width=54 valign=bottom style='width:40.5pt;padding:0in 5.4pt 0in 5.4pt;
  height:11.2pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:68.7pt'>
  <td width=360 colspan=6 valign=top style='width:3.75in;padding:0in 5.4pt 0in 5.4pt;
  height:68.7pt'>
  <p class=MsoNormal align=center style='text-align:center'><span
  style='position:relative;z-index:251660288'><span style='left:0px;position:
  absolute;left:17px;top:-159723px;width:278px;height:1px'><img width=278
  height=1 src="Humalo_files/image013.jpg"></span></span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=132 valign=top style='width:99.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>Outer
  Needle<br>
  Shield</span></p>
  </td>
  <td width=108 colspan=3 valign=top style='width:81.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>Inner
  Needle<br>
  Shield</span></p>
  </td>
  <td width=66 valign=top style='width:49.5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>Needle</span></p>
  </td>
  <td width=54 valign=top style='width:40.5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr height=0>
  <td width=132 style='border:none'></td>
  <td width=24 style='border:none'></td>
  <td width=72 style='border:none'></td>
  <td width=12 style='border:none'></td>
  <td width=66 style='border:none'></td>
  <td width=54 style='border:none'></td>
 </tr>
</table>

</div>

<p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='page-break-after:avoid'><b><span lang=EN-GB
style='letter-spacing:-.05pt'>How to recognize your</span></b><b><span
lang=EN-GB> <span style='letter-spacing:-.05pt'>KwikPen:</span></span></b></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=607
 style='margin-left:.3pt;border-collapse:collapse'>
 <tr style='height:6.25pt'>
  <td width=102 rowspan=3 valign=top style='width:76.35pt;border:solid black 1.0pt;
  border-bottom:none;background:white;padding:0in 0in 0in 0in;height:6.25pt'>
  <p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=138 rowspan=3 valign=top style='width:103.15pt;border-top:solid black 1.0pt;
  border-left:none;border-bottom:none;border-right:solid black 1.0pt;
  background:white;padding:0in 0in 0in 0in;height:6.25pt'>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><b><span lang=EN-GB style='letter-spacing:-.1pt'>&nbsp;</span></b></p>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><b><span lang=EN-GB style='color:black;letter-spacing:-.1pt'>Liprolog</span></b></p>
  </td>
  <td width=26 rowspan=2 valign=top style='width:19.55pt;border:none;
  border-top:solid black 1.0pt;padding:0in 0in 0in 0in;height:6.25pt'>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><b><span lang=EN-GB style='letter-spacing:-.1pt'>&nbsp;</span></b></p>
  </td>
  <td width=63 colspan=3 valign=top style='width:47.05pt;border:none;
  border-top:solid black 1.0pt;padding:0in 0in 0in 0in;height:6.25pt'>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><b><span lang=EN-GB style='letter-spacing:-.1pt'>&nbsp;</span></b></p>
  </td>
  <td width=40 rowspan=2 valign=top style='width:30.15pt;border-top:solid black 1.0pt;
  border-left:none;border-bottom:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:6.25pt'>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><b><span lang=EN-GB style='letter-spacing:-.1pt'>&nbsp;</span></b></p>
  </td>
  <td width=22 rowspan=2 valign=top style='width:16.4pt;border:none;border-top:
  solid black 1.0pt;padding:0in 0in 0in 0in;height:6.25pt'>
  <p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=63 colspan=3 valign=top style='width:47.05pt;border:none;
  border-top:solid black 1.0pt;padding:0in 0in 0in 0in;height:6.25pt'>
  <p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=29 rowspan=2 valign=top style='width:21.5pt;border-top:solid black 1.0pt;
  border-left:none;border-bottom:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:6.25pt'>
  <p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=26 rowspan=2 valign=top style='width:19.55pt;border:none;
  border-top:solid black 1.0pt;padding:0in 0in 0in 0in;height:6.25pt'>
  <p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=63 colspan=3 valign=top style='width:47.05pt;border:none;
  border-top:solid black 1.0pt;padding:0in 0in 0in 0in;height:6.25pt'>
  <p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=37 rowspan=2 valign=top style='width:27.45pt;border-top:solid black 1.0pt;
  border-left:none;border-bottom:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:6.25pt'>
  <p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:12.7pt'>
  <td width=63 colspan=3 valign=top style='width:47.05pt;padding:0in 0in 0in 0in;
  height:12.7pt'>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><b><span style='font-family:"Times New Roman",serif;letter-spacing:
  -.1pt'>Liprolog</span></b></p>
  </td>
  <td width=63 colspan=3 valign=top style='width:47.05pt;padding:0in 0in 0in 0in;
  height:12.7pt'>
  <p class=TableParagraph style='page-break-after:avoid'><b><span
  style='font-family:"Times New Roman",serif;letter-spacing:-.1pt'>Liprolog</span></b></p>
  </td>
  <td width=63 colspan=3 valign=top style='width:47.05pt;padding:0in 0in 0in 0in;
  height:12.7pt'>
  <p class=TableParagraph style='page-break-after:avoid'><b><span
  style='font-family:"Times New Roman",serif;letter-spacing:-.1pt'>Liprolog</span></b></p>
  </td>
 </tr>
 <tr style='height:13.1pt'>
  <td width=37 colspan=2 valign=top style='width:27.7pt;border:none;padding:
  0in 0in 0in 0in;height:13.1pt'>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><b><span lang=EN-GB style='letter-spacing:-.1pt'>&nbsp;</span></b></p>
  </td>
  <td width=41 valign=top style='width:30.5pt;padding:0in 0in 0in 0in;
  height:13.1pt'>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><b><span style='font-family:"Times New Roman",serif;letter-spacing:
  -.1pt'>Mix25</span></b></p>
  </td>
  <td width=51 colspan=2 valign=top style='width:38.55pt;border:none;
  border-right:solid black 1.0pt;padding:0in 0in 0in 0in;height:13.1pt'>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><b><span lang=EN-GB style='letter-spacing:-.1pt'>&nbsp;</span></b></p>
  </td>
  <td width=33 colspan=2 valign=top style='width:24.55pt;border:none;
  padding:0in 0in 0in 0in;height:13.1pt'>
  <p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=41 valign=top style='width:30.5pt;padding:0in 0in 0in 0in;
  height:13.1pt'>
  <p class=TableParagraph style='page-break-after:avoid'><b><span
  style='font-family:"Times New Roman",serif;letter-spacing:-.05pt'>Mix50</span></b></p>
  </td>
  <td width=40 colspan=2 valign=top style='width:29.9pt;border:none;border-right:
  solid black 1.0pt;padding:0in 0in 0in 0in;height:13.1pt'>
  <p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=38 colspan=2 valign=top style='width:28.45pt;border:none;
  padding:0in 0in 0in 0in;height:13.1pt'>
  <p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=39 valign=top style='width:29.3pt;padding:0in 0in 0in 0in;
  height:13.1pt'>
  <p class=TableParagraph style='page-break-after:avoid'><b><span
  style='font-family:"Times New Roman",serif'>Basal</span></b></p>
  </td>
  <td width=48 colspan=2 valign=top style='width:36.3pt;border:none;border-right:
  solid black 1.0pt;padding:0in 0in 0in 0in;height:13.1pt'>
  <p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:28.65pt'>
  <td width=102 valign=top style='width:76.35pt;border-top:none;border-left:
  solid black 1.0pt;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:28.65pt'>
  <p class=TableParagraph style='page-break-after:avoid'><span
  style='font-family:"Times New Roman",serif;letter-spacing:-.05pt'>&nbsp;</span></p>
  </td>
  <td width=138 valign=top style='width:103.15pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:28.65pt'>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif'>Solution </span></p>
  </td>
  <td width=129 colspan=5 valign=top style='width:96.75pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:28.65pt'>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif'>Suspension</span></p>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif'>(cloudy insulin)</span></p>
  </td>
  <td width=113 colspan=5 valign=top style='width:84.95pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:28.65pt'>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif'>Suspension</span></p>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif'>(cloudy insulin)</span></p>
  </td>
  <td width=125 colspan=5 valign=top style='width:94.05pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:28.65pt'>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif'>Suspension</span></p>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif'>(cloudy insulin)</span></p>
  </td>
 </tr>
 <tr style='height:28.65pt'>
  <td width=102 valign=top style='width:76.35pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:28.65pt'>
  <p class=TableParagraph style='page-break-after:avoid'><span
  style='font-family:"Times New Roman",serif;letter-spacing:-.05pt'>Pen colour:</span></p>
  </td>
  <td width=138 valign=top style='width:103.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:28.65pt'>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif'>Blue</span></p>
  </td>
  <td width=129 colspan=5 valign=top style='width:96.75pt;border-top:none;
  border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:28.65pt'>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif'>Blue</span></p>
  </td>
  <td width=113 colspan=5 valign=top style='width:84.95pt;border-top:none;
  border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:28.65pt'>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif'>Blue</span></p>
  </td>
  <td width=125 colspan=5 valign=top style='width:94.05pt;border-top:none;
  border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:28.65pt'>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif'>Blue</span></p>
  </td>
 </tr>
 <tr style='height:51.55pt'>
  <td width=102 valign=top style='width:76.35pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:51.55pt'>
  <p class=TableParagraph style='page-break-after:avoid'><span
  style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  <p class=TableParagraph style='page-break-after:avoid'><span
  style='font-family:"Times New Roman",serif;letter-spacing:-.05pt'>Dose Knob:</span></p>
  </td>
  <td width=138 valign=top style='width:103.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:51.55pt'>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB style='font-family:"Times New Roman",serif'><img
  border=0 width=38 height=38 id=image4.png src="Humalo_files/image014.jpg"></span></p>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif'>Burgundy</span></p>
  </td>
  <td width=129 colspan=5 valign=top style='width:96.75pt;border-top:none;
  border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:51.55pt'>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB style='font-family:"Times New Roman",serif'><img
  border=0 width=38 height=37 id=image5.png src="Humalo_files/image015.jpg"></span></p>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif;letter-spacing:-.05pt'>Yellow</span></p>
  </td>
  <td width=113 colspan=5 valign=top style='width:84.95pt;border-top:none;
  border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:51.55pt'>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB style='font-family:"Times New Roman",serif'><img
  border=0 width=37 height=37 id=image6.png src="Humalo_files/image016.jpg"></span></p>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif'>Red</span></p>
  </td>
  <td width=125 colspan=5 valign=top style='width:94.05pt;border-top:none;
  border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:51.55pt'>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB style='font-family:"Times New Roman",serif'><img
  border=0 width=38 height=38 id=image7.png src="Humalo_files/image017.jpg"></span></p>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif;letter-spacing:-.05pt'>Green</span></p>
  </td>
 </tr>
 <tr style='height:41.1pt'>
  <td width=102 valign=top style='width:76.35pt;border-top:none;border-left:
  solid black 1.0pt;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:41.1pt'>
  <p class=TableParagraph style='page-break-after:avoid'><span
  style='font-family:"Times New Roman",serif'>Labels:</span></p>
  </td>
  <td width=138 valign=top style='width:103.15pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:41.1pt'>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB>White with </span></p>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB>Burgundy </span></p>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB>Colour Bar</span></p>
  </td>
  <td width=129 colspan=5 valign=top style='width:96.75pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:41.1pt'>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB>White with </span></p>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB>Yellow </span></p>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB>Colour Bar</span></p>
  </td>
  <td width=113 colspan=5 valign=top style='width:84.95pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:41.1pt'>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif'>White with </span></p>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif'>Red </span></p>
  <p class=TableParagraph align=center style='text-align:center;page-break-after:
  avoid'><span style='font-family:"Times New Roman",serif'>Colour Bar</span></p>
  </td>
  <td width=125 colspan=5 valign=top style='width:94.05pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:41.1pt'>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB>White with </span></p>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB>Green Colour </span></p>
  <p class=MsoNormal align=center style='text-align:center;page-break-after:
  avoid'><span lang=EN-GB>Bar</span></p>
  </td>
 </tr>
 <tr height=0>
  <td width=102 style='border:none'></td>
  <td width=138 style='border:none'></td>
  <td width=26 style='border:none'></td>
  <td width=11 style='border:none'></td>
  <td width=41 style='border:none'></td>
  <td width=11 style='border:none'></td>
  <td width=40 style='border:none'></td>
  <td width=22 style='border:none'></td>
  <td width=11 style='border:none'></td>
  <td width=41 style='border:none'></td>
  <td width=11 style='border:none'></td>
  <td width=29 style='border:none'></td>
  <td width=26 style='border:none'></td>
  <td width=12 style='border:none'></td>
  <td width=39 style='border:none'></td>
  <td width=12 style='border:none'></td>
  <td width=37 style='border:none'></td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Supplies needed to give your injection:</span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
text-indent:-28.35pt;line-height:normal;page-break-after:auto'><span
style='font-size:11.0pt;font-family:"Arial",sans-serif;letter-spacing:-.05pt;
font-weight:normal'>&#8226;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt;letter-spacing:-.05pt;font-weight:
normal'>KwikPen containing your insulin</span></h3>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>KwikPen compatible
Needle (BD [Becton, Dickinson and Company] Pen</span><span lang=EN-GB
style='letter-spacing:.15pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>Needles recommended)</span></p>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
text-indent:-28.35pt;line-height:normal;page-break-after:auto'><span
style='font-size:11.0pt;font-family:"Arial",sans-serif;font-weight:normal'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt;letter-spacing:-.05pt;font-weight:
normal'>Alcohol swab </span></h3>

<h3 style='margin-top:0in'><span style='font-size:11.0pt;color:black;
font-weight:normal'>Needles and alcohol swab are not included.</span></h3>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>Preparing your Pen </span></b></p>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
text-indent:-28.35pt;line-height:normal;page-break-after:auto'><span
style='font-size:11.0pt;font-family:"Arial",sans-serif;letter-spacing:-.05pt;
font-weight:normal'>&#8226;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt;letter-spacing:-.05pt;font-weight:
normal'>Wash your hands with soap and water.</span></h3>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
text-indent:-28.35pt;line-height:normal;page-break-after:auto'><span
style='font-size:11.0pt;font-family:"Arial",sans-serif;font-weight:normal'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt;letter-spacing:-.05pt;font-weight:
normal'>Check</span><span style='font-size:11.0pt;font-weight:normal'> the<span
style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>Pen</span><span
style='letter-spacing:-.05pt'> to make sure you are taking the right type of</span>
<span style='letter-spacing:-.05pt'>insulin.</span><span style='letter-spacing:
.1pt'> </span><span style='letter-spacing:-.05pt'>This is especially important
if you use</span><span style='letter-spacing:2.6pt'> </span><span
style='letter-spacing:-.05pt'>more</span> <span style='letter-spacing:-.05pt'>than</span>
1 <span style='letter-spacing:-.05pt'>type</span> <span style='letter-spacing:
-.05pt'>of</span><span style='letter-spacing:.05pt'> </span><span
style='letter-spacing:-.1pt'>insulin.</span></span></h3>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif;letter-spacing:
-.05pt'>&#8226;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='letter-spacing:-.05pt'>Do not </span></b><span
lang=EN-GB style='letter-spacing:-.05pt'>use</span><span lang=EN-GB
style='letter-spacing:.05pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>your Pen</span><span lang=EN-GB style='letter-spacing:-.1pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>past the expiration date printed </span><span
lang=EN-GB style='letter-spacing:-.05pt'>on the Label. After you start using
the Pen, throw your Pen away after the in-use time specified in the Package
Leaflet.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Always<span style='letter-spacing:-.2pt'> </span>use
a<span style='letter-spacing:.15pt'> </span><b><span style='letter-spacing:
-.1pt'>new Needle </span></b><span style='letter-spacing:-.05pt'>for</span> <span
style='letter-spacing:-.05pt'>each</span> <span style='letter-spacing:-.05pt'>injection</span><span
style='letter-spacing:-.1pt'> </span><span style='letter-spacing:-.05pt'>to</span>
<span style='letter-spacing:-.05pt'>help</span><span style='letter-spacing:
.05pt'> </span><span style='letter-spacing:-.05pt'>prevent infections</span><span
style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>and
blocked</span> <span style='letter-spacing:-.05pt'>Needles.</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB><img width=598 height=2
src="Humalo_files/image018.gif"></span></p>

<p class=MsoNormal><span style='position:relative;z-index:251649024'><span
style='position:absolute;left:516px;top:-160551px;width:143px;height:1px'><img
width=143 height=1 src="Humalo_files/image019.jpg"></span></span><span
lang=EN-GB><b>Step<span style='letter-spacing:.05pt'> </span><span
style='letter-spacing:-.1pt'>1:</span></b></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:0in;text-indent:0in;line-height:normal'><span
lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Pull the<span style='letter-spacing:-.2pt'> </span>Pen
<span style='letter-spacing:-.15pt'>Cap</span><span style='letter-spacing:-.05pt'>
straight off.</span></span></p>

<p class=MsoListParagraph style='margin-left:56.7pt;text-indent:-28.35pt;
line-height:normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8211;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='letter-spacing:-.05pt'>Do not </span></b><span
lang=EN-GB style='letter-spacing:-.05pt'>remove the Pen Label.</span></p>

<h3 style='margin:0in;text-indent:0in;line-height:normal;page-break-after:auto'><span
style='font-size:11.0pt;font-family:"Arial",sans-serif;font-weight:normal'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt;font-weight:normal'>Wipe<span
style='letter-spacing:-.05pt'> the Rubber Seal with an alcohol swab.</span></span></h3>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB><img width=597 height=2
src="Humalo_files/image020.gif"></span></p>

<p class=MsoNormal><span style='position:relative;z-index:251650048'><span
style='position:absolute;left:523px;top:-160690px;width:143px;height:1px'><img
width=143 height=1 src="Humalo_files/image021.jpg"></span></span><b><span
lang=EN-GB>Step 2:</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>(For LIPROLOG suspensions cloudy insulins
only)</span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:0in;text-indent:0in;line-height:normal'><span
lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Gently roll the
Pen 10 times.</span><span lang=EN-GB style='letter-spacing:1.0pt'> </span></p>

<p class=MsoNormal><span lang=EN-GB>AND</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Invert the Pen</span><span
lang=EN-GB> <span style='letter-spacing:-.05pt'>10 times.</span></span></p>

<p class=MsoNormal><span style='position:relative;z-index:251651072'><span
style='position:absolute;left:522px;top:-160812px;width:143px;height:1px'><img
width=143 height=1 src="Humalo_files/image022.jpg"></span></span><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<br clear=ALL>

<p class=MsoNormal><b><span lang=EN-GB style='letter-spacing:-.05pt'>Mixing is
important </span></b><span lang=EN-GB>to<span style='letter-spacing:.1pt'> </span>make<span
style='letter-spacing:-.05pt'> sure you get the right</span><span
style='letter-spacing:1.35pt'> </span>dose.</span></p>

<p class=MsoNormal><span lang=EN-GB style='letter-spacing:-.05pt'>The insulin
should look evenly mixed.</span></p>

<p class=MsoNormal><span lang=EN-GB style='letter-spacing:-.05pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='letter-spacing:-.05pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='letter-spacing:-.05pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<h1 style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:
0in;text-indent:0in'><span style='font-size:11.0pt'>S</span><span
style='font-size:11.0pt;text-transform:none'>tep</span><span style='font-size:
11.0pt'> 3:</span></h1>

<h1 style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:
0in'><span style='font-size:11.0pt;font-weight:normal'>&nbsp;</span></h1>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
text-indent:-28.35pt;line-height:normal;page-break-after:auto'><span
style='font-size:11.0pt;font-family:"Arial",sans-serif;font-weight:normal'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt;letter-spacing:-.05pt;font-weight:
normal'>Check the appearance of the insulin.</span></h3>

<p class=MsoListParagraph style='margin-left:56.7pt;text-indent:-28.35pt;
line-height:normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8211;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>LIPROLOG solution should
look clear and colourless. D</span><span lang=EN-GB style='letter-spacing:-.05pt'>o
not use if it is cloudy, coloured, or has particles or clumps in</span><span
lang=EN-GB style='letter-spacing:.05pt'> </span><span lang=EN-GB>it.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoListParagraph style='margin-left:56.7pt;text-indent:-28.35pt;
line-height:normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8211;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>LIPROLOG suspensions - cloudy insulins - should
look white after mixing. <b>&nbsp;Do</b></span><b><span lang=EN-GB
style='letter-spacing:-.15pt'> </span></b><b><span lang=EN-GB style='letter-spacing:
-.1pt'>not</span></b><b><span lang=EN-GB style='letter-spacing:-.05pt'> </span></b><span
lang=EN-GB style='letter-spacing:-.05pt'>use if it looks clear</span><span
lang=EN-GB style='letter-spacing:1.45pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>or contains any clumps or particles.</span></p>

<p class=MsoNormal><span lang=EN-GB><img width=597 height=2
src="Humalo_files/image020.gif"></span></p>

<h3 style='margin-top:0in'><span style='position:relative;z-index:251658240'><span
style='position:absolute;left:508px;top:-161141px;width:146px;height:1px'><img
width=146 height=1 src="Humalo_files/image023.jpg"></span></span><span
style='font-size:11.0pt'><span style='letter-spacing:-.05pt'>Step 4:</span></span></h3>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:4.0pt;margin-left:
-.25in'><span style='font-size:11.0pt'>&nbsp;</span></h3>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
text-indent:-28.35pt;line-height:normal;page-break-after:auto'><span
style='font-size:11.0pt;font-family:"Arial",sans-serif;font-weight:normal'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt;letter-spacing:-.05pt;font-weight:
normal'>Select </span><span style='font-size:11.0pt;font-weight:normal'>a<span
style='letter-spacing:-.05pt'> new Needle.</span></span></h3>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Pull off the</span><span
lang=EN-GB> <span style='letter-spacing:-.1pt'>Paper</span><span
style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>Tab </span><span
style='letter-spacing:-.05pt'>from the Outer Needle</span><span
style='letter-spacing:1.3pt'> </span><span style='letter-spacing:-.05pt'>Shield.</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB><img width=595 height=2
src="Humalo_files/image024.gif"></span></p>

<p class=MsoNormal><span style='position:relative;z-index:251652096'><span
style='position:absolute;left:490px;top:-161291px;width:147px;height:1px'><img
width=147 height=1 src="Humalo_files/image025.jpg"></span></span><span
lang=EN-GB><b>Step<span style='letter-spacing:.05pt'> </span><span
style='letter-spacing:-.1pt'>5:</span></b></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
text-indent:-28.35pt;line-height:normal;page-break-after:auto'><span
style='font-size:11.0pt;font-family:"Arial",sans-serif;font-weight:normal'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt;letter-spacing:-.05pt;font-weight:
normal'>Push the capped Needle straight onto the Pen </span></h3>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:4.0pt;margin-left:
28.35pt'><span style='font-size:11.0pt;letter-spacing:-.05pt;font-weight:normal'>and
twist the Needle on</span><span style='font-size:11.0pt;letter-spacing:-.1pt;
font-weight:normal'> </span><span style='font-size:11.0pt;letter-spacing:-.05pt;
font-weight:normal'>until</span><span style='font-size:11.0pt;font-weight:normal'>
<span style='letter-spacing:-.05pt'>it</span> <span style='letter-spacing:-.05pt'>is</span><span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>tight.</span></span></h3>

<p class=MsoNormal><b><span lang=EN-GB style='letter-spacing:-.1pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='text-indent:-28.35pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB><img width=595 height=2
src="Humalo_files/image024.gif"></span></p>

<p class=MsoNormal><span style='position:relative;z-index:251653120'><span
style='position:absolute;left:490px;top:-161419px;width:200px;height:4px'><img
width=200 height=4 src="Humalo_files/image026.gif"></span></span><span
lang=EN-GB><b>Step<span style='letter-spacing:.05pt'> </span><span
style='letter-spacing:-.1pt'>6:</span></b></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Pull off the Outer <span style='letter-spacing:
-.05pt'>Needle</span><span style='letter-spacing:-.15pt'> </span><span
style='letter-spacing:-.05pt'>Shield.</span><span style='letter-spacing:-.15pt'>
</span><b><span style='letter-spacing:-.05pt'>Do not </span></b><span
style='letter-spacing:-.05pt'>thro</span></span><span style='position:relative;
z-index:251671552'><span style='left:0px;position:absolute;left:526px;
top:-161454px;width:131px;height:4px'><img width=131 height=4
src="Humalo_files/image027.gif"></span></span><span lang=EN-GB
style='letter-spacing:-.05pt'>w it</span><span lang=EN-GB style='letter-spacing:
1.45pt'> </span><span lang=EN-GB>away.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Pull off the</span><span
lang=EN-GB style='letter-spacing:.05pt'> </span><span lang=EN-GB
style='letter-spacing:-.1pt'>Inner</span><span lang=EN-GB style='letter-spacing:
.05pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>Needle</span><span
lang=EN-GB> <span style='letter-spacing:-.1pt'>Shield</span><span
style='letter-spacing:-.05pt'> and throw it away.</span></span></p>

<p class=MsoNormal><img width=129 height=1 src="Humalo_files/image028.gif"
align=left hspace=12></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB><img width=594 height=2
src="Humalo_files/image029.gif"></span></p>

<p class=MsoNormal><b><span lang=EN-GB style='letter-spacing:-.05pt'>Priming
your Pen </span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='letter-spacing:-.05pt'>Prime</span></b><b><span
lang=EN-GB> <span style='letter-spacing:-.05pt'>before</span> <span
style='letter-spacing:-.05pt'>each</span><span style='letter-spacing:.05pt'> </span><span
style='letter-spacing:-.1pt'>injection.</span></span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Priming your Pen means removing the air from the
Needle and Cartridge that may collect during normal use and ensures that the
Pen is working correctly.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you <b>do not</b> prime before each
injection, you may get too much or too little insulin.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB><img width=593 height=2
src="Humalo_files/image030.gif"></span></p>

<p class=MsoNormal><span style='position:relative;z-index:251654144'><span
style='position:absolute;left:517px;top:-161717px;width:143px;height:1px'><img
width=143 height=1 src="Humalo_files/image031.jpg"></span></span><span
lang=EN-GB><b>Step<span style='letter-spacing:.05pt'> </span><span
style='letter-spacing:-.1pt'>7:</span></b></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>To prime your Pen, turn the Dose Knob to select
2 units.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB><img width=595 height=2
src="Humalo_files/image024.gif"></span></p>

<p class=MsoNormal><span style='position:relative;z-index:251655168'><span
style='position:absolute;left:538px;top:-161838px;width:148px;height:1px'><img
width=148 height=1 src="Humalo_files/image032.jpg"></span></span><span
lang=EN-GB><b>Step<span style='letter-spacing:.05pt'> </span><span
style='letter-spacing:-.1pt'>8:</span></b></span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Hold your Pen with the Needle pointing up. Tap
the Cartridge </span></p>

<p class=MsoNormal style='margin-left:28.35pt'><span lang=EN-GB>Holder gently
to collect air bubbles at the top</span></p>

<p class=MsoNormal style='margin-left:28.35pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt'><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=581
 style='width:435.45pt;margin-left:5.4pt;border-collapse:collapse;border:none'>
 <tr style='height:202.5pt'>
  <td width=343 valign=top style='width:257.35pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:202.5pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB>Step 9:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Continue holding
  your Pen with Needle pointing up. Push the Dose Knob in until it stops, and
  &#8220;0&#8221; is seen in the Dose Window. Hold the Dose Knob in and count
  to 5 slowly.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt;text-indent:-30.05pt'><span
  lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You should
  see insulin at the tip of the Needle.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:58.4pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
  lang=EN-GB>If you <b>do not</b> see insulin, repeat the priming steps, but
  not more than 4 times.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:58.4pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
  lang=EN-GB>If you <b>still do not</b> see insulin, change the Needle and
  repeat the priming steps.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt'><span lang=EN-GB>Small air
  bubbles are normal and will not affect your dose.</span></p>
  </td>
  <td width=237 valign=top style='width:178.1pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:202.5pt'>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'>
  <table cellpadding=0 cellspacing=0>
   <tr>
    <td width=45 height=0></td>
   </tr>
   <tr>
    <td></td>
    <td><img width=146 height=1 src="Humalo_files/image033.jpg"></td>
   </tr>
  </table>
  <br clear=ALL>
  </p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  6.0pt;margin-left:0in'>
  <table cellpadding=0 cellspacing=0>
   <tr>
    <td width=57 height=0></td>
   </tr>
   <tr>
    <td></td>
    <td><img width=122 height=1 src="Humalo_files/image034.jpg"></td>
   </tr>
  </table>
  <br clear=ALL>
  </p>
  </td>
 </tr>
</table>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>Selecting your dose</span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>You can give from </span><span
lang=EN-GB>1<span style='letter-spacing:.15pt'> </span><span style='letter-spacing:
-.05pt'>to</span><span style='letter-spacing:-.1pt'> </span><span
style='letter-spacing:-.05pt'>60 units in </span>a<span style='letter-spacing:
-.05pt'> single injection.</span></span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>If your dose is
more than 60</span><span lang=EN-GB style='letter-spacing:.1pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>units, you will need to give more than
one injection.</span></p>

<p class=MsoNormal style='margin-left:56.7pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8211;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you need help<span style='letter-spacing:
-.05pt'> deciding how to divide up your dose, ask your healthcare professional.</span></span></p>

<p class=MsoNormal style='margin-left:56.7pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8211;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>You should use </span><span
lang=EN-GB>a<span style='letter-spacing:-.05pt'> new Needle for each injection
and repeat the priming step.</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='margin-left:5.4pt;border-collapse:collapse;border:none'>
 <tr style='height:358.5pt'>
  <td width=278 valign=top style='width:208.75pt;border:none;border-top:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:358.5pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB>Step 10:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turn the Dose
  Knob to select the number of units you need to inject. The Dose Indicator
  should line up with your dose.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:58.4pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
  lang=EN-GB>The Pen </span><span lang=EN-GB>dials 1&nbsp;unit at a time.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:58.4pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Dose Knob
  clicks as you turn it.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:58.4pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <b>DO NOT</b>
  dial your dose by counting the clicks because you may dial the wrong dose.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:58.4pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The dose can be
  corrected by turning the Dose Knob in either direction until the correct dose
  lines up with the Dose Indicator.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:58.4pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The even numbers
  are printed on the dial.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:58.4pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The odd numbers,
  after the number 1, are shown as full lines.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:58.4pt;margin-bottom:.0001pt'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt;text-indent:-30.05pt'><span
  lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <b>Always check
  the number in the Dose Window to make sure you have dialled the correct dose.</b></span></p>
  </td>
  <td width=300 valign=top style='width:224.8pt;border:none;border-top:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:358.5pt'>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'><span
  style='position:relative;z-index:251665408;left:82px;top:-162439px;
  width:135px;height:19px'><img width=135 height=19
  src="Humalo_files/image035.gif"></span><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'>
  <table cellpadding=0 cellspacing=0 align=left>
   <tr>
    <td width=74 height=0></td>
   </tr>
   <tr>
    <td></td>
    <td><img width=136 height=1 src="Humalo_files/image036.jpg"></td>
   </tr>
  </table>
  <br clear=ALL>
  <span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'><span
  lang=EN-GB>&nbsp;</span></p>
  <br clear=ALL>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:1.7in;margin-bottom:.0001pt'><span lang=EN-GB>(Example:
  12&nbsp;units shown in the Dose Window)</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:1.7in;margin-bottom:.0001pt'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:1.7in;margin-bottom:.0001pt'><span style='position:relative;
  z-index:251664384;left:81px;top:-162743px;width:136px;height:19px'><img
  width=136 height=19 src="Humalo_files/image037.gif"></span><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:1.7in;margin-bottom:.0001pt'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:1.7in;margin-bottom:.0001pt'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:1.7in;margin-bottom:.0001pt'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:1.7in;margin-bottom:.0001pt'><span lang=EN-GB>&nbsp;</span></p>
  <br clear=ALL>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:1.7in;margin-bottom:.0001pt'><span lang=EN-GB>(Example:
  25&nbsp;units shown in the Dose Window)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-GB><img width=595 height=2
src="Humalo_files/image024.gif"></span></p>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:4.0pt;margin-left:
28.35pt'><span style='font-size:11.0pt'>&nbsp;</span></h3>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
text-indent:-28.35pt;line-height:normal;page-break-after:auto'><span
style='font-size:11.0pt;font-family:"Arial",sans-serif;font-weight:normal'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt;letter-spacing:-.05pt;font-weight:
normal'>The Pen will not let you dial more than the number of units left in the
Pen.</span></h3>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If<span style='letter-spacing:.1pt'> </span><span
style='letter-spacing:-.05pt'>you need to inject</span><span style='letter-spacing:
.15pt'> </span><span style='letter-spacing:-.05pt'>more than the number of
units left in the Pen, you may</span><span style='letter-spacing:.15pt'> </span><span
style='letter-spacing:-.05pt'>either:</span></span></p>

<p class=MsoNormal style='margin-left:56.7pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8211;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>inject the amount
left in your Pen and then use </span><span lang=EN-GB>a<span style='letter-spacing:
-.05pt'> new Pen to give the rest of your dose,</span><span style='letter-spacing:
.55pt'> </span><b><span style='letter-spacing:-.3pt'>or</span></b></span></p>

<p class=MsoNormal style='margin-left:56.7pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8211;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>get </span><span
lang=EN-GB>a<span style='letter-spacing:-.05pt'> new Pen and inject the full
dose.</span></span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>It is normal to
see </span><span lang=EN-GB>a<span style='letter-spacing:-.05pt'> small amount of
insulin left in the Pen that you cannot inject.</span></span></p>

<p class=MsoNormal><b><span lang=EN-GB style='letter-spacing:-.05pt;background:
silver'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>Giving your injection</span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Inject your</span><span
lang=EN-GB style='letter-spacing:.1pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>insulin </span><span lang=EN-GB>as your<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.05pt'>healthcare
professional</span><span style='letter-spacing:-.15pt'> </span><span
style='letter-spacing:-.05pt'>has shown you.</span></span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Change (rotate)
your injection site for each injection.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='letter-spacing:-.05pt'>Do not</span></b><b><span
lang=EN-GB> </span></b><span lang=EN-GB style='letter-spacing:-.05pt'>try to
change your dose while injecting.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='margin-left:5.4pt;border-collapse:collapse;border:none'>
 <tr style='height:146.25pt'>
  <td width=294 colspan=2 valign=top style='width:220.85pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:146.25pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB>Step 11:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Choose your
  injection site.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt'><span lang=EN-GB>Your insulin
  is injected under the skin (subcutaneously) of your stomach area, buttocks,
  upper legs or upper arms.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wipe your skin
  with an alcohol swab, and <span style='letter-spacing:-.05pt'>let the
  injection site dry before you inject your dose.</span></span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt'><i><span lang=EN-GB
  style='color:#FF33CC'>&nbsp;</span></i></p>
  </td>
  <td width=303 valign=top style='width:227.55pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:146.25pt'>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'><span
  style='position:relative;z-index:251666432'><span style='left:0px;position:
  absolute;left:73px;top:-163197px;width:156px;height:1px'><img width=156
  height=1 src="Humalo_files/image038.jpg"></span></span><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'><span
  lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=294 colspan=2 valign=top style='width:220.85pt;border:none;
  padding:0in 5.4pt 0in 5.4pt'><br clear=ALL>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt;text-indent:-30.05pt'><b><span
  lang=EN-GB>Step 12:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt;text-indent:-30.05pt'><span
  lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Insert the
  Needle into your skin.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt;text-indent:-30.05pt'><span
  style='position:relative;z-index:251656192'><span style='left:0px;position:
  absolute;left:389px;top:-163419px;width:173px;height:1px'><img width=173
  height=1 src="Humalo_files/image039.jpg"></span></span><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Push
  the Dose Knob all the way in.</span></p>
  </td>
  <td style='border:none;padding:0in 0in 0in 0in' width=303><p class='MsoNormal'>&nbsp;</td>
 </tr>
 <tr style='page-break-inside:avoid;height:49.0pt'>
  <td width=213 valign=top style='width:159.85pt;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:49.0pt'>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt;text-indent:-30.05pt'><span
  lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Continue to hold
  the Dose Knob in and <b>slowly count to 5</b> before removing the Needle.</span></p>
  </td>
  <td width=81 valign=top style='width:61.0pt;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:49.0pt'>
  <p class=MsoNormal align=center style='margin-top:6.0pt;margin-right:0in;
  margin-bottom:0in;margin-left:30.05pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-30.05pt'><span style='position:relative;z-index:251667456'><span
  style='left:0px;position:absolute;left:1px;top:-163445px;width:69px;
  height:4px'><img width=69 height=4 src="Humalo_files/image040.gif"></span></span></p>
  </td>
  <td style='border:none;padding:0in 0in 0in 0in' width=303><p class='MsoNormal'>&nbsp;</td>
 </tr>
 <tr style='page-break-inside:avoid;height:49.0pt'>
  <td width=294 colspan=2 valign=top style='width:220.85pt;border:none;
  padding:0in 5.4pt 0in 5.4pt;height:49.0pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB>Do not</span></b><span
  lang=EN-GB> try to inject your insulin by turning the Dose Knob. You will <b>NOT</b>
  receive your insulin by turning the Dose Knob.</span></p>
  </td>
  <td style='border:none;padding:0in 0in 0in 0in' width=303><p class='MsoNormal'>&nbsp;</td>
 </tr>
 <tr height=0>
  <td width=213 style='border:none'></td>
  <td width=81 style='border:none'></td>
  <td width=303 style='border:none'></td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-GB><img width=604 height=2
src="Humalo_files/image041.gif"></span></p>

<p class=MsoNormal style='margin-left:28.35pt'><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=556
 style='width:417.3pt;margin-left:5.4pt;border-collapse:collapse;border:none'>
 <tr style='height:189.25pt'>
  <td width=291 valign=top style='width:218.2pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:189.25pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB>Step 13:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pull the Needle
  out of your skin.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:58.4pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A drop of
  insulin at the Needle tip is normal. It will not affect your dose.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt;text-indent:-30.05pt'><span
  lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Check the number
  in the Dose Window</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:58.4pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you see
  &#8220;0&#8221; in the Dose window, you have received the full amount you
  dialled.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:58.4pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you do not
  see &#8220;0&#8221; in the Dose window, do not<b> </b>redial. Insert the
  needle into your skin and finish your injection.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:58.4pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you<b> still </b>do
  not think you received the full amount you dialled for your injection<b>, do
  not start over or repeat that injection. </b>Monitor your blood glucose as
  instructed by your healthcare professional.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:58.4pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
  lang=EN-GB>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you normally
  need to give 2 injections for your full dose, be sure to give your second
  injection.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:1.7pt;margin-bottom:.0001pt'><span lang=EN-GB>The plunger
  only moves a little with each injection, and you may not notice that it
  moves.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:1.7pt;margin-bottom:.0001pt'><span lang=EN-GB>If you see
  blood after you take the Needle out of your skin, press the injection site
  lightly with a piece of gauze or an alcohol swab. <b>Do not</b> rub the area.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt'><i><span lang=EN-GB
  style='color:#FF33CC'>&nbsp;</span></i></p>
  </td>
  <td width=265 valign=top style='width:199.1pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:189.25pt'>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'><span
  style='position:relative;z-index:251668480'><span style='left:0px;position:
  absolute;left:64px;top:-163622px;width:137px;height:1px'><img width=137
  height=1 src="Humalo_files/image042.jpg"></span></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>After your injection</span></b></p>

<p class=MsoNormal><span lang=EN-GB><img width=587 height=2
src="Humalo_files/image043.gif"></span></p>

<p class=MsoNormal><span style='position:relative;z-index:251657216'><span
style='position:absolute;left:518px;top:-164369px;width:139px;height:1px'><img
width=139 height=1 src="Humalo_files/image044.jpg"></span></span><span
lang=EN-GB>&nbsp;</span></p>

<br clear=ALL>

<p class=MsoNormal><b><span lang=EN-GB>Step<span style='letter-spacing:.1pt'> </span><span
style='letter-spacing:-.1pt'>14:</span></span></b></p>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
text-indent:-28.35pt;line-height:normal;page-break-after:auto'><span
style='font-size:11.0pt;font-family:"Arial",sans-serif;font-weight:normal'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt;letter-spacing:-.05pt;font-weight:
normal'>Carefully</span><span style='font-size:11.0pt;font-weight:normal'> <span
style='letter-spacing:-.05pt'>replace</span><span style='letter-spacing:-.1pt'>
</span>the<span style='letter-spacing:.05pt'> </span><span style='letter-spacing:
-.1pt'>Outer</span><span style='letter-spacing:.05pt'> </span><span
style='letter-spacing:-.05pt'>Needle</span><span style='letter-spacing:.05pt'> </span><span
style='letter-spacing:-.1pt'>Shield.</span></span></h3>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='margin-left:5.4pt;border-collapse:collapse;border:none'>
 <tr style='page-break-inside:avoid'>
  <td width=293 valign=top style='width:219.75pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB>Step 15:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt;text-indent:-30.05pt'><span
  lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unscrew the
  capped Needle and dispose of it as described below (see <b>Disposing of Pens
  and Needles</b> section).</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt;text-indent:-30.05pt'><span
  lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not store the
  Pen with the Needle attached to prevent leaking, blocking the Needle, and air
  from entering the Pen.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=302 valign=top style='width:3.15in;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'><span
  style='position:relative;z-index:251669504'><span style='left:0px;position:
  absolute;left:76px;top:-164492px;width:140px;height:1px'><img width=140
  height=1 src="Humalo_files/image045.jpg"></span></span></p>
  </td>
 </tr>
 <tr>
  <td width=293 valign=top style='width:219.75pt;border:none;border-bottom:
  solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB>Step 16:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:30.05pt;margin-bottom:.0001pt;text-indent:-30.05pt'><span
  lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Replace the Pen
  Cap by lining up the Cap Clip with the Dose Indicator and pushing straight
  on.</span></p>
  </td>
  <td width=302 valign=top style='width:3.15in;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:6.0pt;margin-right:0in;
  margin-bottom:6.0pt;margin-left:0in;text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-top:6.0pt;margin-right:0in;
  margin-bottom:6.0pt;margin-left:0in;text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-top:6.0pt;margin-right:0in;
  margin-bottom:6.0pt;margin-left:0in;text-align:center'><span
  style='position:relative;z-index:251670528'><span style='left:0px;position:
  absolute;left:41px;top:-164747px;width:220px;height:1px'><img width=220
  height=1 src="Humalo_files/image046.jpg"></span></span></p>
  </td>
 </tr>
</table>

<h1 style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:
0in'><span style='font-size:11.0pt'>&nbsp;</span></h1>

<h1 style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:
0in'><span style='font-size:11.0pt;text-transform:none'>Disposing of pens and
needles </span></h1>

<h1 style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:
28.35pt'><span style='font-size:11.0pt'>&nbsp;</span></h1>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Put used Needles in a sharps container or a hard
plastic container with a secure lid. <b>Do not</b> throw needles directly into
your household waste.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The used Pen may be discarded in your household
waste after you have removed the Needle.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB>Do not</span></b><span lang=EN-GB> recycle
the filled sharps container.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Ask your healthcare professional about options
to dispose of the sharps container properly.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>The directions
regarding </span><span lang=EN-GB>needle<span style='letter-spacing:-.05pt'>
handling are not intended to replace local, healthcare professional or</span><span
style='letter-spacing:1.4pt'> </span><span style='letter-spacing:-.05pt'>institutional</span>
<span style='letter-spacing:-.05pt'>policies.</span></span></p>

<h1 style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:
0in'><span style='font-size:11.0pt;font-weight:normal'>&nbsp;</span></h1>

<h1 style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:
0in'><span style='font-size:11.0pt;text-transform:none'>Storing your pen&nbsp; </span></h1>

<h1 style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:
28.35pt'><span style='font-size:11.0pt'>&nbsp;</span></h1>

<h1 style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:
0in'><span style='font-size:11.0pt;text-transform:none'>Unused pens</span></h1>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
text-indent:-28.35pt;line-height:normal;page-break-after:auto'><span
style='font-size:11.0pt;font-family:"Arial",sans-serif;letter-spacing:-.05pt;
font-weight:normal'>&#8226;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt;letter-spacing:-.05pt;font-weight:
normal'>Store unused Pens in the refrigerator at 2&deg;C to 8&deg;C.</span></h3>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
text-indent:-28.35pt;line-height:normal;page-break-after:auto'><span
style='font-size:11.0pt;font-family:"Arial",sans-serif;letter-spacing:-.05pt;
font-weight:normal'>&#8226;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt;letter-spacing:-.05pt'>Do not </span><span
style='font-size:11.0pt;letter-spacing:-.05pt;font-weight:normal'>freeze your
insulin.</span><span style='font-size:11.0pt;letter-spacing:-.05pt'> Do not </span><span
style='font-size:11.0pt;letter-spacing:-.05pt;font-weight:normal'>use if it has
been frozen.</span></h3>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
text-indent:-28.35pt;line-height:normal;page-break-after:auto'><span
style='font-size:11.0pt;font-family:"Arial",sans-serif;font-weight:normal'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt;letter-spacing:-.05pt;font-weight:
normal'>Unused Pens may be used until the expiration date printed on the Label,
if the Pen has been kept in the</span><span style='font-size:11.0pt;letter-spacing:
2.0pt;font-weight:normal'> </span><span style='font-size:11.0pt;font-weight:
normal'>refrigerator.</span></h3>

<h3 style='margin-top:0in'><span style='font-size:11.0pt'>&nbsp;</span></h3>

<p class=MsoNormal><b><span lang=EN-GB style='letter-spacing:-.1pt'>In-use</span></b><b><span
lang=EN-GB style='letter-spacing:.15pt'> </span></b><b><span lang=EN-GB
style='letter-spacing:.05pt'>Pen</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Store <span style='letter-spacing:-.1pt'>the</span><span
style='letter-spacing:-.05pt'> Pen you are currently using</span><span
style='letter-spacing:.1pt'> </span><span style='letter-spacing:-.05pt'>at room
temperature</span><span style='letter-spacing:.05pt'> </span><span
style='letter-spacing:-.05pt'>up to 30&deg;C and away from heat and</span><span
style='letter-spacing:1.6pt'> </span>light.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Throw away </span><span
lang=EN-GB>the<span style='letter-spacing:-.05pt'> Pen you are </span></span><span
lang=EN-GB style='letter-spacing:-.05pt'>using after the time specified in the
Package Leaflet</span><span lang=EN-GB style='letter-spacing:-.05pt'>, even if
it still</span><span lang=EN-GB style='letter-spacing:1.5pt'> </span><span
lang=EN-GB>has insulin <span style='letter-spacing:-.05pt'>left in it.</span></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<h1 style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:
0in'><span style='font-size:11.0pt;text-transform:none'>General information
about the safe and effective use of your pen </span></h1>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB>Keep your Pen and Needles out of the sight
and reach of children.</span></b></p>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
text-indent:-28.35pt;line-height:normal;page-break-after:auto'><span
style='font-size:11.0pt;font-family:"Arial",sans-serif;font-weight:normal'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt'>Do not </span><span
style='font-size:11.0pt;font-weight:normal'>use your Pen if any part looks
broken or damaged.</span></h3>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Always carry an extra Pen in case yours is lost
or damaged.</span></p>

<p class=MsoNormal><span lang=EN-GB style='letter-spacing:-.05pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='letter-spacing:-.05pt'>Troubleshooting</span></b></p>

<h3 style='margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:28.35pt;
text-indent:-28.35pt;line-height:normal;page-break-after:auto'><span
style='font-size:11.0pt;font-family:"Arial",sans-serif;font-weight:normal'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt;font-weight:normal'>If<span
style='letter-spacing:.1pt'> </span><span style='letter-spacing:-.05pt'>you</span><span
style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>cannot</span><span
style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.05pt'>remove
the</span><span style='letter-spacing:.1pt'> </span><span style='letter-spacing:
-.1pt'>Pen</span><span style='letter-spacing:.05pt'> </span><span
style='letter-spacing:-.05pt'>Cap, gently twist the cap back and forth, and
then pull the cap straight off.</span></span></h3>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8226;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.1pt'>If</span><span
lang=EN-GB style='letter-spacing:.35pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>the Dose Knob</span><span lang=EN-GB
style='letter-spacing:.1pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>is</span><span lang=EN-GB style='letter-spacing:-.2pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>hard</span><span lang=EN-GB
style='letter-spacing:.05pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>to push:</span></p>

<p class=MsoNormal style='margin-left:56.7pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8211;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Pushing the Dose
Knob more slowly will make it easier to inject.</span></p>

<p class=MsoNormal style='margin-left:56.7pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8211;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Your Needle may be
blocked.</span><span lang=EN-GB> Put on<span style='letter-spacing:.1pt'> </span>a<span
style='letter-spacing:-.05pt'> new Needle</span><span style='letter-spacing:
.1pt'> </span><span style='letter-spacing:-.05pt'>and prime the Pen.</span></span></p>

<p class=MsoNormal style='margin-left:56.7pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:"Arial",sans-serif'>&#8211;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>You may have dust,
food, or liquid inside the Pen.</span><span lang=EN-GB style='letter-spacing:
.1pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>Throw the Pen away
and get</span><span lang=EN-GB style='letter-spacing:.3pt'> </span><span
lang=EN-GB>a<span style='letter-spacing:-.1pt'> </span><span style='letter-spacing:
-.05pt'>new</span><span style='letter-spacing:-.1pt'> </span><span
style='letter-spacing:-.05pt'>Pen.</span></span></p>

<p class=MsoNormal><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal><span lang=EN-GB style='color:black'>If you have any
questions or problems with your KwikPen, call your healthcare professional for
help or contact your local Lilly affiliate</span></p>

<h3 style='margin-top:0in'><span style='font-size:11.0pt;letter-spacing:-.05pt;
background:aqua'>&nbsp;</span></h3>

<p class=MsoNormal><span lang=EN-GB style='letter-spacing:-.05pt'>Document
Revision Date: </span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=DE>&nbsp;</span></b></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=EN-GB>Package leaflet: Information for the user</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center'><b><span
lang=DA>Liprolog 200&nbsp;units/ml </span></b><b><span lang=EN-GB>KwikPen</span></b><b><span
lang=DA>, solution for injection </span></b><b><span lang=EN-GB>in a pre&#8209;filled
pen</span></b></p>

<p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>insulin
lispro</span></p>

<p class=MsoNormal align=center style='margin-right:-2.25pt;text-align:center;
line-height:normal'><b><span lang=EN-GB>Each </span><span lang=EN-GB>KwikPen </span></b><b><span
lang=EN-GB>delivers 1 &#8211; 60 units in steps of 1 units.</span></b></p>

<p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Read all of this leaflet carefully
before you start using this medicine because it contains important information
for you.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Keep this leaflet. You may need to read it
again.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of illness
are the same as yours.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you get any side effects, talk to your doctor
or pharmacist.</span><span lang=EN-GB> This includes any possible side effects
not listed in this leaflet. See section 4.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB>What is in
this leaflet</span></b><span lang=EN-GB>: </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>What Liprolog </span><span lang=DA>200&nbsp;units/ml
</span><span lang=EN-GB>KwikPen is and what it is used for</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>What you need to know before you use Liprolog </span><span
lang=DA>200&nbsp;units/ml </span><span lang=EN-GB>KwikPen</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>How to use Liprolog </span><span lang=DA>200&nbsp;units/ml
</span><span lang=EN-GB>KwikPen</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Possible side effects</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>How to store Liprolog </span><span lang=DA>200&nbsp;units/ml
</span><span lang=EN-GB>KwikPen</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Contents of the pack and other information</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What
Liprolog </span></b><b><span lang=DA>200&nbsp;units/ml KwikPen is and what it
is used for</span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Liprolog </span><span
lang=DA>200&nbsp;units/ml </span><span lang=EN-GB>KwikPen is used to treat
diabetes. Liprolog works more quickly than normal human insulin because insulin
lispro has been changed slightly in comparison to human insulin. Insulin lispro
is closely related to human insulin which is a natural hormone made by the
pancreas.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>You get diabetes
if your pancreas does not make enough insulin to control the level of glucose
in your blood. Liprolog is a substitute for your own insulin and is used to
control glucose in the long term. It works very quickly and lasts a shorter
time than soluble insulin (2 to 5 hours). You should normally use Liprolog
within 15 minutes of a meal. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Your doctor may
tell you to use Liprolog </span><span lang=DA>200&nbsp;units/ml </span><span
lang=EN-GB>KwikPen as well as a longer-acting insulin. Each kind of insulin
comes with another patient information leaflet to tell you about it. Do not
change your insulin unless your doctor tells you to. </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Liprolog 200&nbsp;units/ml KwikPen should
be reserved for the treatment of adults with diabetes requiring daily doses of
more than 20 units of rapid-acting insulin.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog 200
units/ml KwikPen is a disposable pre-filled pen containing 3 ml (600 units, 200
units/ml) of insulin lispro.&nbsp; One KwikPen contains multiple doses of
insulin.&nbsp; The KwikPen dials 1 unit at a time. <b>The number of units are
displayed in the dose window, always check this before your injection. </b>You
can inject from 1 to 60 units in a single injection.&nbsp; <b>If your dose is
more than 60 units, you will need to give yourself more than one injection. </b></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What
you need to know before you use Liprolog </span></b><b><span lang=DA>200&nbsp;units/ml
</span></b><b><span lang=EN-GB>KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Do NOT use Liprolog </span></b><b><span
lang=DA>200&nbsp;units/ml </span></b><b><span lang=EN-GB>KwikPen </span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you are <b>allergic</b> to insulin lispro or
any of the other ingredients of </span><span lang=EN-GB>this medicine (listed
in section 6)</span><span lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you think <b>hypoglycaemia</b> (low blood
sugar) is starting. Further in this leaflet it tells you how to deal with mild
hypoglycaemia (see section 3: If you take more Liprolog than you need).</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><b><span lang=EN-GB>Warnings
and precautions </span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:14.15pt;margin-bottom:.0001pt;text-indent:-14.15pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><b><span
lang=EN-GB>The Liprolog 200&nbsp;units/ml solution for injection in your
pre-filled pen (the KwikPen) should ONLY be injected with this pre-filled pen.</span></b><span
lang=EN-GB> <b>Do not transfer the insulin lispro from your
Liprolog&nbsp;200&nbsp;units/ml KwikPen to a syringe</b>. The markings on the
insulin syringe will not measure your dose correctly. A severe overdose can result,
causing low blood sugar which may put your life in danger.&nbsp; Do not
transfer insulin from your Liprolog&nbsp;200&nbsp;units/ml KwikPen to any other
insulin delivery devices like insulin infusion pumps.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><b><span
lang=EN-GB>Do NOT mix the Liprolog 200&nbsp;units/ml solution for injection in
your pre-filled pen (the KwikPen) with any other insulin or any other medicine.</span></b><span
lang=EN-GB> The Liprolog 200&nbsp;units/ml solution for injection should not be
diluted.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>If your blood sugar levels are well controlled by your current
insulin therapy, you may not feel the warning symptoms when your blood sugar is
falling too low. Warning signs are listed in section 4 of this leaflet. You
must think carefully about when to have your meals, how often to exercise and
how much to do. You must also keep a close watch on your blood sugar levels by
testing your blood glucose often.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>A few people who have had hypoglycaemia after switching from animal
insulin to human insulin have reported that the early warning symptoms were
less obvious or different. If you often have hypoglycaemia or have difficulty
recognising it, please discuss this with your doctor.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>If you answer YES to any of the following questions, tell your
doctor, pharmacist or diabetes nurse</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have
you recently become ill?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do
you have trouble with your kidneys or liver?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt'><span lang=EN-GB>- &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are
you exercising more than usual?</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>You should also tell your doctor, pharmacist or diabetes nurse if
you are planning to go abroad. The time difference between countries may mean
that you have to have your injections and meals at different times from when
you are at home.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>Some patients with long-standing type 2 diabetes mellitus and heart
disease or previous stroke who were treated with pioglitazone and insulin
experienced the development of heart failure. Inform your doctor as soon as
possible, if you experience signs of heart failure such as unusual shortness of
breath or rapid increase in weight or localised swelling (oedema).</span></p>

<p class=PPILabelingBodyText style='margin-left:14.15pt;text-indent:-14.15pt'><span
style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-family:"Times New Roman",serif'>This Pen is not
recommended for use by the blind or visually impaired without the help of
someone trained to use the Pen.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB>Other
medicines and Liprolog </span></b><b><span lang=DA>200&nbsp;units/ml </span></b><b><span
lang=EN-GB>KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Your insulin
needs may change if you are taking </span></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>the contraceptive pill, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>steroids, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>thyroid hormone replacement therapy, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>oral hypoglycaemics, (e.g. metformin, acarbose, sulphonylurea
     agents, pioglitazone, empagliflozin, DPP-4-inhibitors like sitagliptin or
     saxagliptine, ),</span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>acetyl salicylic acid, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>sulpha antibiotics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB style='color:black'>somatostatin analogues (such as octreotide,
     used to treat an uncommon condition in which you make too much growth
     hormone),</span><span lang=EN-GB> </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>&#8220;beta<sub>2</sub> stimulants&#8221;such as salbutamol or
     terbutaline to treat asthma, or ritodrine </span><span lang=EN>used to
     stop premature labor,</span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>beta-blockers &#8211; to treat high blood pressure., or </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some antidepressants (monoamine oxidase inhibitors or selective
     serotonin reuptake inhibitors), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>danazol <span style='color:black'>(medicine acting on
     ovulation)</span>, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some angiotensin converting (ACE) inhibitors, <span
     style='color:black'>used to treat certain heart conditions or high blood
     pressure</span> (for example captopril, enalapril), and </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN>specific medicines to treat high blood pressure, kidney damage due
     to diabetes, and </span><span lang=EN-GB>some heart problems </span><span
     lang=EN>&nbsp;(angiotensin </span><span lang=EN-GB>II receptor blockers).</span></li>
</ul>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>Please tell your
doctor, if you are taking, have recently taken or might take any other
medicines. (see also section &#8220;Warnings and precautions&#8221;).</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;page-break-after:avoid'><b><span
lang=EN-GB>Liprolog with alcohol</span></b></p>

<p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
lang=EN-GB style='color:black'>&nbsp;</span></b></p>

<p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
lang=EN-GB style='color:black'>Your blood sugar levels may either rise or fall
if you drink alcohol.&nbsp; Therefore the amount of insulin needed may change.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><b><span lang=EN-GB>Pregnancy
and breast-feeding</span></b></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Are you
pregnant or thinking about becoming pregnant, or are you breast-feeding? The
amount of insulin you need usually falls during the first three months of
pregnancy and increases for the remaining six months. If you are
breast-feeding, you may need to alter your insulin intake or diet.</span></p>

<p class=MsoNormal><span lang=EN-GB>Ask your doctor for advice.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB>Driving and
using machines</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>Your ability
to concentrate and react may be reduced if you have hypoglycaemia. Please keep
this possible problem in mind in all situations where you might put yourself
and others at risk (e.g. driving a car or using machines). You should contact
your doctor about the advisability of driving if you have:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>frequent episodes of hypoglycaemia</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>reduced or absent warning signs of hypoglycaemia</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How
to use Liprolog</span></b><span lang=EN-GB> </span><b><span lang=DA>200&nbsp;units/ml
KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Always check
the pack and the label of the pre-filled pen for the name and type of the
insulin when you get it from your pharmacy. Make sure you get the Liprolog </span></b><b><span
lang=DA>200&nbsp;units/ml </span></b><b><span lang=EN-GB>KwikPen that your
doctor has told you to use.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>Always use this
medicine exactly as your doctor has told you. You should check with your doctor
if you are not sure.</span> To prevent the possible transmission of disease,
each pen must be used by you only, even if the needle is changed.</p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>Liprolog&nbsp;200&nbsp;units/ml
KwikPen is for patients taking more than 20&nbsp;units of rapid-acting insulin
a day.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB>Do not
transfer insulin from your Liprolog&nbsp;200&nbsp;units/ml KwikPen to a
syringe. The markings on the insulin syringe will not measure your dose
correctly. A severe overdose can result, causing low blood sugar which may put
your life in danger.</span></b></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Do not use
Liprolog 200&nbsp;units/ml KwikPen solution for injection in an insulin infusion
pump.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Dosage</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You should normally inject Liprolog within 15
minutes of a meal. If you need to, you can inject soon after a meal. But your
doctor will have told you exactly how much to use, when to use it, and how
often. These instructions are only for you. Follow them exactly and visit your
diabetes clinic regularly.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you change the type of insulin you use (for
example from a human or animal insulin to a Liprolog product), you may have to
take more or less than before. This might just be for the first injection or it
may be a gradual change over several weeks or months. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Inject Liprolog under the skin (subcutaneously).
</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><b><span
lang=EN-GB>Preparing Liprolog </span></b><b><span lang=DA>200&nbsp;units/ml </span></b><b><span
lang=EN-GB>KwikPen </span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Liprolog is already dissolved in water, so you
do not need to mix it. But you must use it <b>only </b>if it looks like water.
It must be clear, have no colour and no solid pieces in it. Check each time you
inject yourself.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Getting the
KwikPen ready to use (Please see user manual)</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>First wash your hands.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Read the instructions on how to use your pre-filled
insulin pen. Please follow the instructions carefully. Here are some reminders.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Use a clean needle. (Needles are not included).</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Prime your KwikPen before each use. This checks
that insulin comes out and clears the air bubbles from your KwikPen. There may
still be some small air bubbles left in the pen - these are harmless. But if
the air bubbles are too large it may affect the insulin dose.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Injecting
Liprolog </span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Before you make an injection, clean your skin as
you have been instructed. Inject under the skin, as you were taught. After your
injection, leave the needle in the skin for five seconds to make sure you have
taken the whole dose. Do not rub the area you have just injected. Make sure you
inject at least half an inch (1&nbsp;cm) from the last injection and that you
&#8216;rotate&#8217; the places you inject, as you have been taught. It
doesn&#8217;t matter which injection site you use, either upper arm, thigh,
buttock or abdomen, your Liprolog injection will still work quicker than
soluble human insulin.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;text-autospace:none'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Do not inject Liprolog 200&nbsp;units/ml KwikPen
solution for injection directly into a vein (intravenously).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>After
injecting</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>As soon as you have done the injection, unscrew
the needle from the KwikPen using the outer needle cap. This will keep the
insulin sterile and stop it leaking. It also stops air entering the pen and
your needle clogging. <b>Do not share your needles</b>. <u>Do not share your
pen</u>. Replace the cap on your pen.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Further
injections</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Every time you use a KwikPen you must use a new
needle. Before every injection, clear any air bubbles. You can see how much
insulin is left by holding the KwikPen with the needle pointing up. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Once the KwikPen is empty, do not use it again.
Please get rid of it carefully - your pharmacist or diabetes nurse will tell
you how to do this.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB>If you take
more Liprolog than you need</span></b></p>

<p class=MsoBodyText3><span lang=EN-GB>If you take more Liprolog than you need,
a low blood sugar may occur.&nbsp; Check your blood sugar. </span></p>

<p class=MsoBodyText3><span lang=EN-GB>If your blood sugar is low <b>(mild
hypoglycaemia)</b>, eat glucose tablets, sugar or drink a sugary drink. Then
eat fruit, biscuits, or a sandwich, as your doctor has advised you and have
some rest. This will often get you over mild hypoglycaemia or a minor insulin
overdose. If you get worse and your breathing is shallow and your skin gets
pale, tell your doctor at once. A glucagon injection can treat quite severe
hypoglycaemia. Eat glucose or sugar after the glucagon injection. If you do not
respond to glucagon, you will have to go to hospital. Ask your doctor to tell
you about glucagon.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB>If you forget
to use Liprolog</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>If you take less
Liprolog than you need, a high blood sugar may occur.&nbsp; Check your blood
sugar</span><span class=MsoCommentReference><span lang=EN-GB style='font-size:
8.0pt;display:none'>.</span></span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>If hypoglycaemia
(low blood sugar) or hyperglycaemia (high blood sugar) is not treated, they can
be very serious and cause headaches, feeling sick (nausea), being sick (vomiting),
loss of fluids (dehydration), unconsciousness, coma or even death (see section
4 &#8220;Possible side effects&#8221;). </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB>Three simple
steps </span></b><span lang=EN-GB>to avoid hypoglycaemia or hyperglycaemia are:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
carry a spare pen in case you lose your KwikPen or it gets damaged.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
carry something to show you are diabetic.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
carry sugar with you.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><b><span lang=EN-GB>If you
stop using Liprolog.</span></b></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>If you take
less Liprolog than you need, a high blood sugar may occur. Do not change your
insulin unless your doctor tells you to.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>If you have any
further questions on the use of this medicine, ask your doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible
side effects</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-1.45pt'><span lang=EN-GB>Like all
medicines, this medicine can cause side effects, although not everybody gets
them.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Severe allergy </span><span
lang=EN-GB style='layout-grid-mode:line'>is rare (</span><span lang=EN-GB
style='color:black'>may affect up to 1 in 1,000 people</span><span lang=EN-GB
style='layout-grid-mode:line'>)</span><span lang=EN-GB>.</span><span
lang=EN-GB> The symptoms are as follows:</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash
over the whole body&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood
pressure dropping</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty
in breathing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart
beating fast</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; wheezing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sweating</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>If you think
you are having this sort of insulin allergy with Liprolog, contact a doctor at
once.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Local allergy</span><span
lang=EN-GB style='layout-grid-mode:line'> is common (</span><span lang=EN-GB
style='color:black'>may affect up to 1 in 10 people</span><span lang=EN-GB
style='layout-grid-mode:line'>).</span><span lang=EN-GB>&nbsp; Some people get
redness, swelling or itching around the area of the insulin injection. This
usually clears up in anything from a few days to a few weeks. If this happens
to you, tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Lipodystrophy
(thickening or pitting of the skin)<span style='layout-grid-mode:line'> is
uncommon (</span><span style='color:black'>may affect up to 1 in 100 people</span><span
style='layout-grid-mode:line'>)</span>. If you notice your skin thickening or
pitting at the injection site, tell your doctor.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Oedema (e.g. swelling in arms, ankles;
fluid retention) has been reported, particularly at the start of insulin
therapy or during a change in therapy to improve control of your blood glucose.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Reporting of side effects</span></b></p>

<p class=BodytextAgency style='margin-bottom:0in'><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>If you get any
side effects, talk to your doctor or pharmacist.</span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'> This includes any
possible side effects not listed in this leaflet. You can also report side
effects directly via <span style='background:silver'>the national reporting
system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span>. By reporting side effects you can help provide more information
on the safety of this medicine.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Common
problems of diabetes</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Hypoglycaemia</span></b><span
lang=EN-GB> </span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Hypoglycaemia
(low blood sugar) means there is not enough sugar in the blood. This can be
caused if:</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you
take too much Liprolog or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you
miss or delay meals or change your diet;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you
exercise or work too hard just before or after a meal;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you
have an infection or illness (especially diarrhoea or vomiting);</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; there
is a change in your need for insulin; or</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you
have trouble with your kidneys or liver which gets worse.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Alcohol and some
medicines can affect your blood sugar levels (see section 2).</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>The first
symptoms of low blood sugar usually come on quickly and include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tiredness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rapid
heartbeat</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nervousness
or shakiness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
sick</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cold
sweat</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>While you are
not confident about recognising your warning symptoms, avoid situations such as
driving a car, in which you or others would be put at risk by hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Hyperglycaemia
and diabetic ketoacidosis</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Hyperglycaemia
(too much sugar in the blood) means that your body does not have enough
insulin. Hyperglycaemia can be brought about by:</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not
taking your Liprolog or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; taking
less insulin than your doctor tells you to;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eating
a lot more than your diet allows; or</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever,
infection or emotional stress.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Hyperglycaemia
can lead to diabetic ketoacidosis. The first symptoms come on slowly over many
hours or days. The symptoms include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
sleepy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; no
appetite</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flushed
face&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fruity
smell on the breath</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thirst&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
or being sick</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Severe symptoms
are heavy breathing and a rapid pulse. <b>Get medical help immediately.</b></span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Illness</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>If you are ill,
especially if you feel sick or are sick, the amount of insulin you need may
change. <b>Even when you are not eating normally, you still need insulin.</b>
Test your urine or blood, follow your &#8216;sick rules&#8217;, and tell your
doctor.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><b><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store Liprolog </span></b><b><span
lang=DA>200&nbsp;units/ml </span></b><b><span lang=EN-GB>KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>Keep this
medicine out of the sight and reach of children.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>Do not use
Liprolog </span><b><span lang=DA>200&nbsp;units/ml </span></b><span lang=EN-GB>KwikPen
after the expiry date which is stated on the label and the carton. The expiry
date refers to the last day of that month. </span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>Before the first
use store your Liprolog </span><b><span lang=DA>200&nbsp;units/ml </span></b><span
lang=EN-GB>KwikPen in a refrigerator (2</span><span lang=EN-GB
style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C &#8211; 8</span><span
lang=EN-GB style='font-family:Symbol'>&deg;</span><span lang=EN-GB>C). Do not
freeze. </span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>Keep your
Liprolog </span><b><span lang=DA>200&nbsp;units/ml </span></b><span lang=EN-GB>KwikPen
in use at room temperature (15&deg; - 30&deg;C) and discard after 28 days. Do
not put it near heat or in the sun. Do not keep the KwikPen that you are using
in the fridge. The KwikPen should not be stored with the needle attached.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>Do not use
Liprolog </span><b><span lang=DA>200&nbsp;units/ml </span></b><span lang=EN-GB>KwikPen,
if the solution is coloured or it has solid pieces in it. </span><span
lang=EN-GB>You must use it <b>only</b> if it looks like water. Check this each
time you inject yourself.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>Medicines should
not be disposed of via wastewater or household waste. Ask your pharmacist how
to dispose of medicines no longer required. These measures will help to protect
the environment.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents
of the pack and other information</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB>What </span></b><b><span
lang=EN-GB>Liprolog 200&nbsp;units/ml KwikPen solution for injection contains</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The active substance is insulin lispro. </span><span
lang=EN-GB style='color:black'>&nbsp;Each ml of solution contains 200 units (U)
of insulin lispro. Each pre-filled pen (3 ml) contains 600 units (U) of insulin
lispro</span><span lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The other ingredients are</span><span
lang=EN-GB> metacresol, glycerol, trometamol, zinc oxide and water for
injection. Sodium hydroxide or hydrochloric acid may have been used to adjust
the acidity.<i> </i></span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB>What Liprolog
</span></b><b><span lang=DA>200&nbsp;units/ml </span></b><b><span lang=EN-GB>KwikPen
looks like and contents of the pack</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>Liprolog
200&nbsp;units/ml KwikPen, solution for injection is a sterile, clear,
colourless, aqueous solution and contains 200&nbsp;units of insulin lispro in
each millilitre (200&nbsp;units/ml) solution for injection. Each Liprolog </span><span
lang=DA>200&nbsp;units/ml </span><span lang=EN-GB>KwikPen contains
600&nbsp;units (3&nbsp;millilitres). The Liprolog </span><span lang=DA>200&nbsp;units/ml
</span><span lang=EN-GB>KwikPen comes in a pack of 5 pre-filled pens or
multipacks of 2 x 5 pre-filled pens. Not all pack sizes may be marketed. The
KwikPen simply has a built in cartridge. When the pre-filled pen is empty you
cannot use it again.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;page-break-after:avoid'><b><span
lang=EN-GB>Marketing Authorisation Holder </span></b></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><span
lang=EN-GB>Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The
Netherlands.<b> </b></span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Manufacturer</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Lilly France
S.A.S., Rue du Colonel Lilly, 67640 Fegersheim, France,</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span lang=IT>Eli
Lilly Italia S.p.A., Via&nbsp; Gramsci 731-733, 50019 Sesto Fiorentino, (FI)
Italy.</span></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>For any information
about this medicinal product, please contact the local representative of the
Marketing Authorisation Holder:</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=624
 style='margin-left:-1.7pt;border-collapse:collapse'>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>Belgique/Belgi&euml;/Belgien</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>Lietuva</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Eli Lilly Holdings Limited atstovyb&#279;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel. +370 (5) 2649600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=BG>&#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1058;&#1055;
  &quot;&#1045;&#1083;&#1080; &#1051;&#1080;&#1083;&#1080;
  &#1053;&#1077;&#1076;&#1077;&#1088;&#1083;&#1072;&#1085;&#1076;&quot;
  &#1041;.&#1042;. - &#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1090;&#1077;&#1083;.
  + 359 2 491 41 40</span></p>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>&nbsp;</span></b></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Luxembourg/Luxemburg</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>&#268;esk&aacute; republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>ELI LILLY &#268;R, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 420 234 664 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>Magyarorsz&aacute;g</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Lilly Hung&aacute;ria Kft.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 36 1 328 5100</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>Danmark</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Eli Lilly Danmark A/S </span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tlf: +45 45 26 6000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Malta</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Charles de Giorgio Ltd.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 356 25600 500</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Deutschland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='text-transform:uppercase'>Berlin-Chemie AG</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Postfach
  1108,&nbsp; 12474 Berlin</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Tel.: 030/6707-0</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DA
  style='color:black'>Nederland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DA
  style='color:black'>Eli Lilly Nederland B.V. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 31-(0) 30 60 25 800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=EN-GB style='color:black'>Eesti</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>Eli Lilly Holdings Limited Eesti filiaal </span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: <b>+</b>372 6817 280</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=NO-BOK
  style='color:black'>Norge</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=NO-BOK
  style='color:black'>Eli Lilly Norge A.S. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tlf: + 47 22 88 18 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>&#917;&#955;&#955;&#940;&#948;&#945;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&#934;&#913;&#929;&#924;&#913;&#931;&#917;&#929;&#914;-&#923;&#921;&#923;&#923;&#933;
  &#913;.&#917;.&#914;.&#917;. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&#932;&#951;&#955;: +30 210 629 4600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>&Ouml;sterreich</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Ges. m.b.H. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 43-(0) 1 711 780</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Espa&ntilde;a</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Lilly S.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Tel: + 34-91 663 50 00</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=SV style='color:black'>Polska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Eli Lilly Polska Sp. z o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: +48 22 440 33 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=FR style='color:black'>France</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=FR style='color:black'>Lilly France S.A.S.</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=FR style='color:black'>T&eacute;l: +33-(0) 1 55 49 34 34</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=PT-BR
  style='color:black'>Portugal</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=PT-BR
  style='color:black'>Lilly Portugal - Produtos Farmac&ecirc;uticos, Lda</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 351-21-4126600</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=ES>Hrvatska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Eli Lilly
  Hrvatska d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Tel: +385 1
  2350 999</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=IT>Rom&acirc;nia</span></b></p>
  <p class=MsoNormal><span lang=RO>Eli Lilly Rom&acirc;nia S.R.L.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=RO>Tel: + 40 21
  4023000</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB>Ireland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Eli Lilly and
  Company (Ireland) Limited</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Tel: +
  353-(0) 1 661 4377</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR>Slovenija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR>Eli Lilly
  farmacevtska dru&#382;ba, d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Tel: +386 (0) 1
  580 00 10</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=EN-GB style='color:black'>&Iacute;sland</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>Icepharma hf. </span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>S&iacute;mi + 354 540 8000</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=EN-GB style='color:black'>Slovensk&aacute; republika</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>Eli Lilly Slovakia, s.r.o.</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>Tel: + 421 220 663 111</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=IT style='color:black'>Italia</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=IT style='color:black'>Eli Lilly Italia S.p.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 39- 055 42571</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=SV
  style='color:black'>Suomi/Finland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Oy Eli Lilly Finland Ab </span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Puh/Tel: + 358-(0) 9 85 45 250</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>&#922;&#973;&#960;&#961;&#959;&#962;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Phadisco Ltd </span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&#932;&#951;&#955;: +357 22 715000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Sverige</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Sweden AB</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Tel: + 46-(0) 8 7378800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>Latvija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Eli Lilly Holdings Limited p&#257;rst&#257;vniec&#299;ba
  Latvij&#257;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: <b>+</b>371 67364000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>United Kingdom</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Eli Lilly and Company Limited</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 44-(0) 1256 315000</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB>This leaflet
was last revised in </span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>Detailed
information on this medicine is available on the European Medicines Agency web
site: http://www.ema.europa.eu/.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center;
line-height:normal'><b><span lang=EN-GB>USER MANUAL</span></b></p>

<p class=MsoHeading7 align=center style='margin-top:6.0pt;text-align:center'><b><span
lang=DA style='font-style:normal'>Liprolog 200&nbsp;units/ml </span></b><b><span
lang=EN-GB style='font-style:normal'>KwikPen</span></b><b><span lang=EN-GB>,</span></b><b><span
lang=EN-GB style='font-style:normal'> </span></b><b><span lang=DA
style='font-style:normal'>solution for injection in a pre&#8209;filled pen</span></b></p>

<p class=MsoNormal><span lang=DA>&nbsp;</span></p>

<p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'><span
lang=EN-GB style='color:black'>insulin lispro </span></p>

<p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'><span
lang=EN-GB style='color:black'>&nbsp;</span></p>

<p class=MsoNormal align=center style='margin-top:.5in;text-align:center'><span
lang=EN-GB><img border=0 width=457 height=58 id="Picture 1"
src="Humalo_files/image047.jpg"></span></p>

<p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center'><span
class=A1><span lang=EN-GB style='font-size:14.0pt;font-family:"Times New Roman",serif;
color:red'>PLEASE READ THIS USER MANUAL BEFORE USE</span></span></p>

<p class=Default align=center style='text-align:center'><span style='font-size:
11.0pt;font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=Default align=center style='text-align:center'><span style='font-size:
11.0pt;font-family:"Times New Roman",serif;color:windowtext'>&nbsp;</span></p>

<p class=Default align=center style='text-align:center'><span style='position:
relative;z-index:251639808'><span style='left:0px;position:absolute;left:240px;
top:-172751px;width:199px;height:4px'>

<table cellpadding=0 cellspacing=0>
 <tr>
  <td width=199 height=4 style='vertical-align:top'><span style='position:absolute;
  left:0pt;z-index:251639808'>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td>
    <div style='padding:0pt 0pt 0pt 0pt'>
    <p class=MsoNormal align=center style='text-align:center;line-height:11.0pt'><b><span
    lang=EN-GB style='font-size:10.5pt;font-family:"DIN-Bold",sans-serif'>USE
    ONLY IN THIS PEN, OR</span></b></p>
    <p class=MsoNormal align=center style='text-align:center;line-height:11.0pt'><b><span
    lang=EN-GB style='font-size:10.5pt;font-family:"DIN-Bold",sans-serif'>SEVERE
    OVERDOSE CAN RESULT</span></b></p>
    </div>
    </td>
   </tr>
  </table>
  </span>&nbsp;</td>
 </tr>
</table>

</span></span><span style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:windowtext'><img border=0 width=293 height=51
src="Humalo_files/image048.jpg"></span></p>

<p class=Default align=center style='text-align:center'><span style='font-size:
11.0pt;font-family:"Times New Roman",serif;color:windowtext'>&nbsp;</span></p>

<p class=Default align=center style='text-align:center'><span style='font-size:
11.0pt;font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Read the User Manual before you start
taking Liprolog 200&nbsp;units/ml KwikPen solution for injection and each time
you get another Liprolog 200&nbsp;units/ml KwikPen. There may be new information.
This information does not take the place of talking to your healthcare
professional about your medical condition or your treatment.</span></p>

<p class=MsoNormal style='margin-top:6.0pt;line-height:normal;text-autospace:
none'><span lang=EN-GB>Liprolog<b> </b></span><span lang=DA>200&nbsp;units/ml
KwikPen</span><span lang=DA> </span><span lang=EN-GB>(&#8220;Pen&#8221;) is a
disposable pre-filled pen containing 3&nbsp;ml (600&nbsp;units,
200&nbsp;units/ml) of insulin lispro solution for injection. </span>You can
give yourself multiple doses using one Pen. The Pen dials 1 unit at a time.<span
style='font-size:8.5pt'> </span><span lang=EN-GB>You can inject from 1 to
60&nbsp;units in a single injection. </span><b>If your dose is more than 60
units, you will need to give yourself more than one injection. </b>The plunger
only moves a little with each injection, and you may not notice that it moves.
The plunger will only reach the end of the cartridge when you have used all 600
units in the Pen.</p>

<p class=MsoHeader style='margin-top:6.0pt'><span class=A8><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif;font-weight:normal'>This
pen is designed to allow you to give more doses than other pens you may have
used in the past. Dial your usual dose as instructed by your healthcare
professional.</span></span></p>

<p class=MsoHeader style='margin-top:6.0pt'><b><span style='font-size:11.0pt;
font-family:"Times New Roman",serif'>Liprolog KwikPen is available in two
strengths, 100&nbsp;units/ml and 200&nbsp;units/ml. Inject Liprolog 200&nbsp;</span></b><b><span
lang=DA style='font-size:11.0pt;font-family:"Times New Roman",serif'>units/ml </span></b><b><span
style='font-size:11.0pt;font-family:"Times New Roman",serif'>ONLY with your
Pen. DO NOT transfer insulin from your Pen to another insulin delivery device.
Syringes and insulin pumps will not dose 200&nbsp;units/ml insulin correctly. A
severe overdose can result, causing very low blood sugar which may put your
life in danger.</span></b></p>

<p class=MsoHeader style='margin-top:6.0pt'><b><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>Do not share your
Pen with </span></b><b><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>other
people, even if the needle has been changed. Do not reuse or share needles with
other people</span></b><b><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>. You may give an infection to them or get an
infection from them. </span></b></p>

<p class=MsoNormal style='margin-top:6.0pt;line-height:normal;text-autospace:
none'><span lang=EN-GB>This Pen is not recommended for use by the blind or
visually impaired without the help of someone trained to use the Pen.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB>KwikPen
Parts</span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=659
 style='border-collapse:collapse;border:none'>
 <tr style='height:17.3pt'>
  <td width=60 valign=top style='width:45.0pt;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:17.3pt'>
  <p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=120 colspan=2 valign=top style='width:1.25in;border:none;
  padding:0in 5.75pt 0in 20.9pt;height:17.3pt'>
  <p class=MsoNormal><span style='position:relative;z-index:251629568'><span
  style='position:absolute;left:21px;top:-173281px;width:2px;height:2px'><img
  width=2 height=2 src="Humalo_files/image049.gif"></span></span><b><span
  lang=EN-GB>Pen Cap</span></b></p>
  </td>
  <td width=60 valign=top style='width:45.0pt;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:17.3pt'>
  <p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=180 valign=top style='width:135.0pt;border:none;padding:0in 5.75pt 0in .6in;
  height:17.3pt'>
  <p class=MsoNormal><span style='position:relative;z-index:251630592'><span
  style='position:absolute;left:26px;top:-173281px;width:2px;height:2px'><img
  width=2 height=2 src="Humalo_files/image049.gif"></span></span><b><span
  lang=EN-GB>Cartridge Holder</span></b></p>
  </td>
  <td width=60 valign=top style='width:45.0pt;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:17.3pt'>
  <p class=MsoNormal><span style='position:relative;z-index:251631616'><span
  style='position:absolute;left:29px;top:-173281px;width:2px;height:2px'><img
  width=2 height=2 src="Humalo_files/image049.gif"></span></span><b><span
  lang=EN-GB>Label</span></b></p>
  </td>
  <td width=60 colspan=2 valign=top style='width:45.0pt;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:17.3pt'>
  <p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=119 colspan=2 valign=top style='width:89.45pt;border:none;
  padding:0in 5.4pt 0in 5.4pt;height:17.3pt'>
  <p class=MsoNormal><span style='position:relative;z-index:251634688'><span
  style='position:absolute;left:5px;top:-173281px;width:45px;height:2px'><img
  width=45 height=2 src="Humalo_files/image050.gif"></span></span><b><span
  lang=EN-GB>Dose Indicator</span></b></p>
  </td>
  <td style='height:17.3pt;border:none' width=0 height=23></td>
 </tr>
 <tr style='height:19.3pt'>
  <td width=600 colspan=9 rowspan=2 valign=top style='width:6.25in;border:none;
  padding:0in 5.4pt 0in 5.4pt;height:19.3pt'>
  <p class=MsoNormal align=center style='margin-top:24.0pt;text-align:center;
  line-height:normal'><span style='position:relative;z-index:251637760'><span
  style='left:0px;position:absolute;left:307px;top:-173303px;width:88px;
  height:4px'>
  <table cellpadding=0 cellspacing=0>
   <tr>
    <td width=88 height=4 style='vertical-align:top'><span style='position:
    absolute;left:0pt;z-index:251637760'>
    <table cellpadding=0 cellspacing=0 width="100%">
     <tr>
      <td>
      <div style='padding:0pt 0pt 0pt 0pt'>
      <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
      style='font-size:4.5pt;font-family:"DIN-Bold",sans-serif;letter-spacing:
      -.05pt'>USE ONLY IN THIS PEN OR SEVERE OVERDOSE CAN RESULT</span></b></p>
      </div>
      </td>
     </tr>
    </table>
    </span>&nbsp;</td>
   </tr>
  </table>
  </span></span><span style='position:relative;z-index:251644928'><span
  style='left:0px;position:absolute;left:339px;top:-173304px;width:3px;
  height:2px'><img width=3 height=2 src="Humalo_files/image051.gif"></span></span><span
  style='position:relative;z-index:251633664'><span style='left:0px;position:
  absolute;left:545px;top:-173304px;width:3px;height:2px'><img width=3
  height=2 src="Humalo_files/image051.gif"></span></span><span
  style='position:relative;z-index:251628544'><span style='left:0px;position:
  absolute;left:197px;top:-173304px;width:52px;height:2px'><img width=52
  height=2 src="Humalo_files/image052.gif"></span></span><span
  style='position:relative;z-index:251632640'><span style='left:0px;position:
  absolute;left:449px;top:-173304px;width:2px;height:2px'><img width=2
  height=2 src="Humalo_files/image049.gif"></span></span><span
  style='position:relative;z-index:251627520'><span style='left:0px;position:
  absolute;left:80px;top:-173304px;width:2px;height:2px'><img width=2 height=2
  src="Humalo_files/image049.gif"></span></span><span lang=EN-GB><img border=0
  width=614 height=53 id="Picture 10" src="Humalo_files/image053.jpg"></span></p>
  </td>
  <td width=59 valign=top style='width:44.45pt;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:19.3pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td style='height:19.3pt;border:none' width=0 height=26></td>
 </tr>
 <tr style='height:.2in'>
  <td width=59 rowspan=2 valign=top style='width:44.45pt;border:none;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal><span style='position:relative;z-index:251635712'><span
  style='position:absolute;left:-4px;top:-173347px;width:19px;height:2px'><img
  width=19 height=2 src="Humalo_files/image054.gif"></span></span><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>
  <br clear=ALL>
  <p class=MsoNormal><b><span lang=EN-GB>Dose Knob</span></b></p>
  </td>
  <td style='height:.2in;border:none' width=0 height=19></td>
 </tr>
 <tr style='height:.3in'>
  <td width=120 colspan=2 style='width:1.25in;border:none;padding:0in 5.75pt 0in 48.95pt;
  height:.3in'>
  <p class=MsoNormal><b><span lang=EN-GB>Cap Clip</span></b></p>
  </td>
  <td width=120 colspan=2 style='width:1.25in;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.3in'>
  <p class=MsoNormal align=right style='text-align:right'><b><span lang=EN-GB>Rubber
  Seal</span></b></p>
  </td>
  <td width=180 style='width:135.0pt;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.3in'>
  <p class=MsoNormal><span lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <b>Plunger</b></span></p>
  </td>
  <td width=90 colspan=2 style='width:67.5pt;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.3in'>
  <p class=MsoNormal><span lang=EN-GB>&nbsp;<b>Pen Body</b></span></p>
  </td>
  <td width=90 colspan=2 style='width:67.5pt;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.3in'>
  <p class=MsoNormal><b><span lang=EN-GB>Dose Window</span></b></p>
  </td>
  <span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>
  <td style='height:.3in;border:none' width=0 height=29></td>
  </span>
 </tr>
 <tr height=0>
  <td width=52 style='border:none'></td>
  <td width=69 style='border:none'></td>
  <td width=58 style='border:none'></td>
  <td width=52 style='border:none'></td>
  <td width=215 style='border:none'></td>
  <td width=77 style='border:none'></td>
  <td width=27 style='border:none'></td>
  <td width=25 style='border:none'></td>
  <td width=54 style='border:none'></td>
  <td width=56 style='border:none'></td>
  <td style='border:none' width=0><p class='MsoNormal'>&nbsp;</td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<div align=center>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse'>
 <tr>
  <td width=349 colspan=6 valign=top style='width:261.55pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  lang=EN-GB>Pen Needle Parts</span></b></p>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  lang=EN-GB>(Needles Not Included)</span></b></p>
  </td>
  <td width=301 valign=top style='width:225.55pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  lang=EN-GB>Dose Knob</span></b></p>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  lang=EN-GB>with burgundy ring</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=118 valign=top style='width:88.15pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=72 colspan=2 valign=top style='width:.75in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=80 colspan=2 valign=top style='width:59.7pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span
  style='position:relative;z-index:251643904'><span style='left:0px;position:
  absolute;left:32px;top:-173476px;width:3px;height:2px'><img width=3 height=2
  src="Humalo_files/image051.gif"></span></span><b><span lang=EN-GB>Needle</span></b></p>
  </td>
  <td width=80 valign=top style='width:59.7pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=301 valign=top style='width:225.55pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:61.5pt'>
  <td width=349 colspan=6 valign=top style='width:261.55pt;padding:0in 5.4pt 0in 5.4pt;
  height:61.5pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  style='position:relative;z-index:251640832'><span style='left:0px;position:
  absolute;left:66px;top:-173493px;width:2px;height:2px'><img width=2 height=2
  src="Humalo_files/image049.gif"></span></span><span style='position:relative;
  z-index:251642880'><span style='left:0px;position:absolute;left:292px;
  top:-173493px;width:2px;height:2px'><img width=2 height=2
  src="Humalo_files/image049.gif"></span></span><span style='position:relative;
  z-index:251641856'><span style='left:0px;position:absolute;left:169px;
  top:-173493px;width:2px;height:2px'><img width=2 height=2
  src="Humalo_files/image049.gif"></span></span><span lang=EN-GB><img border=0
  width=304 height=74 id="Picture 23" src="Humalo_files/image055.jpg"></span></p>
  </td>
  <td width=301 style='width:225.55pt;padding:0in 5.4pt 0in 5.4pt;height:61.5pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB><img border=0 width=55 height=58 src="Humalo_files/image056.jpg"></span></p>
  </td>
 </tr>
 <tr>
  <td width=118 valign=top style='width:88.15pt;padding:0in 0in 0in .15in'>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  lang=EN-GB>Outer Needle Shield</span></b></p>
  </td>
  <td width=24 valign=top style='width:.25in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=84 colspan=2 valign=top style='width:63.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  lang=EN-GB>Inner Needle Shield</span></b></p>
  </td>
  <td width=44 valign=top style='width:32.7pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=80 valign=top style='width:59.7pt;padding:0in 0in 0in 5.75pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  lang=EN-GB>Paper Tab</span></b></p>
  </td>
  <td width=301 valign=top style='width:225.55pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  lang=EN-GB>&nbsp;</span></b></p>
  </td>
 </tr>
 <tr height=0>
  <td width=118 style='border:none'></td>
  <td width=24 style='border:none'></td>
  <td width=48 style='border:none'></td>
  <td width=36 style='border:none'></td>
  <td width=44 style='border:none'></td>
  <td width=80 style='border:none'></td>
  <td width=301 style='border:none'></td>
 </tr>
</table>

</div>

<p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>How to recognize your Liprolog
200&nbsp;units/ml KwikPen:</span></b></p>

<p class=MsoNormal style='margin-left:.5in;text-indent:-.25in;line-height:normal'><span
lang=EN-GB style='font-size:12.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Pen colour:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dark
grey</span></p>

<p class=MsoNormal style='margin-left:.5in;text-indent:-.25in;line-height:normal'><span
lang=EN-GB style='font-size:12.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Dose Knob:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dark
grey with burgundy ring on the end</span></p>

<p class=MsoNormal style='margin-left:.5in;text-indent:-.25in;line-height:normal'><span
lang=EN-GB style='font-size:12.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Labels:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Burgundy,
&#8220;200&nbsp;units/ml&#8221; in yellow box.</span></p>

<p class=MsoNormal style='margin-left:1.5in'><span lang=EN-GB>&nbsp; Yellow
warning on cartridge holder</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Supplies needed to give your injection:</span></b></p>

<p class=MsoNormal style='margin-left:35.7pt;text-indent:-17.85pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=DA>Liprolog 200&nbsp;units/ml KwikPen</span></p>

<p class=MsoNormal style='margin-left:35.7pt;text-indent:-17.85pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>KwikPen compatible Needle (BD [<span
style='color:black'>Becton, Dickinson and Company] Pen Needles recommended)</span></span></p>

<p class=MsoNormal style='margin-left:35.7pt;text-indent:-17.85pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Alcohol swab</span></p>

<p class=MsoNormal><span lang=EN-GB>Needles and alcohol swab are not included.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Preparing your Pen</span></b></p>

<h5 align=left style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:17.85pt;margin-bottom:.0001pt;text-align:left;text-indent:-17.85pt;
line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black;
font-weight:normal'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black;font-weight:normal'>Wash your
hands with soap and water.</span></h5>

<h5 align=left style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:17.85pt;margin-bottom:.0001pt;text-align:left;text-indent:-17.85pt;
line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black;
font-weight:normal'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black;font-weight:normal'>Check the
Pen to make sure you are taking the right type of insulin. This is especially
important if you use more than 1 type of insulin. </span></h5>

<h5 align=left style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:17.85pt;margin-bottom:.0001pt;text-align:left;text-indent:-17.85pt;
line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black;
font-weight:normal'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>Do not</span><span
lang=EN-GB style='color:black;font-weight:normal'> use your Pen past the
expiration date printed on the Label </span><span style='font-weight:normal'>or
for more than 28 days after you first start using the Pen</span><span
lang=EN-GB style='color:black;font-weight:normal'>. </span></h5>

<h5 align=left style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:17.85pt;margin-bottom:.0001pt;text-align:left;text-indent:-17.85pt;
line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black;
font-weight:normal'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black;font-weight:normal'>Always
use a </span><span lang=EN-GB style='color:black'>new Needle</span><span
lang=EN-GB style='color:black;font-weight:normal'> for each injection to help
prevent infections and blocked Needles. </span></h5>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoHeader style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:.25in;margin-bottom:.0001pt;text-autospace:none'><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif;color:black'>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=325 valign=top style='width:243.7pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB
  style='color:black'>Step 1:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>Pull the Pen Cap straight off.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.25in;line-height:
  normal'><span lang=EN-GB style='font-family:Symbol;color:black'>&middot;<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><b><span
  lang=EN-GB style='color:black'>Do not</span></b><span lang=EN-GB
  style='color:black'> remove the Pen Label.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>Wipe the Rubber Seal with an alcohol swab. </span></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB>Liprolog<span
  style='color:black'> </span></span><span lang=DA>200&nbsp;units/ml<b> </b></span><span
  lang=EN-GB style='color:black'>solution for injection should look clear and
  colourless. <b>Do not</b> use if it is cloudy, coloured, or has particles or
  clumps in it.</span></p>
  </td>
  <td width=325 valign=top style='width:243.75pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoHeader align=center style='margin-top:6.0pt;text-align:center'><span
  style='font-size:11.0pt;font-family:"Times New Roman",serif;color:black'>&nbsp;</span></p>
  <p class=MsoHeader align=center style='margin-top:6.0pt;text-align:center'><span
  style='font-size:11.0pt;font-family:"Times New Roman",serif;color:black'><img
  border=0 width=152 height=106 src="Humalo_files/image057.gif"></span></p>
  <p class=MsoHeader align=center style='margin-top:6.0pt;text-align:center'><span
  style='position:relative;z-index:251638784'><span style='left:0px;position:
  absolute;left:77px;top:-174222px;width:198px;height:4px'>
  <table cellpadding=0 cellspacing=0>
   <tr>
    <td width=198 height=4 style='vertical-align:top'><span style='position:
    absolute;left:0pt;z-index:251638784'>
    <table cellpadding=0 cellspacing=0 width="100%">
     <tr>
      <td>
      <div style='padding:0pt 0pt 0pt 0pt'>
      <p class=MsoNormal align=center style='text-align:center;line-height:
      11.0pt'><b><span lang=EN-GB style='font-size:9.0pt;font-family:"DIN-Bold",sans-serif'>USE
      ONLY IN THIS PEN OR </span></b></p>
      <p class=MsoNormal align=center style='text-align:center;line-height:
      11.0pt'><b><span lang=EN-GB style='font-size:9.0pt;font-family:"DIN-Bold",sans-serif'>SEVERE
      OVERDOSE CAN RESULT</span></b></p>
      </div>
      </td>
     </tr>
    </table>
    </span>&nbsp;</td>
   </tr>
  </table>
  </span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><img
  border=0 width=237 height=46 src="Humalo_files/image058.jpg"></span></p>
  </td>
 </tr>
 <tr>
  <td width=325 valign=top style='width:243.7pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoHeader style='margin-top:6.0pt'><b><span style='font-size:11.0pt;
  font-family:"Times New Roman",serif;color:black'>Step 2:</span></b></p>
  <p class=MsoHeader style='margin-top:6.0pt'><span style='font-size:11.0pt;
  font-family:"Times New Roman",serif;color:black'>Select a new Needle.</span></p>
  <p class=MsoHeader style='margin-top:6.0pt'><span style='font-size:11.0pt;
  font-family:"Times New Roman",serif;color:black'>Pull off the Paper Tab from
  the Outer Needle Shield.</span></p>
  </td>
  <td width=325 valign=top style='width:243.75pt;border:none;border-bottom:
  solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoHeader align=center style='margin-top:6.0pt;text-align:center'><span
  style='font-size:11.0pt;font-family:"Times New Roman",serif;color:black'>&nbsp;</span></p>
  <p class=MsoHeader align=center style='margin-top:6.0pt;text-align:center'><span
  style='font-size:11.0pt;font-family:"Times New Roman",serif;color:black'><img
  border=0 width=155 height=106 src="Humalo_files/image059.gif"></span></p>
  <p class=MsoHeader align=center style='margin-top:6.0pt;text-align:center'><span
  style='font-size:11.0pt;font-family:"Times New Roman",serif;color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=325 valign=top style='width:243.7pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB
  style='color:black'>Step 3:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>Push the capped Needle straight onto the Pen and twist
  the Needle on until it is tight.</span></p>
  </td>
  <td width=325 valign=top style='width:243.75pt;border:none;border-bottom:
  solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoHeader align=center style='margin-top:6.0pt;text-align:center'><span
  style='font-size:11.0pt;font-family:"Times New Roman",serif;color:black'>&nbsp;</span></p>
  <p class=MsoHeader align=center style='margin-top:6.0pt;text-align:center'><span
  style='font-size:11.0pt;font-family:"Times New Roman",serif;color:black'><img
  border=0 width=150 height=106 src="Humalo_files/image060.gif"></span></p>
  <p class=MsoHeader align=center style='margin-top:6.0pt;text-align:center'><span
  style='font-size:11.0pt;font-family:"Times New Roman",serif;color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=325 valign=top style='width:243.7pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB
  style='color:black'>Step 4:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>Pull off the Outer Needle </span><span lang=EN-GB
  style='color:black'>Shield. <b>Do not</b> throw it away.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>Pull off the Inner Needle Shield and throw it away.</span></p>
  </td>
  <td width=325 valign=top style='width:243.75pt;border:none;border-bottom:
  solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
  lang=EN-GB><img border=0 width=211 height=110 src="Humalo_files/image061.gif"></span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal><b><span lang=EN-GB>Priming your Pen</span></b></p>

<p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB
style='color:black'>Prime before each </span></b><b><span lang=EN-GB
style='color:black'>injection.</span></b><span lang=EN-GB style='color:black'> </span></p>

<h5 align=left style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:17.85pt;margin-bottom:.0001pt;text-align:left;text-indent:-17.85pt;
line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black;
font-weight:normal'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black;font-weight:normal'>Priming
your Pen means removing the air from the Needle and Cartridge that may collect
during normal use and ensures that the Pen is working correctly. </span></h5>

<h5 align=left style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:17.85pt;margin-bottom:.0001pt;text-align:left;text-indent:-17.85pt;
line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black;
font-weight:normal'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black;font-weight:normal'>If you do
not prime before each injection, you may get too much or too little insulin. </span></h5>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=325 valign=top style='width:243.7pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB
  style='color:black'>Step 5:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>To prime your Pen, turn the Dose Knob to <b>select 2
  units</b></span><span lang=EN-GB style='color:black'>.</span></p>
  </td>
  <td width=325 valign=top style='width:243.75pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB><img border=0 width=152 height=106 src="Humalo_files/image062.gif"></span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=325 valign=top style='width:243.7pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB
  style='color:black'>Step 6:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>Hold your Pen with the Needle pointing up. Tap the
  Cartridge Holder gently to collect air bubbles at the top.</span></p>
  </td>
  <td width=325 valign=top style='width:243.75pt;border:none;border-bottom:
  solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center;
  line-height:normal'><span lang=EN-GB><img border=0 width=155 height=106
  src="Humalo_files/image063.gif"></span></p>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center;
  line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=325 valign=top style='width:243.7pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB
  style='color:black'>Step 7:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>Continue holding your Pen with Needle pointing up. Push
  the Dose Knob in until it stops, and &#8220;<b>0</b>&#8221; is seen in the
  Dose Window. Hold the Dose Knob in and <b>count to 5 slowly</b>.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.25in;line-height:
  normal'><span lang=EN-GB style='font-family:Symbol;color:black'>&middot;<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-GB style='color:black'>You should see insulin at
  the tip of the Needle.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:.75in;margin-bottom:.0001pt;text-indent:-.25in;line-height:
  normal'><span lang=EN-GB style='font-family:Wingdings;color:black'>&sect;<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB
  style='color:black'>If you <b>do not</b> see insulin, repeat the priming
  steps, but not more than 8&nbsp;times.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:.75in;margin-bottom:.0001pt;text-indent:-.25in;line-height:
  normal'><span lang=EN-GB style='font-family:Wingdings;color:black'>&sect;<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB
  style='color:black'>If you <b>still</b> <b>do not</b> see insulin, change the
  Needle and repeat the priming steps.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>Small air bubbles are normal and will not affect your
  dose.</span></p>
  </td>
  <td width=325 valign=top style='width:243.75pt;border:none;border-bottom:
  solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center;
  line-height:normal'><span lang=EN-GB><img border=0 width=152 height=163
  src="Humalo_files/image064.jpg"></span></p>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center;
  line-height:normal'><span lang=EN-GB><img border=0 width=151 height=106
  src="Humalo_files/image065.gif"></span></p>
  <p class=MsoNormal align=center style='margin-top:6.0pt;text-align:center;
  line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoHeader style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:.25in;margin-bottom:.0001pt'><span lang=EN-GB style='font-size:
11.0pt;font-family:"Times New Roman",serif;color:black'>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoHeader style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:.25in;margin-bottom:.0001pt'><span lang=EN-GB style='font-size:
11.0pt;font-family:"Times New Roman",serif;color:black'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Selecting your dose</span></b></p>

<p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB
style='color:#211D1E'>This pen has been designed to deliver the dose that is
shown in the window. Dial your usual dose as instructed by your healthcare
professional.</span></b></p>

<h5 align=left style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:17.85pt;margin-bottom:.0001pt;text-align:left;text-indent:-17.85pt;
line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black;
font-weight:normal'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-weight:normal'>You can give from 1 to 60 units
in a single injection.</span><span lang=EN-GB style='color:black;font-weight:
normal'> </span></h5>

<h5 align=left style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:17.85pt;margin-bottom:.0001pt;text-align:left;text-indent:-17.85pt;
line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black;
font-weight:normal'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-weight:normal'>If your dose is more than 60
units, you will need to give more than one injection.</span><span lang=EN-GB
style='color:black;font-weight:normal'> </span></h5>

<h5 align=left style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:32.05pt;margin-bottom:.0001pt;text-align:left;text-indent:-17.85pt;
line-height:normal'><span lang=EN-GB style='font-family:"Courier New";
color:black;font-weight:normal'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span><span style='font-weight:normal'>If you need help deciding how to
divide up your dose, ask your healthcare </span><span lang=EN-GB
style='color:#211D1E;font-weight:normal'>professional</span><span
style='font-weight:normal'>.</span><span lang=EN-GB style='color:black;
font-weight:normal'> </span></h5>

<h5 align=left style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:32.05pt;margin-bottom:.0001pt;text-align:left;text-indent:-17.85pt;
line-height:normal'><span lang=EN-GB style='font-family:"Courier New";
color:black;font-weight:normal'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span><span style='font-weight:normal'>You should use a new Needle for
each injection and repeat the priming step.</span><span lang=EN-GB
style='color:black;font-weight:normal'> </span></h5>

<h5 align=left style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:.25in;margin-bottom:.0001pt;text-align:left;line-height:normal;
text-autospace:none'><span lang=EN-GB style='color:black'>&nbsp;</span></h5>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=325 valign=top style='width:243.7pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB
  style='color:black'>Step 8:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>Turn the Dose Knob to select the number of units you need
  to inject. The Dose Indicator should line up with your dose.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:43.35pt;margin-bottom:.0001pt;text-indent:-17.85pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black'>&middot;<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-GB style='color:black'>The Pen dials 1 unit at a
  time.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:43.35pt;margin-bottom:.0001pt;text-indent:-17.85pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black'>&middot;<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-GB style='color:black'>The Dose Knob clicks as
  you turn it.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:43.35pt;margin-bottom:.0001pt;text-indent:-17.85pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black'>&middot;<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-GB style='color:black'>DO NOT dial your dose by
  counting the clicks because you may dial the wrong dose.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:43.35pt;margin-bottom:.0001pt;text-indent:-17.85pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black'>&middot;<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-GB style='color:black'>The dose can be corrected
  by turning the Dose Knob in either direction until the correct dose lines up
  with the Dose Indicator.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:43.35pt;margin-bottom:.0001pt;text-indent:-17.85pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black'>&middot;<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-GB style='color:black'>The <b>even</b> numbers
  are printed on the dial. </span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:43.35pt;margin-bottom:.0001pt;text-indent:-17.85pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black'>&middot;<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-GB style='color:black'>The <b>odd</b> numbers,
  after the number 1, are shown as full lines.</span></p>
  <h2 style='margin-top:6.0pt'><span lang=EN-GB style='font-size:11.0pt;
  font-family:"Times New Roman",serif;color:black;font-style:normal'>Always
  check the number in the Dose Window to make sure you have dialled the correct
  dose. </span></h2>
  </td>
  <td width=325 valign=top style='width:243.75pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='color:black'><img border=0 width=152 height=105
  src="Humalo_files/image066.gif"></span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  style='position:relative;z-index:251645952'><span style='left:0px;position:
  absolute;left:127px;top:-175863px;width:3px;height:12px'><img width=3
  height=12 src="Humalo_files/image067.gif"></span></span><span lang=EN-GB><img
  border=0 width=147 height=100 src="Humalo_files/image068.gif"></span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='color:black'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
  lang=EN-GB>&nbsp;(Example: 12 units shown in the Dose Window)</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  style='position:relative;z-index:251646976'><span style='left:0px;position:
  absolute;left:118px;top:-176032px;width:3px;height:12px'><img width=3
  height=12 src="Humalo_files/image069.gif"></span></span><span lang=EN-GB><img
  border=0 width=134 height=86 src="Humalo_files/image070.jpg"></span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='color:black'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
  lang=EN-GB>&nbsp;(Example: 25 units shown in the Dose Window)</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoHeader style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:17.85pt;margin-bottom:.0001pt'><span lang=EN-GB style='font-size:
11.0pt;font-family:"Times New Roman",serif;color:black'>&nbsp;</span></p>

<h5 align=left style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:17.85pt;margin-bottom:.0001pt;text-align:left;text-indent:-17.85pt;
line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black;
font-weight:normal'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black;font-weight:normal'>The Pen
will not let you dial more than the number of units left in the Pen. </span></h5>

<h5 align=left style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:17.85pt;margin-bottom:.0001pt;text-align:left;text-indent:-17.85pt;
line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black;
font-weight:normal'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black;font-weight:normal'>If you need
to inject more than the number of units left in the Pen, you may either: </span></h5>

<h5 align=left style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:32.05pt;margin-bottom:.0001pt;text-align:left;text-indent:-17.85pt;
line-height:normal'><span lang=EN-GB style='font-family:"Courier New";
color:black;font-weight:normal'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span><span lang=EN-GB style='color:black;font-weight:normal'>inject
the amount left in your Pen and then use a new Pen to give the rest of your
dose, </span><span lang=EN-GB style='color:black'>or</span></h5>

<h5 align=left style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:32.05pt;margin-bottom:.0001pt;text-align:left;text-indent:-17.85pt;
line-height:normal'><span lang=EN-GB style='font-family:"Courier New";
color:black;font-weight:normal'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span><span lang=EN-GB style='color:black;font-weight:normal'>get a new
Pen and inject the full dose. </span></h5>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></b>

<h5 align=left style='margin-right:0in;text-align:left;line-height:normal'><span
lang=EN-GB style='color:black'>Giving your injection</span></h5>

<h5 align=left style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:17.85pt;margin-bottom:.0001pt;text-align:left;text-indent:-17.85pt;
line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black;
font-weight:normal'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black;font-weight:normal'>Inject
your insulin as your healthcare </span><span lang=EN-GB style='font-weight:
normal'>professional <span style='color:black'>has shown you. </span></span></h5>

<h5 align=left style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:17.85pt;margin-bottom:.0001pt;text-align:left;text-indent:-17.85pt;
line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black;
font-weight:normal'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black;font-weight:normal'>Change
(rotate) your injection site for each injection. </span></h5>

<h5 align=left style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:17.85pt;margin-bottom:.0001pt;text-align:left;text-indent:-17.85pt;
line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black;
font-weight:normal'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>Do not </span><span
lang=EN-GB style='color:black;font-weight:normal'>try to change your dose while
injecting. </span></h5>

<p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:.25in;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=325 valign=top style='width:243.7pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <h2 style='margin-top:6.0pt'><span lang=EN-GB style='font-size:11.0pt;
  font-family:"Times New Roman",serif;color:black;font-style:normal'>Step 9:</span></h2>
  <h2 style='margin-top:6.0pt'><span lang=EN-GB style='font-size:11.0pt;
  font-family:"Times New Roman",serif;color:black;font-weight:normal;
  font-style:normal'>Choose your injection site.</span></h2>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB>Liprolog<span
  style='color:black'> </span></span><span lang=DA>200&nbsp;units/ml<b> </b></span><span
  lang=EN-GB style='color:black'>solution for injection is injected under the
  skin (subcutaneously) of your stomach area, buttocks, upper legs or upper
  arms.</span></p>
  <h2 style='margin-top:6.0pt'><span lang=EN-GB style='font-size:11.0pt;
  font-family:"Times New Roman",serif;color:black;font-weight:normal;
  font-style:normal'>Wipe your skin with an alcohol swab, and let your skin dry
  before you inject your dose.</span></h2>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=325 valign=top style='width:243.75pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='color:black'><img border=0 width=163 height=149
  src="Humalo_files/image071.gif"></span></p>
  </td>
 </tr>
 <tr>
  <td width=325 valign=top style='width:243.7pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB
  style='color:black'>Step 10:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>Insert the Needle into your skin.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>Push the Dose Knob all the way in. </span></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  <table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
   style='border-collapse:collapse;border-collapse:collapse !msorm'>
   <tr>
    <td width=72 valign=top style='width:53.75pt;padding:0in 5.4pt 0in 5.4pt 0in 5.4pt 0in 5.4pt !msorm'>
    <p class=MsoNormal style='margin-top:6.0pt;line-height:normal'><span
    lang=EN-GB><img border=0 width=42 height=48 src="Humalo_files/image072.jpg"></span></p>
    </td>
    <td width=238 valign=top style='width:178.4pt;padding:0in 5.4pt 0in 5.4pt 0in 5.4pt 0in 5.4pt !msorm'>
    <p class=MsoNormal style='margin-top:6.0pt;line-height:normal'><span
    lang=EN-GB style='color:black'>Continue to hold the Dose Knob in and <b>slowly
    count to 5 </b>before removing the Needle.</span></p>
    </td>
   </tr>
  </table>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>Do not try to inject your insulin by turning the Dose
  Knob. You will NOT receive your insulin by turning the Dose Knob.</span></p>
  </td>
  <td width=325 valign=top style='width:243.75pt;border:none;border-bottom:
  solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB><img border=0 width=212 height=126 src="Humalo_files/image073.jpg"></span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:66.1pt'>
  <td width=325 valign=top style='width:243.7pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:66.1pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB
  style='color:black'>Step 11:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>Pull the Needle out of your skin.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:43.35pt;margin-bottom:.0001pt;text-indent:-17.85pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black'>&middot;<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-GB style='color:black'>A drop of insulin at the
  Needle tip is normal. It will not affect your dose. </span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:43.35pt;margin-bottom:.0001pt;text-indent:-17.85pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black'>&middot;<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-GB style='color:black'>Check the number in the
  Dose Window.If you see &#8220;0&#8221; in the Dose Window, you have received
  the full amount you dialled. </span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:43.35pt;margin-bottom:.0001pt;text-indent:-17.85pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black'>&middot;<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-GB style='color:black'>If you do not see
  &#8220;0&#8221; in the Dose Window, do not redial. Insert the needle into
  your skin and finish your injection.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:
  0in;margin-left:43.35pt;margin-bottom:.0001pt;text-indent:-17.85pt;
  line-height:normal'><span lang=EN-GB style='font-family:Symbol;color:black'>&middot;<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-GB style='color:black'>If you <b>still</b> do not
  think you received the full amount you dialled for your injection, <b>do not
  start over or repeat that injection</b>. Monitor your blood glucose as
  instructed by your healthcare professional.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>The plunger only moves a little with each injection and
  you may not notice that it moves.</span></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>If you see blood after you take the Needle out of your
  skin, press the injection site lightly with a piece of gauze or an alcohol
  swab. <b>Do not</b> rub the area.</span></p>
  </td>
  <td width=325 valign=top style='width:243.75pt;border:none;border-bottom:
  solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:66.1pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB><img border=0 width=151 height=106 src="Humalo_files/image065.gif"></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoHeading8 style='margin-left:0in'><b><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif;color:black;
font-style:normal'>After your injection</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=325 valign=top style='width:243.7pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB
  style='color:black'>Step 12:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>Carefully replace the Outer Needle Shield.</span></p>
  </td>
  <td width=325 valign=top style='width:243.75pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='color:black'><img border=0 width=152 height=125
  src="Humalo_files/image074.gif"></span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=325 valign=top style='width:243.7pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB
  style='color:black'>Step 13:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>Unscrew the capped Needle and dispose of it as described
  below (see <b>Disposing of Pens and Needles </b>section).</span></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>Do not store the Pen with the Needle attached to prevent
  leaking, blocking the Needle, and air from entering the Pen.</span></p>
  </td>
  <td width=325 valign=top style='width:243.75pt;border:none;border-bottom:
  solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='color:black'><img border=0 width=152 height=125
  src="Humalo_files/image075.gif"></span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=325 valign=top style='width:243.7pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-top:6.0pt'><b><span lang=EN-GB
  style='color:black'>Step 14:</span></b></p>
  <p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-GB
  style='color:black'>Replace the Pen Cap by lining up the Cap Clip with the
  Dose Indicator and pushing straight on.</span></p>
  </td>
  <td width=325 valign=top style='width:243.75pt;border:none;border-bottom:
  solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
  lang=EN-GB style='color:black'><img border=0 width=217 height=86
  src="Humalo_files/image076.gif"></span></b></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
  lang=EN-GB style='color:black'>&nbsp;</span></b></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<b><span style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></b>

<p class=TableText style='margin-top:0in;page-break-after:auto'><b><span
style='font-size:11.0pt;font-family:"Times New Roman",serif'>Disposing of Pens
and Needles</span></b></p>

<p class=Listenabsatz1 style='margin-left:.5in;text-indent:-.25in;line-height:
115%'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Put used Needles in a sharps container or hard
plastic container with a secure lid. Do not throw needles directly into your
household waste. </span></p>

<p class=Listenabsatz1 style='margin-left:.5in;text-indent:-.25in;line-height:
115%'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The used Pen may be discarded in your household waste
after you have removed the Needle.</span></p>

<p class=Listenabsatz1 style='margin-left:.5in;text-indent:-.25in;line-height:
115%'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Do not recycle the filled sharps container.</span></p>

<p class=Listenabsatz1 style='margin-left:.5in;text-indent:-.25in;line-height:
115%'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Ask your healthcare professional about options
to dispose of the sharps container properly.</span></p>

<p class=Listenabsatz1 style='margin-top:6.0pt;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.25in;line-height:115%'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The directions regarding needle handling are not
intended to replace local, healthcare professional or institutional policies.</span></p>

<p class=TableText style='margin-top:0in;page-break-after:auto'><span
style='font-size:11.0pt;font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=TableText style='margin-top:0in;page-break-after:auto'><b><span
style='font-size:11.0pt;font-family:"Times New Roman",serif'>Storing your Pen</span></b></p>

<p class=TableText style='page-break-after:auto'><b><span style='font-size:
11.0pt;font-family:"Times New Roman",serif'>Unused Pens</span></b></p>

<p class=TableText style='margin-left:.5in;text-indent:-.25in;page-break-after:
auto'><span style='font-size:11.0pt;font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>Store
unused Pens in the refrigerator at 2&deg;C to 8&deg;C.</span></p>

<p class=TableText style='margin-left:.5in;text-indent:-.25in;page-break-after:
auto'><span style='font-size:11.0pt;font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>Do
not</span></b><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>
freeze Liprolog </span><span lang=DA style='font-size:11.0pt;font-family:"Times New Roman",serif'>200&nbsp;units/ml<b>
</b></span><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>solution
for injection. <b>Do not</b> use if it has been frozen.<b> </b></span></p>

<p class=MsoCaption style='margin-top:6.0pt;margin-right:0in;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.25in'><span
style='font-size:11.0pt;font-family:Symbol;color:black'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'>Unused Pens may be used until the expiration date printed on the
Label, if the Pen has been kept in the refrigerator.</span><b><span
style='font-size:11.0pt;font-family:"Times New Roman",serif;color:black'> </span></b></p>

<p class=TableText style='page-break-after:auto'><b><span style='font-size:
11.0pt;font-family:"Times New Roman",serif'>In-use Pen</span></b></p>

<p class=TableText style='margin-left:.5in;text-indent:-.25in;page-break-after:
auto'><span style='font-size:11.0pt;font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>Store
the Pen you are currently using at room temperature (up to 30&deg;C) and away
from heat and light.</span></p>

<p class=MsoHeader style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-indent:-.25in'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol;color:black'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'>Throw away the Pen you are using after 28&nbsp;days, even if it
still has insulin left in it.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=TableText style='margin-top:0in;page-break-after:auto'><b><span
style='font-size:11.0pt;font-family:"Times New Roman",serif'>General
information about the safe and effective use of your Pen</span></b></p>

<p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-indent:-.25in;line-height:normal'><span
lang=EN-GB style='font-family:Symbol;color:black'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='color:black'>Keep your Pen and Needles
out of the sight and reach of children.</span></b></p>

<p class=MsoBodyText2 align=left style='margin-top:6.0pt;margin-right:0in;
margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt;text-align:left;
text-indent:-.25in;line-height:normal'><span lang=EN-GB style='font-size:11.0pt;
font-family:Symbol;color:black'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'>Do not </span></b><span lang=EN-GB style='font-size:11.0pt;
font-family:"Times New Roman",serif;color:black'>use your Pen if any part looks
broken or damaged.</span></p>

<p class=MsoBodyText2 align=left style='margin-top:6.0pt;margin-right:0in;
margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt;text-align:left;
text-indent:-.25in;line-height:normal'><span lang=EN-GB style='font-size:11.0pt;
font-family:Symbol;color:black'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'>Always carry an extra Pen in case yours is lost or damaged.</span></p>

<p class=MsoBodyText2 align=left style='margin-top:6.0pt;text-align:left;
line-height:normal'><b><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif;color:black'>Troubleshooting</span></b></p>

<p class=MsoBodyText2 align=left style='margin-top:6.0pt;margin-right:0in;
margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt;text-align:left;
text-indent:-.25in;line-height:normal'><span lang=EN-GB style='font-size:11.0pt;
font-family:Symbol;color:black'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'>If you cannot remove the Pen Cap, gently twist the cap back and
forth, and then pull the cap straight off.</span></p>

<p class=MsoBodyText2 align=left style='margin-top:6.0pt;margin-right:0in;
margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt;text-align:left;
text-indent:-.25in;line-height:normal'><span lang=EN-GB style='font-size:11.0pt;
font-family:Symbol;color:black'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'>If the Dose Knob is hard to push; </span></p>

<p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:.75in;margin-bottom:.0001pt;text-indent:-.25in;line-height:normal;
text-autospace:none'><span lang=EN-GB style='font-family:"Courier New";
color:black'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
lang=EN-GB style='color:black'>Pushing the Dose Knob more slowly will make it
easier to inject.</span></p>

<p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:.75in;margin-bottom:.0001pt;text-indent:-.25in;line-height:normal;
text-autospace:none'><span lang=EN-GB style='font-family:"Courier New";
color:black'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
lang=EN-GB style='color:black'>Your Needle may be blocked. Put on a new Needle
and prime the Pen.</span></p>

<p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;
margin-left:.75in;margin-bottom:.0001pt;text-indent:-.25in;line-height:normal;
text-autospace:none'><span lang=EN-GB style='font-family:"Courier New";
color:black'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
lang=EN-GB style='color:black'>You may have dust, food, or liquid inside the
Pen. Throw the Pen away and get a new Pen.</span></p>

<p class=MsoBodyText2 align=left style='margin-top:6.0pt;margin-right:0in;
margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt;text-align:left;
text-indent:-.25in;line-height:normal'><span lang=EN-GB style='font-size:11.0pt;
font-family:Symbol;color:black'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'>Do not transfer insulin from the Pen to a syringe or an insulin
pump. Severe overdose can result.</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:6.0pt;text-autospace:none'><span
lang=EN-GB style='color:black'>If you have any questions or problems with your </span><span
lang=DA>Liprolog 200&nbsp;units/ml KwikPen</span><span lang=EN-GB
style='color:black'>, call your healthcare </span><span lang=EN-GB>professional<span
style='color:black'> for help or contact your local Lilly affiliate. </span></span></p>

<p class=MsoNormal style='margin-top:6.0pt;text-autospace:none'><span
lang=EN-GB style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Document<span
style='color:black'> revision date: </span></span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>Package leaflet: Information for the user</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='margin-right:.55pt;text-align:center;
line-height:normal'><b><span lang=DA>Liprolog 100&nbsp;units/ml Junior KwikPen,
solution for injection in a pre-filled pen</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>insulin lispro</span></b></p>

<p class=MsoNormal align=center style='margin-right:-2.25pt;text-align:center;
line-height:normal'><b><span lang=EN-GB>Each </span><span lang=EN-GB>Junior
KwikPen </span></b><b><span lang=EN-GB>delivers 0.5 &#8211; 30 units in steps
of 0.5 units.</span></b></p>

<p class=MsoNormal align=center style='margin-right:-2.25pt;text-align:center;
line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>Read all of this leaflet carefully before you start
using this medicine because it contains important information for you.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Keep this leaflet. You may need to read it
again.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of illness
are the same as yours.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you get any side effects, talk to your doctor
or pharmacist.</span><span lang=EN-GB> This includes any possible side effects
not listed in this leaflet. See section 4.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What is in this leaflet</span></b><span lang=EN-GB>: </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>What Liprolog Junior KwikPen is and what it is
used for</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>What you need to know before you use Liprolog Junior
KwikPen</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>How to use Liprolog Junior KwikPen</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Possible side effects</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>How to store Liprolog Junior KwikPen</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.45pt;margin-bottom:
0in;margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Contents of the pack and other information</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Liprolog Junior KwikPen is
and what it is used for</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Liprolog Junior KwikPen is used to treat diabetes. </span><span
lang=EN-GB>Liprolog works more quickly than normal human insulin because
insulin lispro has been changed slightly in comparison to human insulin.
Insulin lispro is closely related to human insulin which is a natural hormone made
by the pancreas.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>You get diabetes if your pancreas does not make enough insulin to
control the level of glucose in your blood. Liprolog is a substitute for your
own insulin and is used to control glucose in the long term. It works very
quickly and lasts a shorter time than soluble insulin (2 to 5 hours). You
should normally use Liprolog within 15 minutes of a meal. </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Your doctor may tell you to use Liprolog as well as a longer-acting
insulin. Each kind of insulin comes with another patient information leaflet to
tell you about it. Do not change your insulin unless your doctor tells you to. </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog is
suitable for use in adults and children. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog 100
units/ml Junior KwikPen is a disposable pre-filled pen containing 3 ml (300
units, 100 units/ml) of insulin lispro.&nbsp; One KwikPen contains multiple
doses of insulin.&nbsp; The KwikPen dials half unit (0.5 unit) at a time. <b>The
number of units are displayed in the dose window, always check this before your
injection. </b>You can give from 0.5 unit to 30 units in a single
injection.&nbsp; <b>If your dose is more than 30 units, you will need to give
yourself more than one injection. </b></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you use Liprolog<span style='text-transform:uppercase'> </span>Junior KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Do NOT use
Liprolog Junior KwikPen</span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you are <b>allergic</b> to insulin lispro or
any of the other ingredients of this medicine (listed in section 6).</span></p>

<p class=MsoNormal style='margin-left:.25in;text-indent:-.25in;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you think <b>hypoglycaemia</b> (low blood
sugar) is starting. Further in this leaflet it tells you how to deal with mild
hypoglycaemia (see Section 3: If you take more Liprolog than you need).</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Warnings and precautions</span></b></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><b><span
lang=EN-GB>Do NOT mix the Liprolog 100&nbsp;units/ml solution for injection in
your pre-filled pen (the Junior KwikPen) with any other insulins or any other
medicine</span></b><span lang=EN-GB>. </span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>If your blood sugar levels are well controlled by your current
insulin therapy, you may not feel the warning symptoms when your blood sugar is
falling too low. Warning signs are listed in section 4 of this leaflet. You
must think carefully about when to have your meals, how often to exercise and
how much to do. You must also keep a close watch on your blood sugar levels by
testing your blood glucose often.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>A few people who have had hypoglycaemia after switching from animal
insulin to human insulin have reported that the early warning symptoms were
less obvious or different. If you often have hypoglycaemia or have difficulty
recognising it, please discuss this with your doctor.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>If you answer YES to any of the following questions, tell your
doctor, pharmacist or diabetes nurse</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have
you recently become ill?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do
you have trouble with your kidneys or liver?</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal'><span lang=EN-GB>-
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are you exercising more than usual?</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>You should also tell your doctor, pharmacist or diabetes nurse if
you are planning to go abroad. The time difference between countries may mean
that you have to have your injections and meals at different times from when
you are at home.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;text-indent:-14.15pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>Some patients with long-standing type 2 diabetes mellitus and heart
disease or previous stroke who were treated with pioglitazone and insulin
experienced the development of heart failure. Inform your doctor as soon as
possible if you experience signs of heart failure such as unusual shortness of
breath or rapid increase in weight or localised swelling (oedema).</span></p>

<p class=PPILabelingBodyText style='margin-left:14.15pt;text-indent:-14.15pt'><span
style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-family:"Times New Roman",serif'>This Pen is not
recommended for use by the blind or visually impaired without the help of
someone trained to use the Pen.</span></p>

<p class=MsoNormal style='margin-left:14.15pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Other medicines and Liprolog Junior KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Your insulin
needs may change if you are taking </span></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>the contraceptive pill, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>steroids, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>thyroid hormone replacement therapy, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>oral hypoglycaemics, (e.g. metformin, acarbose, sulphonylurea
     agents, pioglitazone, empagliflozin, DPP-4-inhibitors like sitagliptin or
     saxagliptine, ),</span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>acetyl salicylic acid, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>sulpha antibiotics, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB style='color:black'>somatostatin analogues (such as octreotide,
     used to treat an uncommon condition in which you make too much growth
     hormone),</span><span lang=EN-GB> </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>&#8220;beta<sub>2</sub> stimulants&#8221;such as salbutamol or
     terbutaline to treat asthma, or ritodrine </span><span lang=EN>used to
     stop premature labor,</span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>beta-blockers &#8211; to treat high blood pressure., or </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some antidepressants (monoamine oxidase inhibitors or selective
     serotonin reuptake inhibitors), </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>danazol <span style='color:black'>(medicine acting on
     ovulation)</span>, </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN-GB>some angiotensin converting (ACE) inhibitors, <span
     style='color:black'>used to treat certain heart conditions or high blood
     pressure</span> (for example captopril, enalapril), and </span></li>
 <li class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
     lang=EN>specific medicines to treat high blood pressure, kidney damage due
     to diabetes, and </span><span lang=EN-GB>some heart problems </span><span
     lang=EN>&nbsp;(angiotensin </span><span lang=EN-GB>II receptor blockers).</span></li>
</ul>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB>Please tell your
doctor, if you are taking, have recently taken or might take any other
medicines. (see also section &#8220;Warnings and precautions&#8221;).</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Liprolog with alcohol</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Your blood sugar levels may either rise or fall if you drink
alcohol.&nbsp; Therefore the amount of insulin needed may change.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Pregnancy and breast-feeding</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Are you pregnant or thinking about becoming pregnant, or are you
breast-feeding? The amount of insulin you need usually falls during the first
three months of pregnancy and increases for the remaining six months. If you
are breast-feeding, you may need to alter your insulin intake or diet.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Ask your doctor
for advice.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Driving and using machines</span></b></p>

<p class=MsoNormal style='margin-right:-2.25pt;line-height:normal'><span
lang=EN-GB>Your ability to concentrate and react may be reduced if you have
hypoglycaemia. Please keep this possible problem in mind in all situations
where you might put yourself and others at risk (e.g. driving a car or
operating machinery). You should contact your doctor about the advisability of
driving if you have:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-2.25pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>frequent episodes of hypoglycaemia</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>reduced or absent warning signs of hypoglycaemia</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to use
Liprolog Junior KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>Always check the pack and the label of the
pre-filled pen for the name and type of the insulin when you get it from your
pharmacy. Make sure you get the Liprolog 100&nbsp;units/ml Junior KwikPen that
your doctor has told you to use.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Always use this medicine exactly as your doctor has told you. You
should check with your doctor if you are not sure.</span> To prevent the
possible transmission of disease, each pen must be used by you only, even if
the needle is changed.</p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Dosage</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The number of half units (0.5 units) is shown in
the dose window of your pen. The half units (0.5 units) are shown as lines
between the numbers.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Always check the number in the dose window to
make sure you have dialled the correct dose.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You should normally inject Liprolog within 15
minutes of a meal. If you need to, you can inject soon after a meal. But your
doctor will have told you exactly how much to use, when to use it, and how
often. These instructions are only for you. Follow them exactly and visit your
diabetes clinic regularly.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you change the type of insulin you use (for
example from a human or animal insulin to a Liprolog product), you may have to
take more or less than before. This might just be for the first injection or it
may be a gradual change over several weeks or months. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Inject Liprolog under the skin. You should only
inject it into a muscle if your doctor has told you to.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Preparing Liprolog Junior KwikPen</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Liprolog is already dissolved in water, so you
do not need to mix it. But you must use it <b>only </b>if it looks like water.
It must be clear, have no colour and no solid pieces in it. Check each time you
inject yourself.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>Getting the Junior
KwikPen ready to use (Please see user manual)</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>First wash your hands.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Read the instructions on how to use your
pre-filled insulin pen. Please follow the instructions carefully. Here are some
reminders.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Use a clean needle. (Needles are not included).</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Prime your Junior KwikPen before each use. This
checks that insulin comes out and clears the air bubbles from your Junior
KwikPen. There may still be some small air bubbles left in the pen - these are
harmless. But if the air bubbles are too large it may affect the insulin dose.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Injecting Liprolog </span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Before you make an injection, clean your skin as
you have been instructed. Inject under the skin, as you were taught. Do not
inject directly into a vein. After your injection, leave the needle in the skin
for five seconds to make sure you have taken the whole dose. Do not rub the
area you have just injected. Make sure you inject at least half an inch
(1&nbsp;cm) from the last injection and that you &#8216;rotate&#8217; the
places you inject, as you have been taught. It doesn&#8217;t matter which
injection site you use, either upper arm, thigh, buttock or abdomen, your
Liprolog injection will still work quicker than soluble human insulin.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>You must not administer Liprolog by the
intravenous route. Inject Liprolog as your physician or nurse has taught you.
Only your physician can administer Liprolog by the intravenous route. He will
only do this under special circumstances such as surgery or if you are ill and
your glucose levels are too high.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><b><span lang=EN-GB>After
injecting</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-family:Symbol'>&middot;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>As soon as you have done the injection, unscrew
the needle from the Junior KwikPen using the outer needle cap. This will keep
the insulin sterile and stop it leaking. It also stops air entering the pen and
your needle clogging. <b>Do not share your needles</b>. <u>Do not share your
pen.</u> Replace the cap on your pen.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;page-break-after:avoid'><b><span
lang=EN-GB>Further injections</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;page-break-after:
avoid'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Every time you use a Junior KwikPen you must use
a new needle. Before every injection, clear any air bubbles. You can see how
much insulin is left by holding the Junior KwikPen with the needle pointing up.
The scale on the cartridge shows about how many units you have left.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.55pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;page-break-after:
avoid'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Once the Junior KwikPen is empty, do not use it
again. Please get rid of it carefully - your pharmacist or diabetes nurse will
tell you how to do this.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Using Liprolog in an infusion pump</span></b></p>

<p class=BodytextAgency style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>Junior
KwikPen is only suitable for injecting just under the skin.&nbsp; Do not use
the pen to administer Liprolog by a different way.&nbsp; Other forms of Liprolog
</span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>100&nbsp;units</span><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>/ml are
available if this is necessary.&nbsp; Speak to your doctor if this applies to
you.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you take more Liprolog than you need</span></b></p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>If
you take more Liprolog than you need, a low blood sugar may occur.&nbsp; </span>Check
your blood sugar. </p>

<p class=MsoBodyText3 align=left style='text-align:left'><span lang=EN-GB>If
your blood sugar is low <b>(mild hypoglycaemia)</b>, eat glucose tablets, sugar
or drink a sugary drink. Then eat fruit, biscuits, or a sandwich, as your
doctor has advised you and have some rest. This will often get you over mild
hypoglycaemia or a minor insulin overdose. If you get worse and your breathing
is shallow and your skin gets pale, tell your doctor at once. A glucagon injection
can treat quite severe hypoglycaemia. Eat glucose or sugar after the glucagon
injection. If you do not respond to glucagon, you will have to go to hospital.
Ask your doctor to tell you about glucagon.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you forget to use Liprolog</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog than you need, a high blood sugar may
occur.&nbsp; </span>Check your blood sugar<span class=MsoCommentReference><span
lang=EN-GB style='display:none'>.</span></span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If hypoglycaemia (low blood sugar) or hyperglycaemia (high blood
sugar) is not treated they can be very serious and cause headaches, feeling
sick (nausea), being sick (vomiting), loss of fluids (dehydration),
unconsciousness, coma or even death (see section 4 &#8220;Possible Side
Effects&#8221;). </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><b><span
lang=EN-GB>Three simple steps </span></b><span lang=EN-GB>to avoid
hypoglycaemia or hyperglycaemia are:</span></p>

<p class=MsoBlockText align=left style='text-align:left'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always
carry a spare pen in case you lose your Junior KwikPen or it gets damaged.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always carry
something to show you are diabetic.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always carry sugar
with you.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>If you stop using Liprolog.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you take less Liprolog than you need, a high blood sugar may
occur. Do not change your insulin unless your doctor tells you to.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If you have any further questions on the use of this product, ask
your doctor or pharmacist.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible side
effects</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-1.45pt'><span lang=EN-GB>Like all
medicines, this medicine can cause side effects, although not everybody gets
them.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Severe allergy </span><span
lang=EN-GB style='layout-grid-mode:line'>is rare (</span><span lang=EN-GB
style='color:black'>may affect up to 1 in 1,000 people</span><span lang=EN-GB
style='layout-grid-mode:line'>)</span><span lang=EN-GB>.</span><span
lang=EN-GB> The symptoms are as follows:</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash
over the whole body&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood
pressure dropping</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty
in breathing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart
beating fast</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; wheezing&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sweating</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>If you think
you are having this sort of insulin allergy with Liprolog, contact a doctor at
once.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Local allergy</span><span
lang=EN-GB style='layout-grid-mode:line'> is common (</span><span lang=EN-GB
style='color:black'>may affect up to 1 in 10 people</span><span lang=EN-GB
style='layout-grid-mode:line'>).</span><span lang=EN-GB>&nbsp; Some people get
redness, swelling or itching around the area of the insulin injection. This
usually clears up in anything from a few days to a few weeks. If this happens
to you, tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:.55pt'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:.55pt'><span lang=EN-GB>Lipodystrophy
(thickening or pitting of the skin)<span style='layout-grid-mode:line'> is
uncommon (</span><span style='color:black'>may affect up to 1 in 100 people</span><span
style='layout-grid-mode:line'>)</span>. If you notice your skin thickening or
pitting at the injection site, tell your doctor.</span></p>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Oedema (e.g. swelling in arms, ankles;
fluid retention) has been reported, particularly at the start of insulin
therapy or during a change in therapy to improve control of your blood glucose.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Reporting of side effects</span></b></p>

<p class=BodytextAgency style='margin-bottom:0in'><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>If you get any
side effects, talk to your doctor or pharmacist.</span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'> This includes any
possible side effects not listed in this leaflet.</span><span lang=EN-GB
style='font-family:"Times New Roman",serif'> </span><span lang=EN-GB
style='font-size:11.0pt;font-family:"Times New Roman",serif'>You can also
report side effects directly via <span style='background:silver'>the national
reporting system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span></span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>.
By reporting side effects you can help provide more information on the safety
of this medicine.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Common problems of diabetes</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Hypoglycaemia</span></b><span lang=EN-GB> </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hypoglycaemia (low blood sugar) means there is not enough sugar in
the blood. This can be caused if:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you take too much
Liprolog or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you miss or delay
meals or change your diet;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you exercise or
work too hard just before or after a meal;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have an
infection or illness (especially diarrhoea or vomiting);</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; there is a change
in your need for insulin; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have trouble
with your kidneys or liver which gets worse.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Alcohol and some medicines can affect your blood sugar levels (see
section 2).</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>The first symptoms of low blood sugar usually come on quickly and
include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tiredness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rapid
heartbeat</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nervousness or
shakiness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
sick</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cold
sweat.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>While you are not confident about recognising your warning symptoms,
avoid situations such as driving a car, in which you or others would be put at
risk by hypoglycaemia.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Hyperglycaemia and diabetic ketoacidosis</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia (too much sugar in the blood) means that your body
does not have enough insulin. Hyperglycaemia can be brought about by:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not taking your
Liprolog or other insulin;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; taking less insulin
than your doctor tells you to;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eating a lot more
than your diet allows; or</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever, infection
or emotional stress.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Hyperglycaemia can lead to diabetic ketoacidosis. The first symptoms
come on slowly over many hours or days. The symptoms include the following:</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sleepy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; no
appetite</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flushed face&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fruity
smell on the breath</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thirst&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling
or being sick.</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Severe symptoms are heavy breathing and a rapid pulse.&nbsp; <b>Get
medical help immediately.</b></span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Illness</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>If you are ill, especially if you feel sick or are sick, the amount
of insulin you need may change. <b>Even when you are not eating normally, you
still need insulin.</b> Test your urine or blood, follow your &#8216;sick
rules&#8217;, and tell your doctor.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store
Liprolog Junior KwikPen</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep out of the sight and reach of children.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog Junior KwikPen after the expiry date which is
stated on the label and the carton. The expiry date refers to the last day of
that month. </span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Before the first use store your Liprolog Junior KwikPen in a
refrigerator (2</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C &#8211; 8</span><span lang=EN-GB style='font-family:Symbol'>&deg;</span><span
lang=EN-GB>C). Do not freeze. </span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep your Liprolog Junior KwikPen in use at room temperature
(15&deg; - 30&deg;C) and discard after 28 days <b>even if some of the solution
remains</b>. Do not put it near heat or in the sun. Do not keep the Junior
KwikPen that you are using in the fridge. The Junior KwikPen should not be
stored with the needle attached.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use Liprolog Junior KwikPen, if the solution is coloured or
it has solid pieces in it. </span><span lang=EN-GB>You must use it <b>only</b>
if it looks like water. Check this each time you inject yourself.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Medicines should not be disposed of via wastewater or household
waste. Ask your pharmacist how to dispose of medicines no longer required.
These measures will help to protect the environment.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What Liprolog </span></b><b><span lang=EN-GB>100&nbsp;units/ml Junior
KwikPen solution for injection contains</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The active substance is insulin lispro. Each ml
of solution contains 100 units (U) of insulin lispro.&nbsp; Each pre-filled pen
(3ml) contains 300 units (U) of insulin lispro.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The other ingredients are</span><span
lang=EN-GB> metacresol, glycerol, dibasic sodium phosphate 7 H<sub>2</sub>O,
zinc oxide and water for injections. Sodium hydroxide or hydrochloric acid may
have been used to adjust the acidity.<i> </i></span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What Liprolog </span></b><b><span lang=EN-GB>100&nbsp;units/ml Junior
KwikPen looks like and contents of the pack</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Liprolog 100&nbsp;units/ml
Junior KwikPen, solution for injection is a sterile, clear, colourless, aqueous
solution and contains 100 units of insulin lispro in each millilitre
(100&nbsp;units/ml) solution for injection. Each Liprolog Junior KwikPen
contains 300&nbsp;units (3&nbsp;millilitres). The Liprolog Junior KwikPen comes
in a pack of 5 pre-filled pens or multipacks of 2 x 5 pre-filled pens. </span>Not
all pack sizes may be marketed.<span lang=EN-GB> The Junior KwikPen simply has
a built in cartridge. When the pre-filled pen is empty you cannot use it again.
The Junior KwikPen is blue. </span><span lang=EN-GB>The dose knob is blue with
raised ridges.&nbsp; The label is white with an orange colour bar and there is
an orange to yellow, colour band. Each </span><span lang=EN-GB>Junior KwikPen </span><span
lang=EN-GB>delivers 0.5 &#8211; 30 units in steps of 0.5 units.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'>&nbsp;</p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Marketing Authorisation Holder </span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Eli Lilly
Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><b><span
lang=EN-GB>Manufacturer</span></b><span lang=EN-GB> </span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span
lang=EN-GB>Lilly France S.A.S., Rue du Colonel Lilly, 67640 Fegersheim, France,</span></p>

<p class=MsoNormal style='margin-right:.55pt;line-height:normal'><span lang=IT>Eli
Lilly Italia S.p.A., Via&nbsp; Gramsci 731-733, 50019 Sesto Fiorentino, (FI)
Italy.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>For any information about this medicinal product, please contact the
local representative of the Marketing Authorisation Holder:</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=624
 style='margin-left:-1.7pt;border-collapse:collapse'>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>Belgique/Belgi&euml;/Belgien</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Lietuva</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited atstovyb&#279;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel. +370 (5) 2649600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=BG>&#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1058;&#1055;
  &quot;&#1045;&#1083;&#1080; &#1051;&#1080;&#1083;&#1080;
  &#1053;&#1077;&#1076;&#1077;&#1088;&#1083;&#1072;&#1085;&#1076;&quot;
  &#1041;.&#1042;. - &#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=BG>&#1090;&#1077;&#1083;.
  + 359 2 491 41 40</span></p>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=EN-GB
  style='color:black'>&nbsp;</span></b></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Luxembourg/Luxemburg</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Benelux S.A./N.V.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>T&eacute;l/Tel: + 32-(0)2 548 84 84</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#268;esk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>ELI
  LILLY &#268;R, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 420 234 664 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Magyarorsz&aacute;g</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Lilly
  Hung&aacute;ria Kft.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 36 1 328 5100</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  style='color:black'>Danmark</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Eli Lilly Danmark A/S </span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Tlf: +45 45 26 6000</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=DE style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=ES style='color:black'>Malta</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=ES style='color:black'>Charles de Giorgio Ltd.</span></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  lang=EN-GB style='color:black'>Tel: + 356 25600 500</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Deutschland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Berlin-Chemie AG</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE>Postfach
  1108,&nbsp; 12474 Berlin</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=DE>Tel.: 030/6707-0</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DA
  style='color:black'>Nederland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DA
  style='color:black'>Eli Lilly Nederland B.V. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 31-(0) 30 60 25 800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  style='color:black'>Eesti</span></b></p>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><span
  style='color:black'>Eli Lilly Holdings Limited Eesti filiaal </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>372 6817 280</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=NO-BOK
  style='color:black'>Norge</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=NO-BOK
  style='color:black'>Eli Lilly Norge A.S. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tlf:
  + 47 22 88 18 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#917;&#955;&#955;&#940;&#948;&#945;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#934;&#913;&#929;&#924;&#913;&#931;&#917;&#929;&#914;-&#923;&#921;&#923;&#923;&#933;
  &#913;.&#917;.&#914;.&#917;. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +30 210 629 4600</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>&Ouml;sterreich</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Ges. m.b.H. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 43-(0) 1 711 780</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=ES
  style='color:black'>Espa&ntilde;a</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Lilly S.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES
  style='color:black'>Tel: + 34-91 663 50 00</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='page-break-after:avoid;text-autospace:none'><b><span
  lang=SV style='color:black'>Polska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Eli Lilly Polska Sp. z o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  +48 22 440 33 00</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR
  style='color:black'>France</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>Lilly France S.A.S.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR
  style='color:black'>T&eacute;l: +33-(0) 1 55 49 34 34</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=PT-BR
  style='color:black'>Portugal</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=PT-BR
  style='color:black'>Lilly Portugal - Produtos Farmac&ecirc;uticos, Lda</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 351-21-4126600</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=ES>Hrvatska</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Eli Lilly
  Hrvatska d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>Tel: +385 1
  2350 999</span></p>
  <p class=MsoNormal style='text-autospace:none'>&nbsp;</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal><b><span lang=IT>Rom&acirc;nia</span></b></p>
  <p class=MsoNormal><span lang=RO>Eli Lilly Rom&acirc;nia S.R.L.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=RO>Tel: + 40 21
  4023000</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b>Ireland</b></p>
  <p class=MsoNormal style='text-autospace:none'>Eli Lilly and Company (Ireland) Limited</p>
  <p class=MsoNormal style='text-autospace:none'>Tel: + 353-(0) 1 661 4377</p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=FR>Slovenija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=FR>Eli Lilly
  farmacevtska dru&#382;ba, d.o.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=ES>Tel: +386 (0) 1
  580 00 10</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&Iacute;sland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Icepharma
  hf. </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>S&iacute;mi
  + 354 540 8000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Slovensk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Slovakia, s.r.o.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 421 220 663 111</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=IT
  style='color:black'>Italia</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=IT
  style='color:black'>Eli Lilly Italia S.p.A.</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>Tel: + 39- 055 42571</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=SV
  style='color:black'>Suomi/Finland</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=SV
  style='color:black'>Oy Eli Lilly Finland Ab </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Puh/Tel:
  + 358-(0) 9 85 45 250</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>&#922;&#973;&#960;&#961;&#959;&#962;</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Phadisco
  Ltd </span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&#932;&#951;&#955;</span><span
  lang=EN-GB style='color:black'>: +357 22 715000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span lang=DE
  style='color:black'>Sverige</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Eli Lilly Sweden AB</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=DE
  style='color:black'>Tel: + 46-(0) 8 7378800</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 valign=top style='width:234.2pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>Latvija</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly Holdings Limited p&#257;rst&#257;vniec&#299;ba Latvij&#257;</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  <b>+</b>371 67364000</span></p>
  <p class=MsoNormal style='text-autospace:none'><span lang=EN-GB
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 2.0pt 0in 2.0pt'>
  <p class=MsoNormal style='text-autospace:none'><b><span style='color:black'>United
    Kingdom</span></b></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Eli
  Lilly and Company Limited</span></p>
  <p class=MsoNormal style='text-autospace:none'><span style='color:black'>Tel:
  + 44-(0) 1256 315000</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>This leaflet was last revised in </span></b><span lang=EN-GB>{MM/YYYY}.</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-2.25pt'><span lang=EN-GB>USER MANUAL
Please see manual text later.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Detailed information on this medicine is available on the European
Medicines Agency web site: http://www.ema.europa.eu/</span><span lang=EN-GB>.</span></p>

<p class=MsoHeading7 style='margin-top:6.0pt'><span lang=EN-GB>&nbsp;</span></p>

<b><span style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></b>

<p class=PPIGenericName style='margin-bottom:6.0pt'><span style='font-family:
"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIGenericName style='margin-bottom:6.0pt'><span style='font-family:
"Times New Roman",serif'>Instructions for Use</span></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB>Liprolog
</span></b><b><span lang=EN-GB style='color:black'>100&nbsp;units/ml </span><span
lang=EN-GB>Junior KwikPen,</span></b><b><span lang=EN-GB style='color:black'> solution
for injection in a pre&#8209;filled pen</span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=PPIGenericName><span style='font-family:"Times New Roman",serif'>insulin
lispro </span></p>

<p class=PPIBlockBody align=center style='text-align:center'><span
style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIBlockBody align=center style='text-align:center'><span
style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIBlockBody align=center style='text-align:center'><span
style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'><img
border=0 width=597 height=103 src="Humalo_files/image077.jpg"></span></p>

<p class=PPIHeading2 align=center style='text-align:center'><span
style='font-family:"Times New Roman",serif;color:red'>PLEASE READ THESE
INSTRUCTIONS BEFORE USE</span></p>

<p class=PPILabelingBodyText><span style='font-family:"Times New Roman",serif'>Read
the Instructions for Use before you start taking Liprolog Junior KwikPen and
each time you get another Liprolog Junior KwikPen. There may be new
information. This information does not take the place of talking to your
healthcare professsional about your medical condition or your treatment.</span></p>

<p class=PPILabelingBodyText><span style='font-family:"Times New Roman",serif'>Liprolog<b>
</b>10</span><span lang=DA style='font-family:"Times New Roman",serif'>0&nbsp;units/ml
Junior KwikPen </span><span style='font-family:"Times New Roman",serif'>(&#8220;Pen&#8221;)
is a disposable pre-filled pen containing 3&nbsp;ml (300&nbsp;units,
100&nbsp;units/ml) of insulin lispro solution for injection.&nbsp; One pen
contains multiple doses of insulin.</span></p>

<p class=PPILabelingBodyText><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPILabelingBodyText style='margin-left:28.35pt;text-indent:-28.35pt'><span
style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your
healthcare professional will tell you how many units to give as your dose and
how to inject your prescribed dose of insulin.</span></p>

<p class=PPILabelingBodyText style='margin-left:28.35pt;text-indent:-28.35pt'><span
style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
Pen dials half unit (0.5 unit) at a time. You can give from 0.5 unit to
30&nbsp;units in a single injection. </span></p>

<p class=PPILabelingBodyText style='margin-left:25.0pt;text-indent:-25.0pt'><span
style='font-family:"Arial",sans-serif'>&#8226;<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-family:"Times New Roman",serif'>Always check
the number in the dose window to make sure you have dialed the correct dose.</span></p>

<p class=PPILabelingBodyText style='margin-left:28.35pt;text-indent:-28.35pt'><span
style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If
your dose is more than 30&nbsp;units, you will need to give yourself more than
one injection. </span></p>

<p class=PPILabelingBodyText style='margin-left:28.35pt;text-indent:-28.35pt'><span
style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
Plunger only moves a little with each injection, and you may not notice that it
moves. When the Plunger reaches the end of the cartridge, you have used all
300&nbsp;units in the Pen.</span></p>

<p class=PPILabelingBodyText><b><span style='font-family:"Times New Roman",serif'>Do
not share your Pen with other people, even if the needle has been changed. Do
not reuse or share needles with other people. You may give an infection to them
or get an infection from them.</span></b></p>

<p class=PPILabelingBodyText><span style='font-family:"Times New Roman",serif'>This
Pen is not recommended for use by the blind or visually impaired without the
help of someone trained to use the Pen.</span></p>

<p class=PPILabelingBodyText><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIBlockBody align=center style='text-align:center'><b><span
style='font-family:"Times New Roman",serif'>Liprolog Junior KwikPen Parts</span></b></p>

<div align=center>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse'>
 <tr style='height:15.75pt'>
  <td width=86 nowrap valign=bottom style='width:64.3pt;padding:0in 5.4pt 0in 5.4pt;
  height:15.75pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
  <td width=112 nowrap colspan=2 valign=bottom style='width:84.2pt;padding:
  0in 5.4pt 0in 5.4pt;height:15.75pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='font-family:"Times New Roman",serif;color:black'>Pen Cap</span></p>
  </td>
  <td width=24 nowrap valign=bottom style='width:.25in;padding:0in 5.4pt 0in 5.4pt;
  height:15.75pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
  <td width=162 nowrap colspan=2 valign=bottom style='width:121.5pt;padding:
  0in 5.4pt 0in 5.4pt;height:15.75pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='font-family:"Times New Roman",serif;color:black'>Cartridge Holder</span></p>
  </td>
  <td width=24 nowrap colspan=2 valign=bottom style='width:.25in;padding:0in 5.4pt 0in 5.4pt;
  height:15.75pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
  <td width=90 nowrap colspan=2 valign=bottom style='width:67.5pt;padding:0in 5.4pt 0in 5.4pt;
  height:15.75pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif;
  color:black'>Label</span></p>
  </td>
  <td width=102 nowrap colspan=2 valign=bottom style='width:76.6pt;padding:
  0in 5.4pt 0in 5.4pt;height:15.75pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif;
  color:black'>Dose Indicator</span></p>
  </td>
 </tr>
 <tr>
  <td width=600 nowrap colspan=12 valign=top style='width:450.1pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  lang=EN-GB style='font-family:"Times New Roman",serif'><img border=0
  width=540 height=61 id="Picture 4" src="Humalo_files/image078.jpg"></span></p>
  </td>
 </tr>
 <tr>
  <td width=86 nowrap valign=top style='width:64.3pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
  <td width=86 nowrap valign=top style='width:64.3pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif;
  color:black'>Cap Clip</span></p>
  </td>
  <td width=111 nowrap colspan=3 valign=top style='width:82.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif;
  color:black'>Rubber Seal</span></p>
  </td>
  <td width=120 nowrap colspan=2 valign=top style='width:90.05pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='font-family:"Times New Roman",serif;color:black'>Plunger</span></p>
  </td>
  <td width=90 nowrap colspan=2 valign=top style='width:67.55pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='font-family:"Times New Roman",serif;color:black'>Pen Body</span></p>
  </td>
  <td width=60 nowrap colspan=2 valign=top style='width:44.95pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='font-family:"Times New Roman",serif;color:black'>Dose<br>
  Window</span></p>
  </td>
  <td width=48 nowrap valign=top style='width:36.05pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif;
  color:black'>Dose Knob</span></p>
  </td>
 </tr>
 <tr height=0>
  <td width=86 style='border:none'></td>
  <td width=86 style='border:none'></td>
  <td width=27 style='border:none'></td>
  <td width=24 style='border:none'></td>
  <td width=60 style='border:none'></td>
  <td width=102 style='border:none'></td>
  <td width=18 style='border:none'></td>
  <td width=6 style='border:none'></td>
  <td width=84 style='border:none'></td>
  <td width=6 style='border:none'></td>
  <td width=59 style='border:none'></td>
  <td width=48 style='border:none'></td>
 </tr>
</table>

</div>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<div align=center>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse'>
 <tr style='height:61.65pt'>
  <td width=360 colspan=5 valign=top style='width:3.75in;padding:0in 5.4pt 0in 5.4pt;
  height:61.65pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><b><span
  style='font-family:"Times New Roman",serif'>Pen Needle Parts</span></b></p>
  <p class=PPIBlockBody align=center style='text-align:center'><b><span
  style='font-family:"Times New Roman",serif'>(Needles Not Included)</span></b></p>
  </td>
  <td width=72 valign=top style='width:.75in;padding:0in 5.4pt 0in 5.4pt;
  height:61.65pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><b><span
  style='font-family:"Times New Roman",serif'>&nbsp;</span></b></p>
  </td>
  <td width=168 valign=top style='width:1.75in;padding:0in 5.4pt 0in 5.4pt;
  height:61.65pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><b><span
  style='font-family:"Times New Roman",serif'>Dose Knob</span></b></p>
  <p class=PPIBlockBody align=center style='margin-top:3.0pt;text-align:center'><b><span
  style='font-family:"Times New Roman",serif'>Blue, with raised ridges on end
  and side</span></b></p>
  </td>
 </tr>
 <tr style='height:18.9pt'>
  <td width=174 colspan=2 valign=bottom style='width:130.5pt;padding:0in 5.4pt 0in 5.4pt;
  height:18.9pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
  <td width=90 colspan=2 valign=bottom style='width:67.5pt;padding:0in 5.4pt 0in 5.4pt;
  height:18.9pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
  <td width=96 valign=bottom style='width:1.0in;padding:0in 5.4pt 0in 5.4pt;
  height:18.9pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>Paper
  Tab</span></p>
  </td>
  <td width=72 valign=bottom style='width:.75in;padding:0in 5.4pt 0in 5.4pt;
  height:18.9pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
  <td width=168 valign=bottom style='width:1.75in;padding:0in 5.4pt 0in 5.4pt;
  height:18.9pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=360 colspan=5 valign=top style='width:3.75in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  lang=EN-GB style='font-family:"Times New Roman",serif'><img border=0
  width=272 height=68 id="Picture 21" src="Humalo_files/image079.jpg"></span></p>
  </td>
  <td width=72 valign=top style='width:.75in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
  <td width=168 style='width:1.75in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  lang=EN-GB style='font-family:"Times New Roman",serif'><img border=0
  width=63 height=67 id="Picture 9" src="Humalo_files/image080.jpg"></span></p>
  </td>
 </tr>
 <tr>
  <td width=120 valign=top style='width:1.25in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='font-family:"Times New Roman",serif'>Outer Needle<br>
  Shield</span></p>
  </td>
  <td width=108 colspan=2 valign=top style='width:81.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='font-family:"Times New Roman",serif'>Inner Needle<br>
  Shield</span></p>
  </td>
  <td width=132 colspan=2 valign=top style='width:99.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif;
  color:black'>Needle</span><span style='font-family:"Times New Roman",serif'> </span></p>
  </td>
  <td width=72 valign=top style='width:.75in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
  <td width=168 valign=top style='width:1.75in;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
 </tr>
 <tr height=0>
  <td width=120 style='border:none'></td>
  <td width=54 style='border:none'></td>
  <td width=54 style='border:none'></td>
  <td width=36 style='border:none'></td>
  <td width=96 style='border:none'></td>
  <td width=72 style='border:none'></td>
  <td width=168 style='border:none'></td>
 </tr>
</table>

</div>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIHeading1><span style='font-family:"Times New Roman",serif;
color:black'>How to recognize your Liprolog Junior KwikPen:</span></p>

<p class=PPIBulletedList1 style='margin-left:14.2pt;text-indent:-14.2pt'><span
style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; Pen
colour:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blue</span></p>

<p class=PPIBulletedList1 style='margin-left:14.2pt;text-indent:-14.2pt'><span
style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; Dose
Knob:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blue, with raised ridges on end and side</span></p>

<p class=PPIBulletedList1 style='margin-left:14.2pt;text-indent:-14.2pt'><span
style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; Label:&nbsp;&nbsp;&nbsp;&nbsp; White
with an orange colour bar and orange-to-yellow colour band</span></p>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIHeading1><span style='font-family:"Times New Roman",serif;
color:black'>Supplies needed to give your injection:</span></p>

<p class=PPIBulletedList1 style='margin-left:14.2pt;text-indent:-14.2pt'><span
style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; Liprolog
Junior KwikPen</span></p>

<p class=PPIBulletedList1 style='margin-left:14.2pt;text-indent:-14.2pt'><span
style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; KwikPen
compatible Needle (BD [Becton, Dickinson and Company] Pen Needles recommended)</span></p>

<p class=PPIBulletedList1 style='margin-left:14.2pt;text-indent:-14.2pt'><span
style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; Swab</span></p>

<p class=MsoNormal><span lang=EN-GB>Needles and swab are not included.</span></p>

<p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIHeading1><span style='font-family:"Times New Roman",serif;
color:black'>Preparing your Pen</span></p>

<p class=PPIBulletedList1 style='margin-left:14.2pt;text-indent:-14.2pt'><span
style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; Wash your
hands with soap and water.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;
margin-left:14.2pt;text-indent:-14.2pt'><i><span lang=EN-GB style='color:fuchsia'>&nbsp;&nbsp;&nbsp;&nbsp; </span></i><span
lang=EN-GB>Check the Pen to make sure you are taking the right type of insulin.
This is especially important if you use more than 1 type of insulin.</span></p>

<p class=PPIBulletedList1 style='margin-left:14.2pt;text-indent:-14.2pt'><span
style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; <b>Do not</b>
use your Pen past the expiration date printed on the Label or for more than 28
days after you first start using the Pen.</span></p>

<p class=PPIBulletedList1 style='margin-left:14.2pt;text-indent:-14.2pt'><span
style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; Always
use a <b>new Needle</b> for each injection to help prevent infections and
blocked Needles. </span></p>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='margin-left:5.4pt;border-collapse:collapse;border:none'>
 <tr style='page-break-inside:avoid'>
  <td width=360 valign=top style='width:3.75in;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIHeading2><span style='font-family:"Times New Roman",serif'>Step
  1:</span></p>
  <p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Pull
  the Pen Cap straight off.</span></p>
  <p class=PPIBulletedList1 style='text-indent:-.9pt'><span style='font-family:
  "Times New Roman",serif'>&#8211;&nbsp; <b>Do not</b> remove the Pen Label.</span></p>
  <p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Wipe
  the Rubber Seal with a swab.</span></p>
  <p class=PPILabelingBodyText><span style='font-family:"Times New Roman",serif'>Liprolog
  should look clear and colourless. <b>Do not</b> use if it is cloudy,
  coloured, or has particles or clumps in it.</span></p>
  </td>
  <td width=283 style='width:212.05pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  lang=EN-GB style='font-family:"Times New Roman",serif'><img border=0
  width=154 height=110 id="Picture 35" src="Humalo_files/image081.jpg"></span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=360 valign=top style='width:3.75in;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIHeading2><span style='font-family:"Times New Roman",serif'>Step
  2:</span></p>
  <p class=PPIBulletedList1 style='margin-left:15.9pt;text-indent:-15.9pt'><span
  style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; Select
  a new Needle.</span></p>
  <p class=PPIBulletedList1 style='margin-left:15.9pt;text-indent:-15.9pt'><span
  style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; Pull
  off the Paper Tab from the Outer Needle Shield.</span></p>
  </td>
  <td width=283 valign=top style='width:212.05pt;border:none;border-bottom:
  solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  lang=EN-GB style='font-family:"Times New Roman",serif'><img border=0
  width=166 height=122 id="Picture 36" src="Humalo_files/image082.jpg"></span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=360 valign=top style='width:3.75in;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIHeading2><span style='font-family:"Times New Roman",serif'>Step
  3:</span></p>
  <p class=PPIBulletedList1 style='margin-left:15.9pt;text-indent:-15.9pt'><span
  style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; Push
  the capped Needle straight onto the Pen and twist the Needle on until it is
  tight.</span></p>
  </td>
  <td width=283 valign=top style='width:212.05pt;border:none;border-bottom:
  solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  lang=EN-GB style='font-family:"Times New Roman",serif'><img border=0
  width=166 height=122 id="Picture 37" src="Humalo_files/image083.jpg"></span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=360 valign=top style='width:3.75in;border:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIHeading2><span style='font-family:"Times New Roman",serif'>Step
  4:</span></p>
  <p class=PPIBulletedList1 style='margin-left:15.9pt;text-indent:-15.9pt'><span
  style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; Pull
  off the Outer Needle Shield. <b>Do not</b> throw it away.</span></p>
  <p class=PPIBulletedList1 style='margin-left:15.9pt;text-indent:-15.9pt'><span
  style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; Pull
  off the Inner Needle Shield and throw it away.</span></p>
  </td>
  <td width=283 valign=top style='width:212.05pt;border:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='margin-top:2.0pt;margin-right:0in;
  margin-bottom:3.0pt;margin-left:0in;text-align:center'><span
  style='position:relative;z-index:251678720'><span style='left:0px;position:
  absolute;left:112px;top:-187737px;width:49px;height:4px'>
  <table cellpadding=0 cellspacing=0>
   <tr>
    <td width=49 height=4 style='vertical-align:top'><span style='position:
    absolute;left:0pt;z-index:251678720'>
    <table cellpadding=0 cellspacing=0 width="100%">
     <tr>
      <td>
      <div style='padding:0pt 0pt 0pt 0pt'>
      <p class=PPIBlockBody><span style='font-size:8.0pt'>Throw Away</span></p>
      </div>
      </td>
     </tr>
    </table>
    </span>&nbsp;</td>
   </tr>
  </table>
  </span></span><span style='position:relative;z-index:251677696'><span
  style='left:0px;position:absolute;left:57px;top:-187737px;width:44px;
  height:4px'>
  <table cellpadding=0 cellspacing=0>
   <tr>
    <td width=44 height=4 style='vertical-align:top'><span style='position:
    absolute;left:0pt;z-index:251677696'>
    <table cellpadding=0 cellspacing=0 width="100%">
     <tr>
      <td>
      <div style='padding:0pt 0pt 0pt 0pt'>
      <p class=PPIBlockBody><span style='font-size:8.0pt'>Keep</span></p>
      </div>
      </td>
     </tr>
    </table>
    </span>&nbsp;</td>
   </tr>
  </table>
  </span></span><span lang=EN-GB style='font-family:"Times New Roman",serif'><img
  border=0 width=224 height=112 id="Picture 38" src="Humalo_files/image084.jpg"></span></p>
  </td>
 </tr>
</table>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIBlockBody style='page-break-after:avoid'><span style='font-family:
"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIHeading1 style='page-break-after:avoid'><span style='font-family:
"Times New Roman",serif;color:black'>Priming your Pen</span></p>

<p class=PPIHeading2 style='page-break-after:avoid'><span style='font-family:
"Times New Roman",serif'>Prime before each injection.</span></p>

<p class=PPIBulletedList1 style='margin-left:14.2pt;text-indent:-14.2pt'><span
style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; Priming
your Pen means removing the air from the Needle and Cartridge that may collect
during normal use. It is important to prime your Pen so that it will work
correctly.</span></p>

<p class=PPIBulletedList1 style='margin-left:14.2pt;text-indent:-14.2pt'><span
style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; <span
style='color:black'>If you <b>do not</b> prime before each injection, you may
get too much or too little insulin.</span></span></p>

<p class=PPIBlockBody style='page-break-after:avoid'><span style='font-family:
"Times New Roman",serif;layout-grid-mode:line'>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='margin-left:5.4pt;border-collapse:collapse;border:none'>
 <tr style='page-break-inside:avoid'>
  <td width=360 valign=top style='width:3.75in;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIHeading2><span style='font-family:"Times New Roman",serif'>Step
  5:</span></p>
  <p class=PPIBulletedList1 style='margin-left:15.9pt;text-indent:-15.9pt'><span
  style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; To
  prime your Pen, turn the Dose Knob to select 2 units.</span></p>
  </td>
  <td width=283 valign=top style='width:212.05pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='margin-top:2.0pt;text-align:center'><span
  style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  <p class=PPIBlockBody align=center style='margin-top:2.0pt;text-align:center'><span
  lang=EN-GB style='font-family:"Times New Roman",serif'><img border=0
  width=141 height=96 id="Picture 7" src="Humalo_files/image085.jpg"></span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=360 valign=top style='width:3.75in;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIHeading2><span style='font-family:"Times New Roman",serif'>Step
  6:</span></p>
  <p class=PPIBulletedList1 style='margin-left:15.9pt;text-indent:-15.9pt'><span
  style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; Hold
  your Pen with the Needle pointing up. Tap the Cartridge Holder gently to
  collect air bubbles at the top.</span></p>
  </td>
  <td width=283 valign=top style='width:212.05pt;border:none;border-bottom:
  solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  lang=EN-GB style='font-family:"Times New Roman",serif'><img border=0
  width=166 height=122 id="Picture 43" src="Humalo_files/image086.jpg"></span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=360 valign=top style='width:3.75in;border:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIHeading2><span style='font-family:"Times New Roman",serif'>Step
  7:</span></p>
  <p class=PPIBulletedList1 style='margin-left:15.9pt;text-indent:-15.9pt'><span
  style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp; Continue
  holding your Pen with the Needle pointing up. Push the Dose Knob in until it
  stops, and &#8220;<b>0</b>&#8221; is seen in the Dose Window. Hold the Dose
  Knob in and <b>count to 5 slowly</b>.</span></p>
  <p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>You
  should see insulin at the tip of the Needle.</span></p>
  <p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>&#8211;&nbsp;&nbsp;&nbsp; </span><span
  style='font-family:"Times New Roman",serif'>If you <b>do not</b> see insulin,
  repeat the priming steps, but not more than 4 times.</span></p>
  <p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>&#8211;&nbsp;&nbsp;&nbsp; </span><span
  style='font-family:"Times New Roman",serif'>If you <b>still</b> <b>do not</b>
  see insulin, change the Needle and repeat the priming steps.</span></p>
  <p class=PPILabelingBodyText><span style='font-family:"Times New Roman",serif'>Small
  air bubbles are normal and will not affect your dose.</span></p>
  </td>
  <td width=283 style='width:212.05pt;border:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  lang=EN-GB style='font-family:"Times New Roman",serif'><img border=0
  width=154 height=164 src="Humalo_files/image087.jpg"></span></p>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  lang=EN-GB style='font-family:"Times New Roman",serif'><img border=0
  width=126 height=86 id="Picture 5" src="Humalo_files/image088.jpg"></span></p>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<span style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIHeading1><span style='font-family:"Times New Roman",serif;
color:black'>Selecting your dose</span></p>

<p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; You
can give from half unit (0.5 unit) to 30&nbsp;units in a single injection.</span></p>

<p class=PPIBulletedList1><b><span style='font-family:"Times New Roman",serif'>Always
check the number in the Dose Window to make sure you have dialled the correct
dose.</span></b></p>

<p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; If
your dose is more than 30 units, you will need to give more than one injection.</span></p>

<p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>&#8211;&nbsp;&nbsp;&nbsp; 
Talk to your healthcare professional about how to give your dose.</span></p>

<p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>&#8211;&nbsp;&nbsp;&nbsp; Use
a new Needle for each injection and repeat the priming step.</span></p>

<p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>&#8211;&nbsp;&nbsp;&nbsp; If
you <b>usually</b> need more than 30 units, ask your healthcare professional if
a different </span><span style='font-family:"Times New Roman",serif'>Liprolog</span><span
style='font-family:"Times New Roman",serif'> KwikPen would be better for you.</span></p>

<p class=PPIBlockBody style='page-break-after:avoid'><span style='font-family:
"Times New Roman",serif'>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='margin-left:5.4pt;border-collapse:collapse;border:none'>
 <tr style='page-break-inside:avoid'>
  <td width=360 valign=top style='width:3.75in;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIHeading2 style='page-break-after:avoid'><span style='font-family:
  "Times New Roman",serif'>Step 8:</span></p>
  <p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Turn
  the Dose Knob to select the number of units you need to inject. The Dose
  Indicator should line up with your dose.</span></p>
  <p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>&#8211;&nbsp;&nbsp;&nbsp; </span><span
  style='font-family:"Times New Roman",serif'>The Pen </span><span
  style='font-family:"Times New Roman",serif'>dials half unit (0.5 unit) at a
  time.</span></p>
  <p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>&#8211;&nbsp;&nbsp;&nbsp; </span><span
  style='font-family:"Times New Roman",serif'>The Dose Knob clicks as you turn
  it.</span></p>
  <p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>&#8211;&nbsp;&nbsp;&nbsp; </span><b><span
  style='font-family:"Times New Roman",serif'>DO NOT</span></b><span
  style='font-family:"Times New Roman",serif'> dial your dose by counting the
  clicks because you may dial the wrong dose.</span></p>
  <p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>&#8211;&nbsp;&nbsp;&nbsp; The
  dose can be corrected by turning the Dose Knob in either direction until the
  correct dose lines up with the Dose Indicator.</span></p>
  <p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>&#8211;&nbsp;&nbsp;&nbsp; The
  <b>whole unit</b> numbers are printed on the dial.</span></p>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  <p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>&#8211;&nbsp;&nbsp;&nbsp; The
  <b>half units</b> are shown as lines between the numbers.</span></p>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  <p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; <b>Always
  check the number in the Dose Window to make sure you have dialled the correct
  dose.</b></span></p>
  </td>
  <td width=283 valign=top style='width:212.05pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  lang=EN-GB style='font-family:"Times New Roman",serif;color:black'><img
  border=0 width=144 height=106 id="Picture 12" src="Humalo_files/image089.jpg"></span></p>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif;
  color:black'>&nbsp;</span></p>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif;
  color:black'>&nbsp;</span></p>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='position:relative;z-index:251675648'><span style='left:0px;position:
  absolute;left:117px;top:-189033px;width:3px;height:12px'><img width=3
  height=12 src="Humalo_files/image090.gif"></span></span><span lang=EN-GB
  style='font-family:"Times New Roman",serif;color:black'><img border=0
  width=144 height=106 id="Picture 13" src="Humalo_files/image091.jpg"></span></p>
  <p class=PPIBlockBody style='margin-left:1.25in'><span style='font-family:
  "Times New Roman",serif;color:black'>Example: 4 units</span></p>
  <p class=PPIBlockBody style='margin-left:1.25in'><span style='font-family:
  "Times New Roman",serif;color:black'>shown in the </span></p>
  <p class=PPIBlockBody style='margin-left:1.25in'><span style='font-family:
  "Times New Roman",serif;color:black'>Dose Window</span></p>
  <p class=PPIBlockBody><span style='font-family:"Times New Roman",serif;
  color:black'>&nbsp;</span></p>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='font-family:"Times New Roman",serif;color:black'>&nbsp;</span></p>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  lang=EN-GB style='font-family:"Times New Roman",serif;color:black'><img
  border=0 width=144 height=106 id="Picture 14" src="Humalo_files/image092.jpg"></span><span
  style='position:relative;z-index:251676672'><span style='left:0px;position:
  absolute;left:96px;top:-189227px;width:3px;height:12px'><img width=3
  height=12 src="Humalo_files/image067.gif"></span></span></p>
  <p class=PPIBlockBody style='margin-left:1.25in'><span style='font-family:
  "Times New Roman",serif;color:black'>Example: 10 &frac12; (10.5) units shown
  in the Dose Window</span></p>
  </td>
 </tr>
</table>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; The
Pen will not let you dial more than the number of units left in the Pen.</span></p>

<p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; If
you need to inject more than the number of units left in the Pen, you may
either:</span></p>

<p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>&#8211;&nbsp;&nbsp;&nbsp; </span><span
style='font-family:"Times New Roman",serif'>inject the amount left in your Pen
and then use a new Pen to give the rest of your dose, <b>or</b></span></p>

<p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>&#8211;&nbsp;&nbsp;&nbsp; </span><span
style='font-family:"Times New Roman",serif'>get a new Pen and inject the full
dose.</span></p>

<p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; It
is normal to see a small amount of insulin left in the Pen that you can not inject.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIHeading1><span style='font-family:"Times New Roman",serif;
color:black'>Giving your injection</span></p>

<p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Inject
your insulin as your healthcare professional has shown you.</span></p>

<p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Change
(rotate) your injection site for each injection.</span></p>

<p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; <b>Do
not</b> try to change your dose while injecting.</span></p>

<p class=PPIBlockBody style='page-break-after:avoid'><span style='font-family:
"Times New Roman",serif'>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="87%"
 style='width:87.42%;margin-left:5.4pt;border-collapse:collapse;border:none'>
 <tr style='page-break-inside:avoid'>
  <td width="56%" colspan=2 valign=top style='width:56.14%;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIHeading2><span style='font-family:"Times New Roman",serif'>Step
  9:</span></p>
  <p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Choose
  your injection site.</span></p>
  <p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liprolog
  is injected under the skin (subcutaneously) of your stomach area, buttocks,
  upper legs or upper arms.</span></p>
  <p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Wipe
  your skin with a swab, and let your skin dry before you inject your dose.</span></p>
  <p class=PPIBulletedList1 style='margin-left:0in;text-indent:0in'><span
  style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
  <td width="43%" style='width:43.86%;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  lang=EN-GB style='font-family:"Times New Roman",serif'><img border=0
  width=162 height=150 id="Picture 11" src="Humalo_files/image093.jpg"></span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid;height:56.65pt'>
  <td width="56%" colspan=2 valign=top style='width:56.14%;border:none;
  padding:0in 5.4pt 0in 5.4pt;height:56.65pt'>
  <p class=PPIHeading2><span style='font-family:"Times New Roman",serif'>Step
  10:</span></p>
  <p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Insert
  the Needle into your skin.</span></p>
  <p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Push
  the Dose Knob all the way in.</span></p>
  </td>
  <td width="43%" rowspan=2 style='width:43.86%;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:56.65pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  lang=EN-GB style='font-family:"Times New Roman",serif'><img border=0
  width=226 height=125 id="Picture 15" src="Humalo_files/image094.jpg"></span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid;height:62.6pt'>
  <td width="41%" valign=top style='width:41.34%;border:none;border-bottom:
  solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:62.6pt'>
  <p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Continue
  to hold the Dose Knob in and <b>slowly count to 5 </b>before removing the
  Needle.</span></p>
  <p class=PPILabelingBodyText><b><span style='font-family:"Times New Roman",serif'>Do
  not</span></b><span style='font-family:"Times New Roman",serif'> try to
  inject your insulin by turning the Dose Knob. You will <b>NOT</b> receive
  your insulin by turning the Dose Knob.</span></p>
  </td>
  <td width="14%" valign=top style='width:14.8%;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:62.6pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  style='position:relative;z-index:251674624'><span style='left:0px;position:
  absolute;left:10px;top:-189944px;width:60px;height:4px'>
  <table cellpadding=0 cellspacing=0>
   <tr>
    <td width=60 height=4 style='vertical-align:top'><span style='position:
    absolute;left:0pt;z-index:251674624'>
    <table cellpadding=0 cellspacing=0 width="100%">
     <tr>
      <td>
      <div style='padding:0pt 0pt 0pt 0pt'>
      <p class=PPIBlockBody align=center style='text-align:center'><span
      style='font-size:9.0pt'>5sec</span></p>
      </div>
      </td>
     </tr>
    </table>
    </span>&nbsp;</td>
   </tr>
  </table>
  </span></span><span lang=EN-GB style='font-family:"Times New Roman",serif'><img
  border=0 width=55 height=62 id="Picture 20" src="Humalo_files/image095.jpg"
  alt=clock></span></p>
  </td>
 </tr>
 <tr height=0>
  <td width=256 style='border:none'></td>
  <td width=92 style='border:none'></td>
  <td width=271 style='border:none'></td>
 </tr>
</table>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='margin-left:5.4pt;border-collapse:collapse;border:none'>
 <tr style='page-break-inside:avoid;height:41.35pt'>
  <td width=360 valign=top style='width:3.75in;border:none;border-top:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:41.35pt'><span style='font-size:11.0pt;
  font-family:"Times New Roman",serif'><br clear=all style='page-break-before:
  always'>
  </span>
  <p class=PPIHeading2><span style='font-family:"Times New Roman",serif'>Step
  11:</span></p>
  <p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Pull
  the Needle out of your skin.</span></p>
  <p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>&#8211;&nbsp;&nbsp;&nbsp; A
  drop of insulin at the Needle tip is normal. It will not affect your dose.</span></p>
  <p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Check
  the number in the Dose Window</span></p>
  <p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>-&nbsp;&nbsp;&nbsp;&nbsp; If
  you see &#8220;0&#8221; in the Dose window, you have received the full amount
  you dialled.</span></p>
  <p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>-&nbsp;&nbsp;&nbsp;&nbsp; If
  you do not see &#8220;0&#8221; in the Dose window, you did not receive your
  full dose. <b>Do not</b> redial. Insert the needle into your skin and finish
  your injection.</span></p>
  <p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>-&nbsp;&nbsp;&nbsp;&nbsp; If
  you <b>still</b> do not think you received the full amount you dialled for
  your injection, <b>do not start over or repeat that injection</b>. Monitor
  your blood glucose and call your healthcare professional for further
  instructions.</span></p>
  <p class=PPILabelingBodyText><span style='font-family:"Times New Roman",serif'>The
  plunger only moves a little with each injection, and you may not notice that
  it moves.</span></p>
  <p class=PPILabelingBodyText><span style='font-family:"Times New Roman",serif'>If
  you see blood after you take the Needle out of your skin, press the injection
  site lightly with a piece of gauze or a swab. <b>Do not</b> rub the area.</span></p>
  <p class=PPILabelingBodyText><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
  <td width=283 valign=top style='width:212.05pt;border:none;border-top:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:41.35pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  lang=EN-GB style='font-family:"Times New Roman",serif'><img border=0
  width=144 height=106 id="Picture 16" src="Humalo_files/image096.jpg"></span></p>
  </td>
 </tr>
</table>

<p class=PPIBlockBody style='page-break-after:avoid'><span style='font-family:
"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIHeading1 style='page-break-after:avoid'><span style='font-family:
"Times New Roman",serif;color:black'>After your injection</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.4pt;border-collapse:collapse'>
 <tr style='page-break-inside:avoid'>
  <td width=360 valign=top style='width:3.75in;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIHeading2 style='page-break-after:avoid'><span style='font-family:
  "Times New Roman",serif'>Step 12:</span></p>
  <p class=PPIBulletedList1 style='page-break-after:avoid'><span
  style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Carefully
  replace the Outer Needle Shield.</span></p>
  </td>
  <td width=283 valign=top style='width:212.05pt;border:none;border-bottom:
  solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='margin-bottom:3.0pt;text-align:
  center;page-break-after:avoid'><span lang=EN-GB style='font-family:"Times New Roman",serif'><img
  border=0 width=156 height=143 id="Picture 59" src="Humalo_files/image097.jpg"></span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=360 valign=top style='width:3.75in;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIHeading2><span style='font-family:"Times New Roman",serif'>Step
  13:</span></p>
  <p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Unscrew
  the capped Needle and dispose of it as described below (see <b>Disposing of
  Pens and Needles</b> section).</span></p>
  <p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Do
  not store the Pen with the Needle attached to prevent leaking, blocking the
  Needle, and air from entering the Pen.</span></p>
  </td>
  <td width=283 style='width:212.05pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  lang=EN-GB style='font-family:"Times New Roman",serif'><img border=0
  width=162 height=143 id="Picture 60" src="Humalo_files/image098.jpg"></span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width=360 valign=top style='width:3.75in;border:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIHeading2><span style='font-family:"Times New Roman",serif'>Step
  14:</span></p>
  <p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Replace
  the Pen Cap by lining up the Cap Clip with the Dose Indicator and pushing
  straight on.</span></p>
  </td>
  <td width=283 valign=top style='width:212.05pt;border:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=PPIBlockBody align=center style='text-align:center'><span
  lang=EN-GB style='font-family:"Times New Roman",serif'><img border=0
  width=240 height=96 id="Picture 17" src="Humalo_files/image099.jpg"></span></p>
  </td>
 </tr>
</table>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIHeading1><span style='font-family:"Times New Roman",serif;
color:black'>Disposing of Pens and Needles</span></p>

<p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Put
used Needles in a sharps container or a hard plastic container with a secure
lid. <b>Do not</b> throw needles directly into your household waste.</span></p>

<p class=IFUBulletedBodyText><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; The
used Pen may be discarded in your household waste after you have removed the Needle.</span></p>

<p class=IFUBulletedBodyText><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; <b>Do
not</b> recycle the filled sharps container.</span></p>

<p class=IFUBulletedBodyText><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Ask
your healthcare professional about options to dispose of the sharps container
properly.</span></p>

<p class=IFUBulletedBodyText><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; The
directions regarding needle handling are not intended to replace local,
healthcare professional or institutional policies.</span></p>

<p class=PPIHeading1 style='page-break-after:avoid'><span style='font-family:
"Times New Roman",serif;color:black'>Storing your Pen</span></p>

<p class=PPIHeading2 style='page-break-after:avoid'><span style='font-family:
"Times New Roman",serif'>Unused Pens</span></p>

<p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Store
unused Pens in the refrigerator at (2&nbsp;&deg;C to 8&nbsp;&deg;C).</span></p>

<p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; <b>Do
not</b> freeze Liprolog. <b>Do not</b> use if it has been frozen.</span></p>

<p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Unused
Pens may be used until the expiration date printed on the Label, if the Pen has
been kept in the refrigerator.</span></p>

<p class=PPIHeading2><span style='font-family:"Times New Roman",serif'>In-use
Pen</span></p>

<p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Store
the Pen you are currently using at room temperature [up to (30&nbsp;&deg;C)]
and away from heat and light.</span></p>

<p class=PPIBulletedList1><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Throw
away the Pen you are using after 28 days, even if it still has insulin left in
it.</span></p>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIHeading1><span style='font-family:"Times New Roman",serif;
color:black'>General information about the safe and effective use of your Pen</span></p>

<p class=PPIBulletedList2><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; <b>Keep
your Pen and Needles out of the sight and reach of children.</b></span></p>

<p class=PPIBulletedList2><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; <b>Do
not</b> use your Pen if any part looks broken or damaged.</span></p>

<p class=PPIBulletedList2><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; Always
carry an extra Pen in case yours is lost or damaged.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=PPIBlockBody><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=PPIHeading1><span style='font-family:"Times New Roman",serif;
color:black'>Troubleshooting</span></p>

<p class=PPIBulletedList2><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; If
you can not remove the Pen Cap, gently twist the cap back and forth, and then
pull the cap straight off.</span></p>

<p class=PPIBulletedList2><span style='font-family:"Times New Roman",serif'>&#8226;&nbsp;&nbsp;&nbsp;&nbsp; If
the Dose Knob is hard to push:</span></p>

<p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>&#8211;&nbsp;&nbsp;&nbsp; P</span><span
style='font-family:"Times New Roman",serif'>ushing the Dose Knob more slowly
will make it easier to inject.</span></p>

<p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>&#8211;&nbsp;&nbsp;&nbsp; </span><span
style='font-family:"Times New Roman",serif'>Your Needle may be blocked. Put on
a new Needle and prime the Pen.</span></p>

<p class=PPIBulletedList3><span style='font-family:"Times New Roman",serif'>&#8211;&nbsp;&nbsp;&nbsp; </span><span
style='font-family:"Times New Roman",serif'>You may have dust, food, or liquid
inside the Pen. Throw the Pen away and get a new Pen.</span></p>

<p class=PPILabelingBodyText><span style='font-family:"Times New Roman",serif'>If
you have any questions or problems with your Liprolog 100&nbsp;units/ml Junior
KwikPen, call your healthcare professional for help or contact your local Lilly
affiliate.</span><span style='color:black'> </span></p>

<p class=MsoNormal style='margin-top:6.0pt;text-autospace:none'><span
lang=EN-GB style='color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Document revision date: </span></p>

<p class=MsoNormal><b><i><span lang=EN-GB>&nbsp;</span></i></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoHeading7 style='margin-top:6.0pt'><span lang=EN-GB>&nbsp;</span></p>

</div>

</body>

</html>
